Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-04-01
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| AC239799.2 | 4.914675 |
| AP001160.1 | 4.881553 |
| TEX14 | 4.844716 |
| SLC9A3R1 | -4.718422 |
| AC079753.2 | 4.678102 |
| TMEM107 | 4.424086 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 15548 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 11512 |
| num_profile_genes_not_in_sets | 4036 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4524 |
| num_genesets_included | 5937 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 5 | 0.000582 | -0.888 | 0.1160 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 6 | 0.000444 | 0.828 | 0.1030 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 5 | 0.001980 | 0.799 | 0.1930 |
| GOCC HEMOGLOBIN COMPLEX | 5 | 0.002470 | -0.782 | 0.2050 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 0.004050 | -0.742 | 0.2430 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 0.004500 | 0.734 | 0.2470 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 0.000407 | 0.722 | 0.0978 |
| GOCC GID COMPLEX | 5 | 0.005480 | -0.717 | 0.2570 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 0.006860 | 0.698 | 0.2830 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 0.008160 | 0.683 | 0.2950 |
| GOCC SORTING ENDOSOME | 5 | 0.008860 | 0.676 | 0.3030 |
| GOCC CILIARY TRANSITION FIBER | 7 | 0.001990 | 0.675 | 0.1930 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 0.004210 | -0.675 | 0.2470 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 0.009050 | 0.674 | 0.3070 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 0.004280 | 0.673 | 0.2470 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 0.009700 | -0.668 | 0.3200 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 0.009700 | -0.668 | 0.3200 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 0.009830 | -0.667 | 0.3210 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 0.010400 | 0.662 | 0.3300 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 5 | 0.010500 | -0.661 | 0.3320 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 0.000305 | 0.659 | 0.0976 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 0.011100 | 0.655 | 0.3380 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 0.011500 | 0.653 | 0.3430 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 0.002830 | 0.652 | 0.2070 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 0.005700 | 0.652 | 0.2620 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 0.000204 | 0.647 | 0.0976 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 5 | 0.012300 | 0.647 | 0.3560 |
| GOBP CARBON DIOXIDE TRANSPORT | 5 | 0.013200 | -0.640 | 0.3720 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 0.001860 | -0.635 | 0.1930 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 5 | 0.014900 | -0.629 | 0.3740 |
| GOCC CALCINEURIN COMPLEX | 5 | 0.016000 | 0.622 | 0.3760 |
| GOCC DENDRITIC SPINE HEAD | 5 | 0.016200 | 0.621 | 0.3780 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 0.016300 | 0.620 | 0.3790 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 0.004600 | 0.618 | 0.2470 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 8 | 0.002550 | 0.616 | 0.2050 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 0.001400 | -0.615 | 0.1910 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 0.004860 | 0.615 | 0.2500 |
| GOBP HEART VALVE FORMATION | 5 | 0.017900 | -0.611 | 0.3890 |
| GOMF DNA DNA ANNEALING ACTIVITY | 6 | 0.009630 | 0.610 | 0.3200 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 0.018800 | -0.607 | 0.3890 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 5 | 0.019100 | 0.605 | 0.3950 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 0.011100 | 0.598 | 0.3380 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 0.003590 | -0.595 | 0.2250 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 7 | 0.006460 | 0.594 | 0.2750 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 0.021700 | -0.593 | 0.4170 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 0.022400 | -0.590 | 0.4180 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 0.022500 | -0.589 | 0.4180 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 0.023000 | 0.587 | 0.4210 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 5 | 0.023100 | -0.586 | 0.4220 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 0.013300 | 0.584 | 0.3720 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX | 5 | 5.82e-04 | -8.88e-01 | 0.11600 |
| GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION | 6 | 4.44e-04 | 8.28e-01 | 0.10300 |
| GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT | 5 | 1.98e-03 | 7.99e-01 | 0.19300 |
| GOCC HEMOGLOBIN COMPLEX | 5 | 2.47e-03 | -7.82e-01 | 0.20500 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 4.05e-03 | -7.42e-01 | 0.24300 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 4.50e-03 | 7.34e-01 | 0.24700 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 4.07e-04 | 7.22e-01 | 0.09780 |
| GOCC GID COMPLEX | 5 | 5.48e-03 | -7.17e-01 | 0.25700 |
| GOMF ALPHA GLUCOSIDASE ACTIVITY | 5 | 6.86e-03 | 6.98e-01 | 0.28300 |
| GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 5 | 8.16e-03 | 6.83e-01 | 0.29500 |
| GOCC SORTING ENDOSOME | 5 | 8.86e-03 | 6.76e-01 | 0.30300 |
| GOCC CILIARY TRANSITION FIBER | 7 | 1.99e-03 | 6.75e-01 | 0.19300 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 4.21e-03 | -6.75e-01 | 0.24700 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 9.05e-03 | 6.74e-01 | 0.30700 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 4.28e-03 | 6.73e-01 | 0.24700 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 9.70e-03 | -6.68e-01 | 0.32000 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 9.70e-03 | -6.68e-01 | 0.32000 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 9.83e-03 | -6.67e-01 | 0.32100 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 1.04e-02 | 6.62e-01 | 0.33000 |
| GOBP TRACHEA CARTILAGE DEVELOPMENT | 5 | 1.05e-02 | -6.61e-01 | 0.33200 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 3.05e-04 | 6.59e-01 | 0.09760 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 1.11e-02 | 6.55e-01 | 0.33800 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 1.15e-02 | 6.53e-01 | 0.34300 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 2.83e-03 | 6.52e-01 | 0.20700 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.70e-03 | 6.52e-01 | 0.26200 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.04e-04 | 6.47e-01 | 0.09760 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 5 | 1.23e-02 | 6.47e-01 | 0.35600 |
| GOBP CARBON DIOXIDE TRANSPORT | 5 | 1.32e-02 | -6.40e-01 | 0.37200 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 1.86e-03 | -6.35e-01 | 0.19300 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 5 | 1.49e-02 | -6.29e-01 | 0.37400 |
| GOCC CALCINEURIN COMPLEX | 5 | 1.60e-02 | 6.22e-01 | 0.37600 |
| GOCC DENDRITIC SPINE HEAD | 5 | 1.62e-02 | 6.21e-01 | 0.37800 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 1.63e-02 | 6.20e-01 | 0.37900 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 4.60e-03 | 6.18e-01 | 0.24700 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 8 | 2.55e-03 | 6.16e-01 | 0.20500 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 1.40e-03 | -6.15e-01 | 0.19100 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.86e-03 | 6.15e-01 | 0.25000 |
| GOBP HEART VALVE FORMATION | 5 | 1.79e-02 | -6.11e-01 | 0.38900 |
| GOMF DNA DNA ANNEALING ACTIVITY | 6 | 9.63e-03 | 6.10e-01 | 0.32000 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 1.88e-02 | -6.07e-01 | 0.38900 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 5 | 1.91e-02 | 6.05e-01 | 0.39500 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 1.11e-02 | 5.98e-01 | 0.33800 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 3.59e-03 | -5.95e-01 | 0.22500 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 7 | 6.46e-03 | 5.94e-01 | 0.27500 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 2.17e-02 | -5.93e-01 | 0.41700 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 2.24e-02 | -5.90e-01 | 0.41800 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 2.25e-02 | -5.89e-01 | 0.41800 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 2.30e-02 | 5.87e-01 | 0.42100 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 5 | 2.31e-02 | -5.86e-01 | 0.42200 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 1.33e-02 | 5.84e-01 | 0.37200 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 1.47e-03 | 5.81e-01 | 0.19100 |
| GOBP RESPONSE TO TYPE III INTERFERON | 6 | 1.39e-02 | -5.80e-01 | 0.37200 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 1.41e-02 | -5.79e-01 | 0.37200 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 5 | 2.53e-02 | 5.78e-01 | 0.43200 |
| GOBP PARTURITION | 7 | 8.29e-03 | 5.76e-01 | 0.29500 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 1.48e-02 | -5.75e-01 | 0.37400 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.69e-03 | 5.73e-01 | 0.19300 |
| GOCC BOX C D RNP COMPLEX | 5 | 2.69e-02 | 5.72e-01 | 0.44200 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 6 | 1.61e-02 | 5.67e-01 | 0.37700 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 1.64e-02 | 5.66e-01 | 0.37900 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 6 | 1.68e-02 | 5.64e-01 | 0.37900 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 5 | 2.94e-02 | 5.63e-01 | 0.46000 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 2.95e-02 | -5.62e-01 | 0.46100 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 5 | 3.03e-02 | 5.59e-01 | 0.47000 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 1.80e-02 | 5.58e-01 | 0.38900 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 3.10e-02 | 5.57e-01 | 0.47200 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 2.30e-03 | 5.57e-01 | 0.20500 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 1.10e-02 | 5.55e-01 | 0.33500 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 3.26e-02 | -5.52e-01 | 0.47800 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 3.28e-02 | 5.51e-01 | 0.47800 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 13 | 6.18e-04 | 5.48e-01 | 0.11600 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 9 | 4.62e-03 | 5.45e-01 | 0.24700 |
| GOBP REGULATION OF HYPERSENSITIVITY | 9 | 4.63e-03 | 5.45e-01 | 0.24700 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 7 | 1.27e-02 | -5.44e-01 | 0.36200 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 7 | 1.29e-02 | 5.43e-01 | 0.36600 |
| GOBP FAT PAD DEVELOPMENT | 8 | 7.91e-03 | -5.42e-01 | 0.29400 |
| GOMF TAP BINDING | 7 | 1.33e-02 | 5.40e-01 | 0.37200 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 5.18e-03 | -5.38e-01 | 0.25400 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 3.73e-02 | 5.38e-01 | 0.48200 |
| GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 5 | 3.90e-02 | -5.33e-01 | 0.48800 |
| GOBP INSULIN METABOLIC PROCESS | 9 | 5.65e-03 | -5.33e-01 | 0.26200 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 6 | 2.39e-02 | -5.32e-01 | 0.42600 |
| GOMF INTERMEDIATE FILAMENT BINDING | 5 | 4.02e-02 | 5.30e-01 | 0.49100 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 5 | 4.03e-02 | -5.30e-01 | 0.49100 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 12 | 1.57e-03 | -5.27e-01 | 0.19300 |
| GOBP NEURAL FOLD FORMATION | 5 | 4.15e-02 | -5.27e-01 | 0.49700 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 4.28e-02 | 5.23e-01 | 0.50000 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 1.04e-02 | 5.23e-01 | 0.33100 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 4.48e-02 | 5.18e-01 | 0.50300 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 7 | 1.83e-02 | 5.15e-01 | 0.38900 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 1.83e-02 | 5.15e-01 | 0.38900 |
| GOCC BBAF COMPLEX | 9 | 7.73e-03 | 5.13e-01 | 0.29400 |
| GOMF ISOPRENOID BINDING | 9 | 7.75e-03 | -5.13e-01 | 0.29400 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 9 | 8.12e-03 | 5.10e-01 | 0.29500 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 3.10e-02 | -5.09e-01 | 0.47200 |
| GOCC NUCLEAR LAMINA | 12 | 2.41e-03 | 5.06e-01 | 0.20500 |
| GOBP RESPONSE TO ZINC ION STARVATION | 6 | 3.20e-02 | 5.06e-01 | 0.47800 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 5 | 5.03e-02 | 5.06e-01 | 0.52000 |
| GOBP SNORNA LOCALIZATION | 6 | 3.22e-02 | 5.05e-01 | 0.47800 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 6 | 3.24e-02 | -5.04e-01 | 0.47800 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 7 | 2.10e-02 | -5.04e-01 | 0.41200 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 6 | 3.29e-02 | 5.03e-01 | 0.47800 |
| GOBP L SERINE TRANSPORT | 6 | 3.30e-02 | 5.03e-01 | 0.47800 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.30e-02 | 5.03e-01 | 0.47800 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 6 | 3.33e-02 | 5.02e-01 | 0.47800 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 7 | 2.16e-02 | 5.02e-01 | 0.41700 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 10 | 6.06e-03 | -5.01e-01 | 0.27000 |
| GOBP ADULT HEART DEVELOPMENT | 5 | 5.24e-02 | -5.01e-01 | 0.52500 |
| GOCC NEUROFILAMENT | 5 | 5.30e-02 | 5.00e-01 | 0.52700 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 5.30e-02 | -5.00e-01 | 0.52700 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 15 | 8.16e-04 | 4.99e-01 | 0.13200 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 5.34e-02 | 4.99e-01 | 0.52800 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 5.44e-02 | 4.97e-01 | 0.53000 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 8 | 1.51e-02 | -4.96e-01 | 0.37400 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 5.61e-02 | 4.93e-01 | 0.53600 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 13 | 2.08e-03 | -4.93e-01 | 0.19300 |
| GOBP DETECTION OF CALCIUM ION | 12 | 3.11e-03 | 4.93e-01 | 0.21300 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 3.67e-02 | -4.92e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 5.75e-02 | -4.90e-01 | 0.53800 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 7.41e-03 | 4.89e-01 | 0.29300 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 5 | 5.91e-02 | 4.87e-01 | 0.53800 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 1.70e-02 | -4.87e-01 | 0.37900 |
| GOCC SODIUM CHANNEL COMPLEX | 9 | 1.14e-02 | -4.87e-01 | 0.34300 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 12 | 3.56e-03 | 4.86e-01 | 0.22500 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 7.87e-03 | -4.85e-01 | 0.29400 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 5 | 6.02e-02 | 4.85e-01 | 0.54400 |
| GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 6.05e-02 | 4.85e-01 | 0.54500 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 6.17e-02 | 4.83e-01 | 0.54900 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 2.60e-03 | -4.82e-01 | 0.20500 |
| GOMF BH DOMAIN BINDING | 8 | 1.82e-02 | -4.82e-01 | 0.38900 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 8.29e-03 | 4.82e-01 | 0.29500 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 6.20e-02 | -4.82e-01 | 0.54900 |
| GOMF TASTE RECEPTOR ACTIVITY | 6 | 4.15e-02 | -4.81e-01 | 0.49700 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 8 | 1.87e-02 | 4.80e-01 | 0.38900 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 6 | 4.23e-02 | 4.79e-01 | 0.49900 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 10 | 8.88e-03 | -4.78e-01 | 0.30300 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 7 | 2.89e-02 | -4.77e-01 | 0.45700 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 6 | 4.32e-02 | 4.77e-01 | 0.50100 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 6.51e-02 | -4.76e-01 | 0.56000 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 1.33e-02 | -4.76e-01 | 0.37200 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 6.51e-02 | -4.76e-01 | 0.56000 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 4.35e-03 | 4.75e-01 | 0.24700 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 4.39e-02 | 4.75e-01 | 0.50200 |
| GOCC NUCLEAR ENVELOPE LUMEN | 8 | 2.00e-02 | -4.75e-01 | 0.40200 |
| GOBP XMP METABOLIC PROCESS | 7 | 2.98e-02 | 4.74e-01 | 0.46300 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 13 | 3.19e-03 | 4.72e-01 | 0.21700 |
| GOMF U3 SNORNA BINDING | 10 | 1.02e-02 | 4.69e-01 | 0.32900 |
| GOBP OXALATE TRANSPORT | 7 | 3.25e-02 | -4.67e-01 | 0.47800 |
| GOBP HYPERSENSITIVITY | 13 | 3.57e-03 | 4.67e-01 | 0.22500 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 6 | 4.80e-02 | 4.66e-01 | 0.51100 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 7.12e-02 | -4.66e-01 | 0.57700 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 1.08e-02 | -4.66e-01 | 0.33500 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 7.17e-02 | 4.65e-01 | 0.57900 |
| GOBP ORNITHINE METABOLIC PROCESS | 6 | 4.87e-02 | -4.65e-01 | 0.51200 |
| GOBP ERBB2 ERBB4 SIGNALING PATHWAY | 5 | 7.23e-02 | 4.64e-01 | 0.57900 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 6 | 4.91e-02 | 4.64e-01 | 0.51300 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 7.27e-02 | 4.64e-01 | 0.57900 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 14 | 2.68e-03 | -4.63e-01 | 0.20700 |
| GOBP GLYCINE TRANSPORT | 5 | 7.31e-02 | 4.63e-01 | 0.58000 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 2.34e-02 | 4.63e-01 | 0.42300 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 2.34e-02 | -4.63e-01 | 0.42300 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 7.32e-02 | -4.63e-01 | 0.58000 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 2.38e-02 | -4.61e-01 | 0.42500 |
| GOCC BRAHMA COMPLEX | 12 | 5.68e-03 | 4.61e-01 | 0.26200 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 8.14e-03 | 4.61e-01 | 0.29500 |
| GOBP MAST CELL CHEMOTAXIS | 6 | 5.07e-02 | -4.61e-01 | 0.52200 |
| GOBP GLUTAMINE TRANSPORT | 7 | 3.49e-02 | 4.61e-01 | 0.48200 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.49e-02 | 4.61e-01 | 0.48200 |
| GOCC DYNACTIN COMPLEX | 8 | 2.42e-02 | -4.60e-01 | 0.42800 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.68e-02 | -4.60e-01 | 0.37900 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 3.52e-02 | 4.60e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 5.14e-02 | 4.59e-01 | 0.52400 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 6 | 5.16e-02 | -4.59e-01 | 0.52400 |
| GOMF RS DOMAIN BINDING | 5 | 7.58e-02 | -4.59e-01 | 0.58300 |
| GOBP GLYCINE METABOLIC PROCESS | 8 | 2.47e-02 | 4.59e-01 | 0.43100 |
| GOBP BONE MARROW DEVELOPMENT | 7 | 3.57e-02 | 4.58e-01 | 0.48200 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 3.60e-02 | 4.58e-01 | 0.48200 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 9 | 1.75e-02 | -4.57e-01 | 0.38400 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 7.70e-02 | 4.57e-01 | 0.58600 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 5 | 7.82e-02 | -4.55e-01 | 0.58900 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 6 | 5.41e-02 | 4.54e-01 | 0.52900 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 7.90e-02 | 4.54e-01 | 0.59200 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 7.93e-02 | -4.53e-01 | 0.59300 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 7.95e-02 | 4.53e-01 | 0.59300 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 5.49e-02 | 4.53e-01 | 0.53100 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 1.33e-02 | 4.52e-01 | 0.37200 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 5.53e-02 | 4.52e-01 | 0.53100 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 6 | 5.65e-02 | -4.50e-01 | 0.53600 |
| GOBP RENAL WATER HOMEOSTASIS | 8 | 2.78e-02 | 4.49e-01 | 0.44900 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 9 | 1.97e-02 | 4.49e-01 | 0.40100 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 5.70e-02 | 4.49e-01 | 0.53600 |
| GOCC NBAF COMPLEX | 13 | 5.14e-03 | 4.48e-01 | 0.25400 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 5 | 8.29e-02 | 4.48e-01 | 0.60000 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 8.33e-02 | -4.47e-01 | 0.60000 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 5.78e-02 | 4.47e-01 | 0.53800 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 8.33e-02 | 4.47e-01 | 0.60000 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 8 | 2.86e-02 | -4.47e-01 | 0.45600 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 10 | 1.44e-02 | 4.47e-01 | 0.37200 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 1.45e-03 | 4.46e-01 | 0.19100 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 6 | 5.91e-02 | 4.45e-01 | 0.53800 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 1.55e-03 | 4.43e-01 | 0.19300 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 11 | 1.10e-02 | 4.43e-01 | 0.33500 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 8 | 3.03e-02 | -4.42e-01 | 0.47000 |
| GOMF BH3 DOMAIN BINDING | 6 | 6.11e-02 | -4.41e-01 | 0.54800 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 2.22e-02 | -4.40e-01 | 0.41800 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 14 | 4.37e-03 | -4.40e-01 | 0.24700 |
| GOCC PRE SNORNP COMPLEX | 7 | 4.39e-02 | 4.40e-01 | 0.50200 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 8.91e-02 | 4.39e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION | 6 | 6.27e-02 | 4.39e-01 | 0.55200 |
| GOMF KINETOCHORE BINDING | 5 | 8.98e-02 | -4.38e-01 | 0.61300 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.20e-02 | 4.38e-01 | 0.47800 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 6 | 6.34e-02 | -4.38e-01 | 0.55400 |
| GOBP MALATE METABOLIC PROCESS | 7 | 4.51e-02 | 4.37e-01 | 0.50300 |
| GOBP IODIDE TRANSPORT | 5 | 9.04e-02 | -4.37e-01 | 0.61300 |
| GOCC PLATELET DENSE GRANULE LUMEN | 5 | 9.15e-02 | 4.36e-01 | 0.61300 |
| GOCC INNER KINETOCHORE | 15 | 3.49e-03 | 4.36e-01 | 0.22500 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 3.32e-02 | 4.35e-01 | 0.47800 |
| GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION | 6 | 6.51e-02 | -4.35e-01 | 0.56000 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 9.24e-02 | 4.35e-01 | 0.61300 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 2.43e-02 | -4.33e-01 | 0.42900 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 4.72e-02 | -4.33e-01 | 0.50900 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 9.35e-02 | -4.33e-01 | 0.61500 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 5 | 9.38e-02 | -4.33e-01 | 0.61500 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 6.67e-02 | 4.32e-01 | 0.56700 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 10 | 1.80e-02 | -4.32e-01 | 0.38900 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 8 | 3.44e-02 | -4.32e-01 | 0.48200 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 4.91e-02 | -4.30e-01 | 0.51300 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 3.55e-02 | -4.29e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 6.86e-02 | -4.29e-01 | 0.57300 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 5 | 9.64e-02 | 4.29e-01 | 0.62200 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 9.66e-02 | -4.29e-01 | 0.62200 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 4.07e-03 | 4.28e-01 | 0.24300 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 2.61e-02 | 4.28e-01 | 0.43500 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 6.94e-02 | -4.28e-01 | 0.57400 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 9.74e-02 | 4.28e-01 | 0.62300 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 7 | 5.00e-02 | -4.28e-01 | 0.51700 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 7.61e-03 | -4.28e-01 | 0.29400 |
| GOCC EKC KEOPS COMPLEX | 5 | 9.82e-02 | 4.27e-01 | 0.62400 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 3.65e-02 | 4.27e-01 | 0.48200 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 9 | 2.68e-02 | 4.26e-01 | 0.44200 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 6 | 7.11e-02 | -4.25e-01 | 0.57700 |
| GOBP MECHANOSENSORY BEHAVIOR | 5 | 9.96e-02 | -4.25e-01 | 0.62400 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 5.14e-02 | -4.25e-01 | 0.52400 |
| GOBP RESPONSE TO AMINE | 25 | 2.36e-04 | 4.25e-01 | 0.09760 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 7.17e-02 | 4.25e-01 | 0.57900 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 8 | 3.76e-02 | 4.24e-01 | 0.48200 |
| GOMF GALACTOSIDE BINDING | 5 | 1.01e-01 | 4.24e-01 | 0.62600 |
| GOBP PROTEIN POLYGLUTAMYLATION | 9 | 2.77e-02 | 4.24e-01 | 0.44900 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 7.26e-02 | 4.23e-01 | 0.57900 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 7.27e-02 | -4.23e-01 | 0.57900 |
| GOBP PROTEIN TRIMERIZATION | 11 | 1.53e-02 | 4.22e-01 | 0.37400 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 8 | 3.86e-02 | -4.22e-01 | 0.48700 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 5 | 1.02e-01 | -4.22e-01 | 0.62800 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 1.02e-01 | -4.22e-01 | 0.62800 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 1.54e-02 | 4.22e-01 | 0.37400 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 6 | 7.35e-02 | -4.22e-01 | 0.58000 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 2.88e-02 | 4.21e-01 | 0.45700 |
| GOCC CHROMOCENTER | 11 | 1.58e-02 | 4.20e-01 | 0.37600 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 10 | 2.17e-02 | 4.19e-01 | 0.41700 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 5.52e-02 | 4.19e-01 | 0.53100 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 2.82e-03 | -4.18e-01 | 0.20700 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 7.64e-02 | 4.18e-01 | 0.58500 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 1.06e-01 | 4.17e-01 | 0.63500 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 6 | 7.68e-02 | -4.17e-01 | 0.58600 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 5.61e-02 | 4.17e-01 | 0.53600 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 5.61e-02 | 4.17e-01 | 0.53600 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 8 | 4.12e-02 | -4.17e-01 | 0.49700 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 2.25e-02 | 4.17e-01 | 0.41800 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 5.64e-02 | -4.17e-01 | 0.53600 |
| GOBP REGULATION OF T CIRCLE FORMATION | 6 | 7.74e-02 | 4.16e-01 | 0.58600 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 1.07e-01 | -4.16e-01 | 0.63600 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 5.67e-02 | 4.16e-01 | 0.53600 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 5.73e-02 | -4.15e-01 | 0.53700 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 7.70e-04 | 4.14e-01 | 0.13000 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.09e-01 | 4.14e-01 | 0.63900 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 8 | 4.28e-02 | -4.14e-01 | 0.50000 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 1.10e-01 | -4.13e-01 | 0.63900 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 2.37e-02 | 4.13e-01 | 0.42500 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 5.85e-02 | 4.13e-01 | 0.53800 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 6 | 8.01e-02 | 4.13e-01 | 0.59500 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 5.90e-02 | -4.12e-01 | 0.53800 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 8.04e-02 | -4.12e-01 | 0.59600 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 19 | 1.88e-03 | 4.12e-01 | 0.19300 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 9 | 3.28e-02 | -4.11e-01 | 0.47800 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 6.02e-02 | -4.10e-01 | 0.54400 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 8.20e-02 | 4.10e-01 | 0.59900 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 7 | 6.05e-02 | 4.10e-01 | 0.54500 |
| GOCC MHC PROTEIN COMPLEX | 23 | 6.75e-04 | 4.10e-01 | 0.12200 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 4.50e-02 | -4.09e-01 | 0.50300 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 5 | 1.14e-01 | -4.08e-01 | 0.65000 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 8 | 4.55e-02 | 4.08e-01 | 0.50400 |
| GOBP BLOOD COAGULATION INTRINSIC PATHWAY | 6 | 8.32e-02 | -4.08e-01 | 0.60000 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 7 | 6.17e-02 | 4.08e-01 | 0.54900 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 1.10e-02 | -4.07e-01 | 0.33500 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 9 | 3.43e-02 | 4.07e-01 | 0.48200 |
| GOBP REGULATION OF ODONTOGENESIS | 5 | 1.15e-01 | -4.07e-01 | 0.65200 |
| GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 5 | 1.15e-01 | -4.07e-01 | 0.65200 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 2.59e-02 | 4.07e-01 | 0.43400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 4.63e-02 | 4.07e-01 | 0.50700 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 4.68e-02 | -4.06e-01 | 0.50700 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 8.54e-02 | 4.06e-01 | 0.60400 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 1.17e-01 | 4.05e-01 | 0.65800 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 3.92e-03 | -4.04e-01 | 0.24000 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 8.73e-02 | -4.03e-01 | 0.61200 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 18 | 3.08e-03 | -4.03e-01 | 0.21300 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 4.91e-02 | 4.02e-01 | 0.51300 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 1.20e-01 | -4.01e-01 | 0.66400 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 3.72e-02 | -4.01e-01 | 0.48200 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 10 | 2.86e-02 | 4.00e-01 | 0.45600 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 3.80e-02 | 3.99e-01 | 0.48400 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 6 | 9.06e-02 | 3.99e-01 | 0.61300 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 9.08e-02 | 3.99e-01 | 0.61300 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 9.08e-02 | 3.99e-01 | 0.61300 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 1.69e-02 | 3.98e-01 | 0.37900 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 1.23e-01 | 3.98e-01 | 0.66900 |
| GOBP METANEPHRIC TUBULE MORPHOGENESIS | 5 | 1.23e-01 | 3.98e-01 | 0.67000 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 11 | 2.24e-02 | 3.98e-01 | 0.41800 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 9.17e-02 | -3.98e-01 | 0.61300 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 5 | 1.24e-01 | 3.97e-01 | 0.67200 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 17 | 4.63e-03 | 3.97e-01 | 0.24700 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 5 | 1.25e-01 | 3.97e-01 | 0.67200 |
| GOMF IGG BINDING | 6 | 9.26e-02 | 3.96e-01 | 0.61300 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 11 | 2.29e-02 | -3.96e-01 | 0.42100 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 1.25e-01 | 3.96e-01 | 0.67200 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 6 | 9.35e-02 | -3.95e-01 | 0.61500 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 9.37e-02 | 3.95e-01 | 0.61500 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 5.30e-02 | 3.95e-01 | 0.52700 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 13 | 1.37e-02 | -3.95e-01 | 0.37200 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 3.08e-02 | -3.94e-01 | 0.47200 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 5.37e-02 | -3.94e-01 | 0.52800 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 8 | 5.40e-02 | 3.93e-01 | 0.52900 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 13 | 1.41e-02 | -3.93e-01 | 0.37200 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 9.54e-02 | 3.93e-01 | 0.62000 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 14 | 1.09e-02 | 3.93e-01 | 0.33500 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 1.29e-01 | -3.92e-01 | 0.67500 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 12 | 1.87e-02 | 3.92e-01 | 0.38900 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 8 | 5.50e-02 | 3.92e-01 | 0.53100 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.66e-02 | -3.92e-01 | 0.62200 |
| GOBP LEUKOTRIENE SIGNALING PATHWAY | 5 | 1.30e-01 | 3.91e-01 | 0.67600 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 2.49e-02 | -3.91e-01 | 0.43100 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 12 | 1.92e-02 | 3.90e-01 | 0.39500 |
| GOBP CENTRAL NERVOUS SYSTEM MATURATION | 5 | 1.31e-01 | 3.90e-01 | 0.67600 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 9.81e-02 | 3.90e-01 | 0.62400 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 9.83e-02 | -3.90e-01 | 0.62400 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 4.29e-02 | -3.90e-01 | 0.50100 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.43e-02 | -3.90e-01 | 0.58100 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 1.32e-01 | -3.89e-01 | 0.67600 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 20 | 2.59e-03 | -3.89e-01 | 0.20500 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 1.17e-02 | 3.89e-01 | 0.34600 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 9 | 4.33e-02 | 3.89e-01 | 0.50100 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 24 | 9.72e-04 | 3.89e-01 | 0.15300 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 3.32e-02 | 3.89e-01 | 0.47800 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 1.52e-02 | 3.89e-01 | 0.37400 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 9.94e-02 | -3.88e-01 | 0.62400 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 9.97e-02 | -3.88e-01 | 0.62400 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 7 | 7.54e-02 | 3.88e-01 | 0.58300 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 12 | 2.01e-02 | 3.87e-01 | 0.40200 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 9 | 4.44e-02 | 3.87e-01 | 0.50300 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 6 | 1.01e-01 | -3.87e-01 | 0.62600 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 1.35e-01 | 3.86e-01 | 0.67900 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 7.67e-02 | 3.86e-01 | 0.58600 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 5.87e-02 | 3.86e-01 | 0.53800 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 13 | 1.60e-02 | -3.86e-01 | 0.37700 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 3.48e-02 | 3.85e-01 | 0.48200 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 1.02e-01 | 3.85e-01 | 0.62900 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 4.58e-02 | 3.85e-01 | 0.50600 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 1.37e-01 | 3.84e-01 | 0.68000 |
| GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING | 5 | 1.37e-01 | -3.84e-01 | 0.68000 |
| GOMF HYALURONIC ACID BINDING | 12 | 2.13e-02 | 3.84e-01 | 0.41500 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 1.37e-01 | 3.84e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 6 | 1.04e-01 | 3.84e-01 | 0.63300 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 1.38e-01 | 3.83e-01 | 0.68000 |
| GOBP NEGATIVE T CELL SELECTION | 8 | 6.07e-02 | 3.83e-01 | 0.54500 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 21 | 2.38e-03 | 3.83e-01 | 0.20500 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 10 | 3.63e-02 | 3.82e-01 | 0.48200 |
| GOMF OXYGEN CARRIER ACTIVITY | 6 | 1.05e-01 | -3.82e-01 | 0.63500 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 1.70e-02 | -3.82e-01 | 0.37900 |
| GOBP GASTRIC ACID SECRETION | 6 | 1.05e-01 | 3.82e-01 | 0.63500 |
| GOBP IMMATURE T CELL PROLIFERATION | 8 | 6.15e-02 | 3.82e-01 | 0.54900 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 1.06e-01 | 3.81e-01 | 0.63500 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 11 | 2.85e-02 | 3.81e-01 | 0.45600 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 1.06e-01 | 3.81e-01 | 0.63500 |
| GOMF GLUCOSIDASE ACTIVITY | 9 | 4.79e-02 | 3.81e-01 | 0.51100 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 3.71e-02 | 3.81e-01 | 0.48200 |
| GOBP DNA PROTECTION | 5 | 1.40e-01 | 3.81e-01 | 0.68500 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 7 | 8.13e-02 | -3.81e-01 | 0.59900 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 7 | 8.16e-02 | 3.80e-01 | 0.59900 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 1.41e-01 | 3.80e-01 | 0.68500 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 8.21e-02 | -3.79e-01 | 0.59900 |
| GOCC SMAD PROTEIN COMPLEX | 7 | 8.23e-02 | -3.79e-01 | 0.60000 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 1.42e-01 | -3.79e-01 | 0.68500 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 8.24e-02 | -3.79e-01 | 0.60000 |
| GOCC CELL POLE | 5 | 1.43e-01 | -3.79e-01 | 0.68500 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 6.40e-02 | 3.78e-01 | 0.55700 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 3.87e-02 | 3.78e-01 | 0.48700 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 1.09e-01 | 3.78e-01 | 0.63900 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 1.44e-01 | -3.77e-01 | 0.68500 |
| GOBP COBALT ION TRANSPORT | 6 | 1.10e-01 | -3.77e-01 | 0.63900 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 1.10e-01 | 3.77e-01 | 0.63900 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 1.10e-01 | -3.77e-01 | 0.63900 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 9 | 5.05e-02 | 3.76e-01 | 0.52100 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 6.55e-02 | 3.76e-01 | 0.56200 |
| GOCC GAP JUNCTION | 6 | 1.11e-01 | 3.76e-01 | 0.64200 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 1.11e-01 | -3.76e-01 | 0.64300 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 7 | 8.53e-02 | 3.76e-01 | 0.60400 |
| GOBP TRANS SYNAPTIC SIGNALING BY LIPID | 5 | 1.46e-01 | -3.75e-01 | 0.68600 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 6.62e-02 | -3.75e-01 | 0.56500 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 1.47e-01 | -3.75e-01 | 0.68700 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 9 | 5.19e-02 | -3.74e-01 | 0.52400 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 6.75e-02 | 3.73e-01 | 0.57100 |
| GOBP DNA INTEGRATION | 6 | 1.14e-01 | 3.72e-01 | 0.65100 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 3.25e-02 | 3.72e-01 | 0.47800 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 1.14e-01 | -3.72e-01 | 0.65100 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 13 | 2.02e-02 | -3.72e-01 | 0.40200 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 1.50e-01 | 3.72e-01 | 0.69000 |
| GOCC TRANSLOCON COMPLEX | 6 | 1.15e-01 | -3.71e-01 | 0.65200 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 8.89e-02 | 3.71e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 1.15e-01 | 3.71e-01 | 0.65400 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 5 | 1.51e-01 | 3.71e-01 | 0.69000 |
| GOMF WD40 REPEAT DOMAIN BINDING | 5 | 1.52e-01 | -3.70e-01 | 0.69000 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 1.52e-01 | -3.70e-01 | 0.69000 |
| GOCC LAMIN FILAMENT | 5 | 1.52e-01 | 3.70e-01 | 0.69000 |
| GOBP RESPONSE TO AMPHETAMINE | 17 | 8.34e-03 | 3.70e-01 | 0.29500 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 9 | 5.49e-02 | -3.70e-01 | 0.53100 |
| GOCC NPBAF COMPLEX | 14 | 1.67e-02 | 3.70e-01 | 0.37900 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 2.12e-02 | 3.69e-01 | 0.41400 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 19 | 5.40e-03 | -3.69e-01 | 0.25500 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 29 | 5.98e-04 | 3.68e-01 | 0.11600 |
| GOBP SIALYLATION | 5 | 1.54e-01 | -3.68e-01 | 0.69000 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 1.54e-01 | 3.68e-01 | 0.69100 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 9.20e-02 | 3.68e-01 | 0.61300 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 9.20e-02 | 3.68e-01 | 0.61300 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 9.22e-02 | 3.68e-01 | 0.61300 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 8 | 7.21e-02 | 3.67e-01 | 0.57900 |
| GOBP MEMBRANE RAFT LOCALIZATION | 7 | 9.26e-02 | 3.67e-01 | 0.61300 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 7.22e-02 | -3.67e-01 | 0.57900 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 7.22e-02 | -3.67e-01 | 0.57900 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.55e-01 | 3.67e-01 | 0.69300 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 1.56e-01 | 3.67e-01 | 0.69300 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 5.75e-02 | 3.66e-01 | 0.53800 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 7 | 9.39e-02 | -3.66e-01 | 0.61600 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 1.57e-01 | 3.66e-01 | 0.69600 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 1.57e-01 | -3.65e-01 | 0.69600 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 15 | 1.43e-02 | 3.65e-01 | 0.37200 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 9.44e-02 | 3.65e-01 | 0.61800 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 8 | 7.40e-02 | -3.65e-01 | 0.58100 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 1.22e-01 | -3.65e-01 | 0.66800 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 10 | 4.61e-02 | -3.64e-01 | 0.50600 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 8 | 7.45e-02 | 3.64e-01 | 0.58100 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 1.23e-01 | 3.64e-01 | 0.66900 |
| GOBP VITAMIN D METABOLIC PROCESS | 7 | 9.54e-02 | -3.64e-01 | 0.62000 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 7 | 9.57e-02 | 3.64e-01 | 0.62100 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 7.50e-02 | 3.63e-01 | 0.58200 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 1.60e-01 | -3.63e-01 | 0.69900 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 19 | 6.17e-03 | 3.63e-01 | 0.27000 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 20 | 4.97e-03 | -3.63e-01 | 0.25100 |
| GOCC HEMIDESMOSOME | 5 | 1.60e-01 | 3.63e-01 | 0.69900 |
| GOBP REGULATION OF FEAR RESPONSE | 5 | 1.60e-01 | 3.63e-01 | 0.69900 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 1.61e-01 | 3.62e-01 | 0.69900 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 1.61e-01 | 3.62e-01 | 0.69900 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 4.76e-02 | -3.62e-01 | 0.51100 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 6 | 1.26e-01 | 3.61e-01 | 0.67300 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 11 | 3.82e-02 | -3.61e-01 | 0.48400 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 1.26e-01 | -3.61e-01 | 0.67300 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 7.77e-02 | 3.60e-01 | 0.58800 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 2.47e-02 | 3.60e-01 | 0.43100 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 20 | 5.35e-03 | 3.60e-01 | 0.25400 |
| GOBP BILE ACID SIGNALING PATHWAY | 5 | 1.64e-01 | -3.60e-01 | 0.70500 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 1.64e-01 | 3.60e-01 | 0.70500 |
| GOMF FRUCTOSE BINDING | 5 | 1.64e-01 | -3.59e-01 | 0.70500 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 23 | 2.90e-03 | 3.59e-01 | 0.20700 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 4.96e-02 | -3.59e-01 | 0.51600 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 1.65e-01 | -3.59e-01 | 0.70500 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 7 | 1.02e-01 | 3.57e-01 | 0.62700 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 1.30e-01 | 3.57e-01 | 0.67600 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 8.11e-02 | 3.56e-01 | 0.59900 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 6 | 1.31e-01 | -3.56e-01 | 0.67600 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 6.44e-02 | 3.56e-01 | 0.56000 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 25 | 2.06e-03 | -3.56e-01 | 0.19300 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 4.12e-02 | -3.56e-01 | 0.49700 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 3.30e-02 | 3.56e-01 | 0.47800 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 1.03e-01 | 3.56e-01 | 0.63200 |
| GOMF OXYGEN BINDING | 11 | 4.12e-02 | -3.55e-01 | 0.49700 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 15 | 1.73e-02 | -3.55e-01 | 0.38300 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 9 | 6.51e-02 | 3.55e-01 | 0.56000 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 1.69e-01 | 3.55e-01 | 0.71100 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.69e-01 | 3.55e-01 | 0.71100 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 1.70e-01 | 3.55e-01 | 0.71200 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 1.71e-01 | -3.54e-01 | 0.71400 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 18 | 9.48e-03 | 3.53e-01 | 0.31800 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 8 | 8.36e-02 | 3.53e-01 | 0.60000 |
| GOMF CAMP BINDING | 14 | 2.23e-02 | 3.53e-01 | 0.41800 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 5 | 1.72e-01 | 3.53e-01 | 0.71400 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 7 | 1.07e-01 | 3.52e-01 | 0.63500 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 1.73e-01 | -3.52e-01 | 0.71500 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 7.94e-03 | -3.52e-01 | 0.29400 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 1.07e-01 | 3.52e-01 | 0.63500 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 8.50e-02 | -3.52e-01 | 0.60300 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 1.07e-01 | -3.51e-01 | 0.63600 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 10 | 5.44e-02 | 3.51e-01 | 0.53000 |
| GOCC FASCIA ADHERENS | 5 | 1.74e-01 | 3.51e-01 | 0.71600 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 1.74e-01 | 3.51e-01 | 0.71600 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 1.74e-01 | -3.51e-01 | 0.71600 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 5 | 1.75e-01 | 3.50e-01 | 0.71600 |
| GOBP REACTIVE GLIOSIS | 5 | 1.75e-01 | 3.50e-01 | 0.71600 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 9 | 6.95e-02 | -3.49e-01 | 0.57400 |
| GOBP DOPAMINE SECRETION | 15 | 1.92e-02 | 3.49e-01 | 0.39500 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 16 | 1.57e-02 | 3.49e-01 | 0.37400 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 4.54e-02 | 3.49e-01 | 0.50300 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 9 | 7.03e-02 | 3.48e-01 | 0.57400 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 7 | 1.11e-01 | -3.48e-01 | 0.64300 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 14 | 2.42e-02 | -3.48e-01 | 0.42800 |
| GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS | 5 | 1.78e-01 | -3.48e-01 | 0.71700 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 4.60e-02 | -3.48e-01 | 0.50600 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 22 | 4.78e-03 | 3.47e-01 | 0.25000 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 7.12e-02 | 3.47e-01 | 0.57700 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 5 | 1.79e-01 | -3.47e-01 | 0.71700 |
| GOBP BRADYKININ CATABOLIC PROCESS | 5 | 1.79e-01 | -3.47e-01 | 0.71700 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 6 | 1.41e-01 | -3.47e-01 | 0.68500 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 8.96e-02 | 3.47e-01 | 0.61300 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 3.06e-02 | 3.46e-01 | 0.47200 |
| GOBP ELASTIN METABOLIC PROCESS | 6 | 1.42e-01 | -3.46e-01 | 0.68500 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 4.69e-02 | 3.46e-01 | 0.50700 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 9.01e-02 | 3.46e-01 | 0.61300 |
| GOMF DNA BINDING BENDING | 9 | 7.23e-02 | -3.46e-01 | 0.57900 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 1.13e-01 | 3.46e-01 | 0.64900 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 1.43e-01 | -3.46e-01 | 0.68500 |
| GOMF INSULIN BINDING | 5 | 1.81e-01 | 3.45e-01 | 0.71900 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 1.43e-01 | 3.45e-01 | 0.68500 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 6 | 1.43e-01 | 3.45e-01 | 0.68500 |
| GOMF SNORNA BINDING | 32 | 7.30e-04 | 3.45e-01 | 0.12600 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 1.43e-01 | 3.45e-01 | 0.68500 |
| GOCC LAMELLIPODIUM MEMBRANE | 11 | 4.79e-02 | 3.45e-01 | 0.51100 |
| GOBP SEQUESTERING OF METAL ION | 8 | 9.16e-02 | -3.44e-01 | 0.61300 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 1.44e-01 | 3.44e-01 | 0.68500 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 4.82e-02 | 3.44e-01 | 0.51100 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 11 | 4.82e-02 | 3.44e-01 | 0.51100 |
| GOCC X CHROMOSOME | 7 | 1.15e-01 | 3.44e-01 | 0.65300 |
| GOBP PROSTAGLANDIN SECRETION | 10 | 6.00e-02 | 3.44e-01 | 0.54300 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 1.45e-01 | 3.43e-01 | 0.68500 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 1.46e-01 | -3.43e-01 | 0.68500 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 7.48e-02 | -3.43e-01 | 0.58200 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.17e-01 | 3.42e-01 | 0.65800 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 6 | 1.48e-01 | -3.41e-01 | 0.68800 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 1.19e-01 | 3.41e-01 | 0.66300 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 1.88e-01 | -3.40e-01 | 0.72600 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 10 | 6.26e-02 | -3.40e-01 | 0.55200 |
| GOBP KERATINOCYTE MIGRATION | 12 | 4.15e-02 | -3.40e-01 | 0.49700 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 11 | 5.10e-02 | -3.40e-01 | 0.52400 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 6.28e-02 | 3.40e-01 | 0.55300 |
| GOBP RESPONSE TO WATER | 8 | 9.62e-02 | 3.40e-01 | 0.62200 |
| GOBP OXYGEN TRANSPORT | 7 | 1.20e-01 | -3.40e-01 | 0.66400 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 6 | 1.50e-01 | 3.39e-01 | 0.69000 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 9.66e-02 | -3.39e-01 | 0.62200 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 1.20e-01 | 3.39e-01 | 0.66400 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 9.71e-02 | -3.39e-01 | 0.62300 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 9 | 7.85e-02 | 3.39e-01 | 0.59000 |
| GOBP CHONDROCYTE DEVELOPMENT | 15 | 2.33e-02 | -3.38e-01 | 0.42300 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 8 | 9.77e-02 | 3.38e-01 | 0.62300 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 1.52e-01 | 3.38e-01 | 0.69000 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 1.52e-01 | -3.38e-01 | 0.69000 |
| GOBP RRNA TRANSPORT | 5 | 1.91e-01 | 3.38e-01 | 0.73000 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 11 | 5.24e-02 | -3.38e-01 | 0.52500 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 1.91e-01 | -3.38e-01 | 0.73000 |
| GOBP PERICARDIUM DEVELOPMENT | 9 | 7.94e-02 | -3.38e-01 | 0.59300 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 6.46e-02 | 3.37e-01 | 0.56000 |
| GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION | 5 | 1.91e-01 | 3.37e-01 | 0.73000 |
| GOMF LEUCINE BINDING | 6 | 1.53e-01 | -3.37e-01 | 0.69000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 8 | 9.89e-02 | -3.37e-01 | 0.62400 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 15 | 2.40e-02 | 3.37e-01 | 0.42600 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 14 | 2.92e-02 | 3.37e-01 | 0.45800 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 29 | 1.70e-03 | 3.37e-01 | 0.19300 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 8 | 9.93e-02 | 3.37e-01 | 0.62400 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 8.08e-02 | 3.36e-01 | 0.59800 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 8 | 9.98e-02 | 3.36e-01 | 0.62400 |
| GOBP ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY | 5 | 1.93e-01 | 3.36e-01 | 0.73300 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 1.24e-01 | -3.36e-01 | 0.67100 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 8.11e-02 | 3.36e-01 | 0.59900 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 5.38e-02 | 3.36e-01 | 0.52800 |
| GOMF ANKYRIN REPEAT BINDING | 5 | 1.94e-01 | -3.36e-01 | 0.73300 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.14e-02 | 3.35e-01 | 0.59900 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 17 | 1.67e-02 | 3.35e-01 | 0.37900 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 1.55e-01 | -3.35e-01 | 0.69300 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 1.01e-01 | 3.35e-01 | 0.62700 |
| GOBP RESPONSE TO ACIDIC PH | 13 | 3.69e-02 | -3.34e-01 | 0.48200 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 1.96e-01 | -3.34e-01 | 0.73400 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.26e-01 | 3.34e-01 | 0.67300 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 3.72e-02 | 3.34e-01 | 0.48200 |
| GOBP SURFACTANT HOMEOSTASIS | 10 | 6.77e-02 | -3.34e-01 | 0.57100 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 13 | 3.74e-02 | 3.33e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 8.37e-02 | 3.33e-01 | 0.60000 |
| GOBP RRNA METHYLATION | 22 | 6.89e-03 | 3.33e-01 | 0.28300 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 7 | 1.27e-01 | -3.33e-01 | 0.67400 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 8 | 1.03e-01 | -3.33e-01 | 0.63200 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 18 | 1.46e-02 | -3.32e-01 | 0.37400 |
| GOBP REGULATION OF STEM CELL DIVISION | 8 | 1.04e-01 | 3.32e-01 | 0.63200 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 1.59e-01 | 3.32e-01 | 0.69900 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 1.04e-01 | -3.32e-01 | 0.63300 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.61e-02 | 3.32e-01 | 0.43400 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 1.29e-01 | 3.32e-01 | 0.67500 |
| GOBP MOTOR NEURON AXON GUIDANCE | 16 | 2.18e-02 | 3.31e-01 | 0.41700 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 1.60e-01 | 3.31e-01 | 0.69900 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 1.60e-01 | 3.31e-01 | 0.69900 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 8.56e-02 | 3.31e-01 | 0.60400 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 10 | 7.00e-02 | 3.31e-01 | 0.57400 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 8 | 1.05e-01 | 3.31e-01 | 0.63500 |
| GOCC PRP19 COMPLEX | 12 | 4.75e-02 | -3.30e-01 | 0.51000 |
| GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT | 5 | 2.01e-01 | 3.30e-01 | 0.73700 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 1.62e-01 | -3.30e-01 | 0.70100 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 1.62e-01 | 3.30e-01 | 0.70100 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 2.02e-01 | 3.30e-01 | 0.73700 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 1.31e-01 | -3.30e-01 | 0.67600 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 12 | 4.79e-02 | 3.30e-01 | 0.51100 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 1.31e-01 | 3.29e-01 | 0.67600 |
| GOCC SPINDLE MIDZONE | 28 | 2.57e-03 | -3.29e-01 | 0.20500 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 25 | 4.40e-03 | 3.29e-01 | 0.24700 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 4.01e-02 | 3.29e-01 | 0.49100 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 15 | 2.75e-02 | 3.29e-01 | 0.44700 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 5.33e-03 | 3.29e-01 | 0.25400 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.33e-01 | -3.28e-01 | 0.67800 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 6 | 1.64e-01 | 3.28e-01 | 0.70500 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 10 | 7.25e-02 | -3.28e-01 | 0.57900 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 15 | 2.80e-02 | 3.28e-01 | 0.45200 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.65e-01 | -3.27e-01 | 0.70500 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 8.89e-02 | 3.27e-01 | 0.61300 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 30 | 1.91e-03 | 3.27e-01 | 0.19300 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.34e-01 | 3.27e-01 | 0.67900 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 6 | 1.65e-01 | 3.27e-01 | 0.70500 |
| GOBP THALAMUS DEVELOPMENT | 5 | 2.05e-01 | -3.27e-01 | 0.73800 |
| GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE | 5 | 2.05e-01 | -3.27e-01 | 0.73800 |
| GOBP RESPONSE TO OXYGEN RADICAL | 19 | 1.36e-02 | 3.27e-01 | 0.37200 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 9 | 8.96e-02 | -3.27e-01 | 0.61300 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 19 | 1.37e-02 | 3.27e-01 | 0.37200 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 7 | 1.35e-01 | -3.27e-01 | 0.67900 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.10e-01 | -3.27e-01 | 0.63900 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.06e-01 | -3.26e-01 | 0.73900 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 2.07e-01 | -3.26e-01 | 0.73900 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 9.04e-02 | 3.26e-01 | 0.61300 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 2.07e-01 | -3.26e-01 | 0.73900 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 9.08e-02 | -3.26e-01 | 0.61300 |
| GOBP PROTEASOME ASSEMBLY | 12 | 5.09e-02 | -3.25e-01 | 0.52400 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 6 | 1.68e-01 | 3.25e-01 | 0.70800 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 18 | 1.69e-02 | 3.25e-01 | 0.37900 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 2.08e-01 | -3.25e-01 | 0.73900 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 1.37e-01 | 3.25e-01 | 0.68000 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 22 | 8.41e-03 | 3.25e-01 | 0.29500 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 9 | 9.20e-02 | 3.24e-01 | 0.61300 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 8.48e-03 | -3.24e-01 | 0.29500 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 7 | 1.37e-01 | -3.24e-01 | 0.68000 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 1.38e-01 | 3.24e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 1.13e-01 | 3.24e-01 | 0.64800 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 1.38e-01 | 3.24e-01 | 0.68000 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 5 | 2.10e-01 | 3.24e-01 | 0.73900 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 9 | 9.33e-02 | -3.23e-01 | 0.61500 |
| GOBP KERATINOCYTE DEVELOPMENT | 7 | 1.39e-01 | -3.23e-01 | 0.68200 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 2.12e-01 | 3.22e-01 | 0.74000 |
| GOBP CELLULAR RESPONSE TO COCAINE | 5 | 2.12e-01 | 3.22e-01 | 0.74000 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 1.40e-01 | 3.22e-01 | 0.68400 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 2.13e-01 | 3.22e-01 | 0.74000 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 5.41e-02 | -3.21e-01 | 0.52900 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 3.14e-02 | -3.21e-01 | 0.47600 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 12 | 5.42e-02 | 3.21e-01 | 0.52900 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 6.57e-02 | 3.20e-01 | 0.56300 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 1.42e-01 | 3.20e-01 | 0.68500 |
| GOBP CELLULAR RESPONSE TO MAGNESIUM ION | 5 | 2.15e-01 | -3.20e-01 | 0.74200 |
| GOMF TITIN BINDING | 9 | 9.66e-02 | 3.20e-01 | 0.62200 |
| GOMF HISTONE READER ACTIVITY | 11 | 6.65e-02 | 3.20e-01 | 0.56500 |
| GOBP ERBB2 SIGNALING PATHWAY | 12 | 5.53e-02 | 3.20e-01 | 0.53100 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 8 | 1.18e-01 | 3.19e-01 | 0.65900 |
| GOMF GLYCOSPHINGOLIPID BINDING | 5 | 2.16e-01 | 3.19e-01 | 0.74400 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 10 | 8.05e-02 | -3.19e-01 | 0.59600 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 2.17e-01 | -3.19e-01 | 0.74400 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 5 | 2.17e-01 | 3.19e-01 | 0.74500 |
| GOMF FATTY ACID LIGASE ACTIVITY | 13 | 4.67e-02 | 3.19e-01 | 0.50700 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 1.76e-01 | 3.19e-01 | 0.71600 |
| GOBP PLASMA MEMBRANE FUSION | 8 | 1.19e-01 | -3.19e-01 | 0.66300 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 2.18e-01 | 3.18e-01 | 0.74600 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 7 | 1.45e-01 | -3.18e-01 | 0.68500 |
| GOCC ASTROCYTE PROJECTION | 8 | 1.19e-01 | 3.18e-01 | 0.66400 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 11 | 6.79e-02 | -3.18e-01 | 0.57100 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 19 | 1.65e-02 | 3.18e-01 | 0.37900 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 1.45e-01 | 3.18e-01 | 0.68500 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 12 | 5.67e-02 | -3.18e-01 | 0.53600 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 2.19e-01 | -3.18e-01 | 0.74700 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 1.21e-01 | 3.16e-01 | 0.66700 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 4.82e-02 | 3.16e-01 | 0.51100 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 1.80e-01 | -3.16e-01 | 0.71700 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.21e-01 | 3.16e-01 | 0.75000 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 2.22e-01 | -3.16e-01 | 0.75000 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 1.01e-01 | -3.16e-01 | 0.62700 |
| GOBP RESPONSE TO CORTISOL | 5 | 2.22e-01 | 3.15e-01 | 0.75100 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 5.87e-02 | 3.15e-01 | 0.53800 |
| GOCC MCM COMPLEX | 7 | 1.50e-01 | 3.14e-01 | 0.69000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 6 | 1.83e-01 | 3.14e-01 | 0.72100 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 2.24e-01 | -3.14e-01 | 0.75100 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 2.24e-01 | -3.14e-01 | 0.75100 |
| GOBP HEAT ACCLIMATION | 6 | 1.84e-01 | -3.13e-01 | 0.72100 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 4.26e-02 | -3.13e-01 | 0.50000 |
| GOCC OMEGASOME | 5 | 2.26e-01 | -3.13e-01 | 0.75100 |
| GOBP PROTEIN REPAIR | 6 | 1.84e-01 | 3.13e-01 | 0.72100 |
| GOBP OLFACTORY NERVE DEVELOPMENT | 5 | 2.26e-01 | 3.13e-01 | 0.75100 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 1.26e-01 | 3.13e-01 | 0.67300 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 1.26e-01 | 3.13e-01 | 0.67300 |
| GOBP ERBB4 SIGNALING PATHWAY | 7 | 1.52e-01 | 3.12e-01 | 0.69000 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 23 | 9.52e-03 | 3.12e-01 | 0.31800 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 9.53e-03 | -3.12e-01 | 0.31800 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 9 | 1.05e-01 | 3.12e-01 | 0.63500 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 6 | 1.86e-01 | 3.12e-01 | 0.72300 |
| GOBP FACIAL NERVE STRUCTURAL ORGANIZATION | 6 | 1.86e-01 | 3.12e-01 | 0.72300 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 5 | 2.28e-01 | -3.11e-01 | 0.75300 |
| GOMF ICOSANOID BINDING | 7 | 1.54e-01 | -3.11e-01 | 0.69000 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 12 | 6.20e-02 | 3.11e-01 | 0.54900 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 8 | 1.28e-01 | 3.11e-01 | 0.67400 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 1.54e-01 | 3.11e-01 | 0.69000 |
| GOMF ACYL COA OXIDASE ACTIVITY | 6 | 1.87e-01 | 3.11e-01 | 0.72400 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 1.88e-01 | -3.11e-01 | 0.72600 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 8.90e-02 | 3.11e-01 | 0.61300 |
| GOBP RESPONSE TO GLUCAGON | 8 | 1.28e-01 | -3.10e-01 | 0.67500 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 1.07e-01 | 3.10e-01 | 0.63500 |
| GOMF PROTEIN KINASE C ACTIVITY | 14 | 4.45e-02 | 3.10e-01 | 0.50300 |
| GOCC PARASPECKLES | 8 | 1.29e-01 | -3.10e-01 | 0.67500 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 1.29e-01 | 3.10e-01 | 0.67600 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 2.31e-01 | -3.10e-01 | 0.75500 |
| GOMF C C CHEMOKINE BINDING | 12 | 6.35e-02 | 3.09e-01 | 0.55400 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 11 | 7.56e-02 | 3.09e-01 | 0.58300 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 14 | 4.52e-02 | 3.09e-01 | 0.50300 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 8 | 1.30e-01 | 3.09e-01 | 0.67600 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 5 | 2.32e-01 | -3.09e-01 | 0.75600 |
| GOMF STEROL TRANSFER ACTIVITY | 14 | 4.57e-02 | -3.08e-01 | 0.50600 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 4.59e-02 | -3.08e-01 | 0.50600 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 7.68e-02 | 3.08e-01 | 0.58600 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 1.58e-01 | 3.08e-01 | 0.69700 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 16 | 3.30e-02 | 3.08e-01 | 0.47800 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 15 | 3.90e-02 | 3.08e-01 | 0.48800 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 5.47e-02 | -3.08e-01 | 0.53100 |
| GOBP AMINO ACID SALVAGE | 5 | 2.33e-01 | 3.08e-01 | 0.75700 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 2.33e-01 | 3.08e-01 | 0.75700 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 2.34e-01 | 3.07e-01 | 0.75800 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 7.80e-02 | 3.07e-01 | 0.58900 |
| GOMF POLY A BINDING | 21 | 1.49e-02 | 3.07e-01 | 0.37400 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 1.34e-01 | -3.06e-01 | 0.67900 |
| GOBP PYRUVATE TRANSPORT | 5 | 2.36e-01 | -3.06e-01 | 0.76000 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 2.36e-01 | 3.06e-01 | 0.76000 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 2.49e-02 | 3.06e-01 | 0.43100 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 1.35e-01 | 3.05e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 2.37e-01 | -3.05e-01 | 0.76200 |
| GOBP NEURON FATE SPECIFICATION | 6 | 1.96e-01 | 3.05e-01 | 0.73400 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 8 | 1.35e-01 | 3.05e-01 | 0.68000 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 1.96e-01 | -3.05e-01 | 0.73400 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 8 | 1.35e-01 | 3.05e-01 | 0.68000 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 8 | 1.36e-01 | 3.05e-01 | 0.68000 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 21 | 1.57e-02 | 3.05e-01 | 0.37400 |
| GOBP MAST CELL MIGRATION | 8 | 1.37e-01 | -3.04e-01 | 0.68000 |
| GOBP BONE GROWTH | 16 | 3.56e-02 | -3.04e-01 | 0.48200 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 1.37e-01 | 3.03e-01 | 0.68000 |
| GOBP NUCLEAR MIGRATION ALONG MICROTUBULE | 5 | 2.41e-01 | 3.03e-01 | 0.76300 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 1.65e-01 | 3.03e-01 | 0.70500 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 6 | 1.99e-01 | -3.03e-01 | 0.73600 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 4.26e-02 | 3.02e-01 | 0.50000 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 11 | 8.33e-02 | 3.02e-01 | 0.60000 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 10 | 9.88e-02 | -3.01e-01 | 0.62400 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 15 | 4.33e-02 | 3.01e-01 | 0.50100 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 6 | 2.02e-01 | 3.01e-01 | 0.73800 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 20 | 1.99e-02 | -3.01e-01 | 0.40200 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 6 | 2.03e-01 | -3.00e-01 | 0.73800 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 6 | 2.03e-01 | -3.00e-01 | 0.73800 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 9 | 1.19e-01 | 3.00e-01 | 0.66400 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 2.46e-01 | 3.00e-01 | 0.76800 |
| GOBP REGULATION OF CELL MATURATION | 12 | 7.24e-02 | -3.00e-01 | 0.57900 |
| GOBP PREPULSE INHIBITION | 9 | 1.20e-01 | -2.99e-01 | 0.66400 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 11 | 8.58e-02 | 2.99e-01 | 0.60500 |
| GOBP SULFATE TRANSPORT | 12 | 7.28e-02 | -2.99e-01 | 0.57900 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 2.05e-01 | 2.99e-01 | 0.73800 |
| GOBP AMIDE CATABOLIC PROCESS | 9 | 1.20e-01 | -2.99e-01 | 0.66400 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 6.21e-02 | 2.99e-01 | 0.54900 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 1.44e-01 | 2.98e-01 | 0.68500 |
| GOBP R LOOP PROCESSING | 6 | 2.06e-01 | 2.98e-01 | 0.73900 |
| GOBP MITOTIC SPINDLE ELONGATION | 7 | 1.72e-01 | -2.98e-01 | 0.71400 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 13 | 6.30e-02 | 2.98e-01 | 0.55300 |
| GOBP UREA CYCLE | 7 | 1.72e-01 | -2.98e-01 | 0.71400 |
| GOBP UREA METABOLIC PROCESS | 7 | 1.72e-01 | -2.98e-01 | 0.71400 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 2.49e-01 | -2.98e-01 | 0.76800 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 21 | 1.82e-02 | 2.98e-01 | 0.38900 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 6 | 2.07e-01 | -2.98e-01 | 0.73900 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.07e-01 | 2.98e-01 | 0.73900 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 1.73e-01 | -2.97e-01 | 0.71500 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 2.07e-01 | -2.97e-01 | 0.73900 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 2.08e-01 | -2.97e-01 | 0.73900 |
| GOBP THYROID GLAND DEVELOPMENT | 17 | 3.40e-02 | -2.97e-01 | 0.48200 |
| GOBP REGULATION OF NEURON MATURATION | 6 | 2.08e-01 | -2.97e-01 | 0.73900 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 27 | 7.72e-03 | 2.96e-01 | 0.29400 |
| GOMF BIOTIN BINDING | 5 | 2.51e-01 | 2.96e-01 | 0.77200 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 2.09e-01 | -2.96e-01 | 0.73900 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 6.48e-02 | 2.96e-01 | 0.56000 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 5.58e-02 | 2.95e-01 | 0.53500 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 1.48e-01 | 2.95e-01 | 0.68800 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 1.25e-01 | 2.95e-01 | 0.67300 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 2.11e-01 | 2.95e-01 | 0.73900 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 6 | 2.11e-01 | -2.95e-01 | 0.73900 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 25 | 1.08e-02 | -2.94e-01 | 0.33500 |
| GOBP PROTEIN ACTIVATION CASCADE | 10 | 1.07e-01 | -2.94e-01 | 0.63500 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 9.11e-02 | 2.94e-01 | 0.61300 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 1.50e-01 | 2.94e-01 | 0.69000 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 2.55e-01 | 2.94e-01 | 0.77700 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 17 | 3.60e-02 | -2.94e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 1.27e-01 | 2.94e-01 | 0.67300 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 1.51e-01 | 2.94e-01 | 0.69000 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 8 | 1.51e-01 | 2.93e-01 | 0.69000 |
| GOCC DYSTROGLYCAN COMPLEX | 5 | 2.56e-01 | 2.93e-01 | 0.77800 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 11 | 9.23e-02 | -2.93e-01 | 0.61300 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 2.57e-01 | 2.93e-01 | 0.77800 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 2.14e-01 | 2.93e-01 | 0.74100 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 2.14e-01 | 2.93e-01 | 0.74100 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 1.80e-01 | -2.93e-01 | 0.71800 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 9 | 1.29e-01 | 2.92e-01 | 0.67500 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 7 | 1.81e-01 | 2.92e-01 | 0.71900 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 6 | 2.16e-01 | -2.92e-01 | 0.74300 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 2.58e-01 | 2.92e-01 | 0.77900 |
| GOBP STEROID CATABOLIC PROCESS | 10 | 1.10e-01 | 2.92e-01 | 0.64000 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 2.59e-01 | -2.92e-01 | 0.77900 |
| GOBP GROOMING BEHAVIOR | 6 | 2.16e-01 | 2.91e-01 | 0.74400 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 2.08e-02 | 2.91e-01 | 0.41000 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 9 | 1.30e-01 | 2.91e-01 | 0.67600 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 13 | 6.90e-02 | 2.91e-01 | 0.57400 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 2.59e-01 | -2.91e-01 | 0.78000 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 13 | 6.90e-02 | 2.91e-01 | 0.57400 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 31 | 5.05e-03 | 2.91e-01 | 0.25200 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 18 | 3.27e-02 | 2.91e-01 | 0.47800 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 5.96e-02 | 2.91e-01 | 0.54100 |
| GOMF T CELL RECEPTOR BINDING | 11 | 9.50e-02 | 2.91e-01 | 0.61900 |
| GOBP DIAPEDESIS | 6 | 2.18e-01 | -2.91e-01 | 0.74600 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 2.60e-01 | 2.91e-01 | 0.78000 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 11 | 9.53e-02 | 2.90e-01 | 0.62000 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 2.61e-01 | -2.90e-01 | 0.78100 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 12 | 8.17e-02 | -2.90e-01 | 0.59900 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.61e-01 | 2.90e-01 | 0.78100 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 2.19e-01 | 2.90e-01 | 0.74700 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 13 | 7.04e-02 | 2.90e-01 | 0.57400 |
| GOBP REGULATION OF CENTROSOME CYCLE | 49 | 4.52e-04 | 2.90e-01 | 0.10300 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 5.21e-02 | -2.90e-01 | 0.52500 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 2.62e-01 | -2.90e-01 | 0.78300 |
| GOBP TRANSFERRIN TRANSPORT | 9 | 1.33e-01 | -2.89e-01 | 0.67800 |
| GOCC ENDOCYTIC VESICLE LUMEN | 15 | 5.26e-02 | -2.89e-01 | 0.52500 |
| GOBP FUCOSYLATION | 11 | 9.72e-02 | 2.89e-01 | 0.62300 |
| GOBP TRNA THIO MODIFICATION | 5 | 2.64e-01 | -2.89e-01 | 0.78300 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 6 | 2.21e-01 | 2.89e-01 | 0.75000 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 9.76e-02 | -2.88e-01 | 0.62300 |
| GOBP CALCIUM ION IMPORT | 24 | 1.45e-02 | 2.88e-01 | 0.37200 |
| GOBP PROTEIN PALMITOYLATION | 24 | 1.45e-02 | -2.88e-01 | 0.37200 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 2.21e-01 | -2.88e-01 | 0.75000 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 8.39e-02 | 2.88e-01 | 0.60000 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 5 | 2.65e-01 | 2.88e-01 | 0.78300 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 5 | 2.65e-01 | 2.88e-01 | 0.78400 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 16 | 4.64e-02 | 2.88e-01 | 0.50700 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 4.66e-02 | 2.87e-01 | 0.50700 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 16 | 4.69e-02 | 2.87e-01 | 0.50700 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 2.67e-01 | 2.87e-01 | 0.78400 |
| GOMF I SMAD BINDING | 13 | 7.34e-02 | -2.87e-01 | 0.58000 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 7.35e-02 | -2.87e-01 | 0.58000 |
| GOBP C TERMINAL PROTEIN LIPIDATION | 5 | 2.67e-01 | -2.87e-01 | 0.78400 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 1.61e-01 | 2.87e-01 | 0.69900 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 11 | 1.00e-01 | 2.86e-01 | 0.62500 |
| GOBP ENDOCRINE PROCESS | 41 | 1.52e-03 | -2.86e-01 | 0.19300 |
| GOMF TORC2 COMPLEX BINDING | 5 | 2.68e-01 | -2.86e-01 | 0.78500 |
| GOCC PARANODE REGION OF AXON | 7 | 1.90e-01 | -2.86e-01 | 0.72900 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 7 | 1.90e-01 | 2.86e-01 | 0.72900 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 2.25e-01 | 2.86e-01 | 0.75100 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 6 | 2.25e-01 | 2.86e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 1.62e-01 | 2.86e-01 | 0.70100 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 2.69e-01 | 2.86e-01 | 0.78600 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 1.62e-01 | 2.85e-01 | 0.70100 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 1.62e-01 | 2.85e-01 | 0.70100 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 8 | 1.62e-01 | 2.85e-01 | 0.70100 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 11 | 1.01e-01 | -2.85e-01 | 0.62700 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 6 | 2.26e-01 | -2.85e-01 | 0.75100 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 2.26e-01 | -2.85e-01 | 0.75100 |
| GOMF PHOSPHATIDIC ACID BINDING | 19 | 3.15e-02 | 2.85e-01 | 0.47600 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 18 | 3.63e-02 | 2.85e-01 | 0.48200 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 1.39e-01 | 2.85e-01 | 0.68200 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 18 | 3.64e-02 | 2.85e-01 | 0.48200 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 2.71e-01 | -2.85e-01 | 0.78800 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 2.71e-01 | -2.84e-01 | 0.78800 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 2.71e-01 | -2.84e-01 | 0.78800 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 1.40e-01 | 2.84e-01 | 0.68500 |
| GOMF NEUROPEPTIDE BINDING | 5 | 2.72e-01 | 2.84e-01 | 0.78900 |
| GOBP HISTONE UBIQUITINATION | 9 | 1.41e-01 | -2.83e-01 | 0.68500 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 1.94e-01 | 2.83e-01 | 0.73300 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 2.73e-01 | -2.83e-01 | 0.78900 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 2.73e-01 | 2.83e-01 | 0.78900 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 45 | 1.04e-03 | -2.83e-01 | 0.16100 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 1.96e-01 | -2.83e-01 | 0.73400 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 11 | 1.05e-01 | -2.82e-01 | 0.63500 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 7 | 1.96e-01 | -2.82e-01 | 0.73400 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 2.75e-01 | 2.82e-01 | 0.79000 |
| GOBP POLYKETIDE METABOLIC PROCESS | 5 | 2.75e-01 | 2.82e-01 | 0.79000 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 10 | 1.23e-01 | -2.82e-01 | 0.66900 |
| GOBP PROTEIN UNFOLDING | 5 | 2.75e-01 | 2.82e-01 | 0.79000 |
| GOBP LUTEINIZATION | 7 | 1.97e-01 | -2.82e-01 | 0.73500 |
| GOBP REGULATION OF RNA BINDING | 8 | 1.68e-01 | -2.81e-01 | 0.70900 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 4.48e-02 | 2.81e-01 | 0.50300 |
| GOBP CHOLESTEROL STORAGE | 20 | 2.96e-02 | -2.81e-01 | 0.46300 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 7 | 1.98e-01 | -2.81e-01 | 0.73600 |
| GOCC U2AF COMPLEX | 5 | 2.77e-01 | -2.81e-01 | 0.79000 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 1.99e-01 | -2.81e-01 | 0.73600 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 2.78e-01 | 2.80e-01 | 0.79000 |
| GOCC MICROTUBULE MINUS END | 6 | 2.35e-01 | -2.80e-01 | 0.75900 |
| GOBP TRNA METHYLATION | 43 | 1.48e-03 | 2.80e-01 | 0.19100 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 1.46e-01 | 2.80e-01 | 0.68500 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 2.78e-01 | 2.80e-01 | 0.79000 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 5 | 2.78e-01 | 2.80e-01 | 0.79000 |
| GOCC RIBBON SYNAPSE | 9 | 1.46e-01 | 2.80e-01 | 0.68600 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 15 | 6.09e-02 | -2.80e-01 | 0.54600 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.08e-01 | 2.80e-01 | 0.63900 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 13 | 8.10e-02 | -2.80e-01 | 0.59900 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 2.79e-01 | 2.79e-01 | 0.79000 |
| GOMF DNA CLAMP LOADER ACTIVITY | 8 | 1.71e-01 | -2.79e-01 | 0.71400 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 5 | 2.80e-01 | -2.79e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 1.26e-01 | -2.79e-01 | 0.67300 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 11 | 1.09e-01 | 2.79e-01 | 0.63900 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 6 | 2.36e-01 | 2.79e-01 | 0.76000 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 1.27e-01 | -2.79e-01 | 0.67300 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 10 | 1.27e-01 | 2.79e-01 | 0.67300 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 3.09e-02 | 2.79e-01 | 0.47200 |
| GOBP ADRENAL GLAND DEVELOPMENT | 14 | 7.10e-02 | -2.79e-01 | 0.57700 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 6 | 2.37e-01 | 2.79e-01 | 0.76200 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 2.02e-01 | 2.78e-01 | 0.73800 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 9.50e-02 | 2.78e-01 | 0.61900 |
| GOCC HFE TRANSFERRIN RECEPTOR COMPLEX | 5 | 2.82e-01 | -2.78e-01 | 0.79000 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 2.82e-01 | 2.78e-01 | 0.79000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 2.82e-01 | 2.78e-01 | 0.79000 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 1.28e-01 | -2.78e-01 | 0.67500 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 2.83e-01 | 2.78e-01 | 0.79000 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 4.15e-02 | 2.78e-01 | 0.49700 |
| GOBP REGULATION OF GASTRULATION | 9 | 1.50e-01 | 2.77e-01 | 0.69000 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 9 | 1.50e-01 | 2.77e-01 | 0.69000 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 7 | 2.05e-01 | -2.77e-01 | 0.73800 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 7 | 2.05e-01 | 2.77e-01 | 0.73800 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 8 | 1.75e-01 | -2.77e-01 | 0.71600 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 7.34e-02 | 2.76e-01 | 0.58000 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 9.75e-02 | -2.76e-01 | 0.62300 |
| GOBP KERATINIZATION | 10 | 1.30e-01 | -2.76e-01 | 0.67600 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 1.31e-01 | 2.76e-01 | 0.67600 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 2.86e-01 | 2.76e-01 | 0.79100 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 1.31e-01 | 2.76e-01 | 0.67600 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 3.75e-02 | -2.76e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 7.91e-03 | 2.76e-01 | 0.29400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 10 | 1.31e-01 | -2.76e-01 | 0.67600 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 22 | 2.53e-02 | 2.76e-01 | 0.43200 |
| GOBP COPULATION | 8 | 1.77e-01 | -2.75e-01 | 0.71700 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 2.86e-01 | 2.75e-01 | 0.79100 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 11 | 1.14e-01 | 2.75e-01 | 0.65100 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 1.73e-02 | 2.75e-01 | 0.38300 |
| GOBP CELLULAR RESPONSE TO PH | 13 | 8.61e-02 | -2.75e-01 | 0.60600 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 10 | 1.32e-01 | 2.75e-01 | 0.67800 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 9 | 1.54e-01 | -2.75e-01 | 0.69000 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 1.33e-01 | -2.74e-01 | 0.67800 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 6.40e-03 | -2.74e-01 | 0.27400 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 2.45e-01 | -2.74e-01 | 0.76700 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 26 | 1.55e-02 | 2.74e-01 | 0.37400 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 3.39e-02 | -2.74e-01 | 0.48200 |
| GOCC RSC TYPE COMPLEX | 14 | 7.59e-02 | 2.74e-01 | 0.58300 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 2.45e-01 | 2.74e-01 | 0.76800 |
| GOCC PHAGOLYSOSOME | 5 | 2.89e-01 | -2.74e-01 | 0.79300 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 1.80e-01 | 2.74e-01 | 0.71800 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 16 | 5.82e-02 | 2.74e-01 | 0.53800 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 6 | 2.46e-01 | -2.73e-01 | 0.76800 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 43 | 1.92e-03 | -2.73e-01 | 0.19300 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 1.34e-01 | -2.73e-01 | 0.67900 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 5 | 2.90e-01 | -2.73e-01 | 0.79300 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 18 | 4.47e-02 | -2.73e-01 | 0.50300 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 2.47e-01 | 2.73e-01 | 0.76800 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 7.68e-02 | 2.73e-01 | 0.58600 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 2.47e-01 | 2.73e-01 | 0.76800 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 13 | 8.84e-02 | 2.73e-01 | 0.61300 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 1.56e-01 | 2.73e-01 | 0.69400 |
| GOBP SEX DETERMINATION | 7 | 2.12e-01 | 2.73e-01 | 0.74000 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 10 | 1.36e-01 | -2.73e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 8 | 1.82e-01 | -2.72e-01 | 0.72100 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 7 | 2.12e-01 | -2.72e-01 | 0.74000 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 8.93e-02 | 2.72e-01 | 0.61300 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 15 | 6.81e-02 | 2.72e-01 | 0.57100 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 5 | 2.92e-01 | 2.72e-01 | 0.79500 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 1.58e-01 | -2.72e-01 | 0.69700 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 7 | 2.13e-01 | -2.72e-01 | 0.74000 |
| GOCC ASTER | 7 | 2.13e-01 | -2.72e-01 | 0.74000 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 2.49e-01 | -2.72e-01 | 0.76900 |
| GOBP STEROID HORMONE SECRETION | 14 | 7.87e-02 | -2.71e-01 | 0.59100 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 9.03e-02 | 2.71e-01 | 0.61300 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 2.94e-01 | 2.71e-01 | 0.79600 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 5 | 2.94e-01 | -2.71e-01 | 0.79600 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 2.94e-01 | -2.71e-01 | 0.79700 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 9.09e-02 | 2.71e-01 | 0.61300 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 5 | 2.95e-01 | 2.70e-01 | 0.79800 |
| GOCC MICOS COMPLEX | 8 | 1.86e-01 | 2.70e-01 | 0.72300 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 2.95e-01 | 2.70e-01 | 0.79800 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 7.00e-02 | 2.70e-01 | 0.57400 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 2.96e-01 | 2.70e-01 | 0.79900 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 2.96e-01 | -2.70e-01 | 0.79900 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 1.61e-01 | 2.70e-01 | 0.69900 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 32 | 8.24e-03 | 2.70e-01 | 0.29500 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 6 | 2.52e-01 | -2.70e-01 | 0.77200 |
| GOCC CTF18 RFC LIKE COMPLEX | 6 | 2.52e-01 | -2.70e-01 | 0.77200 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 11 | 1.21e-01 | 2.70e-01 | 0.66700 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 13 | 9.23e-02 | -2.70e-01 | 0.61300 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 13 | 9.24e-02 | 2.70e-01 | 0.61300 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 6.20e-02 | 2.70e-01 | 0.54900 |
| GOBP TONGUE MORPHOGENESIS | 5 | 2.97e-01 | 2.69e-01 | 0.80000 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 42 | 2.55e-03 | -2.69e-01 | 0.20500 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 10 | 1.41e-01 | -2.69e-01 | 0.68500 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 10 | 1.41e-01 | -2.69e-01 | 0.68500 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.41e-01 | 2.69e-01 | 0.68500 |
| GOCC TORC1 COMPLEX | 6 | 2.54e-01 | 2.69e-01 | 0.77600 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.98e-01 | 2.69e-01 | 0.80100 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 2.55e-01 | -2.69e-01 | 0.77600 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 2.99e-01 | -2.68e-01 | 0.80100 |
| GOCC DENDRITIC GROWTH CONE | 6 | 2.55e-01 | 2.68e-01 | 0.77700 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 7 | 2.19e-01 | -2.68e-01 | 0.74700 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 9 | 1.64e-01 | 2.68e-01 | 0.70500 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 2.56e-01 | 2.68e-01 | 0.77800 |
| GOBP RRNA BASE METHYLATION | 8 | 1.90e-01 | 2.68e-01 | 0.72900 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 2.20e-01 | -2.68e-01 | 0.74900 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 2.56e-01 | 2.68e-01 | 0.77800 |
| GOBP PEXOPHAGY | 6 | 2.57e-01 | -2.67e-01 | 0.77800 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 12 | 1.09e-01 | 2.67e-01 | 0.63900 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 11 | 1.25e-01 | 2.67e-01 | 0.67200 |
| GOBP LIPID IMPORT INTO CELL | 14 | 8.35e-02 | 2.67e-01 | 0.60000 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 3.01e-01 | 2.67e-01 | 0.80400 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 12 | 1.09e-01 | -2.67e-01 | 0.63900 |
| GOMF SNRNP BINDING | 9 | 1.65e-01 | -2.67e-01 | 0.70500 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 17 | 5.67e-02 | 2.67e-01 | 0.53600 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.21e-01 | 2.67e-01 | 0.75000 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 9.59e-02 | 2.67e-01 | 0.62100 |
| GOBP GAS TRANSPORT | 8 | 1.91e-01 | -2.67e-01 | 0.73000 |
| GOCC COMMITMENT COMPLEX | 5 | 3.02e-01 | 2.67e-01 | 0.80400 |
| GOMF MHC PROTEIN COMPLEX BINDING | 33 | 8.04e-03 | 2.67e-01 | 0.29500 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 14 | 8.45e-02 | -2.66e-01 | 0.60200 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 33 | 8.18e-03 | -2.66e-01 | 0.29500 |
| GOMF MANNOSIDASE ACTIVITY | 14 | 8.49e-02 | 2.66e-01 | 0.60300 |
| GOMF GTPASE INHIBITOR ACTIVITY | 11 | 1.27e-01 | 2.66e-01 | 0.67300 |
| GOMF FILAMIN BINDING | 11 | 1.27e-01 | -2.66e-01 | 0.67300 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 8 | 1.93e-01 | -2.66e-01 | 0.73300 |
| GOMF CTPASE ACTIVITY | 5 | 3.04e-01 | -2.66e-01 | 0.80500 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 15 | 7.53e-02 | 2.65e-01 | 0.58300 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 1.46e-01 | -2.65e-01 | 0.68600 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 8 | 1.94e-01 | 2.65e-01 | 0.73300 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 3.05e-01 | -2.65e-01 | 0.80600 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 9 | 1.69e-01 | -2.65e-01 | 0.71000 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 2.25e-01 | 2.65e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 2.61e-01 | 2.65e-01 | 0.78100 |
| GOBP ADHESION OF SYMBIONT TO HOST | 7 | 2.25e-01 | 2.65e-01 | 0.75100 |
| GOBP RESPONSE TO SALT STRESS | 17 | 5.87e-02 | 2.65e-01 | 0.53800 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 7 | 2.25e-01 | 2.65e-01 | 0.75100 |
| GOBP PLATELET MORPHOGENESIS | 21 | 3.59e-02 | -2.65e-01 | 0.48200 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 2.26e-01 | -2.65e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 16 | 6.70e-02 | -2.65e-01 | 0.56800 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 14 | 8.67e-02 | -2.64e-01 | 0.61000 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 26 | 1.96e-02 | 2.64e-01 | 0.40000 |
| GOBP SKIN MORPHOGENESIS | 7 | 2.26e-01 | -2.64e-01 | 0.75100 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 12 | 1.13e-01 | 2.64e-01 | 0.65000 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 3.07e-01 | -2.64e-01 | 0.80700 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 7 | 2.27e-01 | 2.64e-01 | 0.75100 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 9 | 1.71e-01 | -2.63e-01 | 0.71400 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 2.28e-01 | -2.63e-01 | 0.75200 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 13 | 1.00e-01 | 2.63e-01 | 0.62600 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 3.08e-01 | -2.63e-01 | 0.80700 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 10 | 1.50e-01 | 2.63e-01 | 0.69000 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 5.37e-02 | 2.63e-01 | 0.52800 |
| GOBP RESPONSE TO GONADOTROPIN | 10 | 1.50e-01 | -2.63e-01 | 0.69000 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 30 | 1.28e-02 | -2.63e-01 | 0.36500 |
| GOBP GMP METABOLIC PROCESS | 24 | 2.60e-02 | 2.63e-01 | 0.43400 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 26 | 2.05e-02 | 2.63e-01 | 0.40700 |
| GOBP REGULATION OF NOREPINEPHRINE SECRETION | 5 | 3.09e-01 | -2.63e-01 | 0.80800 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 7 | 2.29e-01 | -2.62e-01 | 0.75400 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 5 | 3.10e-01 | 2.62e-01 | 0.80800 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 1.51e-01 | 2.62e-01 | 0.69000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 2.30e-01 | -2.62e-01 | 0.75400 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 16 | 6.95e-02 | -2.62e-01 | 0.57400 |
| GOBP REGULATION OF RESPIRATORY BURST | 14 | 8.95e-02 | 2.62e-01 | 0.61300 |
| GOBP RRNA 5 END PROCESSING | 5 | 3.10e-01 | 2.62e-01 | 0.80800 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 1.99e-01 | -2.62e-01 | 0.73600 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 9 | 1.73e-01 | -2.62e-01 | 0.71500 |
| GOBP CENTRIOLE ELONGATION | 8 | 1.99e-01 | 2.62e-01 | 0.73600 |
| GOBP RETICULOPHAGY | 16 | 6.98e-02 | -2.62e-01 | 0.57400 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 62 | 3.67e-04 | 2.62e-01 | 0.09760 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 10 | 1.52e-01 | -2.62e-01 | 0.69000 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 3.11e-01 | -2.61e-01 | 0.80800 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 2.01e-01 | 2.61e-01 | 0.73700 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 2.11e-02 | -2.61e-01 | 0.41400 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 11 | 1.34e-01 | 2.61e-01 | 0.67900 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 11 | 1.34e-01 | -2.61e-01 | 0.67900 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 46 | 2.21e-03 | 2.61e-01 | 0.20300 |
| GOBP FATTY ACID HOMEOSTASIS | 10 | 1.53e-01 | -2.61e-01 | 0.69000 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 23 | 3.04e-02 | 2.61e-01 | 0.47000 |
| GOBP DENDRITIC SPINE MAINTENANCE | 14 | 9.12e-02 | 2.61e-01 | 0.61300 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 22 | 3.45e-02 | 2.60e-01 | 0.48200 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 6 | 2.70e-01 | -2.60e-01 | 0.78700 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 3.14e-01 | 2.60e-01 | 0.81000 |
| GOBP DOPAMINE TRANSPORT | 21 | 3.91e-02 | 2.60e-01 | 0.48800 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 27 | 1.94e-02 | 2.60e-01 | 0.39600 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 1.54e-02 | 2.60e-01 | 0.37400 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 15 | 8.16e-02 | 2.60e-01 | 0.59900 |
| GOCC PINOSOME | 6 | 2.71e-01 | -2.60e-01 | 0.78800 |
| GOBP AMINO ACID ACTIVATION | 25 | 2.47e-02 | 2.60e-01 | 0.43100 |
| GOMF SUMO POLYMER BINDING | 5 | 3.15e-01 | 2.60e-01 | 0.81000 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 3.16e-01 | -2.59e-01 | 0.81100 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 3.16e-01 | -2.59e-01 | 0.81100 |
| GOMF FATTY ACID DERIVATIVE BINDING | 13 | 1.06e-01 | 2.59e-01 | 0.63500 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 2.36e-01 | 2.59e-01 | 0.76000 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 2.73e-01 | 2.58e-01 | 0.78900 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 18 | 5.78e-02 | -2.58e-01 | 0.53800 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 8.35e-02 | -2.58e-01 | 0.60000 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 3.61e-02 | 2.58e-01 | 0.48200 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 11 | 1.39e-01 | 2.58e-01 | 0.68200 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 5 | 3.18e-01 | -2.58e-01 | 0.81200 |
| GOBP RENAL VESICLE DEVELOPMENT | 5 | 3.18e-01 | -2.58e-01 | 0.81200 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 22 | 3.64e-02 | -2.58e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 2.07e-01 | -2.58e-01 | 0.73900 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 22 | 3.67e-02 | -2.57e-01 | 0.48200 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 2.75e-01 | -2.57e-01 | 0.79000 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 2.08e-01 | 2.57e-01 | 0.73900 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 20 | 4.69e-02 | 2.57e-01 | 0.50700 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 8 | 2.09e-01 | 2.57e-01 | 0.73900 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 1.83e-01 | 2.57e-01 | 0.72100 |
| GOCC CHROMATOID BODY | 7 | 2.40e-01 | 2.56e-01 | 0.76200 |
| GOBP NUCLEAR MIGRATION | 23 | 3.34e-02 | 2.56e-01 | 0.47800 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 3.21e-01 | 2.56e-01 | 0.81400 |
| GOBP VOCALIZATION BEHAVIOR | 8 | 2.10e-01 | -2.56e-01 | 0.73900 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 8 | 2.10e-01 | 2.56e-01 | 0.73900 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 25 | 2.69e-02 | 2.56e-01 | 0.44200 |
| GOBP PEROXISOME FISSION | 9 | 1.84e-01 | -2.56e-01 | 0.72100 |
| GOMF POTASSIUM ION BINDING | 7 | 2.42e-01 | 2.56e-01 | 0.76400 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 2.78e-01 | 2.56e-01 | 0.79000 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.85e-01 | 2.55e-01 | 0.72200 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 37 | 7.23e-03 | 2.55e-01 | 0.29000 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 2.43e-01 | -2.55e-01 | 0.76500 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 11 | 1.43e-01 | 2.55e-01 | 0.68500 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 1.43e-01 | 2.55e-01 | 0.68500 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 11 | 1.43e-01 | -2.55e-01 | 0.68500 |
| GOBP THYROID HORMONE TRANSPORT | 6 | 2.80e-01 | -2.55e-01 | 0.79000 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 14 | 9.89e-02 | -2.55e-01 | 0.62400 |
| GOBP COBALAMIN METABOLIC PROCESS | 8 | 2.13e-01 | 2.54e-01 | 0.74000 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 6 | 2.81e-01 | -2.54e-01 | 0.79000 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 8 | 2.13e-01 | -2.54e-01 | 0.74000 |
| GOCC COPII VESICLE COAT | 16 | 7.83e-02 | -2.54e-01 | 0.58900 |
| GOMF WNT RECEPTOR ACTIVITY | 7 | 2.44e-01 | 2.54e-01 | 0.76600 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 11 | 1.44e-01 | -2.54e-01 | 0.68500 |
| GOBP TRNA TRANSCRIPTION | 11 | 1.44e-01 | 2.54e-01 | 0.68500 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 1.28e-01 | 2.54e-01 | 0.67500 |
| GOCC U4 SNRNP | 10 | 1.65e-01 | 2.53e-01 | 0.70500 |
| GOCC AXON INITIAL SEGMENT | 7 | 2.46e-01 | -2.53e-01 | 0.76800 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 2.83e-01 | 2.53e-01 | 0.79000 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 8 | 2.15e-01 | 2.53e-01 | 0.74300 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 8 | 2.15e-01 | 2.53e-01 | 0.74300 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 6 | 2.83e-01 | -2.53e-01 | 0.79100 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 3.28e-01 | 2.53e-01 | 0.81800 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 11 | 1.47e-01 | -2.53e-01 | 0.68700 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 2.47e-01 | -2.53e-01 | 0.76800 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 3.29e-01 | 2.52e-01 | 0.81800 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 18 | 6.42e-02 | 2.52e-01 | 0.55900 |
| GOCC PLATELET ALPHA GRANULE | 62 | 6.09e-04 | -2.52e-01 | 0.11600 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 2.49e-01 | -2.52e-01 | 0.76800 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 12 | 1.31e-01 | -2.52e-01 | 0.67600 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 18 | 6.46e-02 | 2.52e-01 | 0.56000 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 3.30e-01 | -2.52e-01 | 0.81800 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 15 | 9.18e-02 | -2.51e-01 | 0.61300 |
| GOCC GLYCOGEN GRANULE | 7 | 2.50e-01 | -2.51e-01 | 0.76900 |
| GOMF TPR DOMAIN BINDING | 7 | 2.50e-01 | 2.51e-01 | 0.76900 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 9 | 1.92e-01 | 2.51e-01 | 0.73100 |
| GOMF GLYCOLIPID BINDING | 18 | 6.51e-02 | 2.51e-01 | 0.56000 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 24 | 3.33e-02 | 2.51e-01 | 0.47800 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 23 | 3.73e-02 | 2.51e-01 | 0.48200 |
| GOCC CKM COMPLEX | 5 | 3.32e-01 | -2.51e-01 | 0.81900 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 10 | 1.70e-01 | 2.50e-01 | 0.71300 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 1.50e-01 | -2.50e-01 | 0.69000 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 5.26e-02 | 2.50e-01 | 0.52500 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 1.94e-01 | 2.50e-01 | 0.73300 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 10 | 1.71e-01 | -2.50e-01 | 0.71400 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 2.89e-01 | 2.50e-01 | 0.79300 |
| GOBP HARD PALATE DEVELOPMENT | 5 | 3.33e-01 | 2.50e-01 | 0.82000 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 17 | 7.44e-02 | -2.50e-01 | 0.58100 |
| GOBP SKELETAL MUSCLE ADAPTATION | 8 | 2.21e-01 | 2.50e-01 | 0.75000 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 51 | 2.07e-03 | 2.49e-01 | 0.19300 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 24 | 3.45e-02 | 2.49e-01 | 0.48200 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 25 | 3.10e-02 | 2.49e-01 | 0.47200 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 10 | 1.72e-01 | -2.49e-01 | 0.71400 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 8 | 2.23e-01 | -2.49e-01 | 0.75100 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 5 | 3.35e-01 | -2.49e-01 | 0.82200 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 2.55e-01 | 2.49e-01 | 0.77600 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 1.53e-01 | -2.49e-01 | 0.69000 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 8.53e-02 | 2.49e-01 | 0.60400 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 9 | 1.97e-01 | -2.48e-01 | 0.73500 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 1.36e-01 | -2.48e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 7.64e-02 | -2.48e-01 | 0.58500 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 6.83e-02 | -2.48e-01 | 0.57100 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 14 | 1.08e-01 | 2.48e-01 | 0.63800 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.92e-01 | -2.48e-01 | 0.79500 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 2.56e-01 | -2.48e-01 | 0.77800 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 22 | 4.42e-02 | 2.48e-01 | 0.50300 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 6 | 2.93e-01 | 2.48e-01 | 0.79600 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 1.37e-01 | 2.48e-01 | 0.68000 |
| GOCC KINOCILIUM | 6 | 2.94e-01 | -2.48e-01 | 0.79600 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 12 | 1.38e-01 | 2.48e-01 | 0.68000 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 8 | 2.26e-01 | 2.47e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 3.38e-01 | -2.47e-01 | 0.82700 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 1.55e-01 | 2.47e-01 | 0.69300 |
| GOBP PROGESTERONE METABOLIC PROCESS | 9 | 1.99e-01 | -2.47e-01 | 0.73600 |
| GOBP CELL FATE DETERMINATION | 14 | 1.09e-01 | 2.47e-01 | 0.63900 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 28 | 2.35e-02 | 2.47e-01 | 0.42300 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 3.39e-01 | 2.47e-01 | 0.82700 |
| GOCC ESC E Z COMPLEX | 9 | 1.99e-01 | -2.47e-01 | 0.73600 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 14 | 1.10e-01 | 2.47e-01 | 0.63900 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 8 | 2.27e-01 | -2.47e-01 | 0.75100 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 10 | 1.76e-01 | 2.47e-01 | 0.71600 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 3.39e-01 | 2.47e-01 | 0.82700 |
| GOMF LIPASE INHIBITOR ACTIVITY | 7 | 2.58e-01 | 2.47e-01 | 0.77900 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 2.58e-01 | 2.47e-01 | 0.77900 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 1.10e-01 | 2.47e-01 | 0.64000 |
| GOBP RRNA MODIFICATION | 31 | 1.77e-02 | 2.46e-01 | 0.38600 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 10 | 1.78e-01 | 2.46e-01 | 0.71700 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 18 | 7.06e-02 | -2.46e-01 | 0.57500 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 2.01e-01 | -2.46e-01 | 0.73700 |
| GOCC LEWY BODY | 7 | 2.60e-01 | -2.46e-01 | 0.78000 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 2.97e-01 | 2.46e-01 | 0.80000 |
| GOMF MHC CLASS IB PROTEIN BINDING | 6 | 2.97e-01 | 2.46e-01 | 0.80000 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 8 | 2.29e-01 | 2.46e-01 | 0.75400 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 3.41e-01 | 2.46e-01 | 0.82800 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 7 | 2.60e-01 | -2.46e-01 | 0.78000 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 1.99e-02 | -2.46e-01 | 0.40200 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 6 | 2.97e-01 | -2.46e-01 | 0.80000 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 2.97e-01 | -2.46e-01 | 0.80000 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 2.97e-01 | -2.46e-01 | 0.80000 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 6 | 2.98e-01 | -2.45e-01 | 0.80100 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 10 | 1.80e-01 | 2.45e-01 | 0.71700 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 3.39e-02 | 2.45e-01 | 0.48200 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 13 | 1.26e-01 | 2.45e-01 | 0.67300 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 23 | 4.21e-02 | 2.45e-01 | 0.49800 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 9 | 2.03e-01 | 2.45e-01 | 0.73800 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 7 | 2.62e-01 | -2.45e-01 | 0.78300 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 3.43e-01 | -2.45e-01 | 0.82900 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 2.04e-01 | 2.45e-01 | 0.73800 |
| GOBP MANGANESE ION TRANSPORT | 9 | 2.04e-01 | 2.45e-01 | 0.73800 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 12 | 1.42e-01 | 2.45e-01 | 0.68500 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 3.44e-01 | -2.45e-01 | 0.82900 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 6 | 3.00e-01 | -2.44e-01 | 0.80400 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 23 | 4.26e-02 | 2.44e-01 | 0.50000 |
| GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 5 | 3.44e-01 | 2.44e-01 | 0.83000 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 2.32e-01 | -2.44e-01 | 0.75600 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 6 | 3.01e-01 | -2.44e-01 | 0.80400 |
| GOBP RESPONSE TO VITAMIN A | 5 | 3.45e-01 | -2.44e-01 | 0.83100 |
| GOBP ICOSANOID SECRETION | 18 | 7.34e-02 | 2.44e-01 | 0.58000 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 2.64e-01 | 2.44e-01 | 0.78300 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 6 | 3.01e-01 | -2.44e-01 | 0.80400 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 7 | 2.65e-01 | -2.43e-01 | 0.78300 |
| GOBP UTERUS DEVELOPMENT | 11 | 1.62e-01 | -2.43e-01 | 0.70100 |
| GOCC METHYLOSOME | 12 | 1.45e-01 | 2.43e-01 | 0.68500 |
| GOCC GROWTH CONE MEMBRANE | 6 | 3.02e-01 | 2.43e-01 | 0.80400 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 3.46e-01 | 2.43e-01 | 0.83200 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 12 | 1.45e-01 | 2.43e-01 | 0.68500 |
| GOMF ACID THIOL LIGASE ACTIVITY | 22 | 4.84e-02 | 2.43e-01 | 0.51200 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 10 | 1.83e-01 | -2.43e-01 | 0.72100 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 3.47e-01 | 2.43e-01 | 0.83200 |
| GOCC 90S PRERIBOSOME | 25 | 3.54e-02 | 2.43e-01 | 0.48200 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 32 | 1.75e-02 | -2.43e-01 | 0.38400 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 10 | 1.84e-01 | -2.43e-01 | 0.72100 |
| GOMF CO SMAD BINDING | 8 | 2.34e-01 | -2.43e-01 | 0.75900 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 3.48e-01 | -2.43e-01 | 0.83300 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 7 | 2.67e-01 | 2.42e-01 | 0.78400 |
| GOCC M BAND | 14 | 1.17e-01 | -2.42e-01 | 0.65700 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 25 | 3.62e-02 | 2.42e-01 | 0.48200 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 7 | 2.68e-01 | -2.42e-01 | 0.78500 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 10 | 1.85e-01 | 2.42e-01 | 0.72300 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 1.31e-01 | 2.42e-01 | 0.67600 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 3.05e-01 | 2.42e-01 | 0.80600 |
| GOCC DENDRITE MEMBRANE | 13 | 1.31e-01 | 2.42e-01 | 0.67600 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 6.14e-02 | 2.42e-01 | 0.54900 |
| GOBP NADH METABOLIC PROCESS | 9 | 2.10e-01 | 2.41e-01 | 0.73900 |
| GOBP CRISTAE FORMATION | 17 | 8.50e-02 | 2.41e-01 | 0.60300 |
| GOCC CILIARY ROOTLET | 11 | 1.66e-01 | -2.41e-01 | 0.70500 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 2.69e-01 | 2.41e-01 | 0.78700 |
| GOCC GBAF COMPLEX | 13 | 1.32e-01 | 2.41e-01 | 0.67800 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 1.48e-01 | 2.41e-01 | 0.68800 |
| GOMF LONG CHAIN FATTY ACID BINDING | 10 | 1.87e-01 | -2.41e-01 | 0.72500 |
| GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 5 | 3.51e-01 | 2.41e-01 | 0.83500 |
| GOBP N ACYLETHANOLAMINE METABOLIC PROCESS | 5 | 3.51e-01 | 2.41e-01 | 0.83500 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 6 | 3.07e-01 | 2.41e-01 | 0.80700 |
| GOCC SPINDLE POLE CENTROSOME | 11 | 1.67e-01 | -2.41e-01 | 0.70800 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 9 | 2.12e-01 | 2.41e-01 | 0.74000 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 37 | 1.14e-02 | 2.40e-01 | 0.34300 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 11 | 1.68e-01 | 2.40e-01 | 0.70800 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 3.08e-01 | 2.40e-01 | 0.80700 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 35 | 1.39e-02 | 2.40e-01 | 0.37200 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 3.52e-01 | -2.40e-01 | 0.83500 |
| GOCC BRCA1 A COMPLEX | 8 | 2.40e-01 | 2.40e-01 | 0.76200 |
| GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 3.53e-01 | 2.40e-01 | 0.83500 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 1.89e-01 | -2.40e-01 | 0.72900 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 10 | 1.89e-01 | 2.40e-01 | 0.72900 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 5 | 3.54e-01 | -2.39e-01 | 0.83600 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 2.73e-01 | -2.39e-01 | 0.78900 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 25 | 3.84e-02 | 2.39e-01 | 0.48600 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 3.54e-01 | 2.39e-01 | 0.83600 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 3.54e-01 | -2.39e-01 | 0.83600 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 8 | 2.42e-01 | 2.39e-01 | 0.76400 |
| GOBP LEUKOTRIENE TRANSPORT | 6 | 3.11e-01 | 2.39e-01 | 0.80800 |
| GOBP SPERM CAPACITATION | 10 | 1.91e-01 | -2.39e-01 | 0.73000 |
| GOBP DESMOSOME ORGANIZATION | 5 | 3.55e-01 | 2.39e-01 | 0.83600 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 7 | 2.74e-01 | -2.39e-01 | 0.79000 |
| GOMF ACTIVIN RECEPTOR BINDING | 6 | 3.11e-01 | -2.39e-01 | 0.80800 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 3.55e-01 | -2.39e-01 | 0.83600 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 3.56e-01 | -2.38e-01 | 0.83600 |
| GOMF PEPTIDE ANTIGEN BINDING | 31 | 2.16e-02 | 2.38e-01 | 0.41700 |
| GOBP NEURONAL ACTION POTENTIAL | 13 | 1.37e-01 | -2.38e-01 | 0.68000 |
| GOCC AUTOLYSOSOME | 12 | 1.53e-01 | -2.38e-01 | 0.69000 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 9 | 2.16e-01 | 2.38e-01 | 0.74300 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 13 | 1.37e-01 | 2.38e-01 | 0.68000 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 2.43e-01 | 2.38e-01 | 0.76600 |
| GOBP DCMP CATABOLIC PROCESS | 5 | 3.57e-01 | -2.38e-01 | 0.83600 |
| GOCC SECONDARY LYSOSOME | 17 | 8.95e-02 | -2.38e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 3.58e-01 | 2.37e-01 | 0.83600 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 7 | 2.77e-01 | 2.37e-01 | 0.79000 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 3.58e-01 | 2.37e-01 | 0.83600 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 8 | 2.45e-01 | 2.37e-01 | 0.76800 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 2.77e-01 | -2.37e-01 | 0.79000 |
| GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS | 5 | 3.58e-01 | -2.37e-01 | 0.83600 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 13 | 1.39e-01 | 2.37e-01 | 0.68200 |
| GOCC ANNULATE LAMELLAE | 5 | 3.59e-01 | 2.37e-01 | 0.83600 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 1.85e-02 | -2.37e-01 | 0.38900 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 1.95e-01 | 2.37e-01 | 0.73400 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 18 | 8.20e-02 | -2.37e-01 | 0.59900 |
| GOBP NUCLEOPHAGY | 17 | 9.12e-02 | -2.37e-01 | 0.61300 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 19 | 7.42e-02 | -2.37e-01 | 0.58100 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 21 | 6.06e-02 | -2.37e-01 | 0.54500 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 3.60e-01 | 2.37e-01 | 0.83700 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 11 | 1.75e-01 | -2.36e-01 | 0.71600 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 14 | 1.26e-01 | -2.36e-01 | 0.67300 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 2.48e-01 | 2.36e-01 | 0.76800 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 2.48e-01 | 2.36e-01 | 0.76800 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 11 | 1.75e-01 | -2.36e-01 | 0.71600 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 9 | 2.20e-01 | 2.36e-01 | 0.75000 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 21 | 6.13e-02 | -2.36e-01 | 0.54900 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 1.97e-01 | 2.36e-01 | 0.73500 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 3.61e-01 | 2.36e-01 | 0.83900 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 3.62e-01 | -2.35e-01 | 0.83900 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 8 | 2.49e-01 | -2.35e-01 | 0.76800 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 3.62e-01 | 2.35e-01 | 0.83900 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 15 | 1.15e-01 | -2.35e-01 | 0.65200 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 3.63e-01 | 2.35e-01 | 0.83900 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 11 | 1.78e-01 | -2.35e-01 | 0.71700 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 3.63e-01 | -2.35e-01 | 0.83900 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 2.23e-01 | 2.35e-01 | 0.75100 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 44 | 7.14e-03 | 2.34e-01 | 0.28800 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 3.64e-01 | -2.34e-01 | 0.83900 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 3.20e-01 | 2.34e-01 | 0.81400 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 2.51e-01 | 2.34e-01 | 0.77200 |
| GOMF MHC CLASS II PROTEIN BINDING | 5 | 3.64e-01 | 2.34e-01 | 0.83900 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 6 | 3.21e-01 | -2.34e-01 | 0.81400 |
| GOBP REPLICATIVE SENESCENCE | 13 | 1.44e-01 | 2.34e-01 | 0.68500 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 18 | 8.57e-02 | -2.34e-01 | 0.60500 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 2.84e-01 | -2.34e-01 | 0.79100 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 6 | 3.21e-01 | -2.34e-01 | 0.81400 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 13 | 1.45e-01 | -2.34e-01 | 0.68500 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 7 | 2.85e-01 | -2.33e-01 | 0.79100 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 9 | 2.26e-01 | 2.33e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 7 | 2.85e-01 | -2.33e-01 | 0.79100 |
| GOBP CYTOLYSIS | 5 | 3.67e-01 | 2.33e-01 | 0.84000 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 2.26e-01 | 2.33e-01 | 0.75100 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 2.02e-01 | 2.33e-01 | 0.73800 |
| GOBP RESPONSE TO CAFFEINE | 12 | 1.62e-01 | 2.33e-01 | 0.70100 |
| GOBP PYROPTOSIS | 30 | 2.72e-02 | 2.33e-01 | 0.44300 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 2.86e-01 | 2.33e-01 | 0.79100 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 46 | 6.25e-03 | 2.33e-01 | 0.27000 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 11 | 1.81e-01 | 2.33e-01 | 0.71900 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 2.86e-01 | -2.33e-01 | 0.79100 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 2.26e-01 | 2.33e-01 | 0.75100 |
| GOBP AGGRESOME ASSEMBLY | 5 | 3.67e-01 | 2.33e-01 | 0.84000 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 2.54e-01 | 2.33e-01 | 0.77600 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 9 | 2.27e-01 | 2.33e-01 | 0.75100 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 2.86e-01 | -2.33e-01 | 0.79100 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 3.24e-01 | 2.33e-01 | 0.81500 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 2.27e-01 | 2.33e-01 | 0.75100 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 9 | 2.27e-01 | 2.33e-01 | 0.75100 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 3.24e-01 | -2.33e-01 | 0.81500 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 19 | 7.95e-02 | 2.32e-01 | 0.59300 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 3.69e-01 | -2.32e-01 | 0.84000 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 15 | 1.20e-01 | -2.32e-01 | 0.66400 |
| GOBP CDP CHOLINE PATHWAY | 6 | 3.25e-01 | 2.32e-01 | 0.81600 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 1.83e-01 | 2.32e-01 | 0.72100 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 2.88e-01 | 2.32e-01 | 0.79300 |
| GOBP REGULATION OF SYNAPSE MATURATION | 11 | 1.83e-01 | 2.32e-01 | 0.72100 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 2.57e-01 | 2.32e-01 | 0.77800 |
| GOBP TROPHOBLAST CELL MIGRATION | 10 | 2.05e-01 | -2.32e-01 | 0.73800 |
| GOBP GOLGI RIBBON FORMATION | 9 | 2.29e-01 | -2.31e-01 | 0.75400 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 3.27e-01 | 2.31e-01 | 0.81700 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 3.71e-01 | 2.31e-01 | 0.84100 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 1.38e-02 | -2.31e-01 | 0.37200 |
| GOBP ORGANELLE INHERITANCE | 13 | 1.49e-01 | 2.31e-01 | 0.69000 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 2.06e-01 | -2.31e-01 | 0.73900 |
| GOCC MLL1 2 COMPLEX | 32 | 2.38e-02 | 2.31e-01 | 0.42500 |
| GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 5 | 3.71e-01 | 2.31e-01 | 0.84100 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 2.06e-01 | 2.31e-01 | 0.73900 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 11 | 1.85e-01 | 2.31e-01 | 0.72300 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 13 | 1.50e-01 | -2.31e-01 | 0.69000 |
| GOCC MALE PRONUCLEUS | 6 | 3.28e-01 | 2.31e-01 | 0.81800 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 17 | 9.97e-02 | 2.31e-01 | 0.62400 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 11 | 1.86e-01 | -2.30e-01 | 0.72300 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 3.28e-01 | -2.30e-01 | 0.81800 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 13 | 1.50e-01 | -2.30e-01 | 0.69000 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 11 | 1.86e-01 | -2.30e-01 | 0.72300 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 10 | 2.07e-01 | -2.30e-01 | 0.73900 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 2.32e-01 | 2.30e-01 | 0.75600 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 33 | 2.23e-02 | 2.30e-01 | 0.41800 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 9 | 2.32e-01 | -2.30e-01 | 0.75600 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 15 | 1.23e-01 | 2.30e-01 | 0.67000 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 1.87e-01 | 2.30e-01 | 0.72500 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 6 | 3.30e-01 | -2.30e-01 | 0.81800 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 10 | 2.09e-01 | 2.29e-01 | 0.73900 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 3.31e-01 | -2.29e-01 | 0.81800 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 2.94e-01 | 2.29e-01 | 0.79600 |
| GOBP PROSTAGLANDIN TRANSPORT | 13 | 1.53e-01 | 2.29e-01 | 0.69000 |
| GOBP RESPONSE TO CALCIUM ION | 88 | 2.06e-04 | 2.29e-01 | 0.09760 |
| GOMF DNA POLYMERASE BINDING | 21 | 6.94e-02 | 2.29e-01 | 0.57400 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 9 | 2.34e-01 | 2.29e-01 | 0.75900 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 9.28e-02 | 2.29e-01 | 0.61300 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 13 | 1.54e-01 | 2.28e-01 | 0.69000 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 2.11e-01 | -2.28e-01 | 0.74000 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 62 | 1.89e-03 | -2.28e-01 | 0.19300 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 38 | 1.49e-02 | 2.28e-01 | 0.37400 |
| GOBP G1 TO G0 TRANSITION | 13 | 1.55e-01 | 2.28e-01 | 0.69100 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 2.36e-01 | -2.28e-01 | 0.76000 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 15 | 1.26e-01 | -2.28e-01 | 0.67300 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 16 | 1.14e-01 | 2.28e-01 | 0.65100 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 23 | 5.85e-02 | 2.28e-01 | 0.53800 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 1.55e-01 | 2.28e-01 | 0.69200 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 10 | 2.12e-01 | -2.28e-01 | 0.74000 |
| GOCC INO80 COMPLEX | 15 | 1.27e-01 | 2.28e-01 | 0.67300 |
| GOMF RETROMER COMPLEX BINDING | 9 | 2.37e-01 | 2.28e-01 | 0.76100 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 3.78e-01 | 2.28e-01 | 0.84400 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 7.12e-02 | 2.27e-01 | 0.57700 |
| GOMF NARROW PORE CHANNEL ACTIVITY | 5 | 3.79e-01 | 2.27e-01 | 0.84400 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 1.92e-01 | 2.27e-01 | 0.73100 |
| GOBP CENTRIOLE ASSEMBLY | 44 | 9.09e-03 | 2.27e-01 | 0.30700 |
| GOBP VASODILATION | 28 | 3.74e-02 | 2.27e-01 | 0.48200 |
| GOBP DORSAL AORTA DEVELOPMENT | 6 | 3.35e-01 | -2.27e-01 | 0.82200 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 12 | 1.73e-01 | 2.27e-01 | 0.71500 |
| GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING | 5 | 3.79e-01 | 2.27e-01 | 0.84400 |
| GOBP TAURINE TRANSPORT | 6 | 3.36e-01 | -2.27e-01 | 0.82300 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 2.67e-01 | 2.27e-01 | 0.78400 |
| GOBP TONGUE DEVELOPMENT | 6 | 3.37e-01 | 2.27e-01 | 0.82400 |
| GOBP PROSTATE GLAND GROWTH | 5 | 3.80e-01 | -2.27e-01 | 0.84400 |
| GOBP CYTOPLASM ORGANIZATION | 10 | 2.15e-01 | -2.26e-01 | 0.74300 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 33 | 2.48e-02 | 2.26e-01 | 0.43100 |
| GOMF AMP BINDING | 13 | 1.59e-01 | -2.26e-01 | 0.69900 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 12 | 1.76e-01 | -2.26e-01 | 0.71600 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 7 | 3.02e-01 | -2.25e-01 | 0.80400 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 3.02e-01 | -2.25e-01 | 0.80400 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 6 | 3.40e-01 | 2.25e-01 | 0.82700 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 1.31e-01 | 2.25e-01 | 0.67600 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 10 | 2.18e-01 | 2.25e-01 | 0.74600 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 6 | 3.40e-01 | -2.25e-01 | 0.82700 |
| GOBP CAMP CATABOLIC PROCESS | 8 | 2.70e-01 | 2.25e-01 | 0.78800 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 1.60e-01 | -2.25e-01 | 0.69900 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 22 | 6.80e-02 | 2.25e-01 | 0.57100 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 11 | 1.97e-01 | 2.25e-01 | 0.73500 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 28 | 3.95e-02 | -2.25e-01 | 0.49000 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 3.84e-01 | 2.25e-01 | 0.84500 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 28 | 3.96e-02 | -2.25e-01 | 0.49000 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 3.84e-01 | -2.25e-01 | 0.84500 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 18 | 9.90e-02 | 2.25e-01 | 0.62400 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 2.71e-01 | -2.25e-01 | 0.78800 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 25 | 5.21e-02 | -2.24e-01 | 0.52500 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 5 | 3.85e-01 | -2.24e-01 | 0.84600 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 2.20e-01 | -2.24e-01 | 0.74900 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 16 | 1.21e-01 | 2.24e-01 | 0.66700 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 2.73e-01 | -2.24e-01 | 0.78900 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 2.73e-01 | -2.24e-01 | 0.78900 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 5.80e-02 | -2.24e-01 | 0.53800 |
| GOBP APICAL PROTEIN LOCALIZATION | 8 | 2.74e-01 | 2.23e-01 | 0.79000 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 1.80e-01 | 2.23e-01 | 0.71800 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 9 | 2.46e-01 | -2.23e-01 | 0.76800 |
| GOCC JUXTAPARANODE REGION OF AXON | 7 | 3.06e-01 | -2.23e-01 | 0.80700 |
| GOBP FAS SIGNALING PATHWAY | 6 | 3.44e-01 | -2.23e-01 | 0.82900 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 6 | 3.44e-01 | 2.23e-01 | 0.82900 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 2.01e-01 | -2.23e-01 | 0.73700 |
| GOBP NUCLEUS LOCALIZATION | 29 | 3.79e-02 | 2.23e-01 | 0.48400 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 2.23e-01 | -2.22e-01 | 0.75100 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 6 | 3.46e-01 | 2.22e-01 | 0.83200 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 1.24e-01 | 2.22e-01 | 0.67200 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 2.49e-01 | 2.22e-01 | 0.76800 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 2.02e-01 | -2.22e-01 | 0.73800 |
| GOBP RNA METHYLATION | 87 | 3.49e-04 | 2.22e-01 | 0.09760 |
| GOBP PHOSPHATE ION TRANSPORT | 16 | 1.24e-01 | -2.22e-01 | 0.67200 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 2.77e-01 | -2.22e-01 | 0.79000 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 2.49e-01 | 2.22e-01 | 0.76900 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 3.90e-01 | 2.22e-01 | 0.85200 |
| GOBP PROTEIN NEDDYLATION | 27 | 4.61e-02 | -2.22e-01 | 0.50600 |
| GOBP CATECHOLAMINE UPTAKE | 7 | 3.10e-01 | 2.22e-01 | 0.80800 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 16 | 1.25e-01 | 2.22e-01 | 0.67200 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 11 | 2.03e-01 | 2.22e-01 | 0.73800 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 8 | 2.78e-01 | -2.22e-01 | 0.79000 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 19 | 9.48e-02 | -2.21e-01 | 0.61900 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 1.04e-01 | -2.21e-01 | 0.63300 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 1.67e-01 | -2.21e-01 | 0.70800 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 3.48e-01 | 2.21e-01 | 0.83300 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 2.79e-01 | -2.21e-01 | 0.79000 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 3.92e-01 | 2.21e-01 | 0.85300 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 3.49e-01 | -2.21e-01 | 0.83300 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 2.26e-01 | 2.21e-01 | 0.75100 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 3.93e-01 | -2.21e-01 | 0.85400 |
| GOMF RAGE RECEPTOR BINDING | 9 | 2.52e-01 | -2.21e-01 | 0.77200 |
| GOBP DELAMINATION | 5 | 3.93e-01 | 2.21e-01 | 0.85400 |
| GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX | 6 | 3.49e-01 | 2.21e-01 | 0.83400 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 2.80e-01 | 2.21e-01 | 0.79000 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 3.93e-01 | -2.21e-01 | 0.85400 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 3.93e-01 | -2.21e-01 | 0.85400 |
| GOBP SECONDARY PALATE DEVELOPMENT | 14 | 1.53e-01 | -2.21e-01 | 0.69000 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 20 | 8.79e-02 | -2.20e-01 | 0.61300 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 14 | 1.54e-01 | -2.20e-01 | 0.69000 |
| GOBP MIDBODY ABSCISSION | 14 | 1.54e-01 | 2.20e-01 | 0.69000 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 36 | 2.23e-02 | 2.20e-01 | 0.41800 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.51e-01 | 2.20e-01 | 0.83500 |
| GOBP SYNAPTIC VESICLE PRIMING | 15 | 1.40e-01 | -2.20e-01 | 0.68500 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 2.82e-01 | 2.20e-01 | 0.79000 |
| GOBP RESPONSE TO INTERFERON BETA | 28 | 4.41e-02 | 2.20e-01 | 0.50200 |
| GOBP NEUTROPHIL HOMEOSTASIS | 18 | 1.06e-01 | 2.20e-01 | 0.63500 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 3.95e-01 | -2.20e-01 | 0.85400 |
| GOMF PROTEOGLYCAN BINDING | 19 | 9.74e-02 | 2.20e-01 | 0.62300 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 2.82e-01 | 2.20e-01 | 0.79000 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 3.95e-01 | 2.20e-01 | 0.85400 |
| GOBP SYNAPSE MATURATION | 18 | 1.07e-01 | 2.20e-01 | 0.63500 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 5 | 3.95e-01 | 2.20e-01 | 0.85400 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 3.96e-01 | -2.19e-01 | 0.85400 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 2.83e-01 | 2.19e-01 | 0.79000 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 10 | 2.30e-01 | -2.19e-01 | 0.75400 |
| GOBP L ALANINE TRANSPORT | 6 | 3.52e-01 | 2.19e-01 | 0.83500 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.52e-01 | 2.19e-01 | 0.83500 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 3.96e-01 | -2.19e-01 | 0.85400 |
| GOBP REGULATION OF SENSORY PERCEPTION | 7 | 3.15e-01 | -2.19e-01 | 0.81100 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 2.08e-01 | -2.19e-01 | 0.73900 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 48 | 8.72e-03 | 2.19e-01 | 0.30000 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 10 | 2.31e-01 | -2.19e-01 | 0.75500 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 21 | 8.28e-02 | 2.19e-01 | 0.60000 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 5 | 3.97e-01 | 2.19e-01 | 0.85500 |
| GOBP KINETOCHORE ORGANIZATION | 19 | 9.91e-02 | 2.19e-01 | 0.62400 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 22 | 7.60e-02 | -2.19e-01 | 0.58400 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 10 | 2.31e-01 | 2.19e-01 | 0.75600 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 20 | 9.07e-02 | -2.19e-01 | 0.61300 |
| GOCC AXONAL GROWTH CONE | 17 | 1.19e-01 | 2.19e-01 | 0.66300 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 1.90e-01 | -2.19e-01 | 0.72900 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 6 | 3.54e-01 | 2.18e-01 | 0.83600 |
| GOBP INTERLEUKIN 5 PRODUCTION | 9 | 2.57e-01 | 2.18e-01 | 0.77800 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 2.32e-01 | 2.18e-01 | 0.75600 |
| GOCC MICROBODY LUMEN | 40 | 1.70e-02 | 2.18e-01 | 0.37900 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 3.18e-01 | -2.18e-01 | 0.81200 |
| GOMF RDNA BINDING | 9 | 2.57e-01 | 2.18e-01 | 0.77800 |
| GOBP LOCOMOTOR RHYTHM | 10 | 2.33e-01 | 2.18e-01 | 0.75600 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 3.55e-01 | 2.18e-01 | 0.83600 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 37 | 2.19e-02 | -2.18e-01 | 0.41800 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 5 | 3.99e-01 | 2.18e-01 | 0.85600 |
| GOCC ZONULA ADHERENS | 7 | 3.20e-01 | -2.17e-01 | 0.81400 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 15 | 1.45e-01 | -2.17e-01 | 0.68500 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 1.93e-01 | 2.17e-01 | 0.73300 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 9 | 2.60e-01 | 2.17e-01 | 0.78000 |
| GOBP MEMBRANE RAFT ORGANIZATION | 19 | 1.02e-01 | 2.17e-01 | 0.62700 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 3.58e-01 | 2.17e-01 | 0.83600 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 16 | 1.34e-01 | -2.17e-01 | 0.67900 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.21e-01 | 2.17e-01 | 0.81400 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 3.58e-01 | -2.16e-01 | 0.83600 |
| GOCC MLL3 4 COMPLEX | 12 | 1.94e-01 | 2.16e-01 | 0.73300 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 5 | 4.02e-01 | 2.16e-01 | 0.85600 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 5 | 4.02e-01 | 2.16e-01 | 0.85600 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 7 | 3.22e-01 | 2.16e-01 | 0.81400 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 2.90e-01 | 2.16e-01 | 0.79300 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 12 | 1.95e-01 | -2.16e-01 | 0.73400 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 2.91e-01 | 2.16e-01 | 0.79300 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 13 | 1.78e-01 | 2.16e-01 | 0.71700 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 2.15e-01 | -2.16e-01 | 0.74300 |
| GOCC BRCA1 C COMPLEX | 6 | 3.60e-01 | 2.16e-01 | 0.83800 |
| GOBP CENTROSOME DUPLICATION | 69 | 1.96e-03 | 2.16e-01 | 0.19300 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 12 | 1.96e-01 | 2.16e-01 | 0.73400 |
| GOMF PROTEIN KINASE B BINDING | 9 | 2.63e-01 | -2.16e-01 | 0.78300 |
| GOMF PHOSPHATIDYLSERINE BINDING | 39 | 1.99e-02 | 2.15e-01 | 0.40200 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 2.63e-01 | -2.15e-01 | 0.78300 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 6 | 3.61e-01 | -2.15e-01 | 0.83900 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 1.97e-01 | 2.15e-01 | 0.73500 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 24 | 6.80e-02 | 2.15e-01 | 0.57100 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 2.39e-01 | 2.15e-01 | 0.76200 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 2.39e-01 | -2.15e-01 | 0.76200 |
| GOBP REGULATION OF PIGMENTATION | 10 | 2.39e-01 | -2.15e-01 | 0.76200 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 20 | 9.59e-02 | -2.15e-01 | 0.62100 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 3.62e-01 | -2.15e-01 | 0.83900 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 10 | 2.40e-01 | -2.15e-01 | 0.76200 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 2.65e-01 | -2.15e-01 | 0.78300 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 23 | 7.50e-02 | 2.15e-01 | 0.58200 |
| GOBP PHENOTYPIC SWITCHING | 6 | 3.63e-01 | 2.14e-01 | 0.83900 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 1.65e-01 | 2.14e-01 | 0.70500 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 4.06e-01 | -2.14e-01 | 0.85800 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 16 | 1.38e-01 | -2.14e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 3.27e-01 | -2.14e-01 | 0.81700 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 43 | 1.52e-02 | -2.14e-01 | 0.37400 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 9 | 2.66e-01 | 2.14e-01 | 0.78400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 30 | 4.27e-02 | -2.14e-01 | 0.50000 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 7 | 3.27e-01 | -2.14e-01 | 0.81800 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 2.42e-01 | 2.14e-01 | 0.76400 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 22 | 8.27e-02 | -2.14e-01 | 0.60000 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 36 | 2.67e-02 | 2.13e-01 | 0.44200 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 2.43e-01 | 2.13e-01 | 0.76500 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 4.09e-01 | -2.13e-01 | 0.85900 |
| GOBP IMP METABOLIC PROCESS | 13 | 1.83e-01 | 2.13e-01 | 0.72100 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 20 | 9.88e-02 | 2.13e-01 | 0.62400 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 4.34e-02 | 2.13e-01 | 0.50100 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 1.84e-01 | 2.13e-01 | 0.72100 |
| GOCC LUMENAL SIDE OF MEMBRANE | 33 | 3.42e-02 | 2.13e-01 | 0.48200 |
| GOMF DEATH DOMAIN BINDING | 11 | 2.21e-01 | -2.13e-01 | 0.75000 |
| GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 6 | 3.66e-01 | -2.13e-01 | 0.84000 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 31 | 4.03e-02 | 2.13e-01 | 0.49100 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 3.30e-01 | 2.13e-01 | 0.81800 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 8.40e-02 | 2.13e-01 | 0.60000 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 19 | 1.08e-01 | 2.13e-01 | 0.63900 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 2.98e-01 | 2.12e-01 | 0.80100 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 1.09e-01 | 2.12e-01 | 0.63900 |
| GOBP AXONAL FASCICULATION | 11 | 2.23e-01 | 2.12e-01 | 0.75100 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 7 | 3.31e-01 | -2.12e-01 | 0.81800 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 3.68e-01 | -2.12e-01 | 0.84000 |
| GOBP SHORT TERM MEMORY | 6 | 3.68e-01 | 2.12e-01 | 0.84000 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 2.23e-01 | 2.12e-01 | 0.75100 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 6 | 3.69e-01 | 2.12e-01 | 0.84000 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 7 | 3.32e-01 | -2.12e-01 | 0.81900 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 4.12e-01 | 2.12e-01 | 0.86000 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 25 | 6.69e-02 | -2.12e-01 | 0.56700 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 7 | 3.32e-01 | 2.12e-01 | 0.81900 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 4.12e-01 | -2.12e-01 | 0.86000 |
| GOBP MONOCYTE CHEMOTAXIS | 34 | 3.27e-02 | 2.12e-01 | 0.47800 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 52 | 8.34e-03 | 2.12e-01 | 0.29500 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 3.33e-01 | -2.11e-01 | 0.82000 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 31 | 4.17e-02 | 2.11e-01 | 0.49700 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 2.47e-01 | -2.11e-01 | 0.76800 |
| GOBP PHAGOSOME LYSOSOME FUSION | 11 | 2.25e-01 | -2.11e-01 | 0.75100 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 3.57e-02 | 2.11e-01 | 0.48200 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 4.13e-01 | 2.11e-01 | 0.86100 |
| GOCC PLATELET DENSE GRANULE | 12 | 2.06e-01 | 2.11e-01 | 0.73800 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 25 | 6.78e-02 | 2.11e-01 | 0.57100 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 12 | 2.06e-01 | 2.11e-01 | 0.73800 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 43 | 1.67e-02 | -2.11e-01 | 0.37900 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 3.71e-01 | 2.11e-01 | 0.84100 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 7 | 3.34e-01 | -2.11e-01 | 0.82200 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 10 | 2.48e-01 | 2.11e-01 | 0.76800 |
| GOBP NUCLEOBASE TRANSPORT | 8 | 3.02e-01 | -2.11e-01 | 0.80400 |
| GOBP GLUTAMATE METABOLIC PROCESS | 19 | 1.12e-01 | -2.11e-01 | 0.64500 |
| GOMF ALPHA CATENIN BINDING | 7 | 3.34e-01 | 2.11e-01 | 0.82200 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 3.35e-01 | -2.11e-01 | 0.82200 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 17 | 1.33e-01 | 2.11e-01 | 0.67800 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 13 | 1.89e-01 | 2.11e-01 | 0.72900 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 25 | 6.86e-02 | -2.10e-01 | 0.57300 |
| GOBP CELLULAR RESPONSE TO UV A | 6 | 3.72e-01 | -2.10e-01 | 0.84100 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 7 | 3.35e-01 | 2.10e-01 | 0.82200 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 9 | 2.75e-01 | 2.10e-01 | 0.79000 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 4.16e-01 | 2.10e-01 | 0.86300 |
| GOMF FERRIC IRON BINDING | 5 | 4.16e-01 | -2.10e-01 | 0.86300 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 3.04e-01 | 2.10e-01 | 0.80500 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 4.16e-01 | -2.10e-01 | 0.86300 |
| GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 6 | 3.73e-01 | -2.10e-01 | 0.84100 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 8.17e-02 | -2.10e-01 | 0.59900 |
| GOBP FACIAL NERVE MORPHOGENESIS | 7 | 3.37e-01 | 2.10e-01 | 0.82400 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 2.09e-01 | 2.10e-01 | 0.73900 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 27 | 5.95e-02 | 2.10e-01 | 0.54100 |
| GOBP TRACHEA FORMATION | 6 | 3.74e-01 | 2.10e-01 | 0.84200 |
| GOMF SIALIC ACID BINDING | 14 | 1.75e-01 | 2.10e-01 | 0.71600 |
| GOBP SEQUESTERING OF IRON ION | 5 | 4.17e-01 | -2.09e-01 | 0.86400 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 1.60e-01 | -2.09e-01 | 0.69900 |
| GOMF ANNEALING ACTIVITY | 9 | 2.77e-01 | 2.09e-01 | 0.79000 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 12 | 2.09e-01 | -2.09e-01 | 0.73900 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 3.75e-01 | 2.09e-01 | 0.84200 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 35 | 3.22e-02 | 2.09e-01 | 0.47800 |
| GOBP ENDOCANNABINOID SIGNALING PATHWAY | 5 | 4.18e-01 | -2.09e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 26 | 6.50e-02 | 2.09e-01 | 0.56000 |
| GOBP SLEEP | 11 | 2.30e-01 | -2.09e-01 | 0.75400 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 10 | 2.52e-01 | 2.09e-01 | 0.77200 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 10 | 2.52e-01 | -2.09e-01 | 0.77200 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 9 | 2.78e-01 | 2.09e-01 | 0.79000 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 3.76e-01 | 2.09e-01 | 0.84200 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 20 | 1.06e-01 | -2.09e-01 | 0.63500 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 11 | 2.31e-01 | -2.08e-01 | 0.75600 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 3.08e-01 | -2.08e-01 | 0.80700 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 8 | 3.08e-01 | -2.08e-01 | 0.80700 |
| GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.20e-01 | 2.08e-01 | 0.86400 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 31 | 4.50e-02 | 2.08e-01 | 0.50300 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 4.20e-01 | -2.08e-01 | 0.86400 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.20e-01 | -2.08e-01 | 0.86400 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.20e-01 | -2.08e-01 | 0.86400 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 1.17e-01 | 2.08e-01 | 0.65700 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 50 | 1.10e-02 | -2.08e-01 | 0.33500 |
| GOBP FORELIMB MORPHOGENESIS | 18 | 1.27e-01 | -2.08e-01 | 0.67300 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 15 | 1.63e-01 | 2.08e-01 | 0.70400 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 7 | 3.41e-01 | -2.08e-01 | 0.82800 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.78e-01 | -2.08e-01 | 0.84400 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 27 | 6.18e-02 | 2.08e-01 | 0.54900 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 4.21e-01 | 2.08e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 25 | 7.24e-02 | -2.08e-01 | 0.57900 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 14 | 1.79e-01 | 2.08e-01 | 0.71700 |
| GOBP PLASMA CELL DIFFERENTIATION | 7 | 3.42e-01 | -2.07e-01 | 0.82900 |
| GOBP REGULATION OF P38MAPK CASCADE | 33 | 3.93e-02 | 2.07e-01 | 0.48900 |
| GOCC SPERM ANNULUS | 6 | 3.80e-01 | -2.07e-01 | 0.84400 |
| GOCC MYOSIN II COMPLEX | 12 | 2.14e-01 | -2.07e-01 | 0.74100 |
| GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION | 5 | 4.23e-01 | -2.07e-01 | 0.86400 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 2.82e-01 | 2.07e-01 | 0.79000 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 3.11e-01 | 2.07e-01 | 0.80800 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 2.58e-01 | 2.07e-01 | 0.77800 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 2.58e-01 | 2.07e-01 | 0.77800 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 16 | 1.52e-01 | -2.07e-01 | 0.69000 |
| GOCC CENTRAL ELEMENT | 6 | 3.81e-01 | -2.07e-01 | 0.84400 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 13 | 1.97e-01 | 2.07e-01 | 0.73500 |
| GOBP PROTEIN UFMYLATION | 6 | 3.81e-01 | -2.07e-01 | 0.84400 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 8.00e-02 | -2.07e-01 | 0.59400 |
| GOBP T CELL CHEMOTAXIS | 18 | 1.29e-01 | 2.06e-01 | 0.67600 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 2.36e-01 | 2.06e-01 | 0.76000 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 21 | 1.02e-01 | 2.06e-01 | 0.62700 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 8 | 3.12e-01 | 2.06e-01 | 0.80900 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 67 | 3.51e-03 | 2.06e-01 | 0.22500 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 10 | 2.59e-01 | -2.06e-01 | 0.77900 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 3.45e-01 | 2.06e-01 | 0.83000 |
| GOBP RRNA TRANSCRIPTION | 32 | 4.35e-02 | 2.06e-01 | 0.50100 |
| GOMF U1 SNRNP BINDING | 6 | 3.82e-01 | -2.06e-01 | 0.84500 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 2.85e-01 | 2.06e-01 | 0.79100 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 2.85e-01 | 2.06e-01 | 0.79100 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 22 | 9.45e-02 | 2.06e-01 | 0.61800 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 3.46e-01 | -2.06e-01 | 0.83100 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 3.83e-01 | -2.06e-01 | 0.84500 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 1.68e-01 | -2.06e-01 | 0.70800 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 1.99e-01 | -2.06e-01 | 0.73600 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 68 | 3.38e-03 | 2.06e-01 | 0.22300 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 2.61e-01 | 2.06e-01 | 0.78000 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 8 | 3.14e-01 | -2.05e-01 | 0.81000 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 3.14e-01 | 2.05e-01 | 0.81000 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 2.61e-01 | -2.05e-01 | 0.78100 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 6 | 3.84e-01 | -2.05e-01 | 0.84500 |
| GOMF FRIZZLED BINDING | 12 | 2.18e-01 | 2.05e-01 | 0.74700 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 4.27e-01 | 2.05e-01 | 0.86400 |
| GOBP DEFINITIVE HEMOPOIESIS | 13 | 2.00e-01 | 2.05e-01 | 0.73700 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 11 | 2.39e-01 | 2.05e-01 | 0.76200 |
| GOCC CCR4 NOT COMPLEX | 14 | 1.84e-01 | -2.05e-01 | 0.72100 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 15 | 1.69e-01 | -2.05e-01 | 0.71100 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 4.27e-01 | -2.05e-01 | 0.86400 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 42 | 2.16e-02 | 2.05e-01 | 0.41700 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 1.56e-01 | 2.05e-01 | 0.69300 |
| GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 4.28e-01 | -2.05e-01 | 0.86400 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 21 | 1.04e-01 | 2.05e-01 | 0.63300 |
| GOBP REGULATION OF ACTIN NUCLEATION | 31 | 4.85e-02 | 2.05e-01 | 0.51200 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 4.28e-01 | -2.05e-01 | 0.86400 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 3.85e-01 | 2.05e-01 | 0.84600 |
| GOCC NODE OF RANVIER | 7 | 3.48e-01 | -2.05e-01 | 0.83300 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 11 | 2.40e-01 | -2.05e-01 | 0.76200 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 11 | 2.40e-01 | 2.05e-01 | 0.76200 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 5 | 4.28e-01 | -2.05e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 3.17e-01 | 2.04e-01 | 0.81100 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 5 | 4.29e-01 | 2.04e-01 | 0.86400 |
| GOBP DIOL METABOLIC PROCESS | 21 | 1.05e-01 | 2.04e-01 | 0.63500 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 2.64e-01 | -2.04e-01 | 0.78300 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 5 | 4.30e-01 | 2.04e-01 | 0.86500 |
| GOBP STEM CELL DIVISION | 22 | 9.80e-02 | 2.04e-01 | 0.62400 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 10 | 2.65e-01 | 2.04e-01 | 0.78300 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 11 | 2.42e-01 | 2.04e-01 | 0.76500 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 17 | 1.46e-01 | 2.04e-01 | 0.68600 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 21 | 1.06e-01 | -2.04e-01 | 0.63500 |
| GOCC NUCLEAR REPLICATION FORK | 30 | 5.37e-02 | 2.04e-01 | 0.52800 |
| GOBP RESPONSE TO DEXAMETHASONE | 22 | 9.86e-02 | 2.03e-01 | 0.62400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 8 | 3.19e-01 | -2.03e-01 | 0.81400 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 4.31e-01 | -2.03e-01 | 0.86600 |
| GOBP NECROPTOTIC PROCESS | 33 | 4.34e-02 | 2.03e-01 | 0.50100 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 7 | 3.53e-01 | 2.03e-01 | 0.83500 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 4.32e-01 | -2.03e-01 | 0.86600 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 3.53e-01 | -2.03e-01 | 0.83500 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 3.53e-01 | 2.03e-01 | 0.83500 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 3.21e-01 | -2.03e-01 | 0.81400 |
| GOCC GRANULAR COMPONENT | 6 | 3.90e-01 | 2.03e-01 | 0.85200 |
| GOCC GOLGI TRANS CISTERNA | 9 | 2.93e-01 | -2.03e-01 | 0.79500 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.21e-01 | 2.02e-01 | 0.81400 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 4.33e-01 | -2.02e-01 | 0.86600 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 2.68e-01 | 2.02e-01 | 0.78600 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 7 | 3.55e-01 | -2.02e-01 | 0.83600 |
| GOCC POLYSOMAL RIBOSOME | 29 | 5.97e-02 | -2.02e-01 | 0.54100 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 3.92e-01 | -2.02e-01 | 0.85300 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 4.34e-01 | 2.02e-01 | 0.86600 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 4.35e-01 | 2.02e-01 | 0.86600 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 3.92e-01 | -2.02e-01 | 0.85300 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 19 | 1.28e-01 | 2.02e-01 | 0.67500 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 15 | 1.76e-01 | 2.02e-01 | 0.71600 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 2.26e-01 | 2.02e-01 | 0.75100 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 2.08e-01 | -2.02e-01 | 0.73900 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 4.35e-01 | -2.02e-01 | 0.86700 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 1.39e-01 | -2.02e-01 | 0.68200 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 3.93e-01 | 2.01e-01 | 0.85400 |
| GOBP MATURATION OF SSU RRNA | 50 | 1.38e-02 | 2.01e-01 | 0.37200 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 41 | 2.58e-02 | 2.01e-01 | 0.43400 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 10 | 2.71e-01 | 2.01e-01 | 0.78800 |
| GOMF 14 3 3 PROTEIN BINDING | 30 | 5.65e-02 | 2.01e-01 | 0.53600 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 7 | 3.57e-01 | 2.01e-01 | 0.83600 |
| GOBP LYMPHANGIOGENESIS | 6 | 3.94e-01 | 2.01e-01 | 0.85400 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 6 | 3.94e-01 | 2.01e-01 | 0.85400 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 18 | 1.40e-01 | 2.01e-01 | 0.68400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 11 | 2.49e-01 | 2.01e-01 | 0.76800 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 2.97e-01 | 2.01e-01 | 0.80000 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 8 | 3.26e-01 | 2.01e-01 | 0.81700 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 3.58e-01 | -2.00e-01 | 0.83600 |
| GOBP MITOCHONDRIAL FUSION | 32 | 4.99e-02 | -2.00e-01 | 0.51700 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 6 | 3.96e-01 | -2.00e-01 | 0.85400 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 9 | 2.98e-01 | -2.00e-01 | 0.80100 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 3.28e-01 | -2.00e-01 | 0.81800 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 9 | 2.99e-01 | -2.00e-01 | 0.80300 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 21 | 1.13e-01 | -2.00e-01 | 0.64900 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 4.39e-01 | 2.00e-01 | 0.86900 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 37 | 3.56e-02 | 2.00e-01 | 0.48200 |
| GOBP PODOSOME ASSEMBLY | 17 | 1.54e-01 | 2.00e-01 | 0.69000 |
| GOBP MITOTIC RECOMBINATION | 22 | 1.05e-01 | 2.00e-01 | 0.63500 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 3.97e-01 | -2.00e-01 | 0.85500 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 8.43e-02 | -2.00e-01 | 0.60100 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 3.61e-01 | -1.99e-01 | 0.83900 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 4.40e-01 | -1.99e-01 | 0.86900 |
| GOMF L ASCORBIC ACID BINDING | 18 | 1.43e-01 | -1.99e-01 | 0.68500 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 9 | 3.01e-01 | -1.99e-01 | 0.80400 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 8 | 3.30e-01 | -1.99e-01 | 0.81800 |
| GOBP ARGININE METABOLIC PROCESS | 12 | 2.33e-01 | -1.99e-01 | 0.75600 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 2.33e-01 | 1.99e-01 | 0.75600 |
| GOCC LATERAL PART OF CELL | 5 | 4.41e-01 | -1.99e-01 | 0.87000 |
| GOMF LIGASE ACTIVITY | 125 | 1.26e-04 | 1.99e-01 | 0.08060 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 7 | 3.62e-01 | 1.99e-01 | 0.83900 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 32 | 5.18e-02 | 1.99e-01 | 0.52400 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 18 | 1.45e-01 | -1.99e-01 | 0.68500 |
| GOBP POSITIVE REGULATION OF ANOIKIS | 5 | 4.42e-01 | 1.99e-01 | 0.87000 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 4.00e-01 | 1.99e-01 | 0.85600 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 14 | 1.99e-01 | -1.98e-01 | 0.73600 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 4.43e-01 | 1.98e-01 | 0.87000 |
| GOMF SELENIUM BINDING | 6 | 4.01e-01 | -1.98e-01 | 0.85600 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 1.57e-01 | 1.98e-01 | 0.69700 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 3.32e-01 | -1.98e-01 | 0.81900 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 23 | 1.00e-01 | 1.98e-01 | 0.62600 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.01e-01 | -1.98e-01 | 0.85600 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 11 | 2.56e-01 | 1.98e-01 | 0.77800 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 16 | 1.71e-01 | 1.98e-01 | 0.71400 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 3.65e-01 | 1.98e-01 | 0.83900 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 2.79e-01 | 1.98e-01 | 0.79000 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 9 | 3.05e-01 | 1.98e-01 | 0.80600 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 4.02e-01 | 1.98e-01 | 0.85600 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 1.72e-01 | -1.97e-01 | 0.71400 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 2.01e-01 | -1.97e-01 | 0.73700 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 22 | 1.09e-01 | -1.97e-01 | 0.63900 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 35 | 4.35e-02 | 1.97e-01 | 0.50100 |
| GOCC CELL TRAILING EDGE | 14 | 2.02e-01 | 1.97e-01 | 0.73800 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 22 | 1.10e-01 | -1.97e-01 | 0.63900 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 1.87e-01 | -1.97e-01 | 0.72400 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 2.38e-01 | -1.97e-01 | 0.76200 |
| GOBP VACUOLAR ACIDIFICATION | 31 | 5.80e-02 | -1.97e-01 | 0.53800 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 2.81e-01 | -1.97e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 5 | 4.46e-01 | 1.97e-01 | 0.87300 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 7.70e-02 | -1.97e-01 | 0.58600 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 7 | 3.68e-01 | -1.97e-01 | 0.84000 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 2.82e-01 | -1.96e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 3.68e-01 | 1.96e-01 | 0.84000 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 32 | 5.46e-02 | 1.96e-01 | 0.53100 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.47e-01 | -1.96e-01 | 0.87300 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 4.47e-01 | -1.96e-01 | 0.87300 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 4.47e-01 | 1.96e-01 | 0.87300 |
| GOBP ZYMOGEN ACTIVATION | 36 | 4.16e-02 | -1.96e-01 | 0.49700 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 12 | 2.39e-01 | 1.96e-01 | 0.76200 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 11 | 2.60e-01 | -1.96e-01 | 0.78000 |
| GOBP LIPID GLYCOSYLATION | 7 | 3.69e-01 | -1.96e-01 | 0.84000 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 30 | 6.33e-02 | -1.96e-01 | 0.55400 |
| GOBP MYOTUBE CELL DEVELOPMENT | 22 | 1.12e-01 | 1.96e-01 | 0.64500 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 14 | 2.05e-01 | 1.96e-01 | 0.73800 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 4.48e-01 | 1.96e-01 | 0.87300 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 4.07e-01 | 1.95e-01 | 0.85800 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 8.47e-02 | -1.95e-01 | 0.60300 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 3.71e-01 | -1.95e-01 | 0.84100 |
| GOBP VESICLE CARGO LOADING | 28 | 7.39e-02 | -1.95e-01 | 0.58100 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 2.85e-01 | 1.95e-01 | 0.79100 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 19 | 1.41e-01 | -1.95e-01 | 0.68500 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 18 | 1.52e-01 | 1.95e-01 | 0.69000 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 2.86e-01 | 1.95e-01 | 0.79100 |
| GOCC WASH COMPLEX | 9 | 3.11e-01 | 1.95e-01 | 0.80800 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 21 | 1.22e-01 | -1.95e-01 | 0.66800 |
| GOMF POLY PURINE TRACT BINDING | 27 | 7.97e-02 | 1.95e-01 | 0.59300 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 15 | 1.91e-01 | -1.95e-01 | 0.73000 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 1.22e-01 | 1.95e-01 | 0.66800 |
| GOCC BLEB | 9 | 3.12e-01 | 1.95e-01 | 0.80800 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 17 | 1.65e-01 | 1.95e-01 | 0.70500 |
| GOMF HORMONE ACTIVITY | 30 | 6.51e-02 | -1.95e-01 | 0.56000 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 1.26e-02 | -1.95e-01 | 0.36200 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 4.51e-01 | 1.95e-01 | 0.87400 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 5 | 4.51e-01 | -1.95e-01 | 0.87400 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 5 | 4.52e-01 | 1.94e-01 | 0.87400 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 39 | 3.57e-02 | 1.94e-01 | 0.48200 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 22 | 1.15e-01 | 1.94e-01 | 0.65200 |
| GOBP GLUCOCORTICOID SECRETION | 8 | 3.41e-01 | -1.94e-01 | 0.82800 |
| GOBP PROTEIN LOCALIZATION TO AXON | 6 | 4.10e-01 | -1.94e-01 | 0.86000 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 11 | 2.65e-01 | -1.94e-01 | 0.78300 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 4.37e-02 | 1.94e-01 | 0.50200 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 9 | 3.13e-01 | -1.94e-01 | 0.81000 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 1.54e-01 | 1.94e-01 | 0.69000 |
| GOCC POSTSYNAPTIC CYTOSOL | 11 | 2.65e-01 | 1.94e-01 | 0.78300 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 4.52e-01 | 1.94e-01 | 0.87400 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 54 | 1.37e-02 | 1.94e-01 | 0.37200 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 7 | 3.74e-01 | 1.94e-01 | 0.84200 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 19 | 1.43e-01 | -1.94e-01 | 0.68500 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 6 | 4.11e-01 | -1.94e-01 | 0.86000 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 4.53e-01 | 1.94e-01 | 0.87400 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 20 | 1.34e-01 | -1.94e-01 | 0.67900 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 10 | 2.89e-01 | 1.94e-01 | 0.79300 |
| GOMF SPECTRIN BINDING | 18 | 1.55e-01 | -1.94e-01 | 0.69200 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 4.11e-01 | 1.94e-01 | 0.86000 |
| GOMF IMMUNOGLOBULIN BINDING | 14 | 2.10e-01 | 1.94e-01 | 0.73900 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 21 | 1.25e-01 | 1.93e-01 | 0.67200 |
| GOMF ADENYLATE CYCLASE BINDING | 5 | 4.54e-01 | 1.93e-01 | 0.87500 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 51 | 1.70e-02 | 1.93e-01 | 0.37900 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 4.54e-01 | 1.93e-01 | 0.87500 |
| GOBP RESPONSE TO PH | 19 | 1.45e-01 | -1.93e-01 | 0.68500 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 4.55e-01 | -1.93e-01 | 0.87500 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 38 | 3.98e-02 | 1.93e-01 | 0.49100 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 18 | 1.57e-01 | -1.93e-01 | 0.69600 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 2.69e-01 | 1.93e-01 | 0.78600 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 4.14e-01 | 1.93e-01 | 0.86200 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 17 | 1.69e-01 | 1.93e-01 | 0.71100 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 21 | 1.27e-01 | 1.93e-01 | 0.67300 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 50 | 1.86e-02 | -1.92e-01 | 0.38900 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 3.78e-01 | -1.92e-01 | 0.84400 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 11 | 2.69e-01 | 1.92e-01 | 0.78700 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 1.11e-01 | 1.92e-01 | 0.64200 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 11 | 2.70e-01 | -1.92e-01 | 0.78800 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 21 | 1.28e-01 | 1.92e-01 | 0.67500 |
| GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 4.57e-01 | -1.92e-01 | 0.87700 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 29 | 7.38e-02 | 1.92e-01 | 0.58100 |
| GOBP RESPONSE TO ACETYLCHOLINE | 21 | 1.29e-01 | 1.92e-01 | 0.67500 |
| GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 5 | 4.58e-01 | 1.92e-01 | 0.87700 |
| GOCC B WICH COMPLEX | 7 | 3.80e-01 | 1.92e-01 | 0.84400 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 2.94e-01 | 1.92e-01 | 0.79700 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 12 | 2.51e-01 | -1.91e-01 | 0.77200 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 5 | 4.59e-01 | -1.91e-01 | 0.87700 |
| GOBP CENTROSOME SEPARATION | 12 | 2.51e-01 | -1.91e-01 | 0.77200 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 1.21e-01 | 1.91e-01 | 0.66600 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 6 | 4.18e-01 | 1.91e-01 | 0.86400 |
| GOBP REGULATION OF DNA LIGATION | 6 | 4.18e-01 | 1.91e-01 | 0.86400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 44 | 2.86e-02 | 1.91e-01 | 0.45600 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 21 | 1.30e-01 | -1.91e-01 | 0.67600 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 4.19e-01 | 1.91e-01 | 0.86400 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 37 | 4.48e-02 | -1.91e-01 | 0.50300 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 18 | 1.61e-01 | 1.91e-01 | 0.70100 |
| GOCC SYNAPTONEMAL STRUCTURE | 29 | 7.57e-02 | -1.91e-01 | 0.58300 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 3.83e-01 | -1.91e-01 | 0.84500 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 1.74e-01 | -1.91e-01 | 0.71600 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 6 | 4.19e-01 | 1.90e-01 | 0.86400 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 3.51e-01 | -1.90e-01 | 0.83500 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 26 | 9.29e-02 | -1.90e-01 | 0.61400 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 42 | 3.28e-02 | 1.90e-01 | 0.47800 |
| GOCC CELL BODY MEMBRANE | 11 | 2.75e-01 | 1.90e-01 | 0.79000 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 3.51e-01 | -1.90e-01 | 0.83500 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 1.75e-01 | 1.90e-01 | 0.71600 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 107 | 6.82e-04 | 1.90e-01 | 0.12200 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 9 | 3.23e-01 | -1.90e-01 | 0.81500 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 4.62e-01 | -1.90e-01 | 0.87900 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 2.18e-01 | -1.90e-01 | 0.74700 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 14 | 2.18e-01 | -1.90e-01 | 0.74700 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 3.84e-01 | 1.90e-01 | 0.84500 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 20 | 1.42e-01 | 1.90e-01 | 0.68500 |
| GOBP RESPONSE TO SORBITOL | 5 | 4.63e-01 | -1.89e-01 | 0.87900 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 20 | 1.43e-01 | 1.89e-01 | 0.68500 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 2.77e-01 | 1.89e-01 | 0.79000 |
| GOBP MISMATCH REPAIR | 26 | 9.48e-02 | 1.89e-01 | 0.61900 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 16 | 1.90e-01 | 1.89e-01 | 0.72900 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 27 | 8.90e-02 | 1.89e-01 | 0.61300 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 1.54e-01 | 1.89e-01 | 0.69000 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 3.30e-03 | 1.89e-01 | 0.21900 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 2.05e-01 | -1.89e-01 | 0.73800 |
| GOCC REPLISOME | 15 | 2.05e-01 | 1.89e-01 | 0.73800 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 8 | 3.55e-01 | -1.89e-01 | 0.83600 |
| GOMF CARBONATE DEHYDRATASE ACTIVITY | 5 | 4.65e-01 | 1.89e-01 | 0.87900 |
| GOBP LIPOXYGENASE PATHWAY | 6 | 4.23e-01 | -1.89e-01 | 0.86400 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 4.23e-01 | -1.89e-01 | 0.86400 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 18 | 1.66e-01 | 1.89e-01 | 0.70500 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 13 | 2.39e-01 | -1.89e-01 | 0.76200 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 18 | 1.66e-01 | 1.89e-01 | 0.70500 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 1.92e-01 | 1.88e-01 | 0.73100 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 2.79e-01 | 1.88e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 13 | 2.40e-01 | 1.88e-01 | 0.76200 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 14 | 2.23e-01 | -1.88e-01 | 0.75100 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 17 | 1.79e-01 | 1.88e-01 | 0.71700 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 17 | 1.80e-01 | 1.88e-01 | 0.71700 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 37 | 4.79e-02 | 1.88e-01 | 0.51100 |
| GOBP RESPONSE TO UV A | 7 | 3.89e-01 | -1.88e-01 | 0.85100 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 50 | 2.15e-02 | 1.88e-01 | 0.41700 |
| GOBP ENDOCRINE HORMONE SECRETION | 26 | 9.73e-02 | -1.88e-01 | 0.62300 |
| GOBP GLUTAMATE SECRETION | 16 | 1.93e-01 | 1.88e-01 | 0.73300 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 3.90e-01 | 1.88e-01 | 0.85100 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 4.68e-01 | -1.88e-01 | 0.87900 |
| GOBP SNRNA TRANSPORT | 6 | 4.27e-01 | -1.87e-01 | 0.86400 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 7 | 3.91e-01 | -1.87e-01 | 0.85300 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 2.25e-01 | 1.87e-01 | 0.75100 |
| GOMF U6 SNRNA BINDING | 14 | 2.25e-01 | -1.87e-01 | 0.75100 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 23 | 1.20e-01 | 1.87e-01 | 0.66400 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 29 | 8.12e-02 | -1.87e-01 | 0.59900 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 6 | 4.27e-01 | 1.87e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 24 | 1.13e-01 | 1.87e-01 | 0.64800 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 20 | 1.48e-01 | -1.87e-01 | 0.68700 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 22 | 1.29e-01 | -1.87e-01 | 0.67500 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 9 | 3.32e-01 | 1.87e-01 | 0.81900 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 2.83e-01 | 1.87e-01 | 0.79100 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 3.92e-01 | -1.87e-01 | 0.85300 |
| GOMF DYNEIN COMPLEX BINDING | 20 | 1.48e-01 | 1.87e-01 | 0.68800 |
| GOMF TAT PROTEIN BINDING | 9 | 3.32e-01 | 1.87e-01 | 0.81900 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 10 | 3.07e-01 | -1.86e-01 | 0.80700 |
| GOBP STARTLE RESPONSE | 16 | 1.97e-01 | -1.86e-01 | 0.73500 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 10 | 3.07e-01 | 1.86e-01 | 0.80700 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 3.08e-01 | 1.86e-01 | 0.80700 |
| GOBP FOREBRAIN MORPHOGENESIS | 6 | 4.29e-01 | 1.86e-01 | 0.86400 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 6 | 4.30e-01 | 1.86e-01 | 0.86500 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 12 | 2.64e-01 | 1.86e-01 | 0.78300 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 8 | 3.62e-01 | -1.86e-01 | 0.83900 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 61 | 1.21e-02 | 1.86e-01 | 0.35300 |
| GOBP QUINONE METABOLIC PROCESS | 30 | 7.81e-02 | 1.86e-01 | 0.58900 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 3.95e-01 | 1.86e-01 | 0.85400 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 4.72e-01 | -1.86e-01 | 0.88000 |
| GOBP REPLACEMENT OSSIFICATION | 13 | 2.47e-01 | 1.86e-01 | 0.76800 |
| GOBP MAMMALIAN OOGENESIS STAGE | 7 | 3.95e-01 | 1.86e-01 | 0.85400 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 2.87e-01 | 1.85e-01 | 0.79100 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 4.31e-01 | 1.85e-01 | 0.86600 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 4.73e-01 | 1.85e-01 | 0.88000 |
| GOBP CELL REDOX HOMEOSTASIS | 35 | 5.78e-02 | 1.85e-01 | 0.53800 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 16 | 1.99e-01 | 1.85e-01 | 0.73600 |
| GOBP HEME TRANSPORT | 8 | 3.64e-01 | -1.85e-01 | 0.83900 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 8 | 3.64e-01 | -1.85e-01 | 0.83900 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.64e-01 | -1.85e-01 | 0.83900 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 19 | 1.62e-01 | 1.85e-01 | 0.70100 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 3.36e-01 | 1.85e-01 | 0.82300 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 2.48e-01 | 1.85e-01 | 0.76800 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 2.00e-01 | 1.85e-01 | 0.73700 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 10 | 3.11e-01 | 1.85e-01 | 0.80800 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 4.33e-01 | 1.85e-01 | 0.86600 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 2.48e-01 | -1.85e-01 | 0.76800 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 10 | 3.12e-01 | -1.85e-01 | 0.80900 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 9 | 3.37e-01 | -1.85e-01 | 0.82500 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 43 | 3.63e-02 | 1.85e-01 | 0.48200 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 7 | 3.98e-01 | -1.85e-01 | 0.85600 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 3.66e-01 | 1.84e-01 | 0.84000 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 49 | 2.56e-02 | 1.84e-01 | 0.43300 |
| GOBP AMELOGENESIS | 11 | 2.90e-01 | -1.84e-01 | 0.79300 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 42 | 3.88e-02 | -1.84e-01 | 0.48700 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 12 | 2.69e-01 | 1.84e-01 | 0.78700 |
| GOBP MRNA METHYLATION | 18 | 1.76e-01 | 1.84e-01 | 0.71600 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 46 | 3.08e-02 | -1.84e-01 | 0.47200 |
| GOMF NOTCH BINDING | 15 | 2.17e-01 | -1.84e-01 | 0.74500 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 4.35e-01 | -1.84e-01 | 0.86700 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 6 | 4.35e-01 | 1.84e-01 | 0.86700 |
| GOMF TELOMERIC DNA BINDING | 37 | 5.29e-02 | 1.84e-01 | 0.52700 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 89 | 2.73e-03 | 1.84e-01 | 0.20700 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 4.35e-01 | 1.84e-01 | 0.86700 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 3.40e-01 | -1.84e-01 | 0.82700 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 4.36e-01 | -1.84e-01 | 0.86700 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 32 | 7.22e-02 | -1.84e-01 | 0.57900 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 4.36e-01 | 1.84e-01 | 0.86700 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 35 | 6.02e-02 | -1.84e-01 | 0.54400 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 10 | 3.15e-01 | -1.84e-01 | 0.81000 |
| GOMF CORECEPTOR ACTIVITY | 27 | 9.88e-02 | 1.84e-01 | 0.62400 |
| GOBP ALANINE TRANSPORT | 10 | 3.15e-01 | 1.84e-01 | 0.81000 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 2.92e-01 | -1.84e-01 | 0.79500 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 9 | 3.40e-01 | -1.84e-01 | 0.82800 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 18 | 1.78e-01 | 1.84e-01 | 0.71700 |
| GOCC TERTIARY GRANULE LUMEN | 46 | 3.14e-02 | -1.83e-01 | 0.47600 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 13 | 2.52e-01 | 1.83e-01 | 0.77200 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 4.78e-01 | 1.83e-01 | 0.88100 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 18 | 1.78e-01 | -1.83e-01 | 0.71700 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 12 | 2.72e-01 | 1.83e-01 | 0.78900 |
| GOMF ANTIOXIDANT ACTIVITY | 56 | 1.79e-02 | -1.83e-01 | 0.38900 |
| GOMF CARDIOLIPIN BINDING | 8 | 3.70e-01 | 1.83e-01 | 0.84000 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 18 | 1.79e-01 | 1.83e-01 | 0.71700 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 8 | 3.70e-01 | -1.83e-01 | 0.84100 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 4.02e-01 | 1.83e-01 | 0.85600 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 2.54e-01 | 1.83e-01 | 0.77600 |
| GOCC SITE OF DOUBLE STRAND BREAK | 82 | 4.26e-03 | 1.83e-01 | 0.24700 |
| GOMF AMIDINE LYASE ACTIVITY | 5 | 4.79e-01 | -1.83e-01 | 0.88200 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.43e-01 | 1.83e-01 | 0.82900 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 71 | 7.84e-03 | -1.83e-01 | 0.29400 |
| GOMF IRON ION BINDING | 80 | 4.79e-03 | -1.83e-01 | 0.25000 |
| GOBP INTRACELLULAR PH REDUCTION | 47 | 3.06e-02 | -1.82e-01 | 0.47200 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 3.72e-01 | 1.82e-01 | 0.84100 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 14 | 2.38e-01 | -1.82e-01 | 0.76200 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 74 | 6.75e-03 | 1.82e-01 | 0.28200 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 4.40e-01 | 1.82e-01 | 0.86900 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 4.04e-01 | -1.82e-01 | 0.85600 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 4.04e-01 | -1.82e-01 | 0.85600 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 2.23e-01 | 1.82e-01 | 0.75100 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 6 | 4.41e-01 | 1.82e-01 | 0.86900 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 16 | 2.08e-01 | 1.82e-01 | 0.73900 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 15 | 2.23e-01 | 1.82e-01 | 0.75100 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 9 | 3.46e-01 | 1.82e-01 | 0.83100 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 1.60e-01 | 1.82e-01 | 0.69900 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 7 | 4.06e-01 | -1.82e-01 | 0.85800 |
| GOBP ENDOCARDIUM DEVELOPMENT | 8 | 3.74e-01 | 1.81e-01 | 0.84200 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 19 | 1.71e-01 | 1.81e-01 | 0.71400 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 5 | 4.83e-01 | 1.81e-01 | 0.88300 |
| GOCC BBSOME | 7 | 4.06e-01 | -1.81e-01 | 0.85800 |
| GOBP MANNOSYLATION | 20 | 1.61e-01 | 1.81e-01 | 0.69900 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 17 | 1.96e-01 | 1.81e-01 | 0.73400 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 8 | 3.75e-01 | -1.81e-01 | 0.84200 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 18 | 1.84e-01 | -1.81e-01 | 0.72100 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 60 | 1.54e-02 | 1.81e-01 | 0.37400 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 13 | 2.59e-01 | 1.81e-01 | 0.77900 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 4.84e-01 | 1.81e-01 | 0.88300 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 50 | 2.71e-02 | 1.81e-01 | 0.44300 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 8 | 3.76e-01 | 1.81e-01 | 0.84200 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 2.42e-01 | -1.81e-01 | 0.76400 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 21 | 1.52e-01 | -1.81e-01 | 0.69000 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 22 | 1.42e-01 | -1.81e-01 | 0.68500 |
| GOBP ODONTOGENESIS | 54 | 2.17e-02 | -1.81e-01 | 0.41700 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 1.34e-01 | -1.81e-01 | 0.67900 |
| GOMF HELICASE ACTIVITY | 136 | 2.83e-04 | 1.81e-01 | 0.09760 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 8 | 3.77e-01 | -1.80e-01 | 0.84300 |
| GOCC FILOPODIUM MEMBRANE | 10 | 3.23e-01 | 1.80e-01 | 0.81500 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 1.12e-01 | 1.80e-01 | 0.64500 |
| GOBP POTASSIUM ION HOMEOSTASIS | 20 | 1.63e-01 | 1.80e-01 | 0.70400 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 29 | 9.32e-02 | -1.80e-01 | 0.61500 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 41 | 4.61e-02 | -1.80e-01 | 0.50600 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 11 | 3.01e-01 | 1.80e-01 | 0.80400 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 10 | 3.24e-01 | 1.80e-01 | 0.81600 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 2.81e-01 | 1.80e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 19 | 1.75e-01 | -1.80e-01 | 0.71600 |
| GOBP TRNA TRANSPORT | 5 | 4.86e-01 | 1.80e-01 | 0.88300 |
| GOBP ETHER METABOLIC PROCESS | 21 | 1.54e-01 | 1.80e-01 | 0.69000 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 6 | 4.46e-01 | 1.80e-01 | 0.87300 |
| GOMF INTERLEUKIN 1 BINDING | 7 | 4.10e-01 | 1.80e-01 | 0.86000 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 9 | 3.50e-01 | -1.80e-01 | 0.83500 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 4.10e-01 | 1.80e-01 | 0.86000 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 15 | 2.28e-01 | 1.80e-01 | 0.75400 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 2.81e-01 | -1.80e-01 | 0.79000 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 32 | 7.89e-02 | 1.80e-01 | 0.59100 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 3.26e-01 | 1.80e-01 | 0.81700 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 58 | 1.81e-02 | 1.80e-01 | 0.38900 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 27 | 1.07e-01 | -1.79e-01 | 0.63500 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 20 | 1.65e-01 | -1.79e-01 | 0.70500 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 4.11e-01 | -1.79e-01 | 0.86000 |
| GOBP AMP METABOLIC PROCESS | 17 | 2.01e-01 | 1.79e-01 | 0.73700 |
| GOBP SPINAL CORD PATTERNING | 6 | 4.47e-01 | 1.79e-01 | 0.87300 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 2.30e-01 | -1.79e-01 | 0.75400 |
| GOCC COP9 SIGNALOSOME | 17 | 2.01e-01 | -1.79e-01 | 0.73700 |
| GOBP T CELL HOMEOSTASIS | 37 | 5.94e-02 | 1.79e-01 | 0.54000 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 13 | 2.64e-01 | 1.79e-01 | 0.78300 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 14 | 2.46e-01 | -1.79e-01 | 0.76800 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 7 | 4.12e-01 | -1.79e-01 | 0.86000 |
| GOBP REGULATION OF VASCULOGENESIS | 7 | 4.12e-01 | -1.79e-01 | 0.86000 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 3.04e-01 | -1.79e-01 | 0.80600 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 15 | 2.30e-01 | 1.79e-01 | 0.75500 |
| GOBP EXCRETION | 10 | 3.27e-01 | -1.79e-01 | 0.81800 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 4.48e-01 | 1.79e-01 | 0.87300 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 2.84e-01 | 1.79e-01 | 0.79100 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 24 | 1.30e-01 | 1.79e-01 | 0.67600 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 4.13e-01 | -1.79e-01 | 0.86000 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 46 | 3.61e-02 | 1.79e-01 | 0.48200 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 4.49e-01 | -1.79e-01 | 0.87300 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 3.82e-01 | 1.78e-01 | 0.84500 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 3.82e-01 | 1.78e-01 | 0.84500 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 2.32e-01 | -1.78e-01 | 0.75600 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 28 | 1.02e-01 | 1.78e-01 | 0.62900 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 3.83e-01 | 1.78e-01 | 0.84500 |
| GOBP MUCUS SECRETION | 10 | 3.29e-01 | -1.78e-01 | 0.81800 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 4.90e-01 | 1.78e-01 | 0.88500 |
| GOBP WNT PROTEIN SECRETION | 5 | 4.91e-01 | -1.78e-01 | 0.88500 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 10 | 3.30e-01 | 1.78e-01 | 0.81800 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 1.79e-01 | -1.78e-01 | 0.71700 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 9 | 3.55e-01 | 1.78e-01 | 0.83600 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 2.67e-01 | 1.78e-01 | 0.78400 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 3.84e-01 | -1.78e-01 | 0.84500 |
| GOMF POLY G BINDING | 8 | 3.84e-01 | -1.78e-01 | 0.84500 |
| GOBP PROTEIN HEXAMERIZATION | 8 | 3.84e-01 | 1.78e-01 | 0.84500 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 22 | 1.50e-01 | 1.77e-01 | 0.69000 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 1.25e-01 | 1.77e-01 | 0.67200 |
| GOBP SNRNA TRANSCRIPTION | 17 | 2.06e-01 | 1.77e-01 | 0.73800 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 4.52e-01 | 1.77e-01 | 0.87400 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 32 | 8.27e-02 | 1.77e-01 | 0.60000 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 24 | 1.33e-01 | 1.77e-01 | 0.67800 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 15 | 2.35e-01 | -1.77e-01 | 0.75900 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 15 | 2.35e-01 | 1.77e-01 | 0.75900 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 23 | 1.41e-01 | 1.77e-01 | 0.68500 |
| GOBP REGULATION OF APPETITE | 9 | 3.58e-01 | -1.77e-01 | 0.83600 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 21 | 1.60e-01 | 1.77e-01 | 0.69900 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 8 | 3.86e-01 | -1.77e-01 | 0.84700 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 8 | 3.86e-01 | -1.77e-01 | 0.84700 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 55 | 2.33e-02 | 1.77e-01 | 0.42300 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 4.18e-01 | 1.77e-01 | 0.86400 |
| GOBP COCHLEA DEVELOPMENT | 14 | 2.52e-01 | -1.77e-01 | 0.77200 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 14 | 2.52e-01 | 1.77e-01 | 0.77200 |
| GOCC DESMOSOME | 12 | 2.89e-01 | -1.77e-01 | 0.79300 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 1.83e-01 | 1.77e-01 | 0.72100 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 13 | 2.70e-01 | 1.77e-01 | 0.78800 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 17 | 2.08e-01 | -1.77e-01 | 0.73900 |
| GOMF NAD BINDING | 49 | 3.26e-02 | 1.77e-01 | 0.47800 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 24 | 1.35e-01 | 1.77e-01 | 0.67900 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 4.54e-01 | 1.76e-01 | 0.87500 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 3.59e-01 | 1.76e-01 | 0.83700 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 42 | 4.80e-02 | -1.76e-01 | 0.51100 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 11 | 3.11e-01 | -1.76e-01 | 0.80800 |
| GOBP TOXIN TRANSPORT | 6 | 4.55e-01 | 1.76e-01 | 0.87500 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 6 | 4.55e-01 | -1.76e-01 | 0.87500 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 39 | 5.70e-02 | 1.76e-01 | 0.53600 |
| GOBP PROTEIN IMPORT | 5 | 4.95e-01 | 1.76e-01 | 0.88600 |
| GOBP PITUITARY GLAND DEVELOPMENT | 8 | 3.88e-01 | 1.76e-01 | 0.85000 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 7 | 4.20e-01 | -1.76e-01 | 0.86400 |
| GOBP MINERALOCORTICOID METABOLIC PROCESS | 5 | 4.95e-01 | -1.76e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 17 | 2.09e-01 | -1.76e-01 | 0.73900 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 26 | 1.20e-01 | -1.76e-01 | 0.66400 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 23 | 1.44e-01 | 1.76e-01 | 0.68500 |
| GOBP AORTA MORPHOGENESIS | 18 | 1.96e-01 | -1.76e-01 | 0.73400 |
| GOBP MELANOCYTE DIFFERENTIATION | 12 | 2.91e-01 | -1.76e-01 | 0.79500 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 47 | 3.71e-02 | -1.76e-01 | 0.48200 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 5 | 4.96e-01 | 1.76e-01 | 0.88600 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 4.96e-01 | -1.76e-01 | 0.88600 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 4.96e-01 | -1.76e-01 | 0.88600 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 6 | 4.56e-01 | 1.76e-01 | 0.87600 |
| GOBP RESPONSE TO CATECHOLAMINE | 45 | 4.17e-02 | 1.76e-01 | 0.49700 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.90e-01 | -1.75e-01 | 0.85200 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 40 | 5.51e-02 | -1.75e-01 | 0.53100 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 85 | 5.27e-03 | 1.75e-01 | 0.25400 |
| GOBP XENOPHAGY | 14 | 2.57e-01 | -1.75e-01 | 0.77800 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 17 | 2.11e-01 | -1.75e-01 | 0.74000 |
| GOCC BETA CATENIN TCF COMPLEX | 11 | 3.15e-01 | -1.75e-01 | 0.81000 |
| GOMF SODIUM CHANNEL ACTIVITY | 13 | 2.75e-01 | -1.75e-01 | 0.79000 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 106 | 1.88e-03 | -1.75e-01 | 0.19300 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 1.63e-03 | -1.75e-01 | 0.19300 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 13 | 2.76e-01 | 1.75e-01 | 0.79000 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 4.99e-01 | 1.75e-01 | 0.88600 |
| GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 5 | 4.99e-01 | 1.75e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 4.59e-01 | 1.74e-01 | 0.87700 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 2.42e-01 | 1.74e-01 | 0.76500 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 10 | 3.40e-01 | -1.74e-01 | 0.82700 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 6 | 4.60e-01 | 1.74e-01 | 0.87700 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 46 | 4.09e-02 | 1.74e-01 | 0.49600 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 3.17e-01 | 1.74e-01 | 0.81100 |
| GOBP G0 TO G1 TRANSITION | 32 | 8.80e-02 | 1.74e-01 | 0.61300 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 5.00e-01 | -1.74e-01 | 0.88600 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 4.25e-01 | 1.74e-01 | 0.86400 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 3.66e-01 | -1.74e-01 | 0.84000 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 79 | 7.50e-03 | -1.74e-01 | 0.29300 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 40 | 5.68e-02 | 1.74e-01 | 0.53600 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 5.00e-01 | 1.74e-01 | 0.88600 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 33 | 8.36e-02 | 1.74e-01 | 0.60000 |
| GOBP TYROSINE CATABOLIC PROCESS | 5 | 5.01e-01 | -1.74e-01 | 0.88600 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 19 | 1.90e-01 | 1.74e-01 | 0.72900 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 5 | 5.01e-01 | 1.74e-01 | 0.88600 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 15 | 2.44e-01 | 1.74e-01 | 0.76600 |
| GOBP REGULATION OF LYASE ACTIVITY | 25 | 1.33e-01 | 1.74e-01 | 0.67800 |
| GOCC SWR1 COMPLEX | 13 | 2.78e-01 | 1.74e-01 | 0.79000 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 16 | 2.29e-01 | 1.74e-01 | 0.75400 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 4.61e-01 | 1.74e-01 | 0.87900 |
| GOBP REGULATION OF HIPPO SIGNALING | 19 | 1.91e-01 | -1.73e-01 | 0.73000 |
| GOMF DNA HELICASE ACTIVITY | 51 | 3.22e-02 | 1.73e-01 | 0.47800 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 10 | 3.43e-01 | -1.73e-01 | 0.82900 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 2.79e-01 | -1.73e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 39 | 6.12e-02 | -1.73e-01 | 0.54800 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 47 | 4.00e-02 | 1.73e-01 | 0.49100 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 8 | 3.96e-01 | -1.73e-01 | 0.85400 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 3.20e-01 | 1.73e-01 | 0.81400 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 5.03e-01 | -1.73e-01 | 0.88700 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 2.46e-01 | 1.73e-01 | 0.76800 |
| GOBP ACROSOME REACTION | 13 | 2.80e-01 | -1.73e-01 | 0.79000 |
| GOBP HORMONE CATABOLIC PROCESS | 5 | 5.03e-01 | -1.73e-01 | 0.88700 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 15 | 2.46e-01 | 1.73e-01 | 0.76800 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 5.03e-01 | 1.73e-01 | 0.88700 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 5 | 5.03e-01 | -1.73e-01 | 0.88700 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 5.03e-01 | 1.73e-01 | 0.88700 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 5.03e-01 | -1.73e-01 | 0.88700 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 2.47e-01 | 1.73e-01 | 0.76800 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.64e-01 | 1.73e-01 | 0.87900 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 9 | 3.70e-01 | 1.73e-01 | 0.84000 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 45 | 4.52e-02 | 1.73e-01 | 0.50300 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 6 | 4.64e-01 | -1.73e-01 | 0.87900 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 6 | 4.64e-01 | 1.73e-01 | 0.87900 |
| GOMF ACYL COA BINDING | 16 | 2.32e-01 | 1.72e-01 | 0.75600 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 5.04e-01 | 1.72e-01 | 0.88800 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 19 | 1.93e-01 | 1.72e-01 | 0.73300 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 6 | 4.65e-01 | -1.72e-01 | 0.87900 |
| GOMF LAMIN BINDING | 14 | 2.65e-01 | 1.72e-01 | 0.78300 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 32 | 9.18e-02 | 1.72e-01 | 0.61300 |
| GOBP KETONE BODY METABOLIC PROCESS | 6 | 4.65e-01 | -1.72e-01 | 0.87900 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 23 | 1.53e-01 | -1.72e-01 | 0.69000 |
| GOCC INO80 TYPE COMPLEX | 26 | 1.29e-01 | 1.72e-01 | 0.67500 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 6 | 4.65e-01 | -1.72e-01 | 0.87900 |
| GOCC ISWI TYPE COMPLEX | 13 | 2.83e-01 | -1.72e-01 | 0.79000 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 3.71e-01 | 1.72e-01 | 0.84100 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 27 | 1.22e-01 | 1.72e-01 | 0.66800 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 20 | 1.83e-01 | -1.72e-01 | 0.72100 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 2.34e-01 | 1.72e-01 | 0.75800 |
| GOMF ADENYLATE KINASE ACTIVITY | 7 | 4.31e-01 | 1.72e-01 | 0.86500 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 31 | 9.76e-02 | 1.72e-01 | 0.62300 |
| GOBP RESPONSE TO DSRNA | 33 | 8.74e-02 | 1.72e-01 | 0.61200 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 3.02e-01 | -1.72e-01 | 0.80400 |
| GOMF PEPTIDE HORMONE BINDING | 18 | 2.07e-01 | -1.72e-01 | 0.73900 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 10 | 3.47e-01 | 1.72e-01 | 0.83300 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 19 | 1.95e-01 | -1.72e-01 | 0.73400 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 4.00e-01 | 1.72e-01 | 0.85600 |
| GOBP SERINE TRANSPORT | 8 | 4.00e-01 | 1.72e-01 | 0.85600 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.00e-01 | 1.72e-01 | 0.85600 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 9 | 3.72e-01 | 1.72e-01 | 0.84100 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 2.66e-01 | -1.72e-01 | 0.78400 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 16 | 2.35e-01 | 1.72e-01 | 0.75900 |
| GOBP BILE ACID SECRETION | 6 | 4.67e-01 | -1.72e-01 | 0.87900 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 12 | 3.03e-01 | -1.72e-01 | 0.80500 |
| GOCC CORVET COMPLEX | 7 | 4.32e-01 | 1.72e-01 | 0.86600 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 13 | 2.85e-01 | -1.71e-01 | 0.79100 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 13 | 2.85e-01 | -1.71e-01 | 0.79100 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 5.07e-01 | 1.71e-01 | 0.88800 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 14 | 2.67e-01 | 1.71e-01 | 0.78400 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 41 | 5.77e-02 | 1.71e-01 | 0.53800 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 32 | 9.36e-02 | 1.71e-01 | 0.61500 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 5.07e-01 | 1.71e-01 | 0.88800 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 60 | 2.18e-02 | 1.71e-01 | 0.41700 |
| GOBP ORGAN INDUCTION | 7 | 4.33e-01 | 1.71e-01 | 0.86600 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 6 | 4.68e-01 | -1.71e-01 | 0.87900 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 24 | 1.47e-01 | 1.71e-01 | 0.68700 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 10 | 3.49e-01 | -1.71e-01 | 0.83300 |
| GOCC NEURON PROJECTION MEMBRANE | 28 | 1.17e-01 | 1.71e-01 | 0.65800 |
| GOBP MATING BEHAVIOR | 16 | 2.37e-01 | -1.71e-01 | 0.76100 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 31 | 9.97e-02 | -1.71e-01 | 0.62400 |
| GOBP T CELL EXTRAVASATION | 12 | 3.06e-01 | -1.71e-01 | 0.80600 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 10 | 3.50e-01 | 1.71e-01 | 0.83400 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 4.69e-01 | 1.71e-01 | 0.88000 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 3.06e-01 | 1.71e-01 | 0.80700 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 3.50e-01 | 1.71e-01 | 0.83500 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 1.76e-01 | 1.71e-01 | 0.71600 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 6 | 4.70e-01 | 1.70e-01 | 0.88000 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 18 | 2.11e-01 | -1.70e-01 | 0.73900 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 3.51e-01 | 1.70e-01 | 0.83500 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 2.70e-01 | 1.70e-01 | 0.78800 |
| GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION | 6 | 4.70e-01 | 1.70e-01 | 0.88000 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 5 | 5.10e-01 | -1.70e-01 | 0.88900 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 5.10e-01 | -1.70e-01 | 0.88900 |
| GOBP PUTRESCINE METABOLIC PROCESS | 6 | 4.71e-01 | -1.70e-01 | 0.88000 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 3.52e-01 | -1.70e-01 | 0.83500 |
| GOBP CARDIOBLAST DIFFERENTIATION | 10 | 3.52e-01 | -1.70e-01 | 0.83500 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 39 | 6.67e-02 | 1.70e-01 | 0.56700 |
| GOBP LYMPH NODE DEVELOPMENT | 11 | 3.30e-01 | -1.70e-01 | 0.81800 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 4.37e-01 | -1.70e-01 | 0.86800 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 17 | 2.26e-01 | -1.70e-01 | 0.75100 |
| GOBP RESPONSE TO GAMMA RADIATION | 43 | 5.46e-02 | 1.69e-01 | 0.53100 |
| GOBP INNERVATION | 12 | 3.10e-01 | 1.69e-01 | 0.80800 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 8 | 4.08e-01 | -1.69e-01 | 0.85800 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 7 | 4.38e-01 | -1.69e-01 | 0.86900 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 9 | 3.80e-01 | -1.69e-01 | 0.84400 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 13 | 2.91e-01 | 1.69e-01 | 0.79500 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 2.02e-01 | 1.69e-01 | 0.73800 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 6 | 4.74e-01 | -1.69e-01 | 0.88000 |
| GOMF SNAP RECEPTOR ACTIVITY | 35 | 8.39e-02 | -1.69e-01 | 0.60000 |
| GOBP ECTODERM DEVELOPMENT | 13 | 2.92e-01 | -1.69e-01 | 0.79500 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 2.58e-01 | -1.69e-01 | 0.77900 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 35 | 8.43e-02 | 1.69e-01 | 0.60100 |
| GOMF U2 SNRNA BINDING | 6 | 4.75e-01 | -1.69e-01 | 0.88100 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 8 | 4.09e-01 | -1.68e-01 | 0.86000 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 49 | 4.15e-02 | 1.68e-01 | 0.49700 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 42 | 5.93e-02 | 1.68e-01 | 0.53900 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 20 | 1.93e-01 | 1.68e-01 | 0.73300 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 26 | 1.38e-01 | 1.68e-01 | 0.68000 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 9 | 3.82e-01 | -1.68e-01 | 0.84500 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 7 | 4.41e-01 | 1.68e-01 | 0.86900 |
| GOBP ICOSANOID TRANSPORT | 26 | 1.38e-01 | 1.68e-01 | 0.68000 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 5.15e-01 | 1.68e-01 | 0.89100 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 15 | 2.61e-01 | 1.68e-01 | 0.78100 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 5.17e-01 | 1.68e-01 | 0.89100 |
| GOBP NEURON RECOGNITION | 26 | 1.40e-01 | 1.67e-01 | 0.68400 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 17 | 2.32e-01 | 1.67e-01 | 0.75600 |
| GOMF EPHRIN RECEPTOR BINDING | 20 | 1.95e-01 | -1.67e-01 | 0.73400 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 16 | 2.47e-01 | 1.67e-01 | 0.76800 |
| GOBP NOTOCHORD DEVELOPMENT | 5 | 5.17e-01 | -1.67e-01 | 0.89100 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 4.13e-01 | 1.67e-01 | 0.86000 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 5.17e-01 | -1.67e-01 | 0.89100 |
| GOBP REGULATION OF HEART GROWTH | 29 | 1.19e-01 | -1.67e-01 | 0.66400 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 7 | 4.44e-01 | 1.67e-01 | 0.87100 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 4.44e-01 | -1.67e-01 | 0.87100 |
| GOBP CELLULAR RESPONSE TO ATP | 15 | 2.62e-01 | -1.67e-01 | 0.78300 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 24 | 1.56e-01 | 1.67e-01 | 0.69400 |
| GOBP HISTONE H4 ACETYLATION | 12 | 3.16e-01 | -1.67e-01 | 0.81100 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 5 | 5.18e-01 | 1.67e-01 | 0.89100 |
| GOBP RESPONSE TO FUNGUS | 38 | 7.49e-02 | 1.67e-01 | 0.58200 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 49 | 4.32e-02 | -1.67e-01 | 0.50100 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 3.86e-01 | -1.67e-01 | 0.84700 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 78 | 1.09e-02 | 1.67e-01 | 0.33500 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 4.14e-01 | 1.67e-01 | 0.86100 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 52 | 3.75e-02 | 1.67e-01 | 0.48200 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 6 | 4.79e-01 | 1.67e-01 | 0.88200 |
| GOBP DETECTION OF BACTERIUM | 13 | 2.98e-01 | 1.67e-01 | 0.80100 |
| GOBP L GLUTAMATE IMPORT | 27 | 1.34e-01 | 1.67e-01 | 0.67900 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 40 | 6.82e-02 | -1.67e-01 | 0.57100 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 36 | 8.40e-02 | 1.66e-01 | 0.60000 |
| GOMF PROLINE RICH REGION BINDING | 14 | 2.81e-01 | -1.66e-01 | 0.79000 |
| GOBP ABSCISSION | 5 | 5.19e-01 | 1.66e-01 | 0.89100 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 40 | 6.90e-02 | -1.66e-01 | 0.57400 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 5.20e-01 | 1.66e-01 | 0.89100 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 4.16e-01 | 1.66e-01 | 0.86300 |
| GOBP PROTEIN HYDROXYLATION | 21 | 1.87e-01 | -1.66e-01 | 0.72500 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 45 | 5.38e-02 | 1.66e-01 | 0.52800 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 23 | 1.68e-01 | 1.66e-01 | 0.70800 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 5.20e-01 | -1.66e-01 | 0.89100 |
| GOBP RETINA LAYER FORMATION | 10 | 3.63e-01 | 1.66e-01 | 0.83900 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 3.88e-01 | -1.66e-01 | 0.85000 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 4.16e-01 | -1.66e-01 | 0.86300 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 5.20e-01 | -1.66e-01 | 0.89100 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 26 | 1.43e-01 | 1.66e-01 | 0.68500 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 7 | 4.48e-01 | -1.66e-01 | 0.87300 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 3.41e-01 | -1.66e-01 | 0.82800 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 5 | 5.21e-01 | 1.66e-01 | 0.89100 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 7 | 4.48e-01 | 1.66e-01 | 0.87300 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 1.89e-01 | -1.66e-01 | 0.72900 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 7 | 4.48e-01 | 1.66e-01 | 0.87300 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 51 | 4.10e-02 | 1.65e-01 | 0.49700 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 5 | 5.22e-01 | 1.65e-01 | 0.89200 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 4.83e-01 | 1.65e-01 | 0.88300 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 53 | 3.75e-02 | -1.65e-01 | 0.48200 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 45 | 5.53e-02 | 1.65e-01 | 0.53100 |
| GOBP RESPONSE TO INACTIVITY | 6 | 4.84e-01 | 1.65e-01 | 0.88300 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 9 | 3.91e-01 | 1.65e-01 | 0.85300 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 8 | 4.19e-01 | 1.65e-01 | 0.86400 |
| GOMF NUCLEOSOME BINDING | 52 | 3.95e-02 | 1.65e-01 | 0.49000 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 4.84e-01 | 1.65e-01 | 0.88300 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 17 | 2.39e-01 | -1.65e-01 | 0.76200 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 4.84e-01 | -1.65e-01 | 0.88300 |
| GOCC HOPS COMPLEX | 9 | 3.92e-01 | 1.65e-01 | 0.85300 |
| GOCC SEX CHROMOSOME | 26 | 1.46e-01 | 1.65e-01 | 0.68600 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 5 | 5.24e-01 | -1.65e-01 | 0.89200 |
| GOBP REGULATION OF FEVER GENERATION | 5 | 5.24e-01 | 1.65e-01 | 0.89200 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 10 | 3.67e-01 | 1.65e-01 | 0.84000 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 4.51e-01 | 1.65e-01 | 0.87400 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 3.05e-01 | -1.64e-01 | 0.80600 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 1.72e-01 | -1.64e-01 | 0.71400 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 7 | 4.52e-01 | 1.64e-01 | 0.87400 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 9 | 3.94e-01 | 1.64e-01 | 0.85400 |
| GOMF SULFURTRANSFERASE ACTIVITY | 10 | 3.69e-01 | -1.64e-01 | 0.84000 |
| GOBP POSTSYNAPSE ASSEMBLY | 21 | 1.93e-01 | -1.64e-01 | 0.73300 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 4.86e-01 | -1.64e-01 | 0.88300 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 7 | 4.52e-01 | -1.64e-01 | 0.87400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 56 | 3.38e-02 | 1.64e-01 | 0.48200 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 4.87e-01 | -1.64e-01 | 0.88300 |
| GOBP SENSORY PERCEPTION OF TASTE | 14 | 2.88e-01 | -1.64e-01 | 0.79300 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 6 | 4.87e-01 | -1.64e-01 | 0.88300 |
| GOCC CALCIUM CHANNEL COMPLEX | 43 | 6.31e-02 | 1.64e-01 | 0.55300 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 8 | 4.22e-01 | 1.64e-01 | 0.86400 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 2.72e-01 | 1.64e-01 | 0.78900 |
| GOMF ADRENERGIC RECEPTOR BINDING | 10 | 3.70e-01 | -1.64e-01 | 0.84000 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 9 | 3.95e-01 | 1.64e-01 | 0.85400 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 13 | 3.07e-01 | -1.64e-01 | 0.80700 |
| GOBP NEURON CELL CELL ADHESION | 10 | 3.70e-01 | -1.64e-01 | 0.84000 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 9 | 3.95e-01 | -1.64e-01 | 0.85400 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 34 | 9.88e-02 | -1.64e-01 | 0.62400 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 16 | 2.58e-01 | 1.64e-01 | 0.77800 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 94 | 6.19e-03 | 1.64e-01 | 0.27000 |
| GOBP SPLEEN DEVELOPMENT | 27 | 1.42e-01 | -1.63e-01 | 0.68500 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 12 | 3.27e-01 | 1.63e-01 | 0.81800 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 39 | 7.76e-02 | -1.63e-01 | 0.58700 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 4.24e-01 | -1.63e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 30 | 1.22e-01 | 1.63e-01 | 0.66800 |
| GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 5 | 5.27e-01 | -1.63e-01 | 0.89400 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 7 | 4.55e-01 | 1.63e-01 | 0.87500 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 22 | 1.86e-01 | 1.63e-01 | 0.72300 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 5.28e-01 | 1.63e-01 | 0.89500 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 19 | 2.19e-01 | 1.63e-01 | 0.74700 |
| GOCC BRISC COMPLEX | 6 | 4.89e-01 | 1.63e-01 | 0.88400 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 11 | 3.50e-01 | -1.63e-01 | 0.83400 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 36 | 9.12e-02 | 1.63e-01 | 0.61300 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 28 | 1.36e-01 | 1.63e-01 | 0.68000 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 6 | 4.90e-01 | -1.63e-01 | 0.88500 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 5.29e-01 | -1.63e-01 | 0.89500 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 3.30e-01 | 1.63e-01 | 0.81800 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 3.99e-01 | -1.63e-01 | 0.85600 |
| GOBP PROTEIN TETRAMERIZATION | 66 | 2.26e-02 | 1.62e-01 | 0.41800 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 4.91e-01 | -1.62e-01 | 0.88500 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 6 | 4.91e-01 | -1.62e-01 | 0.88500 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 26 | 1.52e-01 | 1.62e-01 | 0.69000 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 11 | 3.52e-01 | -1.62e-01 | 0.83500 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 9 | 4.00e-01 | -1.62e-01 | 0.85600 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 4.27e-01 | 1.62e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 16 | 2.62e-01 | 1.62e-01 | 0.78200 |
| GOBP RESPONSE TO DOPAMINE | 34 | 1.02e-01 | 1.62e-01 | 0.62900 |
| GOMF FK506 BINDING | 8 | 4.28e-01 | 1.62e-01 | 0.86400 |
| GOMF MACROLIDE BINDING | 8 | 4.28e-01 | 1.62e-01 | 0.86400 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 9 | 4.00e-01 | -1.62e-01 | 0.85600 |
| GOCC LIPID DROPLET | 81 | 1.18e-02 | -1.62e-01 | 0.34900 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 28 | 1.38e-01 | 1.62e-01 | 0.68200 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 20 | 2.10e-01 | -1.62e-01 | 0.73900 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 31 | 1.19e-01 | 1.62e-01 | 0.66400 |
| GOBP VIRAL BUDDING | 23 | 1.80e-01 | 1.62e-01 | 0.71700 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 15 | 2.78e-01 | 1.62e-01 | 0.79000 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 26 | 1.54e-01 | 1.62e-01 | 0.69000 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 5 | 5.31e-01 | 1.62e-01 | 0.89700 |
| GOBP RESPONSE TO MINERALOCORTICOID | 21 | 2.00e-01 | 1.62e-01 | 0.73700 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 4.59e-01 | 1.62e-01 | 0.87700 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 9 | 4.01e-01 | 1.62e-01 | 0.85600 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 17 | 2.49e-01 | -1.62e-01 | 0.76800 |
| GOBP DNA LIGATION | 16 | 2.63e-01 | 1.62e-01 | 0.78300 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 5.32e-01 | -1.62e-01 | 0.89700 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 4.93e-01 | 1.61e-01 | 0.88600 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 1.90e-01 | 1.61e-01 | 0.72900 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 54 | 4.03e-02 | 1.61e-01 | 0.49100 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 4.60e-01 | 1.61e-01 | 0.87700 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 13 | 3.14e-01 | -1.61e-01 | 0.81000 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 34 | 1.04e-01 | 1.61e-01 | 0.63200 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 4.94e-01 | 1.61e-01 | 0.88600 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 191 | 1.25e-04 | 1.61e-01 | 0.08060 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 37 | 8.99e-02 | -1.61e-01 | 0.61300 |
| GOMF CUPROUS ION BINDING | 6 | 4.94e-01 | 1.61e-01 | 0.88600 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 5.33e-01 | 1.61e-01 | 0.89700 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 2.37e-01 | -1.61e-01 | 0.76100 |
| GOCC PROTEIN LIPID COMPLEX | 20 | 2.13e-01 | 1.61e-01 | 0.74000 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 15 | 2.81e-01 | 1.61e-01 | 0.79000 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 12 | 3.34e-01 | -1.61e-01 | 0.82200 |
| GOBP NK T CELL DIFFERENTIATION | 10 | 3.78e-01 | -1.61e-01 | 0.84400 |
| GOBP NON LYTIC VIRAL RELEASE | 13 | 3.15e-01 | 1.61e-01 | 0.81000 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.33e-01 | -1.61e-01 | 0.89700 |
| GOBP CEREBROSPINAL FLUID CIRCULATION | 5 | 5.33e-01 | -1.61e-01 | 0.89700 |
| GOBP MAGNESIUM ION TRANSPORT | 15 | 2.81e-01 | -1.61e-01 | 0.79000 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 4.95e-01 | 1.61e-01 | 0.88600 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 26 | 1.56e-01 | 1.61e-01 | 0.69300 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 2.98e-01 | -1.61e-01 | 0.80100 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 4.95e-01 | -1.61e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 20 | 2.14e-01 | 1.61e-01 | 0.74000 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 4.04e-01 | 1.61e-01 | 0.85600 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 4.05e-01 | -1.60e-01 | 0.85700 |
| GOBP IRON ION TRANSPORT | 40 | 7.93e-02 | -1.60e-01 | 0.59300 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.29e-01 | -1.60e-01 | 0.67500 |
| GOBP NUCLEOSOME ORGANIZATION | 60 | 3.18e-02 | 1.60e-01 | 0.47800 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 3.80e-01 | -1.60e-01 | 0.84400 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 4.63e-01 | -1.60e-01 | 0.87900 |
| GOBP SEROTONIN METABOLIC PROCESS | 5 | 5.35e-01 | -1.60e-01 | 0.89700 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 3.18e-01 | 1.60e-01 | 0.81200 |
| GOBP RESPONSE TO FRUCTOSE | 6 | 4.98e-01 | 1.60e-01 | 0.88600 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 63 | 2.85e-02 | 1.60e-01 | 0.45600 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 15 | 2.84e-01 | -1.60e-01 | 0.79100 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 2.28e-01 | 1.60e-01 | 0.75400 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 73 | 1.84e-02 | -1.60e-01 | 0.38900 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 21 | 2.06e-01 | 1.60e-01 | 0.73800 |
| GOBP EPITHELIAL CELL MATURATION | 14 | 3.02e-01 | -1.59e-01 | 0.80400 |
| GOBP OVULATION | 8 | 4.35e-01 | 1.59e-01 | 0.86700 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 12 | 3.39e-01 | 1.59e-01 | 0.82700 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 3.21e-01 | 1.59e-01 | 0.81400 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 5.00e-01 | -1.59e-01 | 0.88600 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 11 | 3.61e-01 | 1.59e-01 | 0.83900 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 4.66e-01 | 1.59e-01 | 0.87900 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 7 | 4.66e-01 | 1.59e-01 | 0.87900 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 7 | 4.66e-01 | 1.59e-01 | 0.87900 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 7 | 4.66e-01 | 1.59e-01 | 0.87900 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 37 | 9.42e-02 | -1.59e-01 | 0.61700 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 7 | 4.66e-01 | -1.59e-01 | 0.87900 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 30 | 1.32e-01 | -1.59e-01 | 0.67700 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 5.00e-01 | -1.59e-01 | 0.88600 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 74 | 1.82e-02 | 1.59e-01 | 0.38900 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 18 | 2.43e-01 | -1.59e-01 | 0.76600 |
| GOBP TRNA MODIFICATION | 92 | 8.51e-03 | 1.59e-01 | 0.29500 |
| GOBP TYPE II HYPERSENSITIVITY | 6 | 5.01e-01 | 1.59e-01 | 0.88600 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 22 | 1.98e-01 | 1.59e-01 | 0.73600 |
| GOCC KINETOCHORE MICROTUBULE | 18 | 2.44e-01 | 1.59e-01 | 0.76600 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 3.62e-01 | 1.59e-01 | 0.83900 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 5.39e-01 | 1.59e-01 | 0.89700 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 5.39e-01 | 1.59e-01 | 0.89700 |
| GOMF CENTROMERIC DNA BINDING | 5 | 5.39e-01 | 1.59e-01 | 0.89700 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 3.23e-01 | -1.58e-01 | 0.81500 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 4.10e-01 | 1.58e-01 | 0.86000 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 9 | 4.11e-01 | 1.58e-01 | 0.86000 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 5.02e-01 | 1.58e-01 | 0.88700 |
| GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY | 5 | 5.40e-01 | -1.58e-01 | 0.89700 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 4.39e-01 | 1.58e-01 | 0.86900 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 13 | 3.24e-01 | 1.58e-01 | 0.81500 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 15 | 2.89e-01 | 1.58e-01 | 0.79300 |
| GOBP FIBROBLAST ACTIVATION | 11 | 3.64e-01 | -1.58e-01 | 0.83900 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 14 | 3.06e-01 | -1.58e-01 | 0.80700 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 3.44e-01 | 1.58e-01 | 0.82900 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 7 | 4.69e-01 | -1.58e-01 | 0.88000 |
| GOBP RRNA METABOLIC PROCESS | 245 | 2.17e-05 | 1.58e-01 | 0.04940 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 3.87e-01 | -1.58e-01 | 0.84900 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 26 | 1.64e-01 | 1.58e-01 | 0.70500 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 56 | 4.13e-02 | 1.58e-01 | 0.49700 |
| GOBP MIDDLE EAR MORPHOGENESIS | 7 | 4.70e-01 | -1.58e-01 | 0.88000 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 5.04e-01 | -1.58e-01 | 0.88800 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 28 | 1.49e-01 | 1.58e-01 | 0.69000 |
| GOBP V D J RECOMBINATION | 16 | 2.75e-01 | 1.58e-01 | 0.79000 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 31 | 1.29e-01 | 1.58e-01 | 0.67500 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 35 | 1.07e-01 | 1.57e-01 | 0.63500 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 3.66e-01 | -1.57e-01 | 0.84000 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 4.41e-01 | -1.57e-01 | 0.86900 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 5.42e-01 | -1.57e-01 | 0.89800 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 47 | 6.21e-02 | 1.57e-01 | 0.54900 |
| GOCC EXCITATORY SYNAPSE | 26 | 1.65e-01 | 1.57e-01 | 0.70500 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 4.71e-01 | -1.57e-01 | 0.88000 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 45 | 6.80e-02 | 1.57e-01 | 0.57100 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 5.05e-01 | 1.57e-01 | 0.88800 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 5.05e-01 | -1.57e-01 | 0.88800 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 20 | 2.24e-01 | 1.57e-01 | 0.75100 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 23 | 1.92e-01 | -1.57e-01 | 0.73100 |
| GOBP INTERLEUKIN 2 PRODUCTION | 53 | 4.81e-02 | 1.57e-01 | 0.51100 |
| GOBP SULFATION | 10 | 3.90e-01 | 1.57e-01 | 0.85200 |
| GOCC AXOLEMMA | 11 | 3.67e-01 | 1.57e-01 | 0.84000 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 7 | 4.72e-01 | -1.57e-01 | 0.88000 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 7 | 4.72e-01 | 1.57e-01 | 0.88000 |
| GOBP NEURON PROJECTION ORGANIZATION | 60 | 3.57e-02 | 1.57e-01 | 0.48200 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 2.63e-01 | 1.57e-01 | 0.78300 |
| GOBP NEGATIVE CHEMOTAXIS | 26 | 1.67e-01 | 1.57e-01 | 0.70700 |
| GOBP RESPONSE TO LIGHT INTENSITY | 14 | 3.10e-01 | 1.57e-01 | 0.80800 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 5 | 5.44e-01 | -1.57e-01 | 0.89900 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 5 | 5.44e-01 | 1.57e-01 | 0.89900 |
| GOBP MITRAL VALVE DEVELOPMENT | 8 | 4.43e-01 | -1.57e-01 | 0.87100 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 25 | 1.75e-01 | 1.57e-01 | 0.71600 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 2.04e-01 | 1.57e-01 | 0.73800 |
| GOBP HISTAMINE SECRETION | 11 | 3.69e-01 | 1.56e-01 | 0.84000 |
| GOBP HISTAMINE TRANSPORT | 11 | 3.69e-01 | 1.56e-01 | 0.84000 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 15 | 2.94e-01 | 1.56e-01 | 0.79700 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 4.74e-01 | -1.56e-01 | 0.88000 |
| GOBP PLASMA MEMBRANE REPAIR | 24 | 1.86e-01 | 1.56e-01 | 0.72300 |
| GOBP CHORION DEVELOPMENT | 7 | 4.75e-01 | -1.56e-01 | 0.88100 |
| GOBP TRNA METABOLIC PROCESS | 175 | 3.77e-04 | 1.56e-01 | 0.09760 |
| GOCC SWI SNF COMPLEX | 28 | 1.53e-01 | 1.56e-01 | 0.69000 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 48 | 6.19e-02 | 1.56e-01 | 0.54900 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 2.40e-01 | 1.56e-01 | 0.76200 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 13 | 3.31e-01 | -1.56e-01 | 0.81800 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 15 | 2.97e-01 | 1.56e-01 | 0.80000 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 69 | 2.54e-02 | 1.56e-01 | 0.43200 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 7 | 4.76e-01 | -1.56e-01 | 0.88100 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 26 | 1.70e-01 | 1.55e-01 | 0.71300 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 9 | 4.19e-01 | 1.55e-01 | 0.86400 |
| GOMF NADPH BINDING | 14 | 3.14e-01 | 1.55e-01 | 0.81000 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 37 | 1.02e-01 | 1.55e-01 | 0.62800 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 20 | 2.29e-01 | -1.55e-01 | 0.75400 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 4.76e-01 | -1.55e-01 | 0.88100 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 34 | 1.17e-01 | 1.55e-01 | 0.65800 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 4.77e-01 | -1.55e-01 | 0.88100 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 4.77e-01 | 1.55e-01 | 0.88100 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 23 | 1.98e-01 | 1.55e-01 | 0.73600 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 9 | 4.20e-01 | 1.55e-01 | 0.86400 |
| GOBP PROTEIN DENEDDYLATION | 11 | 3.73e-01 | -1.55e-01 | 0.84100 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 3.96e-01 | 1.55e-01 | 0.85400 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 6 | 5.11e-01 | -1.55e-01 | 0.89000 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 8 | 4.48e-01 | -1.55e-01 | 0.87300 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 4.48e-01 | -1.55e-01 | 0.87300 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 79 | 1.75e-02 | -1.55e-01 | 0.38400 |
| GOBP SECRETORY GRANULE LOCALIZATION | 8 | 4.48e-01 | -1.55e-01 | 0.87300 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 4.49e-01 | 1.55e-01 | 0.87300 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 32 | 1.30e-01 | 1.55e-01 | 0.67600 |
| GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY | 5 | 5.50e-01 | -1.55e-01 | 0.90100 |
| GOBP RESPONSE TO CORTICOSTEROID | 85 | 1.38e-02 | 1.55e-01 | 0.37200 |
| GOMF DYNACTIN BINDING | 11 | 3.76e-01 | 1.54e-01 | 0.84200 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 4.23e-01 | -1.54e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 28 | 1.58e-01 | 1.54e-01 | 0.69700 |
| GOBP VAGINA DEVELOPMENT | 5 | 5.50e-01 | 1.54e-01 | 0.90100 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 3.76e-01 | 1.54e-01 | 0.84200 |
| GOMF CARGO ADAPTOR ACTIVITY | 17 | 2.71e-01 | 1.54e-01 | 0.78800 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 27 | 1.66e-01 | 1.54e-01 | 0.70500 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 12 | 3.56e-01 | -1.54e-01 | 0.83600 |
| GOBP REGULATION OF RECEPTOR BINDING | 9 | 4.24e-01 | -1.54e-01 | 0.86400 |
| GOBP FOREBRAIN CELL MIGRATION | 39 | 9.66e-02 | 1.54e-01 | 0.62200 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 10 | 4.00e-01 | -1.54e-01 | 0.85600 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 11 | 3.77e-01 | 1.54e-01 | 0.84400 |
| GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 5.52e-01 | 1.54e-01 | 0.90100 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 5.52e-01 | 1.54e-01 | 0.90100 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 17 | 2.73e-01 | -1.54e-01 | 0.78900 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 41 | 8.88e-02 | -1.54e-01 | 0.61300 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 62 | 3.65e-02 | 1.54e-01 | 0.48200 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 17 | 2.73e-01 | -1.54e-01 | 0.78900 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 15 | 3.03e-01 | 1.54e-01 | 0.80500 |
| GOMF THIOESTERASE BINDING | 9 | 4.25e-01 | 1.53e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 16 | 2.88e-01 | -1.53e-01 | 0.79300 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 25 | 1.84e-01 | 1.53e-01 | 0.72100 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 4.82e-01 | 1.53e-01 | 0.88300 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 9 | 4.26e-01 | 1.53e-01 | 0.86400 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 100 | 8.20e-03 | 1.53e-01 | 0.29500 |
| GOMF FMN BINDING | 9 | 4.27e-01 | -1.53e-01 | 0.86400 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 59 | 4.22e-02 | -1.53e-01 | 0.49900 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 5.54e-01 | 1.53e-01 | 0.90100 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 34 | 1.23e-01 | 1.53e-01 | 0.66900 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 11 | 3.80e-01 | -1.53e-01 | 0.84400 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 31 | 1.41e-01 | -1.53e-01 | 0.68500 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 26 | 1.77e-01 | -1.53e-01 | 0.71700 |
| GOBP REGULATION OF AXON GUIDANCE | 7 | 4.84e-01 | 1.53e-01 | 0.88300 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 128 | 2.86e-03 | 1.53e-01 | 0.20700 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 4.27e-01 | 1.53e-01 | 0.86400 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 23 | 2.05e-01 | -1.53e-01 | 0.73800 |
| GOBP HEPARIN METABOLIC PROCESS | 14 | 3.23e-01 | 1.53e-01 | 0.81500 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 5.17e-01 | -1.53e-01 | 0.89100 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 3.41e-01 | -1.53e-01 | 0.82800 |
| GOBP MRNA MODIFICATION | 31 | 1.42e-01 | 1.53e-01 | 0.68500 |
| GOBP CERAMIDE CATABOLIC PROCESS | 13 | 3.41e-01 | -1.53e-01 | 0.82800 |
| GOBP MACROMOLECULE METHYLATION | 182 | 3.96e-04 | 1.53e-01 | 0.09760 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 27 | 1.70e-01 | 1.52e-01 | 0.71300 |
| GOBP RESPONSE TO IRON ION | 23 | 2.06e-01 | -1.52e-01 | 0.73800 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 14 | 3.23e-01 | 1.52e-01 | 0.81500 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 17 | 2.77e-01 | -1.52e-01 | 0.79000 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 8 | 4.56e-01 | 1.52e-01 | 0.87600 |
| GOCC POLYSOME | 61 | 3.99e-02 | -1.52e-01 | 0.49100 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 12 | 3.62e-01 | -1.52e-01 | 0.83900 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 13 | 3.43e-01 | -1.52e-01 | 0.82900 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 101 | 8.45e-03 | 1.52e-01 | 0.29500 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 18 | 2.65e-01 | -1.52e-01 | 0.78300 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 3.26e-01 | 1.52e-01 | 0.81700 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 22 | 2.18e-01 | 1.52e-01 | 0.74700 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 42 | 8.93e-02 | 1.52e-01 | 0.61300 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 52 | 5.89e-02 | -1.51e-01 | 0.53800 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 3.85e-01 | -1.51e-01 | 0.84600 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 5.21e-01 | -1.51e-01 | 0.89100 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 21 | 2.30e-01 | -1.51e-01 | 0.75400 |
| GOBP RNA MODIFICATION | 165 | 8.10e-04 | 1.51e-01 | 0.13200 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 15 | 3.10e-01 | 1.51e-01 | 0.80800 |
| GOBP COPII COATED VESICLE BUDDING | 42 | 8.99e-02 | -1.51e-01 | 0.61300 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 19 | 2.54e-01 | 1.51e-01 | 0.77500 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 12 | 3.64e-01 | 1.51e-01 | 0.83900 |
| GOCC PERICENTRIC HETEROCHROMATIN | 28 | 1.66e-01 | 1.51e-01 | 0.70500 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 4.59e-01 | 1.51e-01 | 0.87700 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 81 | 1.87e-02 | 1.51e-01 | 0.38900 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 31 | 1.45e-01 | 1.51e-01 | 0.68500 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 20 | 2.42e-01 | 1.51e-01 | 0.76500 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 35 | 1.22e-01 | 1.51e-01 | 0.66800 |
| GOBP ODONTOBLAST DIFFERENTIATION | 8 | 4.60e-01 | -1.51e-01 | 0.87700 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 7 | 4.89e-01 | -1.51e-01 | 0.88400 |
| GOMF PROTEIN ANTIGEN BINDING | 7 | 4.89e-01 | 1.51e-01 | 0.88400 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 1.83e-01 | -1.51e-01 | 0.72100 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 4.33e-01 | -1.51e-01 | 0.86600 |
| GOBP NEURON MATURATION | 28 | 1.67e-01 | -1.51e-01 | 0.70800 |
| GOBP ONE CARBON METABOLIC PROCESS | 26 | 1.83e-01 | 1.51e-01 | 0.72100 |
| GOBP REGULATION OF ERAD PATHWAY | 19 | 2.55e-01 | -1.51e-01 | 0.77700 |
| GOBP PROTEIN DELIPIDATION | 5 | 5.59e-01 | -1.51e-01 | 0.90400 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 5.59e-01 | -1.51e-01 | 0.90400 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 2.83e-01 | -1.51e-01 | 0.79000 |
| GOMF POLYSACCHARIDE BINDING | 13 | 3.48e-01 | 1.50e-01 | 0.83300 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 17 | 2.83e-01 | 1.50e-01 | 0.79000 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 1.35e-01 | 1.50e-01 | 0.68000 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 16 | 2.98e-01 | -1.50e-01 | 0.80100 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 27 | 1.77e-01 | 1.50e-01 | 0.71700 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 3.49e-01 | 1.50e-01 | 0.83300 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 38 | 1.09e-01 | 1.50e-01 | 0.63900 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 8 | 4.62e-01 | -1.50e-01 | 0.87900 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 3.15e-01 | 1.50e-01 | 0.81000 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 25 | 1.94e-01 | 1.50e-01 | 0.73300 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 155 | 1.30e-03 | 1.50e-01 | 0.18100 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 15 | 3.16e-01 | 1.50e-01 | 0.81100 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 3.69e-01 | 1.50e-01 | 0.84000 |
| GOBP CYTOPLASMIC TRANSLATION | 146 | 1.82e-03 | -1.50e-01 | 0.19300 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 19 | 2.59e-01 | 1.50e-01 | 0.77900 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 7 | 4.93e-01 | -1.50e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 43 | 8.98e-02 | 1.50e-01 | 0.61300 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 49 | 7.03e-02 | 1.50e-01 | 0.57400 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 3.70e-01 | 1.50e-01 | 0.84000 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 14 | 3.33e-01 | 1.49e-01 | 0.82000 |
| GOBP RESPONSE TO TYPE I INTERFERON | 65 | 3.73e-02 | 1.49e-01 | 0.48200 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 5.63e-01 | -1.49e-01 | 0.90600 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 3.91e-01 | -1.49e-01 | 0.85300 |
| GOBP ANOIKIS | 27 | 1.79e-01 | -1.49e-01 | 0.71700 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 6 | 5.27e-01 | 1.49e-01 | 0.89400 |
| GOBP PROTEIN GERANYLGERANYLATION | 7 | 4.94e-01 | 1.49e-01 | 0.88600 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 6 | 5.27e-01 | -1.49e-01 | 0.89400 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 16 | 3.02e-01 | -1.49e-01 | 0.80400 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 15 | 3.18e-01 | -1.49e-01 | 0.81200 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 15 | 3.18e-01 | -1.49e-01 | 0.81200 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 5.64e-01 | 1.49e-01 | 0.90600 |
| GOBP LYMPH VESSEL DEVELOPMENT | 12 | 3.72e-01 | 1.49e-01 | 0.84100 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 28 | 1.73e-01 | -1.49e-01 | 0.71400 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 21 | 2.38e-01 | 1.49e-01 | 0.76200 |
| GOBP CELL CYCLE DNA REPLICATION | 37 | 1.17e-01 | 1.49e-01 | 0.65800 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 13 | 3.53e-01 | 1.49e-01 | 0.83500 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 9 | 4.40e-01 | 1.49e-01 | 0.86900 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 24 | 2.08e-01 | -1.49e-01 | 0.73900 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 40 | 1.04e-01 | 1.48e-01 | 0.63400 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 25 | 1.99e-01 | 1.48e-01 | 0.73600 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 22 | 2.29e-01 | 1.48e-01 | 0.75400 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 49 | 7.26e-02 | 1.48e-01 | 0.57900 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 16 | 3.05e-01 | -1.48e-01 | 0.80600 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 33 | 1.41e-01 | 1.48e-01 | 0.68500 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 8 | 4.68e-01 | 1.48e-01 | 0.87900 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 4.97e-01 | -1.48e-01 | 0.88600 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 4.42e-01 | 1.48e-01 | 0.87000 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 4.97e-01 | -1.48e-01 | 0.88600 |
| GOMF NADPLUS BINDING | 16 | 3.06e-01 | 1.48e-01 | 0.80600 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 124 | 4.50e-03 | -1.48e-01 | 0.24700 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 34 | 1.36e-01 | 1.48e-01 | 0.68000 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 8 | 4.69e-01 | -1.48e-01 | 0.88000 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 7 | 4.99e-01 | 1.48e-01 | 0.88600 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 2.65e-01 | 1.48e-01 | 0.78400 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 10 | 4.20e-01 | -1.47e-01 | 0.86400 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 35 | 1.31e-01 | 1.47e-01 | 0.67600 |
| GOBP POLYAMINE TRANSPORT | 12 | 3.77e-01 | 1.47e-01 | 0.84300 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 15 | 3.23e-01 | -1.47e-01 | 0.81500 |
| GOBP TUBULIN DEACETYLATION | 19 | 2.67e-01 | -1.47e-01 | 0.78400 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 4.72e-01 | -1.47e-01 | 0.88000 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 5.01e-01 | 1.47e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 11 | 3.99e-01 | -1.47e-01 | 0.85600 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 5.01e-01 | -1.47e-01 | 0.88600 |
| GOBP ASTROCYTE DIFFERENTIATION | 50 | 7.24e-02 | -1.47e-01 | 0.57900 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 3.99e-01 | 1.47e-01 | 0.85600 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 25 | 2.04e-01 | 1.47e-01 | 0.73800 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 5.70e-01 | -1.47e-01 | 0.90800 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 23 | 2.23e-01 | 1.47e-01 | 0.75100 |
| GOBP SECONDARY METABOLIC PROCESS | 28 | 1.79e-01 | 1.47e-01 | 0.71700 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 56 | 5.77e-02 | 1.47e-01 | 0.53800 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 3.42e-01 | -1.47e-01 | 0.82900 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 6 | 5.34e-01 | -1.47e-01 | 0.89700 |
| GOMF MODIFIED AMINO ACID BINDING | 51 | 7.04e-02 | 1.47e-01 | 0.57400 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 51 | 7.04e-02 | 1.47e-01 | 0.57400 |
| GOBP LIPOPHAGY | 7 | 5.02e-01 | -1.46e-01 | 0.88700 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 21 | 2.45e-01 | 1.46e-01 | 0.76800 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 5.34e-01 | -1.46e-01 | 0.89700 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 5.34e-01 | -1.46e-01 | 0.89700 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 8 | 4.73e-01 | 1.46e-01 | 0.88000 |
| GOBP RESPONSE TO DIETARY EXCESS | 17 | 2.96e-01 | -1.46e-01 | 0.80000 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 13 | 3.61e-01 | -1.46e-01 | 0.83900 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 15 | 3.27e-01 | -1.46e-01 | 0.81700 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 4.47e-01 | -1.46e-01 | 0.87300 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 4.47e-01 | -1.46e-01 | 0.87300 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 54 | 6.32e-02 | 1.46e-01 | 0.55400 |
| GOBP NOREPINEPHRINE TRANSPORT | 9 | 4.48e-01 | -1.46e-01 | 0.87300 |
| GOCC MEDIATOR COMPLEX | 37 | 1.24e-01 | -1.46e-01 | 0.67200 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 11 | 4.02e-01 | 1.46e-01 | 0.85600 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 2.47e-01 | 1.46e-01 | 0.76800 |
| GOBP CHOLESTEROL EFFLUX | 32 | 1.53e-01 | -1.46e-01 | 0.69000 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 80 | 2.41e-02 | 1.46e-01 | 0.42700 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 67 | 3.89e-02 | 1.46e-01 | 0.48800 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 5.36e-01 | 1.46e-01 | 0.89700 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 16 | 3.13e-01 | -1.46e-01 | 0.81000 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 93 | 1.52e-02 | 1.46e-01 | 0.37400 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 5.36e-01 | -1.46e-01 | 0.89700 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 5.36e-01 | 1.46e-01 | 0.89700 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 58 | 5.50e-02 | 1.46e-01 | 0.53100 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 4.75e-01 | 1.46e-01 | 0.88100 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 4.03e-01 | 1.46e-01 | 0.85600 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 9 | 4.50e-01 | -1.46e-01 | 0.87300 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 29 | 1.75e-01 | 1.46e-01 | 0.71600 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 7 | 5.05e-01 | -1.46e-01 | 0.88800 |
| GOBP TELOMERE CAPPING | 37 | 1.26e-01 | 1.46e-01 | 0.67300 |
| GOBP NERVE DEVELOPMENT | 44 | 9.51e-02 | 1.45e-01 | 0.61900 |
| GOBP GENOMIC IMPRINTING | 12 | 3.83e-01 | 1.45e-01 | 0.84500 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 3.64e-01 | -1.45e-01 | 0.83900 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 45 | 9.18e-02 | -1.45e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 16 | 3.14e-01 | -1.45e-01 | 0.81000 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 2.86e-01 | 1.45e-01 | 0.79100 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 5.38e-01 | -1.45e-01 | 0.89700 |
| GOBP PLASMINOGEN ACTIVATION | 14 | 3.47e-01 | -1.45e-01 | 0.83300 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 34 | 1.43e-01 | 1.45e-01 | 0.68500 |
| GOBP CHEMOSENSORY BEHAVIOR | 8 | 4.77e-01 | -1.45e-01 | 0.88100 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 57 | 5.82e-02 | -1.45e-01 | 0.53800 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 5.74e-01 | 1.45e-01 | 0.90800 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 7 | 5.06e-01 | -1.45e-01 | 0.88800 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 13 | 3.65e-01 | -1.45e-01 | 0.84000 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 5.74e-01 | 1.45e-01 | 0.90800 |
| GOMF SH2 DOMAIN BINDING | 36 | 1.32e-01 | 1.45e-01 | 0.67800 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 2.50e-01 | -1.45e-01 | 0.77100 |
| GOBP THIAMINE TRANSPORT | 5 | 5.75e-01 | -1.45e-01 | 0.90800 |
| GOBP FEVER GENERATION | 7 | 5.07e-01 | 1.45e-01 | 0.88800 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 30 | 1.70e-01 | 1.45e-01 | 0.71300 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 5.39e-01 | 1.45e-01 | 0.89700 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 5.39e-01 | 1.45e-01 | 0.89700 |
| GOCC SNARE COMPLEX | 41 | 1.09e-01 | -1.45e-01 | 0.63900 |
| GOBP PRESYNAPTIC MEMBRANE ORGANIZATION | 6 | 5.40e-01 | -1.45e-01 | 0.89700 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 29 | 1.78e-01 | 1.45e-01 | 0.71700 |
| GOMF DYSTROGLYCAN BINDING | 8 | 4.79e-01 | 1.45e-01 | 0.88200 |
| GOBP DOUBLE STRAND BREAK REPAIR | 269 | 4.69e-05 | 1.45e-01 | 0.05870 |
| GOCC COMPACT MYELIN | 7 | 5.08e-01 | -1.44e-01 | 0.88900 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 2.21e-01 | 1.44e-01 | 0.75000 |
| GOCC CILIARY BASE | 29 | 1.78e-01 | 1.44e-01 | 0.71700 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 5.40e-01 | 1.44e-01 | 0.89700 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 5.41e-01 | -1.44e-01 | 0.89700 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 13 | 3.69e-01 | -1.44e-01 | 0.84000 |
| GOMF MISFOLDED PROTEIN BINDING | 18 | 2.90e-01 | -1.44e-01 | 0.79300 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 5.77e-01 | -1.44e-01 | 0.90900 |
| GOBP LIPID DROPLET ORGANIZATION | 27 | 1.95e-01 | -1.44e-01 | 0.73400 |
| GOBP P38MAPK CASCADE | 42 | 1.07e-01 | 1.44e-01 | 0.63500 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 5.10e-01 | -1.44e-01 | 0.88900 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 3.52e-01 | 1.44e-01 | 0.83500 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 8 | 4.82e-01 | -1.44e-01 | 0.88300 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 6 | 5.42e-01 | 1.44e-01 | 0.89800 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 5.43e-01 | 1.44e-01 | 0.89800 |
| GOBP RESPONSE TO COBALT ION | 10 | 4.32e-01 | -1.44e-01 | 0.86600 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 3.70e-01 | 1.44e-01 | 0.84000 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 1.36e-01 | 1.44e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 16 | 3.21e-01 | 1.43e-01 | 0.81400 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 2.79e-01 | 1.43e-01 | 0.79000 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 59 | 5.70e-02 | 1.43e-01 | 0.53600 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 5.11e-01 | 1.43e-01 | 0.89000 |
| GOCC VESICLE COAT | 57 | 6.14e-02 | -1.43e-01 | 0.54900 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 41 | 1.13e-01 | -1.43e-01 | 0.64800 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 24 | 2.25e-01 | -1.43e-01 | 0.75100 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 5.71e-02 | 1.43e-01 | 0.53600 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 5.79e-01 | 1.43e-01 | 0.91000 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 25 | 2.16e-01 | 1.43e-01 | 0.74300 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 4.83e-01 | -1.43e-01 | 0.88300 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 6 | 5.44e-01 | -1.43e-01 | 0.89900 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 5.44e-01 | 1.43e-01 | 0.89900 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 66 | 4.47e-02 | 1.43e-01 | 0.50300 |
| GOBP TELOMERE MAINTENANCE | 147 | 2.81e-03 | 1.43e-01 | 0.20700 |
| GOCC LATERAL ELEMENT | 11 | 4.12e-01 | -1.43e-01 | 0.86000 |
| GOBP RETINOL METABOLIC PROCESS | 21 | 2.57e-01 | -1.43e-01 | 0.77800 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 10 | 4.34e-01 | -1.43e-01 | 0.86600 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 8 | 4.84e-01 | -1.43e-01 | 0.88300 |
| GOBP METANEPHROS MORPHOGENESIS | 10 | 4.35e-01 | 1.43e-01 | 0.86600 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 30 | 1.76e-01 | 1.43e-01 | 0.71600 |
| GOBP RESPONSE TO SALT | 218 | 2.93e-04 | 1.43e-01 | 0.09760 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 10 | 4.35e-01 | 1.42e-01 | 0.86700 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 29 | 1.84e-01 | 1.42e-01 | 0.72100 |
| GOBP RECOMBINATIONAL REPAIR | 161 | 1.85e-03 | 1.42e-01 | 0.19300 |
| GOCC NEURON PROJECTION TERMINUS | 65 | 4.74e-02 | 1.42e-01 | 0.51000 |
| GOBP CELLULAR RESPONSE TO SALT | 121 | 6.94e-03 | 1.42e-01 | 0.28400 |
| GOMF NEUROPEPTIDE ACTIVITY | 10 | 4.36e-01 | 1.42e-01 | 0.86700 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 3.75e-01 | 1.42e-01 | 0.84200 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 118 | 7.71e-03 | -1.42e-01 | 0.29400 |
| GOBP NEUROBLAST DIVISION | 9 | 4.60e-01 | -1.42e-01 | 0.87800 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 5.47e-01 | -1.42e-01 | 0.89900 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 11 | 4.15e-01 | -1.42e-01 | 0.86300 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 20 | 2.72e-01 | -1.42e-01 | 0.78800 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 5.83e-01 | 1.42e-01 | 0.91200 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 5.16e-01 | -1.42e-01 | 0.89100 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 5.16e-01 | 1.42e-01 | 0.89100 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.16e-01 | -1.42e-01 | 0.89100 |
| GOMF DNA REPLICATION ORIGIN BINDING | 12 | 3.96e-01 | -1.42e-01 | 0.85400 |
| GOBP ACID SECRETION | 21 | 2.62e-01 | 1.42e-01 | 0.78200 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 7 | 5.17e-01 | 1.41e-01 | 0.89100 |
| GOMF ALPHA TUBULIN BINDING | 35 | 1.48e-01 | 1.41e-01 | 0.68700 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 3.60e-01 | -1.41e-01 | 0.83900 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 22 | 2.52e-01 | 1.41e-01 | 0.77200 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 28 | 1.96e-01 | 1.41e-01 | 0.73400 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 37 | 1.38e-01 | 1.41e-01 | 0.68000 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 4.64e-01 | 1.41e-01 | 0.87900 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 17 | 3.14e-01 | 1.41e-01 | 0.81000 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 4.40e-01 | 1.41e-01 | 0.86900 |
| GOBP DNA CATABOLIC PROCESS | 23 | 2.42e-01 | 1.41e-01 | 0.76400 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 1.14e-01 | 1.41e-01 | 0.65100 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 4.19e-01 | 1.41e-01 | 0.86400 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 31 | 1.75e-01 | -1.41e-01 | 0.71600 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 5.19e-01 | -1.41e-01 | 0.89100 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 5 | 5.86e-01 | 1.41e-01 | 0.91300 |
| GOCC AXON HILLOCK | 5 | 5.86e-01 | -1.41e-01 | 0.91300 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 18 | 3.01e-01 | 1.41e-01 | 0.80400 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 7 | 5.19e-01 | 1.41e-01 | 0.89100 |
| GOBP PHAGOSOME MATURATION | 26 | 2.14e-01 | -1.41e-01 | 0.74100 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 5.86e-01 | 1.41e-01 | 0.91300 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 41 | 1.19e-01 | 1.41e-01 | 0.66400 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 5.19e-01 | 1.41e-01 | 0.89100 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 46 | 9.92e-02 | 1.41e-01 | 0.62400 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 24 | 2.33e-01 | 1.41e-01 | 0.75700 |
| GOBP RESPONSE TO INTERFERON ALPHA | 16 | 3.31e-01 | 1.41e-01 | 0.81800 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 51 | 8.30e-02 | 1.40e-01 | 0.60000 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 48 | 9.29e-02 | -1.40e-01 | 0.61400 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 5.21e-01 | 1.40e-01 | 0.89100 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 100 | 1.55e-02 | 1.40e-01 | 0.37400 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 2.90e-01 | 1.40e-01 | 0.79300 |
| GOBP INTRACILIARY TRANSPORT | 40 | 1.26e-01 | 1.40e-01 | 0.67300 |
| GOCC CENTRIOLE | 133 | 5.35e-03 | 1.40e-01 | 0.25400 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 102 | 1.46e-02 | 1.40e-01 | 0.37400 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 39 | 1.31e-01 | 1.40e-01 | 0.67600 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 86 | 2.50e-02 | 1.40e-01 | 0.43100 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 4.93e-01 | -1.40e-01 | 0.88600 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 5.53e-01 | -1.40e-01 | 0.90100 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 103 | 1.43e-02 | 1.40e-01 | 0.37200 |
| GOBP TRANSEPITHELIAL TRANSPORT | 16 | 3.33e-01 | 1.40e-01 | 0.82000 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.88e-01 | 1.40e-01 | 0.91300 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 11 | 4.22e-01 | -1.40e-01 | 0.86400 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 5.89e-01 | 1.40e-01 | 0.91300 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 13 | 3.83e-01 | 1.40e-01 | 0.84500 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 41 | 1.22e-01 | 1.40e-01 | 0.66800 |
| GOBP ESTROUS CYCLE | 11 | 4.23e-01 | 1.40e-01 | 0.86400 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 5.23e-01 | -1.39e-01 | 0.89200 |
| GOBP PROLINE TRANSPORT | 6 | 5.54e-01 | 1.39e-01 | 0.90100 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 13 | 3.84e-01 | -1.39e-01 | 0.84500 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 35 | 1.54e-01 | -1.39e-01 | 0.69000 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 6 | 5.54e-01 | 1.39e-01 | 0.90100 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 4.24e-01 | -1.39e-01 | 0.86400 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 19 | 2.93e-01 | 1.39e-01 | 0.79600 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 4.04e-01 | 1.39e-01 | 0.85600 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 4.46e-01 | 1.39e-01 | 0.87300 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 20 | 2.82e-01 | 1.39e-01 | 0.79000 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 4.96e-01 | -1.39e-01 | 0.88600 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 5 | 5.91e-01 | -1.39e-01 | 0.91300 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 4.25e-01 | 1.39e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 155 | 2.89e-03 | 1.39e-01 | 0.20700 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 4.97e-01 | 1.39e-01 | 0.88600 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 19 | 2.95e-01 | 1.39e-01 | 0.79800 |
| GOCC PROTEASOME COMPLEX | 58 | 6.78e-02 | -1.39e-01 | 0.57100 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 5.56e-01 | 1.39e-01 | 0.90300 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 2.04e-01 | 1.39e-01 | 0.73800 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 6 | 5.57e-01 | 1.39e-01 | 0.90300 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 4.06e-01 | 1.39e-01 | 0.85800 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 17 | 3.23e-01 | 1.39e-01 | 0.81500 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 22 | 2.61e-01 | -1.38e-01 | 0.78100 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 28 | 2.05e-01 | 1.38e-01 | 0.73800 |
| GOBP CARDIAC CONDUCTION | 47 | 1.01e-01 | 1.38e-01 | 0.62600 |
| GOBP MESENCHYME MORPHOGENESIS | 27 | 2.14e-01 | -1.38e-01 | 0.74000 |
| GOBP AMINE TRANSPORT | 46 | 1.05e-01 | 1.38e-01 | 0.63500 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 164 | 2.28e-03 | 1.38e-01 | 0.20500 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 14 | 3.71e-01 | 1.38e-01 | 0.84100 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 32 | 1.77e-01 | 1.38e-01 | 0.71600 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 4.28e-01 | 1.38e-01 | 0.86400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 30 | 1.91e-01 | 1.38e-01 | 0.73000 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 4.08e-01 | -1.38e-01 | 0.85800 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 35 | 1.58e-01 | 1.38e-01 | 0.69700 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 57 | 7.19e-02 | 1.38e-01 | 0.57900 |
| GOBP MONOCYTE ACTIVATION | 10 | 4.50e-01 | 1.38e-01 | 0.87400 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 71 | 4.48e-02 | -1.38e-01 | 0.50300 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 2.63e-01 | -1.38e-01 | 0.78300 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.94e-01 | -1.38e-01 | 0.91300 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 2.64e-01 | 1.38e-01 | 0.78300 |
| GOBP ERBB2 EGFR SIGNALING PATHWAY | 5 | 5.94e-01 | 1.38e-01 | 0.91300 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 5.94e-01 | 1.38e-01 | 0.91300 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 7 | 5.28e-01 | -1.38e-01 | 0.89500 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 14 | 3.73e-01 | -1.38e-01 | 0.84100 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 4.75e-01 | 1.37e-01 | 0.88100 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 18 | 3.13e-01 | 1.37e-01 | 0.81000 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 92 | 2.29e-02 | 1.37e-01 | 0.42100 |
| GOBP APICAL JUNCTION ASSEMBLY | 42 | 1.24e-01 | 1.37e-01 | 0.67100 |
| GOBP REGULATION OF FIBRINOLYSIS | 8 | 5.02e-01 | -1.37e-01 | 0.88700 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 25 | 2.35e-01 | -1.37e-01 | 0.75900 |
| GOBP ASTROCYTE DEVELOPMENT | 28 | 2.09e-01 | -1.37e-01 | 0.73900 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 37 | 1.49e-01 | 1.37e-01 | 0.69000 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 5 | 5.96e-01 | -1.37e-01 | 0.91300 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 5 | 5.96e-01 | -1.37e-01 | 0.91300 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 1.12e-01 | 1.37e-01 | 0.64500 |
| GOBP STRIATUM DEVELOPMENT | 15 | 3.59e-01 | -1.37e-01 | 0.83600 |
| GOBP SUBPALLIUM DEVELOPMENT | 15 | 3.59e-01 | -1.37e-01 | 0.83600 |
| GOBP LEUKOCYTE HOMEOSTASIS | 90 | 2.50e-02 | 1.37e-01 | 0.43100 |
| GOCC CHROMOSOME TELOMERIC REGION | 136 | 5.93e-03 | 1.37e-01 | 0.27000 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 5.97e-01 | 1.37e-01 | 0.91300 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 4.54e-01 | 1.37e-01 | 0.87500 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 5.97e-01 | -1.37e-01 | 0.91300 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 2.47e-01 | -1.37e-01 | 0.76800 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 5.32e-01 | -1.36e-01 | 0.89700 |
| GOBP ACTIN NUCLEATION | 46 | 1.10e-01 | 1.36e-01 | 0.63900 |
| GOCC GOLGI ASSOCIATED VESICLE | 78 | 3.76e-02 | -1.36e-01 | 0.48200 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 2.29e-01 | -1.36e-01 | 0.75400 |
| GOBP MALE MEIOSIS I | 14 | 3.78e-01 | -1.36e-01 | 0.84400 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 5.63e-01 | 1.36e-01 | 0.90600 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 13 | 3.95e-01 | -1.36e-01 | 0.85400 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 9 | 4.79e-01 | -1.36e-01 | 0.88200 |
| GOBP RESPONSE TO TESTOSTERONE | 29 | 2.05e-01 | 1.36e-01 | 0.73800 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 16 | 3.46e-01 | 1.36e-01 | 0.83200 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 2.70e-01 | -1.36e-01 | 0.78700 |
| GOBP KYNURENINE METABOLIC PROCESS | 9 | 4.80e-01 | 1.36e-01 | 0.88200 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 4.80e-01 | 1.36e-01 | 0.88200 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 6 | 5.64e-01 | -1.36e-01 | 0.90600 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 5.64e-01 | -1.36e-01 | 0.90600 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 7 | 5.34e-01 | 1.36e-01 | 0.89700 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 27 | 2.22e-01 | 1.36e-01 | 0.75100 |
| GOBP FOAM CELL DIFFERENTIATION | 26 | 2.31e-01 | -1.36e-01 | 0.75500 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 39 | 1.42e-01 | 1.36e-01 | 0.68500 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 48 | 1.04e-01 | -1.36e-01 | 0.63300 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 36 | 1.59e-01 | 1.36e-01 | 0.69900 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 5.34e-01 | 1.36e-01 | 0.89700 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 1.98e-01 | -1.36e-01 | 0.73600 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 3.97e-01 | 1.36e-01 | 0.85500 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 5.65e-01 | 1.36e-01 | 0.90600 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 5.65e-01 | 1.36e-01 | 0.90600 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 27 | 2.23e-01 | 1.36e-01 | 0.75100 |
| GOCC CATENIN COMPLEX | 12 | 4.16e-01 | -1.36e-01 | 0.86300 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 30 | 1.99e-01 | 1.35e-01 | 0.73600 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 25 | 2.41e-01 | 1.35e-01 | 0.76400 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 95 | 2.26e-02 | 1.35e-01 | 0.41800 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 69 | 5.19e-02 | 1.35e-01 | 0.52400 |
| GOBP MUCOCILIARY CLEARANCE | 5 | 6.00e-01 | 1.35e-01 | 0.91400 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 14 | 3.81e-01 | 1.35e-01 | 0.84400 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 8 | 5.08e-01 | 1.35e-01 | 0.88900 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 52 | 9.17e-02 | -1.35e-01 | 0.61300 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 11 | 4.37e-01 | -1.35e-01 | 0.86900 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 19 | 3.08e-01 | -1.35e-01 | 0.80700 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 3.21e-01 | -1.35e-01 | 0.81400 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 5.67e-01 | 1.35e-01 | 0.90600 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 47 | 1.09e-01 | 1.35e-01 | 0.63900 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 4.38e-01 | 1.35e-01 | 0.86900 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 108 | 1.54e-02 | 1.35e-01 | 0.37400 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 18 | 3.21e-01 | -1.35e-01 | 0.81400 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 31 | 1.94e-01 | 1.35e-01 | 0.73300 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 29 | 2.09e-01 | -1.35e-01 | 0.73900 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 60 | 7.13e-02 | 1.35e-01 | 0.57700 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 4.39e-01 | -1.35e-01 | 0.86900 |
| GOBP RELAXATION OF MUSCLE | 22 | 2.74e-01 | 1.35e-01 | 0.79000 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 12 | 4.19e-01 | 1.35e-01 | 0.86400 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 14 | 3.84e-01 | -1.35e-01 | 0.84500 |
| GOCC MMXD COMPLEX | 5 | 6.03e-01 | 1.34e-01 | 0.91600 |
| GOBP METHYLATION | 236 | 3.84e-04 | 1.34e-01 | 0.09760 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 8 | 5.10e-01 | 1.34e-01 | 0.88900 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 5.69e-01 | -1.34e-01 | 0.90700 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.69e-01 | -1.34e-01 | 0.90700 |
| GOBP EOSINOPHIL MIGRATION | 11 | 4.41e-01 | -1.34e-01 | 0.86900 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 13 | 4.02e-01 | 1.34e-01 | 0.85600 |
| GOBP FIBRINOLYSIS | 13 | 4.02e-01 | -1.34e-01 | 0.85600 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 245 | 3.07e-04 | 1.34e-01 | 0.09760 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 17 | 3.38e-01 | -1.34e-01 | 0.82700 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 5.69e-01 | -1.34e-01 | 0.90700 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 12 | 4.21e-01 | 1.34e-01 | 0.86400 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 13 | 4.03e-01 | 1.34e-01 | 0.85600 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 6.04e-01 | -1.34e-01 | 0.91600 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 2.20e-01 | -1.34e-01 | 0.75000 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 4.22e-01 | 1.34e-01 | 0.86400 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 29 | 2.13e-01 | -1.34e-01 | 0.74000 |
| GOBP EPITHELIAL CELL CELL ADHESION | 9 | 4.87e-01 | -1.34e-01 | 0.88300 |
| GOCC SYNAPTIC CLEFT | 6 | 5.71e-01 | 1.34e-01 | 0.90800 |
| GOBP MELANIN METABOLIC PROCESS | 17 | 3.40e-01 | 1.34e-01 | 0.82700 |
| GOBP TRANSITION METAL ION TRANSPORT | 68 | 5.67e-02 | -1.34e-01 | 0.53600 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 3.70e-01 | 1.34e-01 | 0.84000 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 6 | 5.71e-01 | 1.34e-01 | 0.90800 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 139 | 6.62e-03 | 1.34e-01 | 0.27800 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 95 | 2.46e-02 | 1.34e-01 | 0.43100 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 12 | 4.23e-01 | 1.33e-01 | 0.86400 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 4.65e-01 | 1.33e-01 | 0.87900 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 26 | 2.39e-01 | -1.33e-01 | 0.76200 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 25 | 2.48e-01 | -1.33e-01 | 0.76800 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 2.90e-01 | 1.33e-01 | 0.79300 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 5.72e-01 | -1.33e-01 | 0.90800 |
| GOCC SPERM MIDPIECE | 28 | 2.23e-01 | -1.33e-01 | 0.75100 |
| GOMF DOPAMINE RECEPTOR BINDING | 10 | 4.66e-01 | -1.33e-01 | 0.87900 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 99 | 2.22e-02 | 1.33e-01 | 0.41800 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 2.60e-01 | 1.33e-01 | 0.78000 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 4.45e-01 | -1.33e-01 | 0.87300 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 6.07e-01 | 1.33e-01 | 0.91700 |
| GOBP RESPONSE TO VITAMIN E | 5 | 6.07e-01 | 1.33e-01 | 0.91700 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 3.43e-01 | -1.33e-01 | 0.82900 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 6.07e-01 | 1.33e-01 | 0.91700 |
| GOBP TRANSCYTOSIS | 15 | 3.73e-01 | -1.33e-01 | 0.84100 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 11 | 4.46e-01 | -1.33e-01 | 0.87300 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 39 | 1.52e-01 | 1.33e-01 | 0.69000 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 16 | 3.58e-01 | 1.33e-01 | 0.83600 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 4.46e-01 | -1.33e-01 | 0.87300 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 13 | 4.08e-01 | -1.33e-01 | 0.85800 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 22 | 2.82e-01 | -1.33e-01 | 0.79000 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 5.16e-01 | -1.32e-01 | 0.89100 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 20 | 3.05e-01 | -1.32e-01 | 0.80600 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 25 | 2.52e-01 | 1.32e-01 | 0.77200 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 61 | 7.41e-02 | -1.32e-01 | 0.58100 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 4.69e-01 | -1.32e-01 | 0.88000 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 66 | 6.34e-02 | 1.32e-01 | 0.55400 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 3.06e-01 | 1.32e-01 | 0.80700 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 22 | 2.83e-01 | 1.32e-01 | 0.79100 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 4.70e-01 | -1.32e-01 | 0.88000 |
| GOBP AORTA DEVELOPMENT | 39 | 1.54e-01 | 1.32e-01 | 0.69000 |
| GOCC PERICHROMATIN FIBRILS | 5 | 6.09e-01 | 1.32e-01 | 0.91700 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 1.18e-01 | 1.32e-01 | 0.65900 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 36 | 1.71e-01 | -1.32e-01 | 0.71400 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 5.18e-01 | 1.32e-01 | 0.89100 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 2.49e-02 | 1.32e-01 | 0.43100 |
| GOBP TIGHT JUNCTION ORGANIZATION | 45 | 1.26e-01 | 1.32e-01 | 0.67300 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 4.49e-01 | 1.32e-01 | 0.87300 |
| GOBP FAT CELL PROLIFERATION | 8 | 5.19e-01 | -1.32e-01 | 0.89100 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 5.46e-01 | 1.32e-01 | 0.89900 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 23 | 2.75e-01 | -1.32e-01 | 0.79000 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 17 | 3.48e-01 | -1.32e-01 | 0.83300 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 5.77e-01 | -1.31e-01 | 0.90900 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 11 | 4.50e-01 | -1.31e-01 | 0.87400 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 6 | 5.77e-01 | -1.31e-01 | 0.90900 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 2.06e-01 | 1.31e-01 | 0.73800 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 37 | 1.67e-01 | 1.31e-01 | 0.70800 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 22 | 2.87e-01 | 1.31e-01 | 0.79100 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.20e-01 | -1.31e-01 | 0.89100 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 4.32e-01 | -1.31e-01 | 0.86600 |
| GOMF PROTEIN KINASE A BINDING | 37 | 1.68e-01 | 1.31e-01 | 0.70800 |
| GOCC PORE COMPLEX | 17 | 3.50e-01 | -1.31e-01 | 0.83400 |
| GOCC SARCOPLASM | 59 | 8.19e-02 | 1.31e-01 | 0.59900 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 6.12e-01 | 1.31e-01 | 0.91800 |
| GOBP TRNA PROCESSING | 130 | 1.01e-02 | 1.31e-01 | 0.32600 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 4.74e-01 | 1.31e-01 | 0.88000 |
| GOBP DNA REPLICATION | 239 | 5.12e-04 | 1.31e-01 | 0.11300 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 5.79e-01 | 1.31e-01 | 0.91000 |
| GOBP STEROL HOMEOSTASIS | 48 | 1.17e-01 | -1.31e-01 | 0.65800 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 9 | 4.98e-01 | -1.30e-01 | 0.88600 |
| GOCC SITE OF DNA DAMAGE | 109 | 1.87e-02 | 1.30e-01 | 0.38900 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 4.75e-01 | -1.30e-01 | 0.88100 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 4.76e-01 | 1.30e-01 | 0.88100 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 21 | 3.01e-01 | 1.30e-01 | 0.80400 |
| GOBP REGULATION OF DNA REPLICATION | 102 | 2.31e-02 | 1.30e-01 | 0.42200 |
| GOMF MHC CLASS IB RECEPTOR ACTIVITY | 6 | 5.81e-01 | 1.30e-01 | 0.91100 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 71 | 5.81e-02 | 1.30e-01 | 0.53800 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 4.76e-01 | -1.30e-01 | 0.88100 |
| GOMF CHEMOKINE BINDING | 18 | 3.39e-01 | 1.30e-01 | 0.82700 |
| GOMF TETRAPYRROLE BINDING | 75 | 5.15e-02 | -1.30e-01 | 0.52400 |
| GOCC MANCHETTE | 11 | 4.55e-01 | -1.30e-01 | 0.87500 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 5.24e-01 | 1.30e-01 | 0.89200 |
| GOBP HIPPO SIGNALING | 28 | 2.34e-01 | -1.30e-01 | 0.75800 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 82 | 4.21e-02 | 1.30e-01 | 0.49800 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 29 | 2.26e-01 | 1.30e-01 | 0.75100 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 2.11e-01 | 1.30e-01 | 0.74000 |
| GOBP HINDBRAIN MORPHOGENESIS | 29 | 2.27e-01 | -1.30e-01 | 0.75100 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 7 | 5.53e-01 | 1.30e-01 | 0.90100 |
| GOCC AP 1 ADAPTOR COMPLEX | 10 | 4.79e-01 | -1.29e-01 | 0.88200 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 5.83e-01 | 1.29e-01 | 0.91200 |
| GOCC MICROVILLUS MEMBRANE | 16 | 3.71e-01 | -1.29e-01 | 0.84100 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 32 | 2.06e-01 | 1.29e-01 | 0.73800 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 40 | 1.57e-01 | 1.29e-01 | 0.69700 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 48 | 1.22e-01 | 1.29e-01 | 0.66800 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 4.58e-01 | 1.29e-01 | 0.87700 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 6 | 5.84e-01 | 1.29e-01 | 0.91200 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 8 | 5.27e-01 | -1.29e-01 | 0.89400 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 25 | 2.64e-01 | -1.29e-01 | 0.78300 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 57 | 9.19e-02 | 1.29e-01 | 0.61300 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 73 | 5.66e-02 | -1.29e-01 | 0.53600 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 76 | 5.19e-02 | 1.29e-01 | 0.52400 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 6.17e-01 | 1.29e-01 | 0.92000 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 24 | 2.74e-01 | -1.29e-01 | 0.79000 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 9 | 5.03e-01 | 1.29e-01 | 0.88700 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 39 | 1.63e-01 | 1.29e-01 | 0.70400 |
| GOBP RHYTHMIC BEHAVIOR | 26 | 2.55e-01 | 1.29e-01 | 0.77700 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 70 | 6.24e-02 | 1.29e-01 | 0.55100 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 3.58e-02 | -1.29e-01 | 0.48200 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 10 | 4.81e-01 | -1.29e-01 | 0.88300 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 10 | 4.81e-01 | -1.29e-01 | 0.88300 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 4.04e-01 | 1.29e-01 | 0.85600 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 5.55e-01 | 1.29e-01 | 0.90200 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 16 | 3.73e-01 | -1.29e-01 | 0.84100 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 12 | 4.40e-01 | 1.29e-01 | 0.86900 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 14 | 4.05e-01 | 1.29e-01 | 0.85700 |
| GOBP LIPID STORAGE | 68 | 6.69e-02 | -1.29e-01 | 0.56700 |
| GOBP TELOMERE ORGANIZATION | 152 | 6.31e-03 | 1.29e-01 | 0.27100 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 14 | 4.05e-01 | 1.28e-01 | 0.85700 |
| GOCC GATOR2 COMPLEX | 5 | 6.19e-01 | 1.28e-01 | 0.92100 |
| GOBP TYROSINE METABOLIC PROCESS | 8 | 5.29e-01 | -1.28e-01 | 0.89600 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 11 | 4.61e-01 | 1.28e-01 | 0.87800 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 27 | 2.49e-01 | -1.28e-01 | 0.76800 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 10 | 4.82e-01 | 1.28e-01 | 0.88300 |
| GOBP SPINDLE ELONGATION | 9 | 5.05e-01 | -1.28e-01 | 0.88800 |
| GOBP DNA STRAND ELONGATION | 35 | 1.89e-01 | 1.28e-01 | 0.72900 |
| GOBP RESPONSE TO ETHANOL | 69 | 6.56e-02 | 1.28e-01 | 0.56200 |
| GOCC CHROMOSOMAL REGION | 330 | 6.53e-05 | 1.28e-01 | 0.06270 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 4.06e-01 | 1.28e-01 | 0.85800 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 29 | 2.32e-01 | 1.28e-01 | 0.75600 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 6.20e-01 | -1.28e-01 | 0.92100 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 35 | 1.90e-01 | -1.28e-01 | 0.72900 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 10 | 4.83e-01 | 1.28e-01 | 0.88300 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 167 | 4.37e-03 | 1.28e-01 | 0.24700 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 4.07e-01 | 1.28e-01 | 0.85800 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 4.83e-01 | 1.28e-01 | 0.88300 |
| GOBP LATERAL MESODERM DEVELOPMENT | 5 | 6.20e-01 | -1.28e-01 | 0.92100 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 44 | 1.42e-01 | -1.28e-01 | 0.68500 |
| GOCC MSL COMPLEX | 5 | 6.20e-01 | -1.28e-01 | 0.92100 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 24 | 2.78e-01 | -1.28e-01 | 0.79000 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 13 | 4.25e-01 | -1.28e-01 | 0.86400 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 36 | 1.85e-01 | -1.28e-01 | 0.72200 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 51 | 1.15e-01 | -1.28e-01 | 0.65200 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 3.62e-01 | -1.28e-01 | 0.83900 |
| GOMF UBIQUITIN BINDING | 98 | 2.90e-02 | -1.28e-01 | 0.45700 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 12 | 4.44e-01 | -1.28e-01 | 0.87100 |
| GOMF STEROL ESTERASE ACTIVITY | 6 | 5.88e-01 | -1.28e-01 | 0.91300 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 5.07e-01 | -1.28e-01 | 0.88800 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 10 | 4.85e-01 | 1.28e-01 | 0.88300 |
| GOMF FUCOSE BINDING | 6 | 5.88e-01 | 1.28e-01 | 0.91300 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 23 | 2.90e-01 | 1.28e-01 | 0.79300 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 5.08e-01 | 1.27e-01 | 0.88900 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 5.33e-01 | 1.27e-01 | 0.89700 |
| GOCC POTASSIUM CHANNEL COMPLEX | 37 | 1.80e-01 | 1.27e-01 | 0.71800 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 5.59e-01 | -1.27e-01 | 0.90400 |
| GOMF AMINO ACID BINDING | 25 | 2.71e-01 | -1.27e-01 | 0.78800 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 10 | 4.86e-01 | 1.27e-01 | 0.88300 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 2.71e-01 | 1.27e-01 | 0.78800 |
| GOBP CYTOKINETIC PROCESS | 37 | 1.81e-01 | 1.27e-01 | 0.71900 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 5.89e-01 | 1.27e-01 | 0.91300 |
| GOBP MYOBLAST FUSION | 32 | 2.13e-01 | 1.27e-01 | 0.74000 |
| GOBP ARACHIDONIC ACID SECRETION | 10 | 4.86e-01 | 1.27e-01 | 0.88300 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 28 | 2.44e-01 | -1.27e-01 | 0.76600 |
| GOMF SNRNA BINDING | 45 | 1.40e-01 | -1.27e-01 | 0.68400 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 7 | 5.60e-01 | -1.27e-01 | 0.90500 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 34 | 2.00e-01 | 1.27e-01 | 0.73700 |
| GOCC COLLAGEN TRIMER | 24 | 2.82e-01 | 1.27e-01 | 0.79000 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 10 | 4.87e-01 | -1.27e-01 | 0.88300 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 10 | 4.87e-01 | -1.27e-01 | 0.88300 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 1.33e-01 | 1.27e-01 | 0.67800 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 9 | 5.10e-01 | -1.27e-01 | 0.88900 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 5.10e-01 | -1.27e-01 | 0.88900 |
| GOMF NEUROTRANSMITTER BINDING | 7 | 5.61e-01 | -1.27e-01 | 0.90500 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 24 | 2.82e-01 | 1.27e-01 | 0.79000 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 4.88e-01 | 1.27e-01 | 0.88300 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 5.91e-01 | 1.27e-01 | 0.91300 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 4.67e-01 | 1.27e-01 | 0.87900 |
| GOBP VACUOLE FUSION | 11 | 4.67e-01 | 1.27e-01 | 0.87900 |
| GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY | 6 | 5.91e-01 | 1.27e-01 | 0.91300 |
| GOBP ACROSOME ASSEMBLY | 13 | 4.29e-01 | -1.27e-01 | 0.86400 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 13 | 4.29e-01 | 1.27e-01 | 0.86400 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 33 | 2.08e-01 | -1.27e-01 | 0.73900 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 30 | 2.30e-01 | 1.27e-01 | 0.75500 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 11 | 4.68e-01 | -1.26e-01 | 0.88000 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 5.92e-01 | -1.26e-01 | 0.91300 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 3.68e-01 | 1.26e-01 | 0.84000 |
| GOBP DETOXIFICATION | 89 | 3.99e-02 | -1.26e-01 | 0.49100 |
| GOMF DEACETYLASE ACTIVITY | 33 | 2.10e-01 | 1.26e-01 | 0.73900 |
| GOBP REGULATION OF AXON EXTENSION | 61 | 8.90e-02 | 1.26e-01 | 0.61300 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 4.32e-01 | 1.26e-01 | 0.86600 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 2.76e-01 | -1.26e-01 | 0.79000 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 40 | 1.68e-01 | 1.26e-01 | 0.70900 |
| GOBP CRANIAL NERVE DEVELOPMENT | 29 | 2.41e-01 | 1.26e-01 | 0.76300 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 43 | 1.54e-01 | -1.26e-01 | 0.69000 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 10 | 4.91e-01 | -1.26e-01 | 0.88500 |
| GOCC SPLICEOSOMAL COMPLEX | 190 | 2.87e-03 | -1.26e-01 | 0.20700 |
| GOBP MONOCYTE DIFFERENTIATION | 27 | 2.59e-01 | 1.26e-01 | 0.77900 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 15 | 4.00e-01 | 1.26e-01 | 0.85600 |
| GOCC AUTOPHAGOSOME MEMBRANE | 45 | 1.46e-01 | -1.25e-01 | 0.68500 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 5.15e-01 | 1.25e-01 | 0.89100 |
| GOMF ARP2 3 COMPLEX BINDING | 12 | 4.52e-01 | -1.25e-01 | 0.87400 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 58 | 9.88e-02 | 1.25e-01 | 0.62400 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 4.72e-01 | -1.25e-01 | 0.88000 |
| GOCC NEURONAL DENSE CORE VESICLE | 9 | 5.15e-01 | -1.25e-01 | 0.89100 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 2.43e-01 | 1.25e-01 | 0.76500 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 4.72e-01 | 1.25e-01 | 0.88000 |
| GOBP DENDRITE MORPHOGENESIS | 94 | 3.60e-02 | 1.25e-01 | 0.48200 |
| GOBP XENOBIOTIC TRANSPORT | 27 | 2.60e-01 | -1.25e-01 | 0.78000 |
| GOBP HYALURONAN METABOLIC PROCESS | 21 | 3.21e-01 | 1.25e-01 | 0.81400 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 47 | 1.38e-01 | 1.25e-01 | 0.68000 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 83 | 4.88e-02 | 1.25e-01 | 0.51200 |
| GOBP CILIUM DISASSEMBLY | 5 | 6.28e-01 | 1.25e-01 | 0.92400 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 17 | 3.72e-01 | 1.25e-01 | 0.84100 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 22 | 3.10e-01 | -1.25e-01 | 0.80800 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 26 | 2.69e-01 | -1.25e-01 | 0.78700 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 38 | 1.82e-01 | 1.25e-01 | 0.72100 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 33 | 2.14e-01 | 1.25e-01 | 0.74000 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 6 | 5.96e-01 | -1.25e-01 | 0.91300 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.96e-01 | -1.25e-01 | 0.91300 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 5.96e-01 | -1.25e-01 | 0.91300 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 17 | 3.72e-01 | 1.25e-01 | 0.84100 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 20 | 3.34e-01 | 1.25e-01 | 0.82100 |
| GOBP REGULATION OF IRON ION TRANSPORT | 5 | 6.29e-01 | 1.25e-01 | 0.92400 |
| GOBP LEUCINE TRANSPORT | 8 | 5.41e-01 | -1.25e-01 | 0.89700 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 5.41e-01 | -1.25e-01 | 0.89700 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 5.67e-01 | 1.25e-01 | 0.90600 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 4.94e-01 | -1.25e-01 | 0.88600 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 32 | 2.22e-01 | 1.25e-01 | 0.75100 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 24 | 2.90e-01 | 1.25e-01 | 0.79300 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 5.97e-01 | -1.25e-01 | 0.91300 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 9 | 5.17e-01 | -1.25e-01 | 0.89100 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 2.71e-01 | 1.25e-01 | 0.78800 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 101 | 3.07e-02 | -1.25e-01 | 0.47200 |
| GOCC PLASMA MEMBRANE RAFT | 67 | 7.81e-02 | 1.25e-01 | 0.58900 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 19 | 3.47e-01 | 1.25e-01 | 0.83300 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 5 | 6.30e-01 | -1.25e-01 | 0.92400 |
| GOBP OSTEOCLAST FUSION | 5 | 6.30e-01 | -1.25e-01 | 0.92400 |
| GOCC RAGULATOR COMPLEX | 5 | 6.30e-01 | -1.24e-01 | 0.92400 |
| GOCC UNIPLEX COMPLEX | 5 | 6.30e-01 | 1.24e-01 | 0.92400 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 34 | 2.10e-01 | 1.24e-01 | 0.73900 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 9 | 5.18e-01 | 1.24e-01 | 0.89100 |
| GOCC EARLY PHAGOSOME | 10 | 4.96e-01 | -1.24e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 14 | 4.21e-01 | -1.24e-01 | 0.86400 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 3.25e-01 | -1.24e-01 | 0.81600 |
| GOCC WNT SIGNALOSOME | 9 | 5.19e-01 | 1.24e-01 | 0.89100 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 14 | 4.21e-01 | -1.24e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 33 | 2.17e-01 | 1.24e-01 | 0.74500 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 5.99e-01 | -1.24e-01 | 0.91400 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 6.31e-01 | 1.24e-01 | 0.92400 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 98 | 3.41e-02 | 1.24e-01 | 0.48200 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 6.32e-01 | 1.24e-01 | 0.92400 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 5.71e-01 | -1.24e-01 | 0.90800 |
| GOBP MOLTING CYCLE PROCESS | 45 | 1.52e-01 | -1.24e-01 | 0.69000 |
| GOBP DENDRITE EXTENSION | 25 | 2.85e-01 | -1.24e-01 | 0.79100 |
| GOMF LAMININ BINDING | 15 | 4.08e-01 | 1.24e-01 | 0.85800 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 5.72e-01 | 1.23e-01 | 0.90800 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 5.72e-01 | 1.23e-01 | 0.90800 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 3.40e-01 | 1.23e-01 | 0.82700 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 4.99e-01 | -1.23e-01 | 0.88600 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 55 | 1.14e-01 | 1.23e-01 | 0.65000 |
| GOBP REGULATION OF ICOSANOID SECRETION | 10 | 5.00e-01 | 1.23e-01 | 0.88600 |
| GOBP NEURON FATE COMMITMENT | 17 | 3.79e-01 | -1.23e-01 | 0.84400 |
| GOBP ERAD PATHWAY | 97 | 3.62e-02 | -1.23e-01 | 0.48200 |
| GOBP DNA TEMPLATED DNA REPLICATION | 140 | 1.20e-02 | 1.23e-01 | 0.35000 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 14 | 4.25e-01 | 1.23e-01 | 0.86400 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 46 | 1.49e-01 | -1.23e-01 | 0.69000 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 19 | 3.53e-01 | -1.23e-01 | 0.83500 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 11 | 4.80e-01 | -1.23e-01 | 0.88200 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 40 | 1.78e-01 | -1.23e-01 | 0.71700 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 3.66e-01 | -1.23e-01 | 0.84000 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 10 | 5.01e-01 | 1.23e-01 | 0.88600 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 193 | 3.29e-03 | 1.23e-01 | 0.21900 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 4.61e-01 | 1.23e-01 | 0.87800 |
| GOBP DIET INDUCED THERMOGENESIS | 7 | 5.73e-01 | -1.23e-01 | 0.90800 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 24 | 2.97e-01 | -1.23e-01 | 0.80000 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 22 | 3.19e-01 | 1.23e-01 | 0.81300 |
| GOCC REPLICATION FORK | 59 | 1.03e-01 | 1.23e-01 | 0.63000 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 64 | 8.94e-02 | 1.23e-01 | 0.61300 |
| GOCC CIA COMPLEX | 5 | 6.34e-01 | -1.23e-01 | 0.92400 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 8 | 5.48e-01 | -1.23e-01 | 0.90000 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 4.81e-01 | -1.23e-01 | 0.88300 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 23 | 3.08e-01 | 1.23e-01 | 0.80700 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 16 | 3.96e-01 | -1.23e-01 | 0.85400 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 5.74e-01 | -1.23e-01 | 0.90800 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 5.74e-01 | 1.23e-01 | 0.90800 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 8 | 5.48e-01 | 1.23e-01 | 0.90000 |
| GOBP PLATELET ACTIVATION | 96 | 3.81e-02 | -1.23e-01 | 0.48400 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 55 | 1.16e-01 | 1.23e-01 | 0.65600 |
| GOBP RESPONSE TO GRAVITY | 6 | 6.03e-01 | 1.23e-01 | 0.91600 |
| GOBP POSTREPLICATION REPAIR | 32 | 2.31e-01 | -1.22e-01 | 0.75500 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 84 | 5.25e-02 | 1.22e-01 | 0.52500 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 33 | 2.24e-01 | 1.22e-01 | 0.75100 |
| GOCC ATAC COMPLEX | 13 | 4.45e-01 | -1.22e-01 | 0.87200 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 6 | 6.04e-01 | -1.22e-01 | 0.91600 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 7 | 5.75e-01 | 1.22e-01 | 0.90800 |
| GOCC PHOSPHATASE COMPLEX | 47 | 1.47e-01 | 1.22e-01 | 0.68700 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 5.03e-01 | 1.22e-01 | 0.88700 |
| GOCC BLOC COMPLEX | 14 | 4.28e-01 | 1.22e-01 | 0.86400 |
| GOCC METHYLTRANSFERASE COMPLEX | 91 | 4.38e-02 | 1.22e-01 | 0.50200 |
| GOBP REGULATION OF TELOMERE CAPPING | 24 | 3.00e-01 | 1.22e-01 | 0.80300 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 5.75e-01 | 1.22e-01 | 0.90800 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 7 | 5.75e-01 | -1.22e-01 | 0.90800 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 47 | 1.47e-01 | 1.22e-01 | 0.68700 |
| GOCC PLATELET DENSE GRANULE MEMBRANE | 6 | 6.04e-01 | 1.22e-01 | 0.91600 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 50 | 1.35e-01 | 1.22e-01 | 0.68000 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 82 | 5.63e-02 | 1.22e-01 | 0.53600 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 24 | 3.01e-01 | -1.22e-01 | 0.80400 |
| GOCC PRERIBOSOME | 103 | 3.26e-02 | 1.22e-01 | 0.47800 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 7 | 5.76e-01 | -1.22e-01 | 0.90900 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 6.37e-01 | 1.22e-01 | 0.92400 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 6.37e-01 | -1.22e-01 | 0.92400 |
| GOBP PLACENTA DEVELOPMENT | 98 | 3.72e-02 | -1.22e-01 | 0.48200 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 4.47e-01 | 1.22e-01 | 0.87300 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 24 | 3.02e-01 | 1.22e-01 | 0.80400 |
| GOBP RESPONSE TO ESTROGEN | 40 | 1.83e-01 | 1.22e-01 | 0.72100 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 48 | 1.44e-01 | -1.22e-01 | 0.68500 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 4.65e-01 | -1.22e-01 | 0.87900 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 5 | 6.37e-01 | 1.22e-01 | 0.92400 |
| GOBP DOPAMINE METABOLIC PROCESS | 19 | 3.58e-01 | 1.22e-01 | 0.83600 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 7 | 5.77e-01 | -1.22e-01 | 0.90900 |
| GOCC CLATHRIN VESICLE COAT | 29 | 2.57e-01 | -1.22e-01 | 0.77800 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 50 | 1.37e-01 | 1.22e-01 | 0.68000 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 13 | 4.48e-01 | -1.22e-01 | 0.87300 |
| GOBP PROTEIN KINASE C SIGNALING | 20 | 3.47e-01 | 1.21e-01 | 0.83300 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 94 | 4.21e-02 | 1.21e-01 | 0.49800 |
| GOBP DENDRITIC TRANSPORT | 9 | 5.28e-01 | -1.21e-01 | 0.89500 |
| GOBP CELL JUNCTION MAINTENANCE | 28 | 2.66e-01 | 1.21e-01 | 0.78400 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 10 | 5.06e-01 | -1.21e-01 | 0.88800 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 64 | 9.34e-02 | -1.21e-01 | 0.61500 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 5.78e-01 | -1.21e-01 | 0.90900 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 25 | 2.94e-01 | 1.21e-01 | 0.79700 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 12 | 4.67e-01 | -1.21e-01 | 0.87900 |
| GOBP SULFUR COMPOUND TRANSPORT | 39 | 1.90e-01 | -1.21e-01 | 0.72900 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 6 | 6.07e-01 | -1.21e-01 | 0.91700 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 7.35e-02 | 1.21e-01 | 0.58000 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 4.32e-01 | 1.21e-01 | 0.86600 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 24 | 3.04e-01 | 1.21e-01 | 0.80600 |
| GOCC CLATHRIN COAT | 41 | 1.80e-01 | -1.21e-01 | 0.71800 |
| GOBP GOLGI DISASSEMBLY | 5 | 6.39e-01 | 1.21e-01 | 0.92400 |
| GOMF HEXOSAMINIDASE ACTIVITY | 13 | 4.50e-01 | 1.21e-01 | 0.87400 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 34 | 2.22e-01 | 1.21e-01 | 0.75100 |
| GOBP HEART TRABECULA MORPHOGENESIS | 18 | 3.74e-01 | -1.21e-01 | 0.84200 |
| GOCC TERMINAL BOUTON | 22 | 3.26e-01 | 1.21e-01 | 0.81700 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY | 5 | 6.40e-01 | -1.21e-01 | 0.92400 |
| GOBP ENDODERM DEVELOPMENT | 42 | 1.75e-01 | -1.21e-01 | 0.71600 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 11 | 4.88e-01 | 1.21e-01 | 0.88300 |
| GOBP RESPONSE TO VITAMIN D | 22 | 3.27e-01 | 1.21e-01 | 0.81700 |
| GOBP PML BODY ORGANIZATION | 6 | 6.08e-01 | -1.21e-01 | 0.91700 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 20 | 3.50e-01 | 1.21e-01 | 0.83400 |
| GOCC NEURON SPINE | 106 | 3.19e-02 | 1.21e-01 | 0.47800 |
| GOBP PLATELET AGGREGATION | 52 | 1.32e-01 | -1.21e-01 | 0.67800 |
| GOBP ORGAN GROWTH | 95 | 4.23e-02 | -1.21e-01 | 0.49900 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 16 | 4.04e-01 | 1.21e-01 | 0.85600 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 10 | 5.09e-01 | -1.21e-01 | 0.88900 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 5.55e-01 | -1.20e-01 | 0.90200 |
| GOMF RECEPTOR ANTAGONIST ACTIVITY | 5 | 6.41e-01 | 1.20e-01 | 0.92400 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 116 | 2.52e-02 | 1.20e-01 | 0.43200 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 10 | 5.10e-01 | 1.20e-01 | 0.88900 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 344 | 1.31e-04 | 1.20e-01 | 0.08060 |
| GOBP REGULATION OF ORGAN GROWTH | 46 | 1.58e-01 | -1.20e-01 | 0.69700 |
| GOCC CMG COMPLEX | 7 | 5.81e-01 | 1.20e-01 | 0.91200 |
| GOMF HISTONE KINASE ACTIVITY | 16 | 4.05e-01 | 1.20e-01 | 0.85700 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 24 | 3.08e-01 | 1.20e-01 | 0.80700 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 1.78e-01 | 1.20e-01 | 0.71700 |
| GOCC MIB COMPLEX | 13 | 4.53e-01 | 1.20e-01 | 0.87400 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 167 | 7.46e-03 | 1.20e-01 | 0.29300 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 13 | 4.53e-01 | 1.20e-01 | 0.87400 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 21 | 3.41e-01 | 1.20e-01 | 0.82800 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 113 | 2.76e-02 | 1.20e-01 | 0.44800 |
| GOMF CHITIN BINDING | 5 | 6.42e-01 | -1.20e-01 | 0.92400 |
| GOBP RESPONSE TO LEPTIN | 11 | 4.91e-01 | -1.20e-01 | 0.88500 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.57e-01 | -1.20e-01 | 0.90300 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 4.54e-01 | -1.20e-01 | 0.87500 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 4.72e-01 | 1.20e-01 | 0.88000 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 9 | 5.33e-01 | 1.20e-01 | 0.89700 |
| GOBP FATTY ACID ELONGATION | 10 | 5.11e-01 | -1.20e-01 | 0.89000 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 68 | 8.72e-02 | 1.20e-01 | 0.61200 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 60 | 1.08e-01 | 1.20e-01 | 0.63900 |
| GOCC NUCLEAR PORE | 87 | 5.33e-02 | 1.20e-01 | 0.52800 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 22 | 3.30e-01 | 1.20e-01 | 0.81800 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 12 | 4.72e-01 | -1.20e-01 | 0.88000 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 24 | 3.09e-01 | 1.20e-01 | 0.80800 |
| GOMF KINESIN BINDING | 34 | 2.27e-01 | 1.20e-01 | 0.75100 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 66 | 9.27e-02 | -1.20e-01 | 0.61300 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 6 | 6.12e-01 | -1.20e-01 | 0.91800 |
| GOMF TELOMERASE ACTIVITY | 6 | 6.12e-01 | -1.20e-01 | 0.91800 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 4.92e-01 | -1.20e-01 | 0.88500 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 5.84e-01 | -1.20e-01 | 0.91200 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 11 | 4.92e-01 | 1.20e-01 | 0.88500 |
| GOCC GOLGI CIS CISTERNA | 15 | 4.23e-01 | -1.20e-01 | 0.86400 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 6.12e-01 | 1.20e-01 | 0.91800 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 57 | 1.19e-01 | 1.20e-01 | 0.66300 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 9 | 5.35e-01 | -1.19e-01 | 0.89700 |
| GOBP CAMP METABOLIC PROCESS | 15 | 4.24e-01 | 1.19e-01 | 0.86400 |
| GOMF SUMO TRANSFERASE ACTIVITY | 25 | 3.02e-01 | 1.19e-01 | 0.80400 |
| GOBP SERTOLI CELL DEVELOPMENT | 9 | 5.36e-01 | 1.19e-01 | 0.89700 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 6.45e-01 | 1.19e-01 | 0.92500 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 6.45e-01 | -1.19e-01 | 0.92500 |
| GOBP HISTONE DEACETYLATION | 21 | 3.45e-01 | 1.19e-01 | 0.83000 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 8 | 5.60e-01 | 1.19e-01 | 0.90400 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 88 | 5.38e-02 | 1.19e-01 | 0.52800 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 3.96e-01 | 1.19e-01 | 0.85400 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 11 | 4.95e-01 | -1.19e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 249 | 1.26e-03 | 1.19e-01 | 0.17900 |
| GOBP RIBOSOME BIOGENESIS | 310 | 3.31e-04 | 1.19e-01 | 0.09760 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 5.87e-01 | 1.19e-01 | 0.91300 |
| GOCC CHROMOSOME CENTROMERIC REGION | 207 | 3.30e-03 | 1.19e-01 | 0.21900 |
| GOBP SMOOTH MUSCLE CONTRACTION | 56 | 1.25e-01 | 1.19e-01 | 0.67200 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 6.46e-01 | 1.19e-01 | 0.92600 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 33 | 2.39e-01 | -1.19e-01 | 0.76200 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 75 | 7.63e-02 | 1.18e-01 | 0.58500 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 5.38e-01 | 1.18e-01 | 0.89700 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 39 | 2.01e-01 | 1.18e-01 | 0.73700 |
| GOBP BASE EXCISION REPAIR | 42 | 1.84e-01 | 1.18e-01 | 0.72100 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 12 | 4.78e-01 | 1.18e-01 | 0.88100 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 125 | 2.25e-02 | 1.18e-01 | 0.41800 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 6.16e-01 | -1.18e-01 | 0.91900 |
| GOBP COPPER ION HOMEOSTASIS | 17 | 3.99e-01 | -1.18e-01 | 0.85600 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 6.47e-01 | 1.18e-01 | 0.92600 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 60 | 1.14e-01 | -1.18e-01 | 0.65000 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 9 | 5.39e-01 | 1.18e-01 | 0.89700 |
| GOMF DELTA CATENIN BINDING | 7 | 5.88e-01 | -1.18e-01 | 0.91300 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 28 | 2.79e-01 | 1.18e-01 | 0.79000 |
| GOBP MOTOR NEURON MIGRATION | 6 | 6.17e-01 | -1.18e-01 | 0.91900 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 59 | 1.17e-01 | 1.18e-01 | 0.65800 |
| GOBP ALDITOL METABOLIC PROCESS | 15 | 4.29e-01 | -1.18e-01 | 0.86400 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 43 | 1.81e-01 | 1.18e-01 | 0.71900 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 22 | 3.38e-01 | 1.18e-01 | 0.82700 |
| GOBP CELLULAR DEFENSE RESPONSE | 39 | 2.03e-01 | 1.18e-01 | 0.73800 |
| GOBP DIENCEPHALON DEVELOPMENT | 24 | 3.18e-01 | 1.18e-01 | 0.81200 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 3.62e-01 | 1.18e-01 | 0.83900 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 4.62e-01 | 1.18e-01 | 0.87900 |
| GOBP SPERM DNA CONDENSATION | 7 | 5.90e-01 | -1.18e-01 | 0.91300 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 15 | 4.30e-01 | -1.18e-01 | 0.86500 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 5.90e-01 | -1.18e-01 | 0.91300 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 37 | 2.16e-01 | 1.18e-01 | 0.74300 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 6.49e-01 | 1.18e-01 | 0.92700 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 29 | 2.73e-01 | 1.18e-01 | 0.78900 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 34 | 2.36e-01 | -1.18e-01 | 0.76000 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 22 | 3.41e-01 | -1.17e-01 | 0.82800 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 122 | 2.53e-02 | -1.17e-01 | 0.43200 |
| GOMF DIACYLGLYCEROL BINDING | 11 | 5.00e-01 | 1.17e-01 | 0.88600 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 251 | 1.41e-03 | 1.17e-01 | 0.19100 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 8 | 5.66e-01 | 1.17e-01 | 0.90600 |
| GOBP DETECTION OF BIOTIC STIMULUS | 27 | 2.92e-01 | 1.17e-01 | 0.79500 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 4.32e-01 | 1.17e-01 | 0.86600 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 67 | 9.74e-02 | 1.17e-01 | 0.62300 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 6.50e-01 | -1.17e-01 | 0.92700 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 14 | 4.48e-01 | 1.17e-01 | 0.87300 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 17 | 4.03e-01 | 1.17e-01 | 0.85600 |
| GOMF DOUBLE STRANDED RNA BINDING | 65 | 1.03e-01 | 1.17e-01 | 0.63000 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 33 | 2.45e-01 | 1.17e-01 | 0.76700 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 17 | 4.03e-01 | -1.17e-01 | 0.85600 |
| GOBP IRIS MORPHOGENESIS | 5 | 6.51e-01 | -1.17e-01 | 0.92700 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 66 | 1.01e-01 | 1.17e-01 | 0.62600 |
| GOBP CARNITINE TRANSPORT | 6 | 6.20e-01 | -1.17e-01 | 0.92100 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 4.49e-01 | 1.17e-01 | 0.87300 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 113 | 3.22e-02 | 1.17e-01 | 0.47800 |
| GOCC SET1C COMPASS COMPLEX | 13 | 4.66e-01 | 1.17e-01 | 0.87900 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 4.66e-01 | -1.17e-01 | 0.87900 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 118 | 2.87e-02 | 1.17e-01 | 0.45700 |
| GOCC ORGANELLE ENVELOPE LUMEN | 78 | 7.51e-02 | 1.17e-01 | 0.58200 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 4.84e-01 | -1.17e-01 | 0.88300 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 38 | 2.14e-01 | 1.17e-01 | 0.74000 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 261 | 1.21e-03 | 1.17e-01 | 0.17900 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 7 | 5.94e-01 | -1.17e-01 | 0.91300 |
| GOMF COLLAGEN BINDING | 36 | 2.27e-01 | -1.16e-01 | 0.75100 |
| GOBP ASYMMETRIC CELL DIVISION | 14 | 4.51e-01 | 1.16e-01 | 0.87400 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 6.52e-01 | 1.16e-01 | 0.92700 |
| GOMF SUMO BINDING | 16 | 4.21e-01 | 1.16e-01 | 0.86400 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 6 | 6.22e-01 | -1.16e-01 | 0.92100 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 6.22e-01 | 1.16e-01 | 0.92100 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 9 | 5.46e-01 | -1.16e-01 | 0.89900 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 23 | 3.35e-01 | 1.16e-01 | 0.82200 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 3.06e-01 | -1.16e-01 | 0.80700 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 5.95e-01 | -1.16e-01 | 0.91300 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 4.53e-01 | -1.16e-01 | 0.87400 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 2.42e-01 | 1.16e-01 | 0.76500 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 7 | 5.95e-01 | 1.16e-01 | 0.91300 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 8 | 5.70e-01 | -1.16e-01 | 0.90800 |
| GOBP HYPOTONIC RESPONSE | 8 | 5.70e-01 | -1.16e-01 | 0.90800 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 75 | 8.31e-02 | 1.16e-01 | 0.60000 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 75 | 8.31e-02 | 1.16e-01 | 0.60000 |
| GOMF GROWTH FACTOR ACTIVITY | 58 | 1.28e-01 | -1.16e-01 | 0.67500 |
| GOMF INSULIN RECEPTOR BINDING | 16 | 4.23e-01 | 1.16e-01 | 0.86400 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 6.24e-01 | 1.16e-01 | 0.92200 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 9 | 5.49e-01 | -1.15e-01 | 0.90000 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 4.71e-01 | 1.15e-01 | 0.88000 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 36 | 2.31e-01 | -1.15e-01 | 0.75500 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 140 | 1.85e-02 | 1.15e-01 | 0.38900 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 6.55e-01 | 1.15e-01 | 0.92900 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 6.55e-01 | -1.15e-01 | 0.92900 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 181 | 7.57e-03 | 1.15e-01 | 0.29400 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 68 | 1.01e-01 | 1.15e-01 | 0.62600 |
| GOCC ENDOSOME LUMEN | 23 | 3.39e-01 | -1.15e-01 | 0.82700 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 4.72e-01 | -1.15e-01 | 0.88000 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 70 | 9.59e-02 | 1.15e-01 | 0.62100 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 26 | 3.10e-01 | 1.15e-01 | 0.80800 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 24 | 3.29e-01 | 1.15e-01 | 0.81800 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 4.11e-01 | -1.15e-01 | 0.86000 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 9 | 5.50e-01 | -1.15e-01 | 0.90100 |
| GOMF WNT PROTEIN BINDING | 13 | 4.73e-01 | -1.15e-01 | 0.88000 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 10 | 5.29e-01 | 1.15e-01 | 0.89500 |
| GOBP OSTEOBLAST DEVELOPMENT | 8 | 5.74e-01 | -1.15e-01 | 0.90800 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 15 | 4.41e-01 | 1.15e-01 | 0.87000 |
| GOCC HAUS COMPLEX | 8 | 5.74e-01 | -1.15e-01 | 0.90800 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 4.00e-01 | 1.15e-01 | 0.85600 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 8 | 5.74e-01 | 1.15e-01 | 0.90800 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 66 | 1.07e-01 | 1.15e-01 | 0.63700 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 39 | 2.16e-01 | 1.15e-01 | 0.74300 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 21 | 3.64e-01 | 1.14e-01 | 0.83900 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 2.35e-01 | 1.14e-01 | 0.75900 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 16 | 4.28e-01 | -1.14e-01 | 0.86400 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 5.75e-01 | 1.14e-01 | 0.90800 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 12 | 4.93e-01 | -1.14e-01 | 0.88600 |
| GOBP PROTEIN METHYLATION | 69 | 1.01e-01 | 1.14e-01 | 0.62600 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 151 | 1.55e-02 | 1.14e-01 | 0.37400 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 4.01e-01 | 1.14e-01 | 0.85600 |
| GOBP ERK1 AND ERK2 CASCADE | 186 | 7.29e-03 | 1.14e-01 | 0.29100 |
| GOMF ATPASE INHIBITOR ACTIVITY | 5 | 6.58e-01 | 1.14e-01 | 0.93100 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 21 | 3.65e-01 | 1.14e-01 | 0.84000 |
| GOBP AXON EXTENSION | 82 | 7.41e-02 | 1.14e-01 | 0.58100 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 29 | 2.87e-01 | -1.14e-01 | 0.79200 |
| GOCC SUMO LIGASE COMPLEX | 13 | 4.76e-01 | 1.14e-01 | 0.88100 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 6.28e-01 | 1.14e-01 | 0.92400 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 17 | 4.16e-01 | 1.14e-01 | 0.86300 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 26 | 3.14e-01 | 1.14e-01 | 0.81000 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 22 | 3.55e-01 | -1.14e-01 | 0.83600 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 6.29e-01 | 1.14e-01 | 0.92400 |
| GOCC EUCHROMATIN | 42 | 2.02e-01 | 1.14e-01 | 0.73700 |
| GOBP MALE SEX DETERMINATION | 5 | 6.59e-01 | 1.14e-01 | 0.93100 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 11 | 5.14e-01 | -1.14e-01 | 0.89100 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 64 | 1.16e-01 | 1.14e-01 | 0.65500 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 20 | 3.79e-01 | 1.14e-01 | 0.84400 |
| GOBP OVULATION CYCLE | 40 | 2.14e-01 | 1.14e-01 | 0.74000 |
| GOBP RESPONSE TO MUSCLE STRETCH | 20 | 3.79e-01 | 1.14e-01 | 0.84400 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 7 | 6.03e-01 | 1.14e-01 | 0.91600 |
| GOBP RETROGRADE AXONAL TRANSPORT | 14 | 4.62e-01 | -1.14e-01 | 0.87900 |
| GOMF U4 SNRNA BINDING | 6 | 6.30e-01 | -1.13e-01 | 0.92400 |
| GOBP REPRODUCTIVE BEHAVIOR | 20 | 3.80e-01 | -1.13e-01 | 0.84400 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 140 | 2.08e-02 | 1.13e-01 | 0.41000 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 6.31e-01 | 1.13e-01 | 0.92400 |
| GOBP RNA CAPPING | 36 | 2.40e-01 | 1.13e-01 | 0.76200 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 10 | 5.35e-01 | 1.13e-01 | 0.89700 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 14 | 4.63e-01 | -1.13e-01 | 0.87900 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 16 | 4.33e-01 | -1.13e-01 | 0.86600 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 23 | 3.48e-01 | 1.13e-01 | 0.83300 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 35 | 2.47e-01 | 1.13e-01 | 0.76800 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 6.05e-01 | -1.13e-01 | 0.91600 |
| GOMF HYDRO LYASE ACTIVITY | 41 | 2.11e-01 | 1.13e-01 | 0.73900 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.05e-01 | 1.13e-01 | 0.91600 |
| GOBP DENTATE GYRUS DEVELOPMENT | 11 | 5.17e-01 | 1.13e-01 | 0.89100 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 16 | 4.34e-01 | 1.13e-01 | 0.86600 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 64 | 1.19e-01 | 1.13e-01 | 0.66300 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 6.62e-01 | -1.13e-01 | 0.93200 |
| GOBP SCHWANN CELL MIGRATION | 5 | 6.62e-01 | 1.13e-01 | 0.93200 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 6.05e-01 | 1.13e-01 | 0.91600 |
| GOBP DENDRITIC CELL MIGRATION | 25 | 3.29e-01 | 1.13e-01 | 0.81800 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 28 | 3.02e-01 | 1.13e-01 | 0.80400 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 116 | 3.63e-02 | 1.13e-01 | 0.48200 |
| GOBP THYMIC T CELL SELECTION | 15 | 4.50e-01 | 1.13e-01 | 0.87400 |
| GOBP INTERLEUKIN 12 PRODUCTION | 49 | 1.73e-01 | 1.13e-01 | 0.71500 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 31 | 2.78e-01 | -1.13e-01 | 0.79000 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 15 | 4.51e-01 | -1.12e-01 | 0.87400 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 5.59e-01 | 1.12e-01 | 0.90400 |
| GOBP PROTEIN TARGETING TO VACUOLE | 44 | 1.97e-01 | -1.12e-01 | 0.73500 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 3.72e-01 | -1.12e-01 | 0.84100 |
| GOCC NADPH OXIDASE COMPLEX | 10 | 5.38e-01 | -1.12e-01 | 0.89700 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 6.63e-01 | 1.12e-01 | 0.93200 |
| GOBP NUCLEOTIDE TRANSPORT | 34 | 2.57e-01 | 1.12e-01 | 0.77800 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 37 | 2.37e-01 | 1.12e-01 | 0.76100 |
| GOBP SYNAPTIC VESICLE MATURATION | 22 | 3.62e-01 | -1.12e-01 | 0.83900 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 161 | 1.40e-02 | 1.12e-01 | 0.37200 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 9 | 5.60e-01 | 1.12e-01 | 0.90400 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 5.82e-01 | 1.12e-01 | 0.91200 |
| GOCC MITOTIC SPINDLE POLE | 34 | 2.58e-01 | 1.12e-01 | 0.77800 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 8 | 5.83e-01 | 1.12e-01 | 0.91200 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 30 | 2.88e-01 | 1.12e-01 | 0.79300 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 6.64e-01 | -1.12e-01 | 0.93200 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 5.39e-01 | 1.12e-01 | 0.89700 |
| GOBP POSITIVE REGULATION OF HEART RATE | 13 | 4.84e-01 | 1.12e-01 | 0.88300 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 11 | 5.20e-01 | 1.12e-01 | 0.89100 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 5 | 6.65e-01 | -1.12e-01 | 0.93200 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 6 | 6.35e-01 | -1.12e-01 | 0.92400 |
| GOBP RESPONSE TO COPPER ION | 19 | 3.98e-01 | -1.12e-01 | 0.85600 |
| GOBP HEART TRABECULA FORMATION | 5 | 6.65e-01 | -1.12e-01 | 0.93200 |
| GOBP STORE OPERATED CALCIUM ENTRY | 16 | 4.39e-01 | -1.12e-01 | 0.86900 |
| GOBP SEQUESTERING OF CALCIUM ION | 91 | 6.54e-02 | 1.12e-01 | 0.56200 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 6.35e-01 | 1.12e-01 | 0.92400 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 5.41e-01 | -1.12e-01 | 0.89700 |
| GOBP ATP METABOLIC PROCESS | 120 | 3.47e-02 | 1.12e-01 | 0.48200 |
| GOBP REGULATION OF DNA REPAIR | 196 | 7.09e-03 | 1.12e-01 | 0.28700 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 6.09e-01 | 1.12e-01 | 0.91700 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 5.84e-01 | 1.12e-01 | 0.91300 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 12 | 5.03e-01 | 1.12e-01 | 0.88700 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 13 | 4.86e-01 | 1.12e-01 | 0.88300 |
| GOMF GDP BINDING | 57 | 1.45e-01 | -1.12e-01 | 0.68500 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 10 | 5.41e-01 | 1.12e-01 | 0.89700 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 1.23e-01 | 1.12e-01 | 0.66900 |
| GOBP MRNA 3 END PROCESSING | 48 | 1.81e-01 | -1.12e-01 | 0.71900 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 6.66e-01 | -1.11e-01 | 0.93200 |
| GOBP RESPONSE TO CHEMOKINE | 51 | 1.69e-01 | 1.11e-01 | 0.71000 |
| GOMF ACTIN MONOMER BINDING | 19 | 4.01e-01 | 1.11e-01 | 0.85600 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 61 | 1.33e-01 | 1.11e-01 | 0.67800 |
| GOBP RESPONSE TO EPINEPHRINE | 11 | 5.22e-01 | 1.11e-01 | 0.89200 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 6.10e-01 | -1.11e-01 | 0.91800 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 6.10e-01 | 1.11e-01 | 0.91800 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 6.10e-01 | -1.11e-01 | 0.91800 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 5.86e-01 | 1.11e-01 | 0.91300 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 6.37e-01 | 1.11e-01 | 0.92400 |
| GOMF COMPLEMENT BINDING | 9 | 5.64e-01 | 1.11e-01 | 0.90600 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 4.02e-01 | -1.11e-01 | 0.85600 |
| GOMF TRNA BINDING | 68 | 1.13e-01 | 1.11e-01 | 0.65000 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 21 | 3.79e-01 | 1.11e-01 | 0.84400 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 22 | 3.67e-01 | -1.11e-01 | 0.84000 |
| GOBP REFLEX | 5 | 6.67e-01 | -1.11e-01 | 0.93200 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 56 | 1.51e-01 | 1.11e-01 | 0.69000 |
| GOBP ENDOCYTIC RECYCLING | 71 | 1.06e-01 | -1.11e-01 | 0.63500 |
| GOBP NAD METABOLIC PROCESS | 33 | 2.71e-01 | 1.11e-01 | 0.78800 |
| GOBP RESPONSE TO FORSKOLIN | 7 | 6.12e-01 | -1.11e-01 | 0.91800 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 55 | 1.56e-01 | 1.11e-01 | 0.69300 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 6.39e-01 | 1.11e-01 | 0.92400 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 6.12e-01 | -1.11e-01 | 0.91800 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 160 | 1.59e-02 | 1.11e-01 | 0.37600 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 38 | 2.38e-01 | 1.11e-01 | 0.76200 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 65 | 1.23e-01 | 1.11e-01 | 0.67000 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 31 | 2.87e-01 | -1.11e-01 | 0.79100 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 4.44e-01 | 1.11e-01 | 0.87100 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 10 | 5.45e-01 | 1.11e-01 | 0.89900 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 60 | 1.39e-01 | -1.11e-01 | 0.68200 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 209 | 5.99e-03 | 1.10e-01 | 0.27000 |
| GOBP OSTEOBLAST PROLIFERATION | 17 | 4.30e-01 | 1.10e-01 | 0.86500 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 18 | 4.18e-01 | -1.10e-01 | 0.86400 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 19 | 4.05e-01 | 1.10e-01 | 0.85700 |
| GOBP RESPONSE TO ZINC ION | 27 | 3.21e-01 | -1.10e-01 | 0.81400 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 5.08e-01 | 1.10e-01 | 0.88900 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 13 | 4.91e-01 | 1.10e-01 | 0.88500 |
| GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS | 5 | 6.69e-01 | 1.10e-01 | 0.93200 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 19 | 4.05e-01 | 1.10e-01 | 0.85700 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 6.69e-01 | 1.10e-01 | 0.93200 |
| GOCC CAVEOLA | 50 | 1.77e-01 | 1.10e-01 | 0.71700 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 22 | 3.71e-01 | -1.10e-01 | 0.84100 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 6.40e-01 | 1.10e-01 | 0.92400 |
| GOBP REGULATION OF HAIR CYCLE | 10 | 5.46e-01 | -1.10e-01 | 0.89900 |
| GOBP METHIONINE METABOLIC PROCESS | 13 | 4.91e-01 | 1.10e-01 | 0.88500 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 5.09e-01 | -1.10e-01 | 0.88900 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 6 | 6.41e-01 | -1.10e-01 | 0.92400 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 167 | 1.43e-02 | 1.10e-01 | 0.37200 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 179 | 1.13e-02 | 1.10e-01 | 0.34100 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 81 | 8.74e-02 | 1.10e-01 | 0.61200 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 14 | 4.76e-01 | 1.10e-01 | 0.88100 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 33 | 2.75e-01 | -1.10e-01 | 0.79000 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 24 | 3.52e-01 | 1.10e-01 | 0.83500 |
| GOBP FERTILIZATION | 84 | 8.20e-02 | -1.10e-01 | 0.59900 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 27 | 3.23e-01 | 1.10e-01 | 0.81500 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 45 | 2.03e-01 | 1.10e-01 | 0.73800 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 4.20e-01 | -1.10e-01 | 0.86400 |
| GOBP RNA 5 END PROCESSING | 22 | 3.73e-01 | 1.10e-01 | 0.84100 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 3.73e-01 | 1.10e-01 | 0.84100 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 2.14e-01 | 1.10e-01 | 0.74000 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 15 | 4.62e-01 | -1.10e-01 | 0.87900 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 5.69e-01 | 1.10e-01 | 0.90700 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 8 | 5.92e-01 | -1.09e-01 | 0.91300 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 25 | 3.44e-01 | 1.09e-01 | 0.82900 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 54 | 1.65e-01 | 1.09e-01 | 0.70500 |
| GOBP MYOTUBE DIFFERENTIATION | 76 | 9.98e-02 | 1.09e-01 | 0.62400 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 19 | 4.10e-01 | 1.09e-01 | 0.86000 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 12 | 5.13e-01 | 1.09e-01 | 0.89000 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 48 | 1.91e-01 | 1.09e-01 | 0.73000 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 5 | 6.73e-01 | -1.09e-01 | 0.93200 |
| GOBP CALCIUM MEDIATED SIGNALING | 131 | 3.15e-02 | 1.09e-01 | 0.47600 |
| GOBP T CELL MEDIATED IMMUNITY | 101 | 5.88e-02 | 1.09e-01 | 0.53800 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 44 | 2.11e-01 | 1.09e-01 | 0.74000 |
| GOBP CHROMOSOME SEPARATION | 60 | 1.45e-01 | 1.09e-01 | 0.68500 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 8 | 5.94e-01 | 1.09e-01 | 0.91300 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 119 | 4.06e-02 | 1.09e-01 | 0.49400 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 19 | 4.12e-01 | 1.09e-01 | 0.86000 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 6.45e-01 | 1.09e-01 | 0.92500 |
| GOMF SYNTAXIN 1 BINDING | 13 | 4.98e-01 | -1.09e-01 | 0.88600 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 3.68e-01 | 1.08e-01 | 0.84000 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 10 | 5.53e-01 | 1.08e-01 | 0.90100 |
| GOBP TOLERANCE INDUCTION | 19 | 4.13e-01 | 1.08e-01 | 0.86100 |
| GOCC SARCOPLASMIC RETICULUM | 47 | 1.99e-01 | 1.08e-01 | 0.73600 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 3.69e-01 | 1.08e-01 | 0.84000 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 26 | 3.39e-01 | 1.08e-01 | 0.82700 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 8 | 5.96e-01 | -1.08e-01 | 0.91300 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 78 | 9.87e-02 | 1.08e-01 | 0.62400 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 43 | 2.20e-01 | 1.08e-01 | 0.74900 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 10 | 5.54e-01 | 1.08e-01 | 0.90100 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 10 | 5.54e-01 | 1.08e-01 | 0.90100 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 5.35e-01 | 1.08e-01 | 0.89700 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 13 | 5.00e-01 | -1.08e-01 | 0.88600 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 8 | 5.97e-01 | 1.08e-01 | 0.91300 |
| GOMF G QUADRUPLEX RNA BINDING | 6 | 6.47e-01 | 1.08e-01 | 0.92600 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 5.97e-01 | -1.08e-01 | 0.91300 |
| GOBP RESPONSE TO PROGESTERONE | 27 | 3.32e-01 | -1.08e-01 | 0.81900 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 19 | 4.15e-01 | 1.08e-01 | 0.86300 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 19 | 4.15e-01 | 1.08e-01 | 0.86300 |
| GOBP NCRNA PROCESSING | 401 | 2.22e-04 | 1.08e-01 | 0.09760 |
| GOBP PODOCYTE CELL MIGRATION | 6 | 6.48e-01 | 1.08e-01 | 0.92600 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 5.76e-01 | -1.08e-01 | 0.90800 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 14 | 4.85e-01 | 1.08e-01 | 0.88300 |
| GOMF MISMATCHED DNA BINDING | 14 | 4.85e-01 | -1.08e-01 | 0.88300 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 31 | 3.00e-01 | -1.08e-01 | 0.80300 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 83 | 9.02e-02 | 1.08e-01 | 0.61300 |
| GOBP SYNAPSE ASSEMBLY | 100 | 6.31e-02 | 1.08e-01 | 0.55300 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 36 | 2.64e-01 | 1.08e-01 | 0.78300 |
| GOBP DTMP METABOLIC PROCESS | 5 | 6.77e-01 | 1.08e-01 | 0.93200 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 32 | 2.93e-01 | 1.08e-01 | 0.79500 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 6.22e-01 | 1.07e-01 | 0.92100 |
| GOBP REGULATION OF DENDRITE EXTENSION | 17 | 4.43e-01 | -1.07e-01 | 0.87100 |
| GOBP REGULATION OF TUBE SIZE | 73 | 1.13e-01 | 1.07e-01 | 0.64800 |
| GOBP RESPONSE TO UV B | 16 | 4.57e-01 | -1.07e-01 | 0.87700 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 11 | 5.38e-01 | 1.07e-01 | 0.89700 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 35 | 2.72e-01 | 1.07e-01 | 0.78900 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 6.49e-01 | -1.07e-01 | 0.92700 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 8 | 6.00e-01 | 1.07e-01 | 0.91400 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 6.49e-01 | -1.07e-01 | 0.92700 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 7 | 6.24e-01 | -1.07e-01 | 0.92200 |
| GOBP CELL VOLUME HOMEOSTASIS | 25 | 3.54e-01 | 1.07e-01 | 0.83600 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 56 | 1.66e-01 | 1.07e-01 | 0.70500 |
| GOBP FEEDING BEHAVIOR | 41 | 2.36e-01 | 1.07e-01 | 0.76000 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 13 | 5.04e-01 | 1.07e-01 | 0.88800 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 11 | 5.39e-01 | 1.07e-01 | 0.89700 |
| GOBP DNA RECOMBINATION | 272 | 2.43e-03 | 1.07e-01 | 0.20500 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 18 | 4.32e-01 | -1.07e-01 | 0.86600 |
| GOMF CHEMOKINE ACTIVITY | 21 | 3.96e-01 | 1.07e-01 | 0.85400 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 169 | 1.66e-02 | 1.07e-01 | 0.37900 |
| GOBP RESPONSE TO ATP | 20 | 4.08e-01 | -1.07e-01 | 0.85800 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 15 | 4.73e-01 | -1.07e-01 | 0.88000 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 6.01e-01 | -1.07e-01 | 0.91400 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 4.20e-01 | 1.07e-01 | 0.86400 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 6.50e-01 | 1.07e-01 | 0.92700 |
| GOBP NCRNA METABOLIC PROCESS | 542 | 2.29e-05 | 1.07e-01 | 0.04940 |
| GOCC PRC1 COMPLEX | 15 | 4.74e-01 | -1.07e-01 | 0.88000 |
| GOCC AMPHISOME MEMBRANE | 10 | 5.59e-01 | 1.07e-01 | 0.90400 |
| GOBP PIGMENT CATABOLIC PROCESS | 6 | 6.51e-01 | -1.07e-01 | 0.92700 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 55 | 1.71e-01 | 1.07e-01 | 0.71400 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 122 | 4.19e-02 | 1.07e-01 | 0.49800 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 16 | 4.60e-01 | -1.07e-01 | 0.87700 |
| GOCC VARICOSITY | 6 | 6.51e-01 | -1.07e-01 | 0.92700 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 12 | 5.23e-01 | 1.07e-01 | 0.89200 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 6.80e-01 | -1.07e-01 | 0.93400 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 31 | 3.05e-01 | 1.07e-01 | 0.80600 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 77 | 1.06e-01 | 1.07e-01 | 0.63500 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 24 | 3.66e-01 | 1.07e-01 | 0.84000 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 3.77e-02 | 1.06e-01 | 0.48200 |
| GOCC CILIARY TIP | 35 | 2.76e-01 | 1.06e-01 | 0.79000 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 24 | 3.67e-01 | 1.06e-01 | 0.84000 |
| GOBP CELLULAR RESPONSE TO CAMP | 26 | 3.48e-01 | 1.06e-01 | 0.83300 |
| GOCC RIPOPTOSOME | 6 | 6.52e-01 | -1.06e-01 | 0.92700 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 6 | 6.52e-01 | -1.06e-01 | 0.92700 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 5.24e-01 | 1.06e-01 | 0.89200 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 6.52e-01 | 1.06e-01 | 0.92700 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 10 | 5.61e-01 | 1.06e-01 | 0.90500 |
| GOMF METAL CLUSTER BINDING | 63 | 1.45e-01 | 1.06e-01 | 0.68500 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 113 | 5.17e-02 | 1.06e-01 | 0.52400 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 5.61e-01 | -1.06e-01 | 0.90500 |
| GOBP ORGANELLE DISASSEMBLY | 129 | 3.77e-02 | -1.06e-01 | 0.48200 |
| GOCC CYTOLYTIC GRANULE | 13 | 5.09e-01 | 1.06e-01 | 0.88900 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 53 | 1.83e-01 | 1.06e-01 | 0.72100 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 6.82e-01 | 1.06e-01 | 0.93400 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 37 | 2.66e-01 | -1.06e-01 | 0.78400 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 9 | 5.83e-01 | -1.06e-01 | 0.91200 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 59 | 1.61e-01 | 1.06e-01 | 0.69900 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 34 | 2.87e-01 | -1.06e-01 | 0.79100 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 30 | 3.17e-01 | -1.06e-01 | 0.81100 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 50 | 1.97e-01 | -1.06e-01 | 0.73500 |
| GOBP NEURAL PLATE DEVELOPMENT | 5 | 6.83e-01 | 1.05e-01 | 0.93400 |
| GOBP RESPONSE TO LEUCINE | 13 | 5.11e-01 | -1.05e-01 | 0.88900 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 63 | 1.48e-01 | -1.05e-01 | 0.68800 |
| GOBP NUCLEOSIDE SALVAGE | 9 | 5.84e-01 | 1.05e-01 | 0.91200 |
| GOMF ATPASE BINDING | 61 | 1.55e-01 | 1.05e-01 | 0.69200 |
| GOBP RESPONSE TO PAIN | 16 | 4.66e-01 | -1.05e-01 | 0.87900 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 434 | 1.82e-04 | 1.05e-01 | 0.09760 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 6.30e-01 | -1.05e-01 | 0.92400 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 535 | 3.48e-05 | 1.05e-01 | 0.05870 |
| GOBP RESPONSE TO OXYGEN LEVELS | 229 | 6.26e-03 | -1.05e-01 | 0.27000 |
| GOCC CONTRACTILE RING | 9 | 5.85e-01 | 1.05e-01 | 0.91300 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 31 | 3.12e-01 | 1.05e-01 | 0.80800 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 11 | 5.46e-01 | -1.05e-01 | 0.89900 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 11 | 5.46e-01 | -1.05e-01 | 0.89900 |
| GOBP LACTATION | 26 | 3.54e-01 | -1.05e-01 | 0.83600 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 48 | 2.08e-01 | 1.05e-01 | 0.73900 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 80 | 1.05e-01 | 1.05e-01 | 0.63500 |
| GOBP RESPONSE TO IONIZING RADIATION | 118 | 4.93e-02 | 1.05e-01 | 0.51300 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 10 | 5.66e-01 | -1.05e-01 | 0.90600 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 5.47e-01 | 1.05e-01 | 0.90000 |
| GOBP BRAIN MORPHOGENESIS | 22 | 3.95e-01 | -1.05e-01 | 0.85400 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 17 | 4.55e-01 | -1.05e-01 | 0.87500 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 4.68e-01 | 1.05e-01 | 0.88000 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 116 | 5.16e-02 | -1.05e-01 | 0.52400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 6.32e-01 | -1.05e-01 | 0.92400 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 6.08e-01 | 1.05e-01 | 0.91700 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 5 | 6.85e-01 | -1.05e-01 | 0.93500 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 210 | 9.10e-03 | 1.05e-01 | 0.30700 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 59 | 1.65e-01 | 1.05e-01 | 0.70500 |
| GOBP ATP BIOSYNTHETIC PROCESS | 94 | 8.00e-02 | 1.05e-01 | 0.59400 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 13 | 5.14e-01 | -1.05e-01 | 0.89100 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 119 | 4.90e-02 | 1.05e-01 | 0.51300 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 147 | 2.89e-02 | 1.05e-01 | 0.45700 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 12 | 5.31e-01 | 1.04e-01 | 0.89700 |
| GOBP APPENDAGE MORPHOGENESIS | 76 | 1.16e-01 | -1.04e-01 | 0.65400 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 24 | 3.76e-01 | 1.04e-01 | 0.84200 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 24 | 3.76e-01 | 1.04e-01 | 0.84200 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 3.86e-01 | 1.04e-01 | 0.84800 |
| GOBP BONE TRABECULA MORPHOGENESIS | 6 | 6.58e-01 | 1.04e-01 | 0.93100 |
| GOBP P BODY ASSEMBLY | 21 | 4.08e-01 | -1.04e-01 | 0.85800 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 243 | 5.21e-03 | 1.04e-01 | 0.25400 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 32 | 3.08e-01 | 1.04e-01 | 0.80700 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 6.58e-01 | -1.04e-01 | 0.93100 |
| GOCC GLIAL CELL PROJECTION | 20 | 4.20e-01 | 1.04e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 11 | 5.50e-01 | 1.04e-01 | 0.90100 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 4.57e-01 | 1.04e-01 | 0.87700 |
| GOMF EXTRACELLULAR MATRIX BINDING | 26 | 3.59e-01 | -1.04e-01 | 0.83600 |
| GOBP DE NOVO PROTEIN FOLDING | 38 | 2.67e-01 | -1.04e-01 | 0.78400 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 20 | 4.21e-01 | -1.04e-01 | 0.86400 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 19 | 4.33e-01 | 1.04e-01 | 0.86600 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 6.87e-01 | 1.04e-01 | 0.93500 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 1.61e-01 | -1.04e-01 | 0.69900 |
| GOCC PRONUCLEUS | 11 | 5.51e-01 | 1.04e-01 | 0.90100 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 35 | 2.88e-01 | -1.04e-01 | 0.79300 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 16 | 4.73e-01 | 1.04e-01 | 0.88000 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 6.35e-01 | 1.04e-01 | 0.92400 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 10 | 5.70e-01 | -1.04e-01 | 0.90800 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 5.90e-01 | -1.04e-01 | 0.91300 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 42 | 2.45e-01 | 1.04e-01 | 0.76800 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 7.51e-02 | 1.04e-01 | 0.58200 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 4.60e-01 | 1.04e-01 | 0.87700 |
| GOBP EAR DEVELOPMENT | 95 | 8.13e-02 | -1.04e-01 | 0.59900 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 19 | 4.35e-01 | -1.04e-01 | 0.86700 |
| GOBP RESPONSE TO COLD | 33 | 3.04e-01 | 1.04e-01 | 0.80500 |
| GOBP RESPONSE TO ALCOHOL | 156 | 2.60e-02 | 1.03e-01 | 0.43400 |
| GOBP REGULATION OF AXONOGENESIS | 99 | 7.56e-02 | 1.03e-01 | 0.58300 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 49 | 2.11e-01 | 1.03e-01 | 0.73900 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 15 | 4.88e-01 | -1.03e-01 | 0.88300 |
| GOBP PROTEIN KINASE A SIGNALING | 19 | 4.36e-01 | 1.03e-01 | 0.86700 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 5.19e-01 | -1.03e-01 | 0.89100 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 6.36e-01 | 1.03e-01 | 0.92400 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 32 | 3.12e-01 | 1.03e-01 | 0.80900 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 56 | 1.82e-01 | -1.03e-01 | 0.72000 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 58 | 1.74e-01 | 1.03e-01 | 0.71600 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 15 | 4.89e-01 | -1.03e-01 | 0.88400 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 20 | 4.25e-01 | 1.03e-01 | 0.86400 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 22 | 4.03e-01 | 1.03e-01 | 0.85600 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 6.14e-01 | 1.03e-01 | 0.91800 |
| GOBP SYNAPSE PRUNING | 8 | 6.14e-01 | 1.03e-01 | 0.91800 |
| GOCC ENDOPEPTIDASE COMPLEX | 75 | 1.23e-01 | -1.03e-01 | 0.66900 |
| GOCC MEMBRANE COAT | 87 | 9.69e-02 | -1.03e-01 | 0.62300 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 6.62e-01 | 1.03e-01 | 0.93200 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 6.62e-01 | 1.03e-01 | 0.93200 |
| GOBP REGULATION OF ANOIKIS | 18 | 4.49e-01 | -1.03e-01 | 0.87300 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 6.14e-01 | 1.03e-01 | 0.91800 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 6.62e-01 | 1.03e-01 | 0.93200 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 25 | 3.73e-01 | 1.03e-01 | 0.84100 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 6 | 6.62e-01 | 1.03e-01 | 0.93200 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 90 | 9.17e-02 | 1.03e-01 | 0.61300 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 108 | 6.49e-02 | 1.03e-01 | 0.56000 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 5.73e-01 | 1.03e-01 | 0.90800 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 107 | 6.63e-02 | -1.03e-01 | 0.56500 |
| GOCC INTEGRIN COMPLEX | 21 | 4.15e-01 | -1.03e-01 | 0.86300 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 18 | 4.50e-01 | 1.03e-01 | 0.87400 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 37 | 2.80e-01 | 1.03e-01 | 0.79000 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 6.63e-01 | -1.03e-01 | 0.93200 |
| GOMF ANTIGEN BINDING | 64 | 1.56e-01 | 1.03e-01 | 0.69300 |
| GOBP HAIR CELL DIFFERENTIATION | 26 | 3.65e-01 | 1.03e-01 | 0.84000 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 8 | 6.15e-01 | 1.03e-01 | 0.91900 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 16 | 4.77e-01 | -1.03e-01 | 0.88100 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 2.01e-01 | -1.03e-01 | 0.73700 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 4.78e-01 | -1.03e-01 | 0.88100 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 33 | 3.08e-01 | 1.03e-01 | 0.80700 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 26 | 3.65e-01 | 1.03e-01 | 0.84000 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 22 | 4.05e-01 | -1.03e-01 | 0.85700 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 17 | 4.64e-01 | 1.03e-01 | 0.87900 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 114 | 5.90e-02 | -1.02e-01 | 0.53800 |
| GOBP INTERFERON ALPHA PRODUCTION | 24 | 3.85e-01 | 1.02e-01 | 0.84600 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 23 | 3.95e-01 | -1.02e-01 | 0.85400 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 56 | 1.85e-01 | 1.02e-01 | 0.72300 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 38 | 2.75e-01 | 1.02e-01 | 0.79000 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 18 | 4.52e-01 | -1.02e-01 | 0.87400 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 6.92e-01 | -1.02e-01 | 0.93700 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 6.39e-01 | 1.02e-01 | 0.92400 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 73 | 1.31e-01 | -1.02e-01 | 0.67600 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 17 | 4.66e-01 | -1.02e-01 | 0.87900 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 270 | 3.99e-03 | 1.02e-01 | 0.24200 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 6.65e-01 | -1.02e-01 | 0.93200 |
| GOBP HORMONE METABOLIC PROCESS | 106 | 7.00e-02 | -1.02e-01 | 0.57400 |
| GOBP RESPONSE TO YEAST | 7 | 6.41e-01 | 1.02e-01 | 0.92400 |
| GOCC COPI VESICLE COAT | 13 | 5.25e-01 | -1.02e-01 | 0.89300 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 7 | 6.41e-01 | 1.02e-01 | 0.92400 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 93 | 8.98e-02 | -1.02e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 4.95e-01 | -1.02e-01 | 0.88600 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 12 | 5.41e-01 | -1.02e-01 | 0.89700 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 25 | 3.78e-01 | -1.02e-01 | 0.84400 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 6.94e-01 | 1.02e-01 | 0.93800 |
| GOBP NK T CELL PROLIFERATION | 8 | 6.18e-01 | -1.02e-01 | 0.92000 |
| GOBP REGULATION OF BLOOD VESSEL REMODELING | 5 | 6.94e-01 | -1.02e-01 | 0.93800 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 6.66e-01 | -1.02e-01 | 0.93200 |
| GOMF CYCLOSPORIN A BINDING | 16 | 4.82e-01 | 1.02e-01 | 0.88300 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 3.89e-01 | 1.02e-01 | 0.85100 |
| GOMF MANGANESE ION BINDING | 59 | 1.78e-01 | -1.02e-01 | 0.71700 |
| GOMF INTEGRIN BINDING | 84 | 1.08e-01 | 1.01e-01 | 0.63900 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 7 | 6.42e-01 | 1.01e-01 | 0.92400 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 7 | 6.42e-01 | 1.01e-01 | 0.92400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 51 | 2.11e-01 | 1.01e-01 | 0.73900 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 15 | 4.97e-01 | -1.01e-01 | 0.88600 |
| GOBP RHYTHMIC PROCESS | 199 | 1.39e-02 | 1.01e-01 | 0.37200 |
| GOMF TROPOMYOSIN BINDING | 11 | 5.61e-01 | -1.01e-01 | 0.90500 |
| GOBP HINDLIMB MORPHOGENESIS | 14 | 5.12e-01 | -1.01e-01 | 0.89000 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 59 | 1.79e-01 | 1.01e-01 | 0.71700 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 14 | 5.12e-01 | 1.01e-01 | 0.89000 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 6.68e-01 | -1.01e-01 | 0.93200 |
| GOCC CATION CHANNEL COMPLEX | 88 | 1.02e-01 | 1.01e-01 | 0.62700 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 6.68e-01 | -1.01e-01 | 0.93200 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 179 | 1.99e-02 | 1.01e-01 | 0.40200 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 108 | 7.03e-02 | 1.01e-01 | 0.57400 |
| GOCC BLOC 1 COMPLEX | 9 | 6.00e-01 | 1.01e-01 | 0.91400 |
| GOBP REGULATION OF STEROL TRANSPORT | 35 | 3.02e-01 | -1.01e-01 | 0.80400 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 7 | 6.44e-01 | 1.01e-01 | 0.92500 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 23 | 4.03e-01 | -1.01e-01 | 0.85600 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 171 | 2.31e-02 | 1.01e-01 | 0.42200 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 14 | 5.14e-01 | 1.01e-01 | 0.89100 |
| GOBP RESPONSE TO ISCHEMIA | 45 | 2.43e-01 | -1.01e-01 | 0.76500 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 29 | 3.48e-01 | 1.01e-01 | 0.83300 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 6.22e-01 | -1.01e-01 | 0.92100 |
| GOBP SPHINGOID METABOLIC PROCESS | 15 | 5.00e-01 | 1.01e-01 | 0.88600 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 11 | 5.64e-01 | -1.00e-01 | 0.90600 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 5.82e-01 | 1.00e-01 | 0.91200 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 224 | 9.76e-03 | 1.00e-01 | 0.32000 |
| GOBP CHROMOSOME LOCALIZATION | 96 | 8.94e-02 | 1.00e-01 | 0.61300 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 82 | 1.17e-01 | -1.00e-01 | 0.65700 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 6 | 6.71e-01 | -1.00e-01 | 0.93200 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 12 | 5.48e-01 | 1.00e-01 | 0.90000 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 87 | 1.07e-01 | 1.00e-01 | 0.63500 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 6.24e-01 | -1.00e-01 | 0.92200 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 276 | 4.29e-03 | 1.00e-01 | 0.24700 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 357 | 1.20e-03 | 1.00e-01 | 0.17900 |
| GOBP SOMITOGENESIS | 33 | 3.20e-01 | -1.00e-01 | 0.81400 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 51 | 2.16e-01 | 1.00e-01 | 0.74400 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 6.71e-01 | -1.00e-01 | 0.93200 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 5.48e-01 | -1.00e-01 | 0.90000 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 6.47e-01 | 1.00e-01 | 0.92600 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 14 | 5.17e-01 | -1.00e-01 | 0.89100 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 51 | 2.17e-01 | 1.00e-01 | 0.74500 |
| GOBP TRACHEA DEVELOPMENT | 12 | 5.49e-01 | -9.99e-02 | 0.90000 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 5.18e-01 | -9.99e-02 | 0.89100 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 2.27e-01 | 9.99e-02 | 0.75100 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 11 | 5.66e-01 | 9.99e-02 | 0.90600 |
| GOBP MIDBRAIN DEVELOPMENT | 54 | 2.05e-01 | 9.98e-02 | 0.73800 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 9 | 6.04e-01 | -9.98e-02 | 0.91600 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 29 | 3.52e-01 | 9.98e-02 | 0.83500 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 24 | 3.98e-01 | -9.97e-02 | 0.85600 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 8 | 6.25e-01 | 9.97e-02 | 0.92300 |
| GOMF ATP HYDROLYSIS ACTIVITY | 325 | 2.07e-03 | 9.97e-02 | 0.19300 |
| GOBP PENTOSE METABOLIC PROCESS | 9 | 6.05e-01 | 9.96e-02 | 0.91600 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 2.43e-01 | 9.96e-02 | 0.76500 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 6.73e-01 | 9.96e-02 | 0.93200 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 13 | 5.34e-01 | -9.96e-02 | 0.89700 |
| GOCC INTEGRATOR COMPLEX | 16 | 4.91e-01 | 9.96e-02 | 0.88500 |
| GOBP DNA REPAIR | 525 | 1.03e-04 | 9.95e-02 | 0.08060 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 6.73e-01 | 9.95e-02 | 0.93200 |
| GOBP COLLATERAL SPROUTING | 15 | 5.05e-01 | -9.95e-02 | 0.88800 |
| GOCC AMPHISOME | 12 | 5.51e-01 | 9.94e-02 | 0.90100 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 15 | 5.05e-01 | 9.94e-02 | 0.88800 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 34 | 3.16e-01 | 9.94e-02 | 0.81100 |
| GOBP MUSCLE CELL MIGRATION | 56 | 1.99e-01 | -9.94e-02 | 0.73600 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 6.06e-01 | 9.93e-02 | 0.91700 |
| GOBP AXIS SPECIFICATION | 43 | 2.60e-01 | -9.93e-02 | 0.78000 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 1.84e-01 | -9.93e-02 | 0.72100 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 10 | 5.87e-01 | -9.92e-02 | 0.91300 |
| GOCC FIBRILLAR CENTER | 130 | 5.12e-02 | 9.92e-02 | 0.52400 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 55 | 2.04e-01 | 9.91e-02 | 0.73800 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 6.07e-01 | -9.91e-02 | 0.91700 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 171 | 2.56e-02 | 9.91e-02 | 0.43300 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 9 | 6.07e-01 | -9.91e-02 | 0.91700 |
| GOBP ZYMOGEN INHIBITION | 8 | 6.28e-01 | 9.90e-02 | 0.92400 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 28 | 3.65e-01 | -9.90e-02 | 0.83900 |
| GOMF 7S RNA BINDING | 7 | 6.50e-01 | -9.90e-02 | 0.92700 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 6.28e-01 | 9.89e-02 | 0.92400 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 6.75e-01 | 9.89e-02 | 0.93200 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 24 | 4.02e-01 | -9.89e-02 | 0.85600 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 9 | 6.08e-01 | -9.89e-02 | 0.91700 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 6.75e-01 | -9.89e-02 | 0.93200 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 3.33e-01 | 9.88e-02 | 0.82100 |
| GOMF GAMMA CATENIN BINDING | 6 | 6.75e-01 | -9.87e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 6.08e-01 | 9.86e-02 | 0.91700 |
| GOMF OXYSTEROL BINDING | 7 | 6.51e-01 | -9.86e-02 | 0.92700 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 12 | 5.54e-01 | -9.86e-02 | 0.90100 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 16 | 4.95e-01 | -9.86e-02 | 0.88600 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 14 | 5.23e-01 | -9.86e-02 | 0.89200 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 6.76e-01 | -9.85e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 16 | 4.95e-01 | 9.85e-02 | 0.88600 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 17 | 4.82e-01 | -9.84e-02 | 0.88300 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 6.52e-01 | 9.84e-02 | 0.92700 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 3.28e-01 | 9.84e-02 | 0.81800 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 6.76e-01 | -9.84e-02 | 0.93200 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 175 | 2.50e-02 | 9.84e-02 | 0.43100 |
| GOBP CELL AGGREGATION | 7 | 6.52e-01 | -9.84e-02 | 0.92700 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 17 | 4.83e-01 | 9.83e-02 | 0.88300 |
| GOBP KERATINOCYTE DIFFERENTIATION | 69 | 1.58e-01 | -9.83e-02 | 0.69700 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 7.03e-01 | 9.83e-02 | 0.94200 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 6.77e-01 | -9.82e-02 | 0.93200 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 6.77e-01 | -9.82e-02 | 0.93200 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 5.91e-01 | -9.80e-02 | 0.91300 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 49 | 2.36e-01 | 9.79e-02 | 0.76000 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 3.30e-01 | 9.79e-02 | 0.81800 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 4.98e-01 | 9.79e-02 | 0.88600 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 15 | 5.11e-01 | 9.79e-02 | 0.89000 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 6.32e-01 | -9.79e-02 | 0.92400 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 20 | 4.49e-01 | -9.79e-02 | 0.87300 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 75 | 1.43e-01 | 9.78e-02 | 0.68500 |
| GOCC CLATHRIN COAT OF COATED PIT | 16 | 4.98e-01 | -9.78e-02 | 0.88600 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 7.05e-01 | -9.78e-02 | 0.94200 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 5.75e-01 | -9.77e-02 | 0.90800 |
| GOBP COLLAGEN CATABOLIC PROCESS | 23 | 4.17e-01 | -9.77e-02 | 0.86400 |
| GOCC ATPASE COMPLEX | 133 | 5.20e-02 | 9.77e-02 | 0.52400 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 6.55e-01 | 9.77e-02 | 0.92900 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 36 | 3.11e-01 | 9.76e-02 | 0.80800 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 30 | 3.55e-01 | 9.76e-02 | 0.83600 |
| GOCC LAMELLIPODIUM | 157 | 3.51e-02 | 9.76e-02 | 0.48200 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 4.08e-01 | 9.76e-02 | 0.85800 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 4.18e-01 | -9.75e-02 | 0.86400 |
| GOBP CHROMATIN LOOPING | 11 | 5.76e-01 | 9.75e-02 | 0.90800 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 5.43e-01 | 9.75e-02 | 0.89900 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 53 | 2.20e-01 | -9.75e-02 | 0.74900 |
| GOBP FATTY ACID BETA OXIDATION | 66 | 1.71e-01 | 9.74e-02 | 0.71400 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 26 | 3.90e-01 | 9.74e-02 | 0.85200 |
| GOCC PCG PROTEIN COMPLEX | 34 | 3.26e-01 | -9.74e-02 | 0.81700 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 12 | 5.59e-01 | -9.74e-02 | 0.90400 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 22 | 4.29e-01 | 9.74e-02 | 0.86400 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 58 | 2.00e-01 | -9.74e-02 | 0.73700 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 8 | 6.34e-01 | -9.73e-02 | 0.92400 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 6.13e-01 | 9.73e-02 | 0.91800 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 6.80e-01 | 9.73e-02 | 0.93400 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 40 | 2.87e-01 | 9.73e-02 | 0.79200 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 102 | 9.01e-02 | -9.72e-02 | 0.61300 |
| GOBP DETECTION OF OTHER ORGANISM | 16 | 5.01e-01 | 9.72e-02 | 0.88600 |
| GOCC DENDRITIC SHAFT | 27 | 3.82e-01 | 9.72e-02 | 0.84500 |
| GOBP SKELETAL MUSCLE CONTRACTION | 23 | 4.20e-01 | 9.72e-02 | 0.86400 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 66 | 1.73e-01 | -9.72e-02 | 0.71400 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 6.80e-01 | -9.71e-02 | 0.93400 |
| GOBP SYNAPTIC VESICLE DOCKING | 6 | 6.80e-01 | -9.71e-02 | 0.93400 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 31 | 3.50e-01 | 9.70e-02 | 0.83400 |
| GOBP CELLULAR RESPIRATION | 210 | 1.56e-02 | 9.70e-02 | 0.37400 |
| GOMF ACTININ BINDING | 18 | 4.76e-01 | -9.70e-02 | 0.88100 |
| GOMF ALDEHYDE LYASE ACTIVITY | 6 | 6.81e-01 | -9.69e-02 | 0.93400 |
| GOMF OLIGOSACCHARIDE BINDING | 6 | 6.81e-01 | 9.69e-02 | 0.93400 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 37 | 3.08e-01 | 9.69e-02 | 0.80700 |
| GOBP NEUROTRANSMITTER REUPTAKE | 14 | 5.31e-01 | 9.68e-02 | 0.89700 |
| GOBP JNK CASCADE | 129 | 5.84e-02 | 9.66e-02 | 0.53800 |
| GOCC OUTER KINETOCHORE | 13 | 5.46e-01 | 9.66e-02 | 0.89900 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 6.82e-01 | 9.66e-02 | 0.93400 |
| GOBP REGULATION OF INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 7.08e-01 | -9.66e-02 | 0.94400 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 41 | 2.85e-01 | 9.66e-02 | 0.79100 |
| GOBP RESPONSE TO REDOX STATE | 12 | 5.63e-01 | 9.65e-02 | 0.90600 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 38 | 3.04e-01 | 9.65e-02 | 0.80500 |
| GOMF PRIMARY MIRNA BINDING | 10 | 5.98e-01 | -9.64e-02 | 0.91300 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 5.05e-01 | 9.63e-02 | 0.88800 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 7 | 6.59e-01 | -9.63e-02 | 0.93100 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 57 | 2.09e-01 | -9.63e-02 | 0.73900 |
| GOMF CYTOKINE BINDING | 87 | 1.21e-01 | 9.63e-02 | 0.66600 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 17 | 4.92e-01 | -9.63e-02 | 0.88500 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 51 | 2.35e-01 | 9.62e-02 | 0.75900 |
| GOBP BONE REMODELING | 53 | 2.26e-01 | 9.62e-02 | 0.75100 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 29 | 3.70e-01 | 9.62e-02 | 0.84000 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 16 | 5.05e-01 | -9.62e-02 | 0.88800 |
| GOMF CARGO RECEPTOR ACTIVITY | 46 | 2.59e-01 | 9.62e-02 | 0.78000 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 6.17e-01 | 9.62e-02 | 0.92000 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 30 | 3.62e-01 | 9.61e-02 | 0.83900 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 6 | 6.84e-01 | -9.61e-02 | 0.93400 |
| GOBP INTERLEUKIN 10 PRODUCTION | 42 | 2.81e-01 | 9.61e-02 | 0.79000 |
| GOBP PROTEIN DEMETHYLATION | 12 | 5.64e-01 | 9.61e-02 | 0.90600 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 6.18e-01 | 9.61e-02 | 0.92000 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 157 | 3.81e-02 | 9.60e-02 | 0.48400 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 13 | 5.49e-01 | 9.60e-02 | 0.90000 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 21 | 4.47e-01 | 9.59e-02 | 0.87300 |
| GOBP KIDNEY MORPHOGENESIS | 40 | 2.94e-01 | 9.59e-02 | 0.79700 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 60 | 1.99e-01 | 9.59e-02 | 0.73600 |
| GOBP DNA BIOSYNTHETIC PROCESS | 159 | 3.74e-02 | 9.58e-02 | 0.48200 |
| GOBP PROTEIN NITROSYLATION | 11 | 5.82e-01 | -9.58e-02 | 0.91200 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 7 | 6.61e-01 | -9.58e-02 | 0.93200 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 100 | 9.83e-02 | 9.57e-02 | 0.62400 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 5.21e-01 | -9.57e-02 | 0.89100 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 150 | 4.34e-02 | 9.57e-02 | 0.50100 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 5.36e-01 | -9.56e-02 | 0.89700 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 10 | 6.01e-01 | 9.56e-02 | 0.91400 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 34 | 3.35e-01 | 9.56e-02 | 0.82200 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 54 | 2.25e-01 | 9.55e-02 | 0.75100 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 15 | 5.22e-01 | 9.55e-02 | 0.89200 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 99 | 1.01e-01 | 9.55e-02 | 0.62600 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 5.67e-01 | 9.54e-02 | 0.90600 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 61 | 1.98e-01 | 9.54e-02 | 0.73600 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 14 | 5.37e-01 | 9.54e-02 | 0.89700 |
| GOBP PEROXISOME ORGANIZATION | 33 | 3.43e-01 | -9.54e-02 | 0.82900 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 6.86e-01 | -9.54e-02 | 0.93500 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 30 | 3.66e-01 | -9.53e-02 | 0.84000 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 12 | 5.68e-01 | 9.53e-02 | 0.90600 |
| GOBP GENITALIA DEVELOPMENT | 17 | 4.97e-01 | 9.53e-02 | 0.88600 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 6.86e-01 | -9.52e-02 | 0.93500 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 87 | 1.25e-01 | -9.52e-02 | 0.67200 |
| GOMF ATP DEPENDENT ACTIVITY | 446 | 5.98e-04 | 9.52e-02 | 0.11600 |
| GOBP PROTEIN LIPOYLATION | 5 | 7.12e-01 | 9.52e-02 | 0.94500 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 6.63e-01 | 9.51e-02 | 0.93200 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 76 | 1.52e-01 | 9.51e-02 | 0.69000 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 8 | 6.42e-01 | -9.51e-02 | 0.92400 |
| GOCC PERIKARYON | 80 | 1.42e-01 | 9.51e-02 | 0.68500 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 8 | 6.42e-01 | -9.50e-02 | 0.92400 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 9 | 6.22e-01 | 9.50e-02 | 0.92100 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 13 | 5.54e-01 | -9.49e-02 | 0.90100 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 6.42e-01 | 9.49e-02 | 0.92400 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 4.52e-01 | 9.49e-02 | 0.87400 |
| GOBP PROTEIN AUTOUBIQUITINATION | 58 | 2.12e-01 | -9.49e-02 | 0.74000 |
| GOBP DECIDUALIZATION | 15 | 5.25e-01 | -9.48e-02 | 0.89300 |
| GOMF GAMMA TUBULIN BINDING | 30 | 3.69e-01 | 9.48e-02 | 0.84000 |
| GOBP CHROMATIN REMODELING | 487 | 3.64e-04 | 9.48e-02 | 0.09760 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 5.39e-01 | -9.47e-02 | 0.89700 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 5.40e-01 | 9.47e-02 | 0.89700 |
| GOBP LIPID EXPORT FROM CELL | 27 | 3.94e-01 | -9.47e-02 | 0.85400 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 9 | 6.23e-01 | -9.47e-02 | 0.92200 |
| GOBP NEPHRON MORPHOGENESIS | 30 | 3.70e-01 | 9.47e-02 | 0.84000 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 12 | 5.71e-01 | -9.46e-02 | 0.90800 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 3.26e-01 | 9.46e-02 | 0.81700 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 9 | 6.23e-01 | 9.45e-02 | 0.92200 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 12 | 5.71e-01 | 9.45e-02 | 0.90800 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 44 | 2.78e-01 | 9.45e-02 | 0.79000 |
| GOBP RESPONSE TO PROSTAGLANDIN | 18 | 4.88e-01 | 9.44e-02 | 0.88300 |
| GOMF MANNOSE BINDING | 18 | 4.88e-01 | -9.44e-02 | 0.88300 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 6.65e-01 | 9.44e-02 | 0.93200 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 27 | 3.96e-01 | 9.44e-02 | 0.85400 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 6.24e-01 | 9.44e-02 | 0.92200 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 32 | 3.56e-01 | -9.44e-02 | 0.83600 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 61 | 2.03e-01 | -9.43e-02 | 0.73800 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 35 | 3.35e-01 | 9.43e-02 | 0.82200 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 21 | 4.55e-01 | 9.42e-02 | 0.87500 |
| GOBP PEPTIDYL LYSINE METHYLATION | 46 | 2.69e-01 | 9.42e-02 | 0.78700 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 7.15e-01 | -9.42e-02 | 0.94700 |
| GOBP REGULATION OF JNK CASCADE | 100 | 1.04e-01 | 9.42e-02 | 0.63300 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 7.15e-01 | -9.42e-02 | 0.94700 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 5.89e-01 | -9.41e-02 | 0.91300 |
| GOBP SPERMATID DIFFERENTIATION | 95 | 1.14e-01 | -9.40e-02 | 0.65000 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 6.67e-01 | 9.39e-02 | 0.93200 |
| GOBP DEVELOPMENTAL PIGMENTATION | 30 | 3.74e-01 | -9.39e-02 | 0.84100 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 6 | 6.90e-01 | 9.39e-02 | 0.93700 |
| GOBP CILIUM ORGANIZATION | 307 | 4.80e-03 | 9.38e-02 | 0.25000 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 6.67e-01 | -9.38e-02 | 0.93200 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 17 | 5.04e-01 | 9.37e-02 | 0.88800 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 38 | 3.18e-01 | 9.37e-02 | 0.81200 |
| GOBP RESPONSE TO NITRIC OXIDE | 13 | 5.59e-01 | -9.36e-02 | 0.90400 |
| GOBP REGULATION OF BLOOD PRESSURE | 91 | 1.23e-01 | -9.36e-02 | 0.66900 |
| GOCC COSTAMERE | 12 | 5.75e-01 | -9.36e-02 | 0.90800 |
| GOBP EXIT FROM MITOSIS | 26 | 4.09e-01 | -9.36e-02 | 0.85900 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 62 | 2.03e-01 | 9.36e-02 | 0.73800 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 20 | 4.69e-01 | -9.35e-02 | 0.88000 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 4.00e-01 | 9.35e-02 | 0.85600 |
| GOBP LUTEOLYSIS | 5 | 7.17e-01 | 9.35e-02 | 0.94800 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 100 | 1.07e-01 | 9.34e-02 | 0.63500 |
| GOBP FOCAL ADHESION ASSEMBLY | 61 | 2.07e-01 | -9.34e-02 | 0.73900 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 13 | 5.60e-01 | 9.34e-02 | 0.90400 |
| GOCC CALYX OF HELD | 11 | 5.92e-01 | 9.34e-02 | 0.91300 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 6.09e-01 | -9.33e-02 | 0.91700 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 24 | 4.29e-01 | 9.33e-02 | 0.86400 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 5.32e-01 | 9.33e-02 | 0.89700 |
| GOCC COPI COATED VESICLE | 24 | 4.29e-01 | -9.32e-02 | 0.86400 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 6 | 6.93e-01 | -9.32e-02 | 0.93700 |
| GOMF GLUCOSE BINDING | 9 | 6.28e-01 | 9.32e-02 | 0.92400 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 20 | 4.71e-01 | 9.31e-02 | 0.88000 |
| GOBP STABILIZATION OF MEMBRANE POTENTIAL | 5 | 7.18e-01 | -9.31e-02 | 0.94900 |
| GOMF P53 BINDING | 55 | 2.33e-01 | 9.31e-02 | 0.75600 |
| GOMF U1 SNRNA BINDING | 8 | 6.49e-01 | -9.31e-02 | 0.92700 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 94 | 1.19e-01 | 9.30e-02 | 0.66400 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 224 | 1.67e-02 | -9.30e-02 | 0.37900 |
| GOBP PEPTIDE CATABOLIC PROCESS | 16 | 5.20e-01 | -9.29e-02 | 0.89100 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 20 | 4.72e-01 | 9.29e-02 | 0.88000 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 5.94e-01 | 9.29e-02 | 0.91300 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 117 | 8.30e-02 | 9.29e-02 | 0.60000 |
| GOCC CONDENSED CHROMOSOME | 237 | 1.40e-02 | 9.29e-02 | 0.37200 |
| GOMF DIOXYGENASE ACTIVITY | 78 | 1.57e-01 | -9.29e-02 | 0.69400 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 4.51e-01 | 9.28e-02 | 0.87400 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 5.08e-01 | 9.27e-02 | 0.88900 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 5.95e-01 | -9.27e-02 | 0.91300 |
| GOBP CELLULAR RESPONSE TO IRON ION | 7 | 6.71e-01 | -9.27e-02 | 0.93200 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 289 | 6.88e-03 | 9.27e-02 | 0.28300 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 145 | 5.44e-02 | 9.27e-02 | 0.53000 |
| GOBP ORGANIC CATION TRANSPORT | 33 | 3.57e-01 | -9.26e-02 | 0.83600 |
| GOCC POLE PLASM | 15 | 5.35e-01 | -9.26e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 17 | 5.10e-01 | 9.24e-02 | 0.88900 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 13 | 5.64e-01 | -9.23e-02 | 0.90600 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 16 | 5.23e-01 | -9.23e-02 | 0.89200 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 5.50e-01 | 9.22e-02 | 0.90100 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 27 | 4.07e-01 | -9.22e-02 | 0.85800 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 6.14e-01 | 9.22e-02 | 0.91800 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 20 | 4.75e-01 | -9.22e-02 | 0.88100 |
| GOBP MOLTING CYCLE | 52 | 2.51e-01 | -9.21e-02 | 0.77200 |
| GOMF MONOCARBOXYLIC ACID BINDING | 39 | 3.20e-01 | -9.20e-02 | 0.81400 |
| GOBP APOPTOTIC CELL CLEARANCE | 30 | 3.83e-01 | -9.20e-02 | 0.84500 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 6.33e-01 | -9.20e-02 | 0.92400 |
| GOMF LRR DOMAIN BINDING | 14 | 5.52e-01 | 9.19e-02 | 0.90100 |
| GOBP VIRAL PROTEIN PROCESSING | 31 | 3.76e-01 | 9.19e-02 | 0.84200 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 402 | 1.64e-03 | 9.18e-02 | 0.19300 |
| GOBP REGULATION OF HEMOPOIESIS | 309 | 5.65e-03 | 9.18e-02 | 0.26200 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 7 | 6.74e-01 | -9.18e-02 | 0.93200 |
| GOBP NEUTROPHIL EXTRAVASATION | 11 | 5.98e-01 | -9.17e-02 | 0.91400 |
| GOBP AEROBIC RESPIRATION | 175 | 3.67e-02 | 9.17e-02 | 0.48200 |
| GOBP BLASTODERM SEGMENTATION | 10 | 6.16e-01 | 9.17e-02 | 0.91900 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 149 | 5.38e-02 | 9.16e-02 | 0.52800 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 20 | 4.78e-01 | 9.16e-02 | 0.88100 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 59 | 2.24e-01 | 9.16e-02 | 0.75100 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 22 | 4.57e-01 | -9.16e-02 | 0.87700 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 7.23e-01 | 9.16e-02 | 0.94900 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 17 | 5.14e-01 | 9.15e-02 | 0.89100 |
| GOCC EXOCYTIC VESICLE | 150 | 5.34e-02 | -9.15e-02 | 0.52800 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 12 | 5.83e-01 | 9.15e-02 | 0.91200 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 17 | 5.14e-01 | -9.15e-02 | 0.89100 |
| GOBP RESPONSE TO NICOTINE | 25 | 4.29e-01 | 9.15e-02 | 0.86400 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 4.29e-01 | -9.14e-02 | 0.86400 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 132 | 7.01e-02 | 9.14e-02 | 0.57400 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 7 | 6.75e-01 | 9.14e-02 | 0.93200 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 7 | 6.75e-01 | -9.14e-02 | 0.93200 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 25 | 4.29e-01 | 9.13e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 20 | 4.80e-01 | -9.13e-02 | 0.88200 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 9 | 6.35e-01 | -9.13e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 5 | 7.24e-01 | -9.12e-02 | 0.94900 |
| GOCC NURD COMPLEX | 15 | 5.41e-01 | -9.12e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 11 | 6.01e-01 | 9.12e-02 | 0.91400 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 9 | 6.36e-01 | 9.12e-02 | 0.92400 |
| GOBP RESPIRATORY BURST | 30 | 3.88e-01 | 9.11e-02 | 0.85000 |
| GOCC GABA ERGIC SYNAPSE | 28 | 4.04e-01 | 9.11e-02 | 0.85600 |
| GOBP PHOTOPERIODISM | 23 | 4.50e-01 | 9.11e-02 | 0.87300 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 34 | 3.58e-01 | -9.11e-02 | 0.83600 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 3.96e-01 | 9.11e-02 | 0.85400 |
| GOBP NEGATIVE REGULATION OF NEURON MIGRATION | 5 | 7.24e-01 | 9.11e-02 | 0.95000 |
| GOBP ANIMAL ORGAN MATURATION | 15 | 5.41e-01 | -9.11e-02 | 0.89700 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 120 | 8.53e-02 | -9.11e-02 | 0.60400 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 147 | 5.70e-02 | 9.11e-02 | 0.53600 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 48 | 2.76e-01 | -9.10e-02 | 0.79000 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 24 | 4.40e-01 | 9.10e-02 | 0.86900 |
| GOMF COPPER ION BINDING | 38 | 3.32e-01 | -9.09e-02 | 0.81900 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 6.37e-01 | -9.09e-02 | 0.92400 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 10 | 6.19e-01 | 9.08e-02 | 0.92100 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 480 | 6.93e-04 | 9.08e-02 | 0.12200 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 37 | 3.40e-01 | -9.07e-02 | 0.82700 |
| GOBP SKIN DEVELOPMENT | 136 | 6.82e-02 | -9.07e-02 | 0.57100 |
| GOBP TRABECULA FORMATION | 10 | 6.20e-01 | 9.07e-02 | 0.92100 |
| GOBP RESPONSE TO FATTY ACID | 35 | 3.54e-01 | 9.07e-02 | 0.83600 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 7.26e-01 | 9.07e-02 | 0.95000 |
| GOBP SPERM AXONEME ASSEMBLY | 14 | 5.57e-01 | -9.06e-02 | 0.90300 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 11 | 6.03e-01 | -9.06e-02 | 0.91600 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 40 | 3.22e-01 | 9.05e-02 | 0.81400 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 28 | 4.07e-01 | 9.05e-02 | 0.85800 |
| GOBP INTERFERON BETA PRODUCTION | 53 | 2.55e-01 | 9.05e-02 | 0.77700 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 41 | 3.16e-01 | -9.05e-02 | 0.81100 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 39 | 3.28e-01 | -9.05e-02 | 0.81800 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 20 | 4.84e-01 | 9.05e-02 | 0.88300 |
| GOBP VACUOLAR LOCALIZATION | 74 | 1.79e-01 | -9.04e-02 | 0.71700 |
| GOBP MONOATOMIC ANION TRANSPORT | 86 | 1.48e-01 | 9.04e-02 | 0.68700 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 15 | 5.44e-01 | 9.04e-02 | 0.89900 |
| GOBP CELL MATURATION | 99 | 1.21e-01 | -9.04e-02 | 0.66500 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 4.74e-01 | -9.03e-02 | 0.88000 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.02e-01 | 9.03e-02 | 0.94100 |
| GOBP RNA SURVEILLANCE | 17 | 5.19e-01 | -9.03e-02 | 0.89100 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 7.27e-01 | 9.02e-02 | 0.95100 |
| GOBP HEAD MORPHOGENESIS | 22 | 4.64e-01 | -9.02e-02 | 0.87900 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 5.59e-01 | -9.01e-02 | 0.90400 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 6.80e-01 | 9.01e-02 | 0.93400 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 86 | 1.49e-01 | 9.01e-02 | 0.69000 |
| GOMF SINGLE STRANDED RNA BINDING | 71 | 1.90e-01 | 9.00e-02 | 0.72900 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 242 | 1.61e-02 | 9.00e-02 | 0.37800 |
| GOBP ORGANELLE FUSION | 133 | 7.37e-02 | -8.99e-02 | 0.58100 |
| GOMF WW DOMAIN BINDING | 15 | 5.47e-01 | 8.99e-02 | 0.89900 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 7 | 6.80e-01 | -8.99e-02 | 0.93400 |
| GOBP ENDODERM FORMATION | 27 | 4.19e-01 | -8.99e-02 | 0.86400 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 32 | 3.79e-01 | 8.98e-02 | 0.84400 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 42 | 3.14e-01 | 8.98e-02 | 0.81000 |
| GOBP GLUTAMINE METABOLIC PROCESS | 17 | 5.22e-01 | 8.98e-02 | 0.89200 |
| GOBP ENDOTHELIUM DEVELOPMENT | 91 | 1.39e-01 | 8.98e-02 | 0.68300 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 5 | 7.28e-01 | 8.98e-02 | 0.95100 |
| GOBP LIPID DIGESTION | 5 | 7.28e-01 | 8.98e-02 | 0.95100 |
| GOBP SYNAPTIC VESICLE BUDDING | 8 | 6.60e-01 | -8.97e-02 | 0.93200 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 47 | 2.87e-01 | -8.97e-02 | 0.79200 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 26 | 4.29e-01 | 8.97e-02 | 0.86400 |
| GOBP MAST CELL ACTIVATION | 57 | 2.42e-01 | -8.97e-02 | 0.76400 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 8 | 6.61e-01 | -8.97e-02 | 0.93200 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 5.48e-01 | -8.96e-02 | 0.90000 |
| GOCC CELL LEADING EDGE | 319 | 6.06e-03 | 8.96e-02 | 0.27000 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 41 | 3.21e-01 | -8.96e-02 | 0.81400 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 7.29e-01 | 8.96e-02 | 0.95100 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 7.29e-01 | 8.96e-02 | 0.95100 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 2.51e-01 | -8.96e-02 | 0.77200 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 209 | 2.59e-02 | -8.95e-02 | 0.43400 |
| GOCC P BODY | 88 | 1.47e-01 | -8.95e-02 | 0.68700 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 26 | 4.30e-01 | 8.94e-02 | 0.86500 |
| GOBP CATECHOLAMINE SECRETION | 23 | 4.58e-01 | 8.94e-02 | 0.87700 |
| GOBP POST EMBRYONIC DEVELOPMENT | 72 | 1.90e-01 | -8.94e-02 | 0.72900 |
| GOBP NUCLEAR BODY ORGANIZATION | 12 | 5.92e-01 | -8.93e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 27 | 4.22e-01 | -8.92e-02 | 0.86400 |
| GOMF CYCLASE REGULATOR ACTIVITY | 10 | 6.25e-01 | -8.92e-02 | 0.92300 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 6.25e-01 | -8.92e-02 | 0.92300 |
| GOBP L AMINO ACID TRANSPORT | 56 | 2.48e-01 | 8.92e-02 | 0.76800 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 33 | 3.75e-01 | -8.92e-02 | 0.84200 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 15 | 5.50e-01 | -8.91e-02 | 0.90100 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 6 | 7.05e-01 | -8.91e-02 | 0.94200 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 27 | 4.23e-01 | 8.91e-02 | 0.86400 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 4.60e-01 | -8.91e-02 | 0.87700 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 120 | 9.23e-02 | 8.91e-02 | 0.61300 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 564 | 3.22e-04 | 8.91e-02 | 0.09760 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 6.83e-01 | 8.91e-02 | 0.93400 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 6.63e-01 | -8.91e-02 | 0.93200 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 40 | 3.30e-01 | 8.90e-02 | 0.81800 |
| GOBP STEROL METABOLIC PROCESS | 95 | 1.34e-01 | -8.90e-02 | 0.67900 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 1.04e-01 | -8.89e-02 | 0.63400 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 72 | 1.92e-01 | -8.89e-02 | 0.73200 |
| GOMF S100 PROTEIN BINDING | 11 | 6.10e-01 | 8.89e-02 | 0.91700 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 381 | 2.99e-03 | 8.89e-02 | 0.21000 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 93 | 1.39e-01 | -8.89e-02 | 0.68200 |
| GOBP ENTRY INTO HOST | 115 | 1.00e-01 | 8.88e-02 | 0.62600 |
| GOBP RESPONSE TO ALKALOID | 59 | 2.38e-01 | 8.88e-02 | 0.76200 |
| GOCC PEPTIDASE COMPLEX | 106 | 1.15e-01 | -8.88e-02 | 0.65200 |
| GOBP GROWTH HORMONE SECRETION | 8 | 6.64e-01 | -8.88e-02 | 0.93200 |
| GOCC GEMINI OF COILED BODIES | 12 | 5.95e-01 | -8.87e-02 | 0.91300 |
| GOBP FLUID TRANSPORT | 14 | 5.66e-01 | 8.87e-02 | 0.90600 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 12 | 5.95e-01 | 8.86e-02 | 0.91300 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 11 | 6.11e-01 | -8.86e-02 | 0.91800 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 5.95e-01 | 8.85e-02 | 0.91300 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 14 | 5.66e-01 | 8.85e-02 | 0.90600 |
| GOCC AUTOPHAGOSOME | 102 | 1.23e-01 | -8.85e-02 | 0.66900 |
| GOMF MICROTUBULE PLUS END BINDING | 19 | 5.04e-01 | 8.85e-02 | 0.88800 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 236 | 1.95e-02 | 8.85e-02 | 0.39800 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 5.04e-01 | 8.85e-02 | 0.88800 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 11 | 6.11e-01 | 8.85e-02 | 0.91800 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 2.79e-01 | 8.85e-02 | 0.79000 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 64 | 2.21e-01 | -8.85e-02 | 0.75000 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 6.65e-01 | 8.84e-02 | 0.93200 |
| GOMF STEROL BINDING | 44 | 3.11e-01 | -8.83e-02 | 0.80800 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 350 | 4.66e-03 | 8.83e-02 | 0.24700 |
| GOBP HEART VALVE MORPHOGENESIS | 33 | 3.80e-01 | -8.83e-02 | 0.84400 |
| GOBP NEGATIVE REGULATION OF SISTER CHROMATID COHESION | 5 | 7.32e-01 | -8.83e-02 | 0.95300 |
| GOCC TRAMP COMPLEX | 5 | 7.32e-01 | 8.83e-02 | 0.95300 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 97 | 1.33e-01 | 8.83e-02 | 0.67800 |
| GOBP B CELL HOMEOSTASIS | 31 | 3.95e-01 | -8.82e-02 | 0.85400 |
| GOCC COHESIN COMPLEX | 9 | 6.47e-01 | -8.82e-02 | 0.92600 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 79 | 1.76e-01 | -8.82e-02 | 0.71600 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 55 | 2.59e-01 | -8.81e-02 | 0.77900 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 30 | 4.04e-01 | 8.81e-02 | 0.85600 |
| GOBP RESPONSE TO VIRUS | 332 | 5.99e-03 | 8.80e-02 | 0.27000 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 8 | 6.66e-01 | -8.80e-02 | 0.93200 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 6.67e-01 | 8.80e-02 | 0.93200 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 8 | 6.67e-01 | 8.80e-02 | 0.93200 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 25 | 4.47e-01 | -8.79e-02 | 0.87300 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 15 | 5.55e-01 | -8.79e-02 | 0.90200 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 463 | 1.26e-03 | -8.79e-02 | 0.17900 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 7.34e-01 | 8.78e-02 | 0.95300 |
| GOBP REGULATION OF NUCLEAR DIVISION | 86 | 1.60e-01 | 8.78e-02 | 0.69900 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 42 | 3.26e-01 | -8.77e-02 | 0.81700 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 6.15e-01 | 8.77e-02 | 0.91800 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 34 | 3.77e-01 | 8.76e-02 | 0.84300 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 12 | 5.99e-01 | -8.76e-02 | 0.91400 |
| GOMF SH3 DOMAIN BINDING | 93 | 1.45e-01 | 8.76e-02 | 0.68500 |
| GOBP CIRCADIAN RHYTHM | 140 | 7.41e-02 | 8.75e-02 | 0.58100 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 24 | 4.59e-01 | -8.74e-02 | 0.87700 |
| GOCC NUCLEOID | 42 | 3.27e-01 | 8.74e-02 | 0.81800 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 14 | 5.71e-01 | 8.74e-02 | 0.90800 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 13 | 5.86e-01 | 8.73e-02 | 0.91300 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 212 | 2.89e-02 | 8.72e-02 | 0.45700 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 16 | 5.46e-01 | -8.72e-02 | 0.89900 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 34 | 3.79e-01 | 8.72e-02 | 0.84400 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 24 | 4.60e-01 | 8.72e-02 | 0.87700 |
| GOBP VESICLE TARGETING | 62 | 2.36e-01 | -8.72e-02 | 0.76000 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 3.23e-01 | -8.71e-02 | 0.81500 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 32 | 3.94e-01 | -8.70e-02 | 0.85400 |
| GOBP REGULATION OF NEURON MIGRATION | 29 | 4.17e-01 | 8.70e-02 | 0.86400 |
| GOBP ENAMEL MINERALIZATION | 9 | 6.51e-01 | -8.70e-02 | 0.92700 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 41 | 3.35e-01 | 8.70e-02 | 0.82200 |
| GOBP REGULATION OF T CELL MIGRATION | 35 | 3.73e-01 | 8.70e-02 | 0.84100 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 49 | 2.93e-01 | 8.69e-02 | 0.79500 |
| GOMF OXIDIZED DNA BINDING | 10 | 6.34e-01 | 8.69e-02 | 0.92400 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 9 | 6.52e-01 | 8.69e-02 | 0.92700 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 6.91e-01 | -8.69e-02 | 0.93700 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 108 | 1.19e-01 | 8.68e-02 | 0.66400 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 114 | 1.10e-01 | 8.68e-02 | 0.63900 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 6.71e-01 | -8.68e-02 | 0.93200 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 249 | 1.88e-02 | 8.67e-02 | 0.38900 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 281 | 1.27e-02 | 8.67e-02 | 0.36200 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 7.13e-01 | -8.66e-02 | 0.94600 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 80 | 1.81e-01 | 8.66e-02 | 0.71900 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 5 | 7.37e-01 | 8.66e-02 | 0.95400 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 5 | 7.38e-01 | -8.66e-02 | 0.95400 |
| GOBP RESPONSE TO ALDOSTERONE | 14 | 5.75e-01 | 8.66e-02 | 0.90800 |
| GOBP RESPONSE TO FOOD | 21 | 4.92e-01 | 8.65e-02 | 0.88600 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 5 | 7.38e-01 | 8.65e-02 | 0.95400 |
| GOCC MYOSIN FILAMENT | 10 | 6.36e-01 | -8.65e-02 | 0.92400 |
| GOBP CANNABINOID SIGNALING PATHWAY | 6 | 7.14e-01 | -8.64e-02 | 0.94600 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 34 | 3.83e-01 | -8.64e-02 | 0.84500 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 29 | 4.21e-01 | 8.63e-02 | 0.86400 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 78 | 1.88e-01 | 8.63e-02 | 0.72600 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 17 | 5.38e-01 | 8.63e-02 | 0.89700 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 2.12e-01 | 8.63e-02 | 0.74000 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 13 | 5.90e-01 | -8.63e-02 | 0.91300 |
| GOBP NEURON PROJECTION MAINTENANCE | 7 | 6.93e-01 | -8.63e-02 | 0.93700 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 53 | 2.78e-01 | 8.63e-02 | 0.79000 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 223 | 2.68e-02 | 8.63e-02 | 0.44200 |
| GOMF CYCLIN BINDING | 24 | 4.65e-01 | 8.62e-02 | 0.87900 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 39 | 3.52e-01 | 8.61e-02 | 0.83500 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 29 | 4.22e-01 | 8.61e-02 | 0.86400 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 54 | 2.74e-01 | -8.61e-02 | 0.79000 |
| GOBP RESPONSE TO UV C | 12 | 6.06e-01 | -8.61e-02 | 0.91700 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 15 | 5.64e-01 | -8.60e-02 | 0.90600 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 10 | 6.38e-01 | 8.60e-02 | 0.92400 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 77 | 1.93e-01 | -8.60e-02 | 0.73200 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 56 | 2.66e-01 | -8.59e-02 | 0.78400 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 3.66e-01 | 8.59e-02 | 0.84000 |
| GOBP UV PROTECTION | 9 | 6.56e-01 | 8.59e-02 | 0.92900 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 48 | 3.04e-01 | -8.59e-02 | 0.80500 |
| GOBP RESPONSE TO OSMOTIC STRESS | 63 | 2.39e-01 | 8.59e-02 | 0.76200 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 74 | 2.02e-01 | -8.58e-02 | 0.73800 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 4.86e-01 | -8.58e-02 | 0.88300 |
| GOCC MYOSIN COMPLEX | 32 | 4.01e-01 | -8.58e-02 | 0.85600 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 6.74e-01 | 8.58e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 321 | 8.42e-03 | 8.58e-02 | 0.29500 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 5.93e-01 | -8.57e-02 | 0.91300 |
| GOBP B CELL MEDIATED IMMUNITY | 103 | 1.33e-01 | 8.57e-02 | 0.67800 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 5.93e-01 | -8.56e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 90 | 1.61e-01 | 8.56e-02 | 0.69900 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 296 | 1.15e-02 | 8.56e-02 | 0.34300 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 15 | 5.66e-01 | -8.56e-02 | 0.90600 |
| GOBP POSITIVE REGULATION OF SECRETION | 194 | 4.02e-02 | -8.56e-02 | 0.49100 |
| GOBP RESPONSE TO ACTIVITY | 45 | 3.21e-01 | 8.56e-02 | 0.81400 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 6.75e-01 | -8.55e-02 | 0.93200 |
| GOBP DETECTION OF CELL DENSITY | 6 | 7.17e-01 | -8.55e-02 | 0.94800 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 24 | 4.69e-01 | -8.54e-02 | 0.88000 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 6.57e-01 | -8.54e-02 | 0.93100 |
| GOBP CHLORIDE TRANSPORT | 54 | 2.78e-01 | 8.54e-02 | 0.79000 |
| GOCC RETROMER COMPLEX | 12 | 6.09e-01 | -8.54e-02 | 0.91700 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 10 | 6.40e-01 | 8.54e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 6.76e-01 | -8.53e-02 | 0.93200 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 6.09e-01 | 8.53e-02 | 0.91700 |
| GOBP GOLGI VESICLE TRANSPORT | 269 | 1.63e-02 | -8.53e-02 | 0.37800 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 6 | 7.17e-01 | 8.53e-02 | 0.94800 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 181 | 4.83e-02 | 8.52e-02 | 0.51100 |
| GOBP TRNA SURVEILLANCE | 8 | 6.76e-01 | -8.52e-02 | 0.93200 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 19 | 5.20e-01 | 8.52e-02 | 0.89100 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 228 | 2.70e-02 | -8.52e-02 | 0.44300 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 49 | 3.03e-01 | -8.52e-02 | 0.80400 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 12 | 6.10e-01 | -8.52e-02 | 0.91700 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 91 | 1.61e-01 | -8.52e-02 | 0.69900 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 128 | 9.66e-02 | 8.52e-02 | 0.62200 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 7.18e-01 | -8.51e-02 | 0.94800 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 6.41e-01 | -8.51e-02 | 0.92400 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 73 | 2.09e-01 | 8.51e-02 | 0.73900 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 148 | 7.45e-02 | 8.50e-02 | 0.58100 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 7.42e-01 | -8.50e-02 | 0.95400 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 4.36e-01 | -8.50e-02 | 0.86700 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 106 | 1.31e-01 | 8.50e-02 | 0.67600 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 7.42e-01 | -8.50e-02 | 0.95400 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 7.42e-01 | 8.49e-02 | 0.95400 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 69 | 2.23e-01 | 8.49e-02 | 0.75100 |
| GOCC XY BODY | 12 | 6.11e-01 | 8.49e-02 | 0.91800 |
| GOCC INHIBITORY SYNAPSE | 6 | 7.19e-01 | 8.48e-02 | 0.94900 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 7.43e-01 | 8.48e-02 | 0.95400 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 13 | 5.97e-01 | -8.48e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 13 | 5.97e-01 | -8.48e-02 | 0.91300 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 6.60e-01 | 8.48e-02 | 0.93200 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 18 | 5.34e-01 | 8.47e-02 | 0.89700 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 3.67e-01 | 8.47e-02 | 0.84000 |
| GOBP PROTEIN REFOLDING | 21 | 5.02e-01 | 8.46e-02 | 0.88700 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 58 | 2.66e-01 | 8.46e-02 | 0.78400 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 201 | 3.91e-02 | 8.45e-02 | 0.48800 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 8 | 6.79e-01 | 8.44e-02 | 0.93400 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 42 | 3.44e-01 | 8.44e-02 | 0.82900 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 5.24e-01 | 8.44e-02 | 0.89200 |
| GOBP NEUROTRANSMITTER UPTAKE | 18 | 5.35e-01 | 8.44e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 17 | 5.47e-01 | 8.43e-02 | 0.90000 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 69 | 2.27e-01 | 8.42e-02 | 0.75100 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 30 | 4.25e-01 | 8.42e-02 | 0.86400 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 52 | 2.94e-01 | 8.42e-02 | 0.79700 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 44 | 3.34e-01 | 8.42e-02 | 0.82200 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 20 | 5.15e-01 | 8.42e-02 | 0.89100 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 7.00e-01 | 8.41e-02 | 0.94100 |
| GOBP SNRNA MODIFICATION | 7 | 7.01e-01 | 8.39e-02 | 0.94100 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 34 | 3.97e-01 | -8.39e-02 | 0.85500 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 7.45e-01 | -8.38e-02 | 0.95500 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 5 | 7.46e-01 | 8.38e-02 | 0.95500 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 89 | 1.72e-01 | -8.38e-02 | 0.71400 |
| GOMF PHOSPHOLIPASE BINDING | 19 | 5.28e-01 | 8.37e-02 | 0.89400 |
| GOBP INTERLEUKIN 1 PRODUCTION | 88 | 1.75e-01 | 8.36e-02 | 0.71600 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 21 | 5.07e-01 | -8.36e-02 | 0.88800 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 4.28e-01 | 8.36e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 9 | 6.64e-01 | 8.36e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 89 | 1.73e-01 | 8.36e-02 | 0.71500 |
| GOCC BRUSH BORDER MEMBRANE | 28 | 4.44e-01 | -8.35e-02 | 0.87200 |
| GOCC BLOOD MICROPARTICLE | 61 | 2.60e-01 | -8.35e-02 | 0.78000 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 12 | 6.17e-01 | 8.35e-02 | 0.91900 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 9 | 6.65e-01 | 8.35e-02 | 0.93200 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 20 | 5.18e-01 | -8.35e-02 | 0.89100 |
| GOBP LIVER MORPHOGENESIS | 16 | 5.64e-01 | 8.34e-02 | 0.90600 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 22 | 4.99e-01 | 8.33e-02 | 0.88600 |
| GOBP TOOTH MINERALIZATION | 13 | 6.03e-01 | -8.33e-02 | 0.91600 |
| GOBP WALKING BEHAVIOR | 20 | 5.19e-01 | -8.33e-02 | 0.89100 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 6.83e-01 | -8.33e-02 | 0.93400 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1263 | 9.19e-07 | 8.32e-02 | 0.00794 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 25 | 4.72e-01 | 8.32e-02 | 0.88000 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 60 | 2.66e-01 | 8.31e-02 | 0.78400 |
| GOBP VIRION ASSEMBLY | 31 | 4.24e-01 | 8.30e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 7.25e-01 | -8.30e-02 | 0.95000 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 34 | 4.03e-01 | 8.30e-02 | 0.85600 |
| GOBP LYTIC VACUOLE ORGANIZATION | 91 | 1.72e-01 | -8.29e-02 | 0.71400 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 23 | 4.91e-01 | 8.29e-02 | 0.88500 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 9 | 6.67e-01 | 8.29e-02 | 0.93200 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 62 | 2.59e-01 | 8.29e-02 | 0.78000 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 6.05e-01 | 8.28e-02 | 0.91600 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 82 | 1.95e-01 | 8.28e-02 | 0.73400 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 49 | 3.16e-01 | 8.28e-02 | 0.81100 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 13 | 6.06e-01 | 8.27e-02 | 0.91700 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 48 | 3.22e-01 | -8.27e-02 | 0.81400 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 6.86e-01 | -8.26e-02 | 0.93500 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 15 | 5.80e-01 | 8.26e-02 | 0.91000 |
| GOMF MONOOXYGENASE ACTIVITY | 33 | 4.12e-01 | -8.25e-02 | 0.86000 |
| GOBP DNA REPLICATION INITIATION | 29 | 4.42e-01 | 8.25e-02 | 0.87000 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 22 | 5.03e-01 | -8.24e-02 | 0.88700 |
| GOBP HEMOSTASIS | 155 | 7.71e-02 | -8.24e-02 | 0.58600 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 7 | 7.06e-01 | 8.24e-02 | 0.94200 |
| GOBP MEMBRANE HYPERPOLARIZATION | 6 | 7.27e-01 | 8.24e-02 | 0.95100 |
| GOBP PIGMENT CELL DIFFERENTIATION | 23 | 4.94e-01 | -8.24e-02 | 0.88600 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 4.76e-01 | -8.24e-02 | 0.88100 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 7.27e-01 | 8.24e-02 | 0.95100 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 471 | 2.30e-03 | 8.23e-02 | 0.20500 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 47 | 3.29e-01 | -8.23e-02 | 0.81800 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 223 | 3.45e-02 | 8.23e-02 | 0.48200 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 10 | 6.52e-01 | 8.23e-02 | 0.92700 |
| GOMF JUN KINASE BINDING | 10 | 6.52e-01 | 8.23e-02 | 0.92700 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 42 | 3.56e-01 | -8.23e-02 | 0.83600 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 36 | 3.93e-01 | -8.23e-02 | 0.85400 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 62 | 2.63e-01 | 8.23e-02 | 0.78300 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 91 | 1.76e-01 | 8.22e-02 | 0.71600 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 147 | 8.59e-02 | 8.22e-02 | 0.60500 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 7.07e-01 | 8.20e-02 | 0.94300 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 24 | 4.87e-01 | 8.19e-02 | 0.88300 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 33 | 4.15e-01 | 8.19e-02 | 0.86300 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 10 | 6.54e-01 | -8.19e-02 | 0.92800 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 43 | 3.53e-01 | 8.19e-02 | 0.83500 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 68 | 2.43e-01 | 8.19e-02 | 0.76500 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 7.51e-01 | -8.19e-02 | 0.95600 |
| GOCC NSL COMPLEX | 11 | 6.38e-01 | 8.19e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 4.16e-01 | 8.19e-02 | 0.86300 |
| GOBP DNA CONFORMATION CHANGE | 79 | 2.09e-01 | 8.18e-02 | 0.73900 |
| GOBP B CELL CHEMOTAXIS | 6 | 7.29e-01 | 8.18e-02 | 0.95100 |
| GOMF ORGANIC ACID BINDING | 117 | 1.27e-01 | -8.18e-02 | 0.67300 |
| GOBP POSITIVE REGULATION OF COAGULATION | 20 | 5.27e-01 | -8.17e-02 | 0.89400 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 30 | 4.39e-01 | 8.17e-02 | 0.86900 |
| GOBP FERROPTOSIS | 5 | 7.52e-01 | -8.17e-02 | 0.95600 |
| GOCC LATE ENDOSOME MEMBRANE | 147 | 8.78e-02 | -8.17e-02 | 0.61300 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 155 | 7.97e-02 | 8.17e-02 | 0.59300 |
| GOBP DNA METABOLIC PROCESS | 855 | 5.78e-05 | 8.17e-02 | 0.06240 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 6.10e-01 | 8.17e-02 | 0.91800 |
| GOBP RECEPTOR INTERNALIZATION | 86 | 1.91e-01 | -8.16e-02 | 0.73000 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 8 | 6.90e-01 | 8.16e-02 | 0.93700 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 6.72e-01 | 8.16e-02 | 0.93200 |
| GOMF CHONDROITIN SULFATE BINDING | 7 | 7.09e-01 | 8.15e-02 | 0.94400 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 7.52e-01 | 8.15e-02 | 0.95600 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 4.90e-01 | 8.14e-02 | 0.88500 |
| GOCC NUCLEAR CHROMOSOME | 193 | 5.15e-02 | 8.14e-02 | 0.52400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 100 | 1.60e-01 | -8.14e-02 | 0.69900 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 7.53e-01 | -8.14e-02 | 0.95600 |
| GOBP VACUOLE ORGANIZATION | 198 | 4.88e-02 | -8.14e-02 | 0.51200 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 31 | 4.33e-01 | 8.14e-02 | 0.86600 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 133 | 1.06e-01 | 8.14e-02 | 0.63500 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 12 | 6.26e-01 | 8.13e-02 | 0.92300 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 75 | 2.24e-01 | 8.13e-02 | 0.75100 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 8 | 6.90e-01 | -8.13e-02 | 0.93700 |
| GOBP AMINE CATABOLIC PROCESS | 11 | 6.41e-01 | 8.13e-02 | 0.92400 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 7.30e-01 | -8.13e-02 | 0.95200 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 32 | 4.26e-01 | -8.13e-02 | 0.86400 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 44 | 3.51e-01 | -8.13e-02 | 0.83500 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 17 | 5.62e-01 | 8.12e-02 | 0.90600 |
| GOMF GROWTH FACTOR BINDING | 74 | 2.27e-01 | 8.12e-02 | 0.75200 |
| GOBP T CELL CYTOKINE PRODUCTION | 30 | 4.42e-01 | 8.12e-02 | 0.87000 |
| GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 7.53e-01 | -8.12e-02 | 0.95600 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 93 | 1.76e-01 | 8.12e-02 | 0.71600 |
| GOBP PROTEIN PROCESSING | 155 | 8.16e-02 | -8.12e-02 | 0.59900 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 21 | 5.20e-01 | -8.12e-02 | 0.89100 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 17 | 5.63e-01 | -8.11e-02 | 0.90600 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 14 | 5.99e-01 | -8.11e-02 | 0.91400 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 22 | 5.10e-01 | 8.11e-02 | 0.88900 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 23 | 5.01e-01 | 8.11e-02 | 0.88600 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 23 | 5.01e-01 | 8.11e-02 | 0.88600 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 476 | 2.56e-03 | 8.11e-02 | 0.20500 |
| GOBP MICROVILLUS ASSEMBLY | 18 | 5.52e-01 | 8.11e-02 | 0.90100 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 71 | 2.38e-01 | 8.10e-02 | 0.76200 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 12 | 6.27e-01 | -8.10e-02 | 0.92400 |
| GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE | 6 | 7.31e-01 | -8.10e-02 | 0.95200 |
| GOBP STEM CELL PROLIFERATION | 57 | 2.90e-01 | -8.10e-02 | 0.79300 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 43 | 3.58e-01 | -8.10e-02 | 0.83600 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 6.74e-01 | 8.09e-02 | 0.93200 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 5.75e-01 | -8.09e-02 | 0.90800 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 96 | 1.71e-01 | 8.09e-02 | 0.71400 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 11 | 6.43e-01 | -8.08e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 6.75e-01 | 8.08e-02 | 0.93200 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 20 | 5.32e-01 | 8.08e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 10 | 6.58e-01 | 8.08e-02 | 0.93100 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 7.54e-01 | -8.08e-02 | 0.95600 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 37 | 3.95e-01 | 8.08e-02 | 0.85400 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 51 | 3.19e-01 | 8.08e-02 | 0.81300 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 344 | 1.03e-02 | 8.07e-02 | 0.33000 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 314 | 1.42e-02 | 8.07e-02 | 0.37200 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 7.32e-01 | 8.07e-02 | 0.95300 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 7.55e-01 | -8.07e-02 | 0.95600 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 200 | 4.96e-02 | 8.07e-02 | 0.51600 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 52 | 3.15e-01 | -8.07e-02 | 0.81000 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 7.55e-01 | 8.06e-02 | 0.95600 |
| GOBP SINGLE FERTILIZATION | 62 | 2.73e-01 | -8.06e-02 | 0.78900 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 676 | 3.86e-04 | 8.06e-02 | 0.09760 |
| GOCC SMN COMPLEX | 10 | 6.59e-01 | -8.06e-02 | 0.93100 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 6.76e-01 | 8.05e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 8 | 6.93e-01 | 8.05e-02 | 0.93800 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 57 | 2.94e-01 | 8.05e-02 | 0.79600 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 4.78e-01 | -8.04e-02 | 0.88100 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 5.14e-01 | 8.04e-02 | 0.89100 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 6.94e-01 | -8.03e-02 | 0.93800 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 19 | 5.45e-01 | 8.03e-02 | 0.89900 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 12 | 6.30e-01 | 8.03e-02 | 0.92400 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 22 | 5.15e-01 | 8.03e-02 | 0.89100 |
| GOBP RUFFLE ORGANIZATION | 44 | 3.57e-01 | 8.03e-02 | 0.83600 |
| GOMF APOLIPOPROTEIN BINDING | 9 | 6.77e-01 | 8.02e-02 | 0.93200 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 56 | 3.00e-01 | -8.02e-02 | 0.80300 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 26 | 4.79e-01 | -8.01e-02 | 0.88200 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 28 | 4.63e-01 | -8.01e-02 | 0.87900 |
| GOBP REGULATION OF T CELL ACTIVATION | 284 | 2.05e-02 | 8.01e-02 | 0.40700 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 6.46e-01 | -7.99e-02 | 0.92600 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 7.35e-01 | -7.99e-02 | 0.95300 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 10 | 6.62e-01 | -7.99e-02 | 0.93200 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 220 | 4.18e-02 | -7.98e-02 | 0.49700 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 6.96e-01 | 7.98e-02 | 0.93800 |
| GOBP CARTILAGE DEVELOPMENT | 104 | 1.60e-01 | -7.98e-02 | 0.69900 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 7.58e-01 | -7.97e-02 | 0.95600 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 98 | 1.73e-01 | -7.97e-02 | 0.71500 |
| GOMF STEROL TRANSPORTER ACTIVITY | 25 | 4.90e-01 | -7.97e-02 | 0.88500 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 23 | 5.08e-01 | -7.97e-02 | 0.88900 |
| GOBP REGULATION OF VESICLE FUSION | 17 | 5.70e-01 | 7.97e-02 | 0.90800 |
| GOMF CALCIUM ION BINDING | 352 | 1.05e-02 | 7.97e-02 | 0.33200 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 12 | 6.33e-01 | 7.96e-02 | 0.92400 |
| GOMF ALKALI METAL ION BINDING | 10 | 6.63e-01 | 7.96e-02 | 0.93200 |
| GOBP REGULATION OF VIRAL PROCESS | 133 | 1.14e-01 | 7.96e-02 | 0.65000 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 142 | 1.02e-01 | 7.96e-02 | 0.62800 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 6.97e-01 | -7.96e-02 | 0.93800 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 127 | 1.22e-01 | 7.95e-02 | 0.66800 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 28 | 4.67e-01 | -7.95e-02 | 0.87900 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 24 | 5.00e-01 | -7.95e-02 | 0.88600 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 20 | 5.38e-01 | 7.95e-02 | 0.89700 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 6.80e-01 | -7.94e-02 | 0.93400 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 10 | 6.64e-01 | -7.94e-02 | 0.93200 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 7.59e-01 | -7.93e-02 | 0.95700 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 46 | 3.52e-01 | -7.93e-02 | 0.83500 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 5.10e-01 | 7.93e-02 | 0.88900 |
| GOMF FATTY ACID BINDING | 26 | 4.84e-01 | -7.93e-02 | 0.88300 |
| GOBP FATTY ACID CATABOLIC PROCESS | 88 | 1.99e-01 | 7.93e-02 | 0.73600 |
| GOBP REGULATION OF PROTON TRANSPORT | 14 | 6.08e-01 | -7.92e-02 | 0.91700 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 168 | 7.70e-02 | 7.92e-02 | 0.58600 |
| GOMF TOLL LIKE RECEPTOR BINDING | 13 | 6.21e-01 | 7.92e-02 | 0.92100 |
| GOBP RECEPTOR CLUSTERING | 36 | 4.11e-01 | 7.92e-02 | 0.86000 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 363 | 9.82e-03 | 7.92e-02 | 0.32100 |
| GOBP CONVERGENT EXTENSION | 9 | 6.81e-01 | -7.92e-02 | 0.93400 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 17 | 5.72e-01 | 7.91e-02 | 0.90800 |
| GOBP MICROGLIA DIFFERENTIATION | 10 | 6.65e-01 | -7.91e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 177 | 6.99e-02 | 7.91e-02 | 0.57400 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 94 | 1.85e-01 | 7.91e-02 | 0.72300 |
| GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION | 5 | 7.59e-01 | 7.91e-02 | 0.95700 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 26 | 4.86e-01 | -7.90e-02 | 0.88300 |
| GOBP CHROMOSOME ORGANIZATION | 494 | 2.77e-03 | 7.90e-02 | 0.20700 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 46 | 3.54e-01 | -7.90e-02 | 0.83600 |
| GOBP MYELOID CELL DEVELOPMENT | 68 | 2.61e-01 | -7.90e-02 | 0.78000 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 7.38e-01 | 7.89e-02 | 0.95400 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 9 | 6.82e-01 | -7.89e-02 | 0.93400 |
| GOCC THO COMPLEX | 6 | 7.38e-01 | 7.89e-02 | 0.95400 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 32 | 4.40e-01 | -7.89e-02 | 0.86900 |
| GOBP VESICLE UNCOATING | 5 | 7.60e-01 | 7.89e-02 | 0.95700 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 18 | 5.63e-01 | 7.89e-02 | 0.90600 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS | 6 | 7.38e-01 | 7.88e-02 | 0.95400 |
| GOBP APPENDAGE DEVELOPMENT | 97 | 1.81e-01 | -7.87e-02 | 0.71900 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 55 | 3.13e-01 | -7.87e-02 | 0.81000 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 7.00e-01 | -7.87e-02 | 0.94100 |
| GOBP PULMONARY VALVE DEVELOPMENT | 15 | 5.98e-01 | -7.87e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 33 | 4.34e-01 | -7.87e-02 | 0.86600 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 286 | 2.24e-02 | 7.87e-02 | 0.41800 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 22 | 5.23e-01 | 7.87e-02 | 0.89200 |
| GOBP AXON GUIDANCE | 114 | 1.47e-01 | 7.86e-02 | 0.68700 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 273 | 2.58e-02 | 7.86e-02 | 0.43400 |
| GOBP BONE RESORPTION | 45 | 3.62e-01 | 7.86e-02 | 0.83900 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 11 | 6.52e-01 | 7.86e-02 | 0.92700 |
| GOMF R SMAD BINDING | 22 | 5.24e-01 | 7.85e-02 | 0.89200 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 7.01e-01 | 7.85e-02 | 0.94100 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 42 | 3.79e-01 | -7.85e-02 | 0.84400 |
| GOBP STEM CELL DEVELOPMENT | 49 | 3.42e-01 | 7.85e-02 | 0.82900 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 3.97e-01 | 7.85e-02 | 0.85400 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 8 | 7.01e-01 | -7.85e-02 | 0.94100 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 7 | 7.19e-01 | -7.85e-02 | 0.94900 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 27 | 4.81e-01 | -7.84e-02 | 0.88300 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 82 | 2.20e-01 | 7.84e-02 | 0.74900 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 786 | 2.07e-04 | 7.84e-02 | 0.09760 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 5.15e-01 | 7.84e-02 | 0.89100 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 28 | 4.73e-01 | -7.84e-02 | 0.88000 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 735 | 3.30e-04 | -7.83e-02 | 0.09760 |
| GOCC TERTIARY GRANULE | 139 | 1.11e-01 | -7.83e-02 | 0.64400 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 6 | 7.40e-01 | -7.83e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 224 | 4.40e-02 | 7.83e-02 | 0.50200 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 23 | 5.16e-01 | -7.82e-02 | 0.89100 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 450 | 4.63e-03 | 7.82e-02 | 0.24700 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 23 | 5.16e-01 | -7.82e-02 | 0.89100 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 867 | 1.06e-04 | -7.82e-02 | 0.08060 |
| GOMF BETA TUBULIN BINDING | 35 | 4.24e-01 | 7.82e-02 | 0.86400 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 12 | 6.39e-01 | -7.81e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 16 | 5.89e-01 | 7.81e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 331 | 1.49e-02 | 7.81e-02 | 0.37400 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 21 | 5.36e-01 | -7.81e-02 | 0.89700 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 14 | 6.13e-01 | -7.81e-02 | 0.91800 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 49 | 3.45e-01 | -7.80e-02 | 0.83100 |
| GOMF HISTONE BINDING | 214 | 4.98e-02 | 7.80e-02 | 0.51700 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 25 | 5.00e-01 | -7.79e-02 | 0.88600 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 7 | 7.21e-01 | 7.79e-02 | 0.94900 |
| GOBP ADENOSINE METABOLIC PROCESS | 5 | 7.63e-01 | 7.79e-02 | 0.95800 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 106 | 1.66e-01 | 7.79e-02 | 0.70600 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 14 | 6.14e-01 | 7.79e-02 | 0.91800 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 36 | 4.19e-01 | -7.78e-02 | 0.86400 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 36 | 4.19e-01 | 7.78e-02 | 0.86400 |
| GOBP REGULATION OF PROTEIN MATURATION | 47 | 3.56e-01 | -7.78e-02 | 0.83600 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 86 | 2.13e-01 | 7.78e-02 | 0.74000 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 5.68e-01 | 7.78e-02 | 0.90700 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 28 | 4.76e-01 | 7.78e-02 | 0.88100 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 20 | 5.47e-01 | 7.78e-02 | 0.90000 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 41 | 3.90e-01 | 7.77e-02 | 0.85100 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 546 | 2.02e-03 | 7.77e-02 | 0.19300 |
| GOBP FOREBRAIN DEVELOPMENT | 222 | 4.66e-02 | 7.77e-02 | 0.50700 |
| GOBP MUSCLE ATROPHY | 6 | 7.42e-01 | 7.76e-02 | 0.95400 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 12 | 6.42e-01 | -7.76e-02 | 0.92400 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 7.42e-01 | 7.76e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 443 | 5.35e-03 | 7.75e-02 | 0.25400 |
| GOBP LATE NUCLEOPHAGY | 7 | 7.23e-01 | -7.75e-02 | 0.94900 |
| GOBP CELL PROJECTION ASSEMBLY | 452 | 4.96e-03 | 7.74e-02 | 0.25100 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 5.59e-01 | -7.74e-02 | 0.90400 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 5.81e-01 | 7.74e-02 | 0.91100 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 10 | 6.72e-01 | -7.74e-02 | 0.93200 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 14 | 6.16e-01 | 7.74e-02 | 0.91900 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 13 | 6.29e-01 | 7.74e-02 | 0.92400 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 31 | 4.56e-01 | -7.73e-02 | 0.87700 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 95 | 1.93e-01 | 7.73e-02 | 0.73300 |
| GOBP SENSORY PERCEPTION OF PAIN | 37 | 4.16e-01 | -7.73e-02 | 0.86300 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 22 | 5.31e-01 | 7.72e-02 | 0.89700 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 29 | 4.72e-01 | -7.72e-02 | 0.88000 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 7.24e-01 | -7.72e-02 | 0.94900 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 7.05e-01 | -7.72e-02 | 0.94200 |
| GOMF PRE MRNA BINDING | 30 | 4.65e-01 | -7.72e-02 | 0.87900 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 48 | 3.55e-01 | 7.71e-02 | 0.83600 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 13 | 6.30e-01 | 7.71e-02 | 0.92400 |
| GOCC DENSE CORE GRANULE | 15 | 6.06e-01 | -7.70e-02 | 0.91700 |
| GOMF MAP KINASE ACTIVITY | 12 | 6.44e-01 | -7.70e-02 | 0.92500 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 351 | 1.35e-02 | 7.70e-02 | 0.37200 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 6.44e-01 | 7.70e-02 | 0.92500 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 6.89e-01 | -7.69e-02 | 0.93700 |
| GOCC NUCLEAR INNER MEMBRANE | 44 | 3.78e-01 | 7.69e-02 | 0.84400 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 12 | 6.45e-01 | -7.69e-02 | 0.92500 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 6.59e-01 | 7.69e-02 | 0.93100 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 5 | 7.66e-01 | -7.69e-02 | 0.95900 |
| GOBP BLOOD VESSEL REMODELING | 25 | 5.06e-01 | -7.68e-02 | 0.88800 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 128 | 1.34e-01 | 7.68e-02 | 0.67900 |
| GOBP OOGENESIS | 57 | 3.16e-01 | 7.68e-02 | 0.81100 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 9 | 6.90e-01 | 7.67e-02 | 0.93700 |
| GOCC ORGANELLAR RIBOSOME | 89 | 2.11e-01 | 7.67e-02 | 0.74000 |
| GOCC MITOCHONDRIAL MATRIX | 432 | 6.49e-03 | 7.67e-02 | 0.27500 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 87 | 2.17e-01 | 7.67e-02 | 0.74500 |
| GOBP STRIATED MUSCLE CONTRACTION | 104 | 1.77e-01 | 7.66e-02 | 0.71700 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 14 | 6.20e-01 | -7.66e-02 | 0.92100 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 802 | 2.55e-04 | 7.65e-02 | 0.09760 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 60 | 3.06e-01 | -7.65e-02 | 0.80600 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 7.08e-01 | -7.65e-02 | 0.94300 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 99 | 1.89e-01 | 7.64e-02 | 0.72900 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 7.26e-01 | -7.64e-02 | 0.95100 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 236 | 4.36e-02 | 7.64e-02 | 0.50100 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 12 | 6.47e-01 | -7.64e-02 | 0.92600 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 191 | 6.93e-02 | 7.63e-02 | 0.57400 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 18 | 5.75e-01 | 7.63e-02 | 0.90800 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 6.61e-01 | -7.63e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 21 | 5.45e-01 | 7.63e-02 | 0.89900 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 7.27e-01 | 7.62e-02 | 0.95100 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 342 | 1.57e-02 | 7.62e-02 | 0.37400 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 10 | 6.77e-01 | -7.62e-02 | 0.93200 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 7.84e-02 | -7.62e-02 | 0.59000 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 4.78e-01 | 7.61e-02 | 0.88100 |
| GOBP KETONE CATABOLIC PROCESS | 10 | 6.77e-01 | -7.61e-02 | 0.93200 |
| GOMF ELECTRON TRANSFER ACTIVITY | 100 | 1.89e-01 | 7.61e-02 | 0.72900 |
| GOBP GLUTATHIONE TRANSPORT | 7 | 7.27e-01 | 7.61e-02 | 0.95100 |
| GOBP RESPONSE TO LEAD ION | 16 | 5.99e-01 | -7.60e-02 | 0.91400 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 127 | 1.40e-01 | 7.60e-02 | 0.68400 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 55 | 3.30e-01 | -7.60e-02 | 0.81800 |
| GOBP IRON IMPORT INTO CELL | 7 | 7.28e-01 | 7.60e-02 | 0.95100 |
| GOBP NUCLEUS ORGANIZATION | 120 | 1.51e-01 | 7.59e-02 | 0.69000 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 75 | 2.56e-01 | -7.59e-02 | 0.77800 |
| GOBP CILIUM MOVEMENT | 93 | 2.07e-01 | 7.58e-02 | 0.73900 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 30 | 4.72e-01 | 7.58e-02 | 0.88000 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 69 | 2.76e-01 | -7.58e-02 | 0.79000 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 22 | 5.38e-01 | -7.58e-02 | 0.89700 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 211 | 5.84e-02 | 7.57e-02 | 0.53800 |
| GOCC PHAGOCYTIC CUP | 25 | 5.12e-01 | -7.57e-02 | 0.89000 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 13 | 6.36e-01 | 7.57e-02 | 0.92400 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 33 | 4.52e-01 | -7.57e-02 | 0.87400 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 37 | 4.26e-01 | 7.57e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 86 | 2.26e-01 | 7.56e-02 | 0.75100 |
| GOCC PHAGOCYTIC VESICLE | 128 | 1.40e-01 | -7.56e-02 | 0.68400 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 305 | 2.35e-02 | 7.56e-02 | 0.42300 |
| GOBP BONE CELL DEVELOPMENT | 15 | 6.12e-01 | 7.56e-02 | 0.91800 |
| GOBP OSTEOCLAST DIFFERENTIATION | 75 | 2.58e-01 | 7.56e-02 | 0.77900 |
| GOCC GOLGI LUMEN | 38 | 4.20e-01 | -7.56e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 29 | 4.81e-01 | 7.55e-02 | 0.88300 |
| GOCC DYNEIN COMPLEX | 34 | 4.46e-01 | 7.55e-02 | 0.87300 |
| GOBP SYNCYTIUM FORMATION | 41 | 4.03e-01 | 7.55e-02 | 0.85600 |
| GOBP FIBROBLAST PROLIFERATION | 66 | 2.89e-01 | -7.55e-02 | 0.79300 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 1.04e-01 | -7.55e-02 | 0.63400 |
| GOMF CHANNEL REGULATOR ACTIVITY | 82 | 2.38e-01 | 7.54e-02 | 0.76200 |
| GOBP RESPONSE TO HYPEROXIA | 13 | 6.38e-01 | 7.53e-02 | 0.92400 |
| GOMF VIRION BINDING | 8 | 7.12e-01 | 7.53e-02 | 0.94500 |
| GOMF DEATH RECEPTOR BINDING | 15 | 6.14e-01 | 7.52e-02 | 0.91800 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 9 | 6.96e-01 | 7.51e-02 | 0.93800 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 40 | 4.12e-01 | 7.50e-02 | 0.86000 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 7.50e-01 | 7.50e-02 | 0.95600 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 9 | 6.97e-01 | -7.49e-02 | 0.93800 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 7.51e-01 | -7.49e-02 | 0.95600 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 174 | 8.88e-02 | 7.49e-02 | 0.61300 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 59 | 3.22e-01 | -7.46e-02 | 0.81400 |
| GOBP DEVELOPMENTAL INDUCTION | 11 | 6.68e-01 | 7.46e-02 | 0.93200 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 36 | 4.39e-01 | -7.46e-02 | 0.86900 |
| GOMF LIPID TRANSFER ACTIVITY | 36 | 4.39e-01 | -7.46e-02 | 0.86900 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 38 | 4.26e-01 | 7.46e-02 | 0.86400 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 5 | 7.73e-01 | 7.46e-02 | 0.96000 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 38 | 4.27e-01 | 7.46e-02 | 0.86400 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 9 | 6.99e-01 | -7.45e-02 | 0.94000 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 410 | 9.95e-03 | 7.45e-02 | 0.32200 |
| GOBP LUNG MORPHOGENESIS | 29 | 4.88e-01 | -7.45e-02 | 0.88300 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 68 | 2.89e-01 | -7.44e-02 | 0.79300 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 36 | 4.40e-01 | 7.44e-02 | 0.86900 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 128 | 1.46e-01 | -7.44e-02 | 0.68600 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 28 | 4.96e-01 | 7.44e-02 | 0.88600 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 492 | 4.93e-03 | 7.44e-02 | 0.25100 |
| GOBP DENDRITE ARBORIZATION | 7 | 7.34e-01 | -7.43e-02 | 0.95300 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 71 | 2.80e-01 | 7.43e-02 | 0.79000 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 13 | 6.43e-01 | -7.42e-02 | 0.92500 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 26 | 5.13e-01 | 7.42e-02 | 0.89000 |
| GOMF SYNTAXIN BINDING | 47 | 3.79e-01 | -7.42e-02 | 0.84400 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 11 | 6.70e-01 | 7.41e-02 | 0.93200 |
| GOCC FILAMENTOUS ACTIN | 17 | 5.97e-01 | 7.40e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 33 | 4.62e-01 | -7.40e-02 | 0.87900 |
| GOBP FOLIC ACID METABOLIC PROCESS | 14 | 6.32e-01 | 7.40e-02 | 0.92400 |
| GOCC HOST CELLULAR COMPONENT | 8 | 7.17e-01 | -7.40e-02 | 0.94800 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 19 | 5.77e-01 | 7.39e-02 | 0.90900 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 7.75e-01 | 7.39e-02 | 0.96100 |
| GOBP ER OVERLOAD RESPONSE | 10 | 6.86e-01 | -7.38e-02 | 0.93500 |
| GOBP CHONDROCYTE DIFFERENTIATION | 63 | 3.11e-01 | -7.38e-02 | 0.80800 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 7.54e-01 | 7.38e-02 | 0.95600 |
| GOMF ANKYRIN BINDING | 8 | 7.18e-01 | 7.37e-02 | 0.94800 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 232 | 5.36e-02 | 7.37e-02 | 0.52800 |
| GOMF CHEMOATTRACTANT ACTIVITY | 13 | 6.45e-01 | -7.37e-02 | 0.92600 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 99 | 2.05e-01 | 7.37e-02 | 0.73800 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 6.87e-01 | -7.37e-02 | 0.93500 |
| GOBP BODY FLUID SECRETION | 48 | 3.78e-01 | -7.37e-02 | 0.84400 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 33 | 4.64e-01 | -7.36e-02 | 0.87900 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 38 | 4.32e-01 | 7.36e-02 | 0.86600 |
| GOCC TRANSPORT VESICLE | 299 | 2.90e-02 | -7.36e-02 | 0.45700 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 7.76e-01 | 7.36e-02 | 0.96100 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 22 | 5.50e-01 | -7.36e-02 | 0.90100 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 30 | 4.86e-01 | 7.35e-02 | 0.88300 |
| GOBP LIPID DROPLET FORMATION | 11 | 6.73e-01 | -7.35e-02 | 0.93200 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.55e-01 | 7.34e-02 | 0.95600 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 5 | 7.76e-01 | -7.34e-02 | 0.96100 |
| GOBP SYMPATHETIC NEURON PROJECTION EXTENSION | 5 | 7.76e-01 | -7.34e-02 | 0.96100 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 34 | 4.59e-01 | -7.34e-02 | 0.87700 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 6.74e-01 | 7.34e-02 | 0.93200 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 133 | 1.45e-01 | 7.33e-02 | 0.68500 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 6 | 7.56e-01 | 7.33e-02 | 0.95600 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 26 | 5.18e-01 | -7.33e-02 | 0.89100 |
| GOBP TELENCEPHALON DEVELOPMENT | 164 | 1.06e-01 | 7.32e-02 | 0.63500 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 2.44e-01 | -7.32e-02 | 0.76600 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 122 | 1.63e-01 | 7.32e-02 | 0.70300 |
| GOCC MYOFILAMENT | 14 | 6.36e-01 | -7.32e-02 | 0.92400 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 24 | 5.35e-01 | -7.32e-02 | 0.89700 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 306 | 2.82e-02 | 7.32e-02 | 0.45400 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 49 | 3.76e-01 | -7.31e-02 | 0.84200 |
| GOBP FEMALE MEIOSIS I | 6 | 7.57e-01 | 7.31e-02 | 0.95600 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 53 | 3.58e-01 | -7.31e-02 | 0.83600 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 39 | 4.30e-01 | 7.30e-02 | 0.86500 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 145 | 1.30e-01 | 7.30e-02 | 0.67600 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 9 | 7.05e-01 | -7.30e-02 | 0.94200 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 7 | 7.38e-01 | 7.30e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 553 | 3.54e-03 | 7.29e-02 | 0.22500 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 74 | 2.79e-01 | 7.29e-02 | 0.79000 |
| GOMF HISTONE MODIFYING ACTIVITY | 184 | 8.87e-02 | 7.29e-02 | 0.61300 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 50 | 3.73e-01 | 7.29e-02 | 0.84100 |
| GOCC CASPASE COMPLEX | 9 | 7.05e-01 | 7.29e-02 | 0.94200 |
| GOBP RESPONSE TO IRON II ION | 5 | 7.78e-01 | 7.29e-02 | 0.96100 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 7.78e-01 | 7.28e-02 | 0.96100 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 7.57e-01 | -7.28e-02 | 0.95600 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 14 | 6.37e-01 | 7.28e-02 | 0.92400 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 10 | 6.90e-01 | 7.28e-02 | 0.93700 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 23 | 5.46e-01 | 7.28e-02 | 0.89900 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 67 | 3.03e-01 | 7.27e-02 | 0.80500 |
| GOMF FLIPPASE ACTIVITY | 12 | 6.63e-01 | 7.27e-02 | 0.93200 |
| GOBP MYOBLAST MIGRATION | 7 | 7.39e-01 | 7.27e-02 | 0.95400 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 7.58e-01 | -7.27e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 31 | 4.84e-01 | -7.27e-02 | 0.88300 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 69 | 2.97e-01 | 7.27e-02 | 0.80000 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 23 | 5.46e-01 | 7.27e-02 | 0.89900 |
| GOMF NADP BINDING | 40 | 4.27e-01 | 7.26e-02 | 0.86400 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 7.39e-01 | 7.26e-02 | 0.95400 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 282 | 3.64e-02 | -7.26e-02 | 0.48200 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 51 | 3.70e-01 | 7.26e-02 | 0.84000 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 32 | 4.77e-01 | 7.26e-02 | 0.88100 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 6.91e-01 | -7.26e-02 | 0.93700 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 33 | 4.71e-01 | 7.26e-02 | 0.88000 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 6.27e-01 | -7.25e-02 | 0.92400 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 12 | 6.64e-01 | 7.25e-02 | 0.93200 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 33 | 4.71e-01 | 7.25e-02 | 0.88000 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 114 | 1.82e-01 | -7.24e-02 | 0.72100 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 385 | 1.51e-02 | 7.24e-02 | 0.37400 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 21 | 5.66e-01 | 7.24e-02 | 0.90600 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 7.23e-01 | 7.23e-02 | 0.94900 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 9 | 7.07e-01 | 7.23e-02 | 0.94300 |
| GOCC BOX H ACA RNP COMPLEX | 5 | 7.80e-01 | -7.23e-02 | 0.96100 |
| GOCC BOX H ACA TELOMERASE RNP COMPLEX | 5 | 7.80e-01 | -7.23e-02 | 0.96100 |
| GOBP OVULATION CYCLE PROCESS | 27 | 5.16e-01 | 7.23e-02 | 0.89100 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 5.76e-01 | 7.22e-02 | 0.90800 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 11 | 6.79e-01 | 7.22e-02 | 0.93300 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 6.40e-01 | -7.21e-02 | 0.92400 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 15 | 6.29e-01 | 7.21e-02 | 0.92400 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 10 | 6.93e-01 | -7.21e-02 | 0.93800 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 207 | 7.45e-02 | 7.20e-02 | 0.58100 |
| GOCC CHLORIDE CHANNEL COMPLEX | 16 | 6.18e-01 | 7.20e-02 | 0.92000 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 30 | 4.95e-01 | 7.20e-02 | 0.88600 |
| GOBP RESPONSE TO ANGIOTENSIN | 25 | 5.34e-01 | 7.19e-02 | 0.89700 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 52 | 3.70e-01 | -7.19e-02 | 0.84000 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 10 | 6.94e-01 | 7.19e-02 | 0.93800 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 288 | 3.66e-02 | 7.18e-02 | 0.48200 |
| GOBP SUCKLING BEHAVIOR | 7 | 7.42e-01 | -7.18e-02 | 0.95400 |
| GOBP DEMETHYLATION | 39 | 4.38e-01 | 7.17e-02 | 0.86900 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 62 | 3.29e-01 | 7.17e-02 | 0.81800 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 14 | 6.42e-01 | 7.17e-02 | 0.92400 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 6.67e-01 | 7.17e-02 | 0.93200 |
| GOCC MICROFIBRIL | 8 | 7.26e-01 | 7.17e-02 | 0.95000 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 78 | 2.74e-01 | -7.17e-02 | 0.79000 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 7.61e-01 | 7.16e-02 | 0.95700 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 12 | 6.68e-01 | 7.15e-02 | 0.93200 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 5.20e-01 | -7.15e-02 | 0.89100 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 26 | 5.28e-01 | 7.15e-02 | 0.89500 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 66 | 3.16e-01 | 7.15e-02 | 0.81100 |
| GOCC FLEMMING BODY | 30 | 4.98e-01 | 7.15e-02 | 0.88600 |
| GOBP COPPER ION IMPORT | 5 | 7.82e-01 | -7.14e-02 | 0.96200 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 33 | 4.78e-01 | 7.14e-02 | 0.88100 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 30 | 4.99e-01 | 7.13e-02 | 0.88600 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 7.83e-01 | -7.13e-02 | 0.96200 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 5.91e-01 | -7.12e-02 | 0.91300 |
| GOBP SPINDLE LOCALIZATION | 47 | 3.99e-01 | -7.11e-02 | 0.85600 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 54 | 3.66e-01 | 7.11e-02 | 0.84000 |
| GOCC EARLY ENDOSOME MEMBRANE | 143 | 1.43e-01 | -7.11e-02 | 0.68500 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 7.12e-01 | 7.10e-02 | 0.94500 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 112 | 1.95e-01 | -7.10e-02 | 0.73400 |
| GOCC MITOTIC SPINDLE MIDZONE | 9 | 7.12e-01 | -7.10e-02 | 0.94500 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 7.83e-01 | 7.10e-02 | 0.96200 |
| GOBP REGULATION OF CELL CYCLE | 828 | 5.78e-04 | 7.10e-02 | 0.11600 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 83 | 2.65e-01 | -7.09e-02 | 0.78300 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 26 | 5.32e-01 | -7.09e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 23 | 5.57e-01 | 7.08e-02 | 0.90300 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 274 | 4.43e-02 | -7.08e-02 | 0.50300 |
| GOBP HEXOSE CATABOLIC PROCESS | 31 | 4.95e-01 | 7.08e-02 | 0.88600 |
| GOBP MONOAMINE TRANSPORT | 35 | 4.69e-01 | 7.08e-02 | 0.88000 |
| GOBP ACUTE PHASE RESPONSE | 25 | 5.41e-01 | -7.07e-02 | 0.89700 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 8 | 7.29e-01 | -7.07e-02 | 0.95200 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 8 | 7.29e-01 | -7.07e-02 | 0.95200 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 35 | 4.70e-01 | -7.07e-02 | 0.88000 |
| GOCC MITOCHONDRION | 1395 | 1.29e-05 | 7.07e-02 | 0.04940 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 195 | 8.97e-02 | 7.06e-02 | 0.61300 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 97 | 2.30e-01 | 7.06e-02 | 0.75400 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 64 | 3.29e-01 | 7.05e-02 | 0.81800 |
| GOBP REGULATION OF PH | 75 | 2.91e-01 | -7.05e-02 | 0.79500 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 6 | 7.65e-01 | -7.05e-02 | 0.95900 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 81 | 2.73e-01 | -7.05e-02 | 0.78900 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 46 | 4.09e-01 | 7.04e-02 | 0.85900 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 138 | 1.54e-01 | 7.04e-02 | 0.69000 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 35 | 4.71e-01 | -7.04e-02 | 0.88000 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 28 | 5.19e-01 | -7.04e-02 | 0.89100 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 24 | 5.51e-01 | 7.04e-02 | 0.90100 |
| GOBP REGULATION OF KINASE ACTIVITY | 403 | 1.57e-02 | 7.04e-02 | 0.37400 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 22 | 5.68e-01 | 7.03e-02 | 0.90700 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 48 | 3.99e-01 | -7.03e-02 | 0.85600 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 6.37e-01 | -7.03e-02 | 0.92400 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 7.65e-01 | -7.03e-02 | 0.95900 |
| GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS | 5 | 7.85e-01 | -7.03e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 5.77e-01 | -7.03e-02 | 0.90900 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 19 | 5.97e-01 | 7.02e-02 | 0.91300 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 7.86e-01 | -7.01e-02 | 0.96200 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 127 | 1.73e-01 | 7.01e-02 | 0.71500 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 7.48e-01 | -7.01e-02 | 0.95600 |
| GOBP ARTERY DEVELOPMENT | 58 | 3.56e-01 | 7.00e-02 | 0.83600 |
| GOCC CILIARY MEMBRANE | 46 | 4.12e-01 | -7.00e-02 | 0.86000 |
| GOBP BONE MATURATION | 14 | 6.50e-01 | -7.00e-02 | 0.92700 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 30 | 5.07e-01 | -7.00e-02 | 0.88800 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 7.02e-01 | 6.99e-02 | 0.94100 |
| GOBP REGULATION OF DEFENSE RESPONSE | 570 | 4.54e-03 | 6.99e-02 | 0.24700 |
| GOMF MONOSACCHARIDE BINDING | 62 | 3.42e-01 | -6.99e-02 | 0.82900 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 13 | 6.63e-01 | -6.99e-02 | 0.93200 |
| GOMF MHC PROTEIN BINDING | 26 | 5.38e-01 | 6.98e-02 | 0.89700 |
| GOCC LAMELLAR BODY | 5 | 7.87e-01 | -6.97e-02 | 0.96200 |
| GOCC PRESYNAPSE | 345 | 2.65e-02 | -6.97e-02 | 0.44000 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 4.58e-01 | -6.97e-02 | 0.87700 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 7.50e-01 | 6.96e-02 | 0.95600 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 32 | 4.96e-01 | 6.96e-02 | 0.88600 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 23 | 5.63e-01 | 6.96e-02 | 0.90600 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 8 | 7.33e-01 | -6.96e-02 | 0.95300 |
| GOBP SECRETORY GRANULE ORGANIZATION | 44 | 4.25e-01 | -6.95e-02 | 0.86400 |
| GOMF CHROMATIN DNA BINDING | 81 | 2.80e-01 | -6.95e-02 | 0.79000 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 151 | 1.41e-01 | 6.94e-02 | 0.68500 |
| GOBP BILE ACID METABOLIC PROCESS | 29 | 5.18e-01 | 6.94e-02 | 0.89100 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 23 | 5.65e-01 | 6.94e-02 | 0.90600 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 34 | 4.84e-01 | 6.94e-02 | 0.88300 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 122 | 1.86e-01 | 6.93e-02 | 0.72300 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 42 | 4.37e-01 | 6.93e-02 | 0.86800 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 59 | 3.57e-01 | 6.93e-02 | 0.83600 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 10 | 7.04e-01 | 6.93e-02 | 0.94200 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 23 | 5.65e-01 | 6.93e-02 | 0.90600 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 72 | 3.10e-01 | 6.93e-02 | 0.80800 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 3.10e-01 | -6.93e-02 | 0.80800 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 70 | 3.17e-01 | 6.93e-02 | 0.81100 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 8 | 7.34e-01 | -6.93e-02 | 0.95300 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 7.51e-01 | 6.92e-02 | 0.95600 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 10 | 7.05e-01 | -6.91e-02 | 0.94200 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 260 | 5.56e-02 | 6.91e-02 | 0.53400 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 39 | 4.55e-01 | 6.91e-02 | 0.87500 |
| GOCC NURF COMPLEX | 6 | 7.69e-01 | -6.91e-02 | 0.95900 |
| GOBP O GLYCAN PROCESSING | 29 | 5.20e-01 | -6.91e-02 | 0.89100 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 25 | 5.50e-01 | 6.91e-02 | 0.90100 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 7.52e-01 | -6.90e-02 | 0.95600 |
| GOBP MESONEPHROS DEVELOPMENT | 43 | 4.34e-01 | -6.90e-02 | 0.86600 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 7.70e-01 | -6.90e-02 | 0.95900 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 13 | 6.67e-01 | 6.90e-02 | 0.93200 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 5.00e-01 | -6.89e-02 | 0.88600 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 60 | 3.57e-01 | -6.89e-02 | 0.83600 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 6 | 7.70e-01 | -6.88e-02 | 0.96000 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 14 | 6.56e-01 | 6.88e-02 | 0.93000 |
| GOMF TELOMERASE RNA BINDING | 21 | 5.85e-01 | -6.88e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 29 | 5.21e-01 | -6.88e-02 | 0.89100 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 65 | 3.38e-01 | 6.88e-02 | 0.82600 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 400 | 1.87e-02 | 6.88e-02 | 0.38900 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 95 | 2.47e-01 | -6.88e-02 | 0.76800 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 36 | 4.75e-01 | -6.88e-02 | 0.88100 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 88 | 2.65e-01 | -6.87e-02 | 0.78400 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 12 | 6.81e-01 | -6.86e-02 | 0.93400 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 16 | 6.35e-01 | -6.86e-02 | 0.92400 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 87 | 2.69e-01 | 6.86e-02 | 0.78700 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 12 | 6.81e-01 | 6.86e-02 | 0.93400 |
| GOCC FEMALE PRONUCLEUS | 8 | 7.37e-01 | 6.86e-02 | 0.95400 |
| GOBP NEURON PROJECTION EXTENSION | 118 | 1.99e-01 | 6.86e-02 | 0.73600 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 25 | 5.53e-01 | 6.86e-02 | 0.90100 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 281 | 4.86e-02 | 6.85e-02 | 0.51200 |
| GOBP RESPONSE TO AXON INJURY | 47 | 4.17e-01 | 6.85e-02 | 0.86300 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 27 | 5.38e-01 | -6.85e-02 | 0.89700 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 9 | 7.22e-01 | -6.85e-02 | 0.94900 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 39 | 4.59e-01 | 6.85e-02 | 0.87700 |
| GOBP VITAMIN METABOLIC PROCESS | 70 | 3.22e-01 | 6.85e-02 | 0.81500 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 28 | 5.31e-01 | -6.85e-02 | 0.89700 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 8 | 7.38e-01 | 6.84e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 39 | 4.60e-01 | -6.84e-02 | 0.87700 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 86 | 2.73e-01 | -6.84e-02 | 0.78900 |
| GOCC CENTROSOME | 537 | 7.05e-03 | 6.83e-02 | 0.28700 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 74 | 3.10e-01 | 6.83e-02 | 0.80800 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 211 | 8.79e-02 | 6.83e-02 | 0.61300 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 39 | 4.61e-01 | -6.82e-02 | 0.87800 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 275 | 5.22e-02 | -6.82e-02 | 0.52500 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 5 | 7.92e-01 | 6.82e-02 | 0.96200 |
| GOBP COPPER ION TRANSPORT | 14 | 6.59e-01 | -6.82e-02 | 0.93100 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 5.98e-01 | 6.81e-02 | 0.91300 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 77 | 3.02e-01 | 6.81e-02 | 0.80400 |
| GOBP RESPONSE TO MONOSACCHARIDE | 122 | 1.94e-01 | 6.81e-02 | 0.73300 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 18 | 6.17e-01 | -6.81e-02 | 0.92000 |
| GOBP PRIMARY MIRNA PROCESSING | 18 | 6.17e-01 | -6.81e-02 | 0.92000 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 31 | 5.12e-01 | -6.81e-02 | 0.89000 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 7.92e-01 | 6.81e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 30 | 5.19e-01 | 6.80e-02 | 0.89100 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 8 | 7.39e-01 | -6.80e-02 | 0.95400 |
| GOCC CILIARY BASAL BODY | 134 | 1.75e-01 | 6.80e-02 | 0.71600 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 18 | 6.18e-01 | 6.79e-02 | 0.92000 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 9 | 7.24e-01 | -6.79e-02 | 0.95000 |
| GOBP TYPE II INTERFERON PRODUCTION | 83 | 2.86e-01 | 6.79e-02 | 0.79100 |
| GOCC LEADING EDGE MEMBRANE | 118 | 2.04e-01 | 6.78e-02 | 0.73800 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 36 | 4.81e-01 | 6.78e-02 | 0.88300 |
| GOMF MRNA 5 UTR BINDING | 23 | 5.74e-01 | -6.78e-02 | 0.90800 |
| GOBP DENDRITE DEVELOPMENT | 160 | 1.40e-01 | 6.78e-02 | 0.68300 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 19 | 6.09e-01 | 6.78e-02 | 0.91700 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 7.56e-01 | 6.77e-02 | 0.95600 |
| GOBP CELL CYCLE PHASE TRANSITION | 441 | 1.52e-02 | 6.77e-02 | 0.37400 |
| GOCC ZYMOGEN GRANULE | 8 | 7.40e-01 | -6.77e-02 | 0.95400 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 81 | 2.93e-01 | 6.76e-02 | 0.79600 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 22 | 5.83e-01 | 6.76e-02 | 0.91200 |
| GOCC PAR POLARITY COMPLEX | 5 | 7.94e-01 | 6.75e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 362 | 2.79e-02 | 6.75e-02 | 0.45000 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 5.67e-01 | -6.75e-02 | 0.90600 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 7.75e-01 | -6.75e-02 | 0.96100 |
| GOCC TRANSPORT VESICLE MEMBRANE | 158 | 1.44e-01 | -6.75e-02 | 0.68500 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 101 | 2.42e-01 | -6.75e-02 | 0.76400 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 7 | 7.57e-01 | -6.75e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 73 | 3.19e-01 | -6.75e-02 | 0.81400 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 6.86e-01 | 6.75e-02 | 0.93500 |
| GOBP REGULATION OF FERTILIZATION | 5 | 7.94e-01 | 6.75e-02 | 0.96200 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 26 | 5.52e-01 | 6.74e-02 | 0.90100 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 10 | 7.12e-01 | -6.74e-02 | 0.94500 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 84 | 2.86e-01 | -6.73e-02 | 0.79100 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 8 | 7.42e-01 | 6.73e-02 | 0.95400 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 6.74e-01 | -6.73e-02 | 0.93200 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 7 | 7.58e-01 | -6.73e-02 | 0.95600 |
| GOMF HORMONE BINDING | 37 | 4.79e-01 | -6.72e-02 | 0.88200 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 98 | 2.51e-01 | 6.72e-02 | 0.77200 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 143 | 1.66e-01 | 6.72e-02 | 0.70500 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 5.69e-01 | -6.72e-02 | 0.90700 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 3.57e-01 | -6.72e-02 | 0.83600 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 45 | 4.36e-01 | 6.72e-02 | 0.86700 |
| GOBP RESPONSE TO HEAT | 76 | 3.12e-01 | 6.72e-02 | 0.80900 |
| GOBP ELECTRON TRANSPORT CHAIN | 146 | 1.62e-01 | 6.71e-02 | 0.70100 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 7.95e-01 | -6.71e-02 | 0.96200 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 7.95e-01 | -6.71e-02 | 0.96200 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 21 | 5.94e-01 | 6.71e-02 | 0.91300 |
| GOBP VESICLE ORGANIZATION | 298 | 4.69e-02 | -6.71e-02 | 0.50700 |
| GOCC POLAR MICROTUBULE | 5 | 7.95e-01 | 6.71e-02 | 0.96200 |
| GOMF SIGNAL SEQUENCE BINDING | 40 | 4.63e-01 | 6.71e-02 | 0.87900 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 63 | 3.57e-01 | 6.71e-02 | 0.83600 |
| GOBP RUFFLE ASSEMBLY | 34 | 4.99e-01 | 6.71e-02 | 0.88600 |
| GOCC SEPTIN CYTOSKELETON | 13 | 6.76e-01 | 6.70e-02 | 0.93200 |
| GOBP NCRNA TRANSCRIPTION | 105 | 2.36e-01 | 6.70e-02 | 0.76000 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 47 | 4.27e-01 | -6.70e-02 | 0.86400 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 285 | 5.25e-02 | 6.69e-02 | 0.52500 |
| GOBP DNA DAMAGE RESPONSE | 764 | 1.79e-03 | 6.69e-02 | 0.19300 |
| GOMF ACTIN BINDING | 306 | 4.49e-02 | 6.69e-02 | 0.50300 |
| GOCC AXONEMAL MICROTUBULE | 20 | 6.05e-01 | -6.68e-02 | 0.91600 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 42 | 4.54e-01 | -6.68e-02 | 0.87500 |
| GOMF ATPASE REGULATOR ACTIVITY | 45 | 4.38e-01 | -6.68e-02 | 0.86900 |
| GOCC CENTRIOLAR SATELLITE | 91 | 2.71e-01 | 6.68e-02 | 0.78800 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 128 | 1.92e-01 | 6.68e-02 | 0.73200 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 23 | 5.79e-01 | -6.68e-02 | 0.91000 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 36 | 4.88e-01 | 6.68e-02 | 0.88300 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 35 | 4.95e-01 | -6.67e-02 | 0.88600 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 28 | 5.41e-01 | 6.67e-02 | 0.89700 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 87 | 2.82e-01 | 6.67e-02 | 0.79000 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 73 | 3.25e-01 | -6.67e-02 | 0.81600 |
| GOCC MICROTUBULE ORGANIZING CENTER | 693 | 2.96e-03 | 6.67e-02 | 0.21000 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 156 | 1.51e-01 | 6.66e-02 | 0.69000 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 3.53e-01 | -6.66e-02 | 0.83500 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 29 | 5.35e-01 | -6.66e-02 | 0.89700 |
| GOCC RUFFLE | 148 | 1.63e-01 | 6.66e-02 | 0.70200 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 5.35e-01 | -6.66e-02 | 0.89700 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 30 | 5.28e-01 | 6.66e-02 | 0.89500 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 6.90e-01 | 6.65e-02 | 0.93700 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 7 | 7.60e-01 | -6.65e-02 | 0.95700 |
| GOBP LIPID PHOSPHORYLATION | 8 | 7.45e-01 | 6.65e-02 | 0.95500 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 8 | 7.45e-01 | 6.65e-02 | 0.95500 |
| GOBP ADP METABOLIC PROCESS | 7 | 7.61e-01 | -6.65e-02 | 0.95700 |
| GOBP HISTONE H3 ACETYLATION | 6 | 7.78e-01 | 6.65e-02 | 0.96100 |
| GOBP INNATE IMMUNE RESPONSE | 667 | 3.67e-03 | 6.64e-02 | 0.22700 |
| GOBP VESICLE DOCKING | 52 | 4.08e-01 | -6.64e-02 | 0.85800 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 5.10e-01 | -6.64e-02 | 0.88900 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 7.45e-01 | 6.63e-02 | 0.95500 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 26 | 5.58e-01 | 6.63e-02 | 0.90400 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 36 | 4.91e-01 | -6.63e-02 | 0.88500 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 146 | 1.67e-01 | 6.63e-02 | 0.70800 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 390 | 2.52e-02 | 6.63e-02 | 0.43200 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 7.31e-01 | 6.63e-02 | 0.95200 |
| GOBP HEART VALVE DEVELOPMENT | 41 | 4.63e-01 | -6.62e-02 | 0.87900 |
| GOBP CYTIDINE METABOLIC PROCESS | 9 | 7.31e-01 | -6.62e-02 | 0.95200 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 9 | 7.31e-01 | -6.62e-02 | 0.95200 |
| GOBP REGULATION OF GTP BINDING | 9 | 7.31e-01 | -6.62e-02 | 0.95200 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 10 | 7.17e-01 | -6.62e-02 | 0.94800 |
| GOMF PHOSPHOLIPASE ACTIVITY | 69 | 3.42e-01 | 6.62e-02 | 0.82900 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 121 | 2.09e-01 | 6.61e-02 | 0.73900 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 6.09e-01 | -6.61e-02 | 0.91700 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 187 | 1.20e-01 | 6.61e-02 | 0.66400 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 17 | 6.37e-01 | 6.61e-02 | 0.92400 |
| GOCC APICAL DENDRITE | 11 | 7.04e-01 | 6.61e-02 | 0.94200 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 38 | 4.81e-01 | 6.61e-02 | 0.88300 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 7.79e-01 | -6.61e-02 | 0.96100 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 8 | 7.46e-01 | 6.60e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 26 | 5.60e-01 | -6.60e-02 | 0.90500 |
| GOCC ACROSOMAL VESICLE | 70 | 3.40e-01 | -6.59e-02 | 0.82800 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 725 | 2.68e-03 | 6.59e-02 | 0.20700 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 220 | 9.27e-02 | 6.59e-02 | 0.61300 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 6.48e-01 | -6.59e-02 | 0.92700 |
| GOBP IMPORT INTO NUCLEUS | 136 | 1.86e-01 | 6.58e-02 | 0.72300 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 244 | 7.73e-02 | 6.58e-02 | 0.58600 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 41 | 4.66e-01 | 6.58e-02 | 0.87900 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 359 | 3.29e-02 | 6.58e-02 | 0.47800 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 31 | 5.26e-01 | 6.57e-02 | 0.89400 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 41 | 4.67e-01 | 6.57e-02 | 0.87900 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 7.63e-01 | 6.57e-02 | 0.95800 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 20 | 6.11e-01 | 6.57e-02 | 0.91800 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 5.94e-01 | 6.56e-02 | 0.91300 |
| GOBP OTIC VESICLE DEVELOPMENT | 5 | 8.00e-01 | -6.56e-02 | 0.96400 |
| GOCC CYTOSOLIC REGION | 18 | 6.30e-01 | 6.56e-02 | 0.92400 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 4.09e-01 | -6.55e-02 | 0.86000 |
| GOBP RESPONSE TO METAL ION | 227 | 8.96e-02 | 6.55e-02 | 0.61300 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 70 | 3.43e-01 | -6.55e-02 | 0.82900 |
| GOBP RESPONSE TO STEROL | 22 | 5.95e-01 | 6.55e-02 | 0.91300 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 43 | 4.58e-01 | 6.55e-02 | 0.87700 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 487 | 1.38e-02 | 6.55e-02 | 0.37200 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 6.50e-01 | -6.54e-02 | 0.92700 |
| GOCC NUCLEAR OUTER MEMBRANE | 24 | 5.79e-01 | 6.54e-02 | 0.91000 |
| GOBP SYNAPSE ORGANIZATION | 269 | 6.58e-02 | 6.53e-02 | 0.56300 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 8.00e-01 | 6.53e-02 | 0.96400 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 8.00e-01 | -6.53e-02 | 0.96400 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 7.21e-01 | -6.52e-02 | 0.94900 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 14 | 6.73e-01 | -6.52e-02 | 0.93200 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 5.88e-01 | 6.52e-02 | 0.91300 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 16 | 6.52e-01 | -6.52e-02 | 0.92700 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 168 | 1.46e-01 | 6.52e-02 | 0.68500 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 42 | 4.65e-01 | 6.51e-02 | 0.87900 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 12 | 6.96e-01 | 6.51e-02 | 0.93800 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 27 | 5.59e-01 | 6.51e-02 | 0.90400 |
| GOCC AXONEMAL DYNEIN COMPLEX | 10 | 7.22e-01 | -6.50e-02 | 0.94900 |
| GOBP SELECTIVE AUTOPHAGY | 88 | 2.92e-01 | -6.50e-02 | 0.79500 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 7.36e-01 | 6.50e-02 | 0.95400 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 39 | 4.83e-01 | -6.50e-02 | 0.88300 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 104 | 2.53e-01 | 6.50e-02 | 0.77300 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 6.74e-01 | -6.50e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 6 | 7.83e-01 | -6.49e-02 | 0.96200 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 5.07e-01 | 6.49e-02 | 0.88800 |
| GOMF ACTIVIN BINDING | 10 | 7.23e-01 | 6.48e-02 | 0.94900 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 46 | 4.47e-01 | 6.48e-02 | 0.87300 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 7.51e-01 | -6.48e-02 | 0.95600 |
| GOBP REGULATION OF IMMUNE RESPONSE | 688 | 4.01e-03 | 6.48e-02 | 0.24200 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 11 | 7.10e-01 | 6.48e-02 | 0.94400 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 49 | 4.33e-01 | -6.48e-02 | 0.86600 |
| GOMF LIPASE ACTIVITY | 85 | 3.03e-01 | 6.47e-02 | 0.80400 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 7.51e-01 | 6.47e-02 | 0.95600 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 25 | 5.76e-01 | 6.47e-02 | 0.90800 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 53 | 4.16e-01 | 6.47e-02 | 0.86300 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 8.02e-01 | 6.47e-02 | 0.96400 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 8.02e-01 | 6.47e-02 | 0.96400 |
| GOCC ENDOSOME MEMBRANE | 444 | 2.00e-02 | -6.46e-02 | 0.40200 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 18 | 6.35e-01 | -6.46e-02 | 0.92400 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 18 | 6.35e-01 | -6.46e-02 | 0.92400 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 5.27e-01 | -6.46e-02 | 0.89400 |
| GOBP MACROPHAGE ACTIVATION | 77 | 3.28e-01 | 6.46e-02 | 0.81800 |
| GOMF REGULATORY RNA BINDING | 42 | 4.69e-01 | -6.45e-02 | 0.88000 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 7.68e-01 | -6.45e-02 | 0.95900 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 388 | 2.98e-02 | 6.45e-02 | 0.46300 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 6.36e-01 | 6.45e-02 | 0.92400 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 5.77e-01 | 6.44e-02 | 0.90900 |
| GOBP VIRAL LIFE CYCLE | 251 | 7.94e-02 | 6.44e-02 | 0.59300 |
| GOBP RNA LOCALIZATION | 180 | 1.37e-01 | 6.44e-02 | 0.68000 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 40 | 4.81e-01 | 6.44e-02 | 0.88300 |
| GOBP MRNA PROCESSING | 433 | 2.23e-02 | -6.43e-02 | 0.41800 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 42 | 4.71e-01 | -6.43e-02 | 0.88000 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 6.56e-01 | 6.43e-02 | 0.93000 |
| GOBP CGMP MEDIATED SIGNALING | 14 | 6.77e-01 | -6.42e-02 | 0.93200 |
| GOMF G PROTEIN ACTIVITY | 36 | 5.05e-01 | -6.42e-02 | 0.88800 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 84 | 3.09e-01 | -6.42e-02 | 0.80800 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 78 | 3.27e-01 | -6.42e-02 | 0.81800 |
| GOBP ESTROGEN METABOLIC PROCESS | 13 | 6.89e-01 | -6.42e-02 | 0.93600 |
| GOBP FILOPODIUM ASSEMBLY | 55 | 4.11e-01 | 6.42e-02 | 0.86000 |
| GOBP CELLULAR RESPONSE TO RADIATION | 138 | 1.94e-01 | 6.42e-02 | 0.73300 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 6.78e-01 | -6.42e-02 | 0.93200 |
| GOCC CELL DIVISION SITE | 61 | 3.86e-01 | 6.42e-02 | 0.84800 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 15 | 6.67e-01 | -6.41e-02 | 0.93200 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 23 | 5.95e-01 | -6.41e-02 | 0.91300 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 24 | 5.87e-01 | -6.41e-02 | 0.91300 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.47e-01 | -6.41e-02 | 0.92600 |
| GOCC EMC COMPLEX | 10 | 7.26e-01 | -6.40e-02 | 0.95000 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 5.25e-01 | 6.40e-02 | 0.89300 |
| GOMF STEROID BINDING | 65 | 3.73e-01 | -6.40e-02 | 0.84100 |
| GOBP RESPONSE TO KETONE | 127 | 2.14e-01 | 6.40e-02 | 0.74000 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 24 | 5.88e-01 | -6.40e-02 | 0.91300 |
| GOMF CASPASE BINDING | 9 | 7.40e-01 | -6.40e-02 | 0.95400 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 39 | 4.90e-01 | -6.40e-02 | 0.88500 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 12 | 7.01e-01 | 6.39e-02 | 0.94100 |
| GOBP AMINO ACID METABOLIC PROCESS | 183 | 1.37e-01 | 6.39e-02 | 0.68000 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 7.70e-01 | -6.39e-02 | 0.95900 |
| GOBP MACROPHAGE PROLIFERATION | 7 | 7.70e-01 | 6.39e-02 | 0.95900 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 37 | 5.01e-01 | 6.39e-02 | 0.88700 |
| GOBP OSTEOBLAST DIFFERENTIATION | 135 | 2.01e-01 | 6.39e-02 | 0.73700 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 7.87e-01 | -6.38e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 75 | 3.40e-01 | 6.38e-02 | 0.82700 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 6.21e-01 | 6.38e-02 | 0.92100 |
| GOBP SUPEROXIDE ANION GENERATION | 27 | 5.66e-01 | -6.38e-02 | 0.90600 |
| GOBP SOMATIC STEM CELL DIVISION | 6 | 7.87e-01 | 6.38e-02 | 0.96200 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 391 | 3.10e-02 | 6.38e-02 | 0.47200 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 22 | 6.05e-01 | -6.38e-02 | 0.91600 |
| GOBP MICROTUBULE BASED PROCESS | 676 | 4.99e-03 | 6.37e-02 | 0.25100 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 5.74e-01 | -6.37e-02 | 0.90800 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 7 | 7.71e-01 | 6.36e-02 | 0.96000 |
| GOBP MUSCLE CONTRACTION | 190 | 1.31e-01 | 6.36e-02 | 0.67600 |
| GOBP REGULATION OF MRNA PROCESSING | 107 | 2.57e-01 | -6.35e-02 | 0.77800 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 54 | 4.20e-01 | 6.35e-02 | 0.86400 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 7.88e-01 | 6.35e-02 | 0.96200 |
| GOBP CHIASMA ASSEMBLY | 6 | 7.88e-01 | -6.34e-02 | 0.96200 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 62 | 3.88e-01 | 6.34e-02 | 0.85000 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 54 | 4.21e-01 | 6.34e-02 | 0.86400 |
| GOBP SNRNA 3 END PROCESSING | 21 | 6.15e-01 | -6.34e-02 | 0.91900 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 22 | 6.07e-01 | -6.33e-02 | 0.91700 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 456 | 2.10e-02 | 6.33e-02 | 0.41200 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 136 | 2.03e-01 | 6.33e-02 | 0.73800 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 14 | 6.82e-01 | -6.33e-02 | 0.93400 |
| GOMF QUINONE BINDING | 13 | 6.93e-01 | 6.33e-02 | 0.93700 |
| GOMF PURINE NUCLEOTIDE BINDING | 1527 | 4.76e-05 | 6.33e-02 | 0.05870 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 78 | 3.34e-01 | 6.33e-02 | 0.82200 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 15 | 6.71e-01 | 6.33e-02 | 0.93200 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 7.88e-01 | -6.32e-02 | 0.96200 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 7.72e-01 | 6.32e-02 | 0.96000 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 15 | 6.72e-01 | 6.32e-02 | 0.93200 |
| GOCC ORGANELLE INNER MEMBRANE | 475 | 1.89e-02 | 6.32e-02 | 0.39000 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 5.31e-01 | 6.31e-02 | 0.89700 |
| GOCC BASEMENT MEMBRANE | 35 | 5.18e-01 | 6.31e-02 | 0.89100 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 2.86e-01 | 6.30e-02 | 0.79100 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 5 | 8.07e-01 | 6.30e-02 | 0.96600 |
| GOBP SISTER CHROMATID COHESION | 47 | 4.55e-01 | 6.30e-02 | 0.87500 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 117 | 2.40e-01 | 6.30e-02 | 0.76200 |
| GOBP REGULATION OF CELL DEVELOPMENT | 557 | 1.16e-02 | 6.29e-02 | 0.34500 |
| GOMF GLUTATHIONE BINDING | 7 | 7.73e-01 | 6.28e-02 | 0.96100 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 82 | 3.26e-01 | 6.28e-02 | 0.81700 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 7.31e-01 | 6.28e-02 | 0.95200 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 30 | 5.52e-01 | -6.28e-02 | 0.90100 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 14 | 6.84e-01 | 6.28e-02 | 0.93500 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 6.54e-01 | 6.28e-02 | 0.92800 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 10 | 7.31e-01 | -6.28e-02 | 0.95200 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 336 | 4.88e-02 | 6.27e-02 | 0.51200 |
| GOBP PROTEIN DEACETYLATION | 51 | 4.39e-01 | 6.27e-02 | 0.86900 |
| GOBP LIVER REGENERATION | 18 | 6.45e-01 | -6.27e-02 | 0.92600 |
| GOCC NUCLEAR SPECK | 368 | 3.97e-02 | -6.27e-02 | 0.49000 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 380 | 3.66e-02 | 6.27e-02 | 0.48200 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 7.07e-01 | 6.26e-02 | 0.94300 |
| GOBP REGULATION OF LIPID STORAGE | 40 | 4.94e-01 | -6.26e-02 | 0.88600 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 110 | 2.58e-01 | -6.25e-02 | 0.77800 |
| GOCC CELL BODY | 330 | 5.16e-02 | 6.25e-02 | 0.52400 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 64 | 3.88e-01 | -6.24e-02 | 0.85000 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 54 | 4.28e-01 | 6.24e-02 | 0.86400 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 58 | 4.11e-01 | 6.24e-02 | 0.86000 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 7.91e-01 | 6.24e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 42 | 4.84e-01 | -6.24e-02 | 0.88300 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 16 | 6.66e-01 | -6.24e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 10 | 7.33e-01 | -6.24e-02 | 0.95300 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.09e-01 | -6.24e-02 | 0.96700 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 828 | 2.49e-03 | 6.24e-02 | 0.20500 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 400 | 3.31e-02 | 6.23e-02 | 0.47800 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 25 | 5.90e-01 | 6.23e-02 | 0.91300 |
| GOBP AXONAL TRANSPORT | 51 | 4.42e-01 | -6.23e-02 | 0.87000 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 10 | 7.33e-01 | -6.22e-02 | 0.95300 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 7.47e-01 | 6.22e-02 | 0.95600 |
| GOBP FEAR RESPONSE | 22 | 6.14e-01 | 6.22e-02 | 0.91800 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 114 | 2.52e-01 | -6.22e-02 | 0.77200 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 118 | 2.44e-01 | 6.22e-02 | 0.76600 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 57 | 4.17e-01 | 6.22e-02 | 0.86400 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 13 | 6.98e-01 | 6.22e-02 | 0.93900 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 7.47e-01 | 6.22e-02 | 0.95600 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 9 | 7.47e-01 | -6.22e-02 | 0.95600 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 354 | 4.53e-02 | 6.21e-02 | 0.50300 |
| GOBP RESPONSE TO INSULIN | 199 | 1.31e-01 | 6.21e-02 | 0.67600 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 124 | 2.33e-01 | 6.21e-02 | 0.75600 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 44 | 4.76e-01 | 6.21e-02 | 0.88100 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 24 | 5.99e-01 | -6.21e-02 | 0.91400 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 67 | 3.80e-01 | -6.21e-02 | 0.84400 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 77 | 3.47e-01 | 6.20e-02 | 0.83300 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 11 | 7.22e-01 | -6.20e-02 | 0.94900 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 34 | 5.32e-01 | 6.20e-02 | 0.89700 |
| GOBP PIRNA PROCESSING | 9 | 7.48e-01 | -6.20e-02 | 0.95600 |
| GOBP REGULATION OF MYOBLAST FUSION | 16 | 6.68e-01 | 6.19e-02 | 0.93200 |
| GOCC UBIQUITIN LIGASE COMPLEX | 281 | 7.48e-02 | -6.19e-02 | 0.58200 |
| GOMF PORIN ACTIVITY | 6 | 7.93e-01 | 6.19e-02 | 0.96200 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 232 | 1.05e-01 | 6.19e-02 | 0.63500 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 7.11e-01 | 6.19e-02 | 0.94500 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 54 | 4.32e-01 | 6.19e-02 | 0.86600 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 7.22e-01 | -6.19e-02 | 0.94900 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 98 | 2.90e-01 | -6.19e-02 | 0.79300 |
| GOCC IMMUNOGLOBULIN COMPLEX | 14 | 6.89e-01 | -6.19e-02 | 0.93600 |
| GOBP RESPONSE TO TYPE II INTERFERON | 99 | 2.89e-01 | 6.18e-02 | 0.79300 |
| GOMF ENDONUCLEASE ACTIVITY | 104 | 2.77e-01 | 6.18e-02 | 0.79000 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 25 | 5.93e-01 | 6.18e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 21 | 6.24e-01 | -6.17e-02 | 0.92200 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 450 | 2.54e-02 | 6.17e-02 | 0.43200 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 8 | 7.63e-01 | 6.17e-02 | 0.95800 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 92 | 3.07e-01 | 6.17e-02 | 0.80700 |
| GOBP LIPID CATABOLIC PROCESS | 219 | 1.17e-01 | 6.17e-02 | 0.65700 |
| GOBP CARDIAC MUSCLE CONTRACTION | 79 | 3.44e-01 | 6.16e-02 | 0.82900 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 7.94e-01 | 6.16e-02 | 0.96200 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 197 | 1.37e-01 | 6.16e-02 | 0.68000 |
| GOBP REGULATION OF OSSIFICATION | 73 | 3.63e-01 | -6.16e-02 | 0.83900 |
| GOMF MIRNA BINDING | 33 | 5.41e-01 | -6.16e-02 | 0.89700 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 111 | 2.63e-01 | 6.16e-02 | 0.78300 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 6.51e-01 | 6.15e-02 | 0.92700 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 63 | 3.99e-01 | 6.15e-02 | 0.85600 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 120 | 2.45e-01 | 6.15e-02 | 0.76800 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 10 | 7.36e-01 | -6.15e-02 | 0.95400 |
| GOBP RESPONSE TO PEPTIDE | 349 | 4.92e-02 | 6.15e-02 | 0.51300 |
| GOBP EOSINOPHIL ACTIVATION | 9 | 7.49e-01 | 6.15e-02 | 0.95600 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 102 | 2.84e-01 | 6.15e-02 | 0.79100 |
| GOBP TRABECULA MORPHOGENESIS | 26 | 5.88e-01 | -6.14e-02 | 0.91300 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 46 | 4.72e-01 | 6.14e-02 | 0.88000 |
| GOBP REGULATION OF LIPID TRANSPORT | 77 | 3.52e-01 | -6.14e-02 | 0.83500 |
| GOBP OTOLITH DEVELOPMENT | 6 | 7.95e-01 | 6.13e-02 | 0.96200 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 43 | 4.87e-01 | -6.13e-02 | 0.88300 |
| GOBP RESPONSE TO VITAMIN | 48 | 4.63e-01 | 6.13e-02 | 0.87900 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 13 | 7.02e-01 | 6.13e-02 | 0.94200 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 48 | 4.63e-01 | 6.13e-02 | 0.87900 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 53 | 4.41e-01 | 6.13e-02 | 0.86900 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 7.79e-01 | -6.12e-02 | 0.96100 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 157 | 1.86e-01 | 6.12e-02 | 0.72300 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 34 | 5.37e-01 | 6.12e-02 | 0.89700 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 41 | 4.99e-01 | 6.11e-02 | 0.88600 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 45 | 4.79e-01 | -6.10e-02 | 0.88200 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 19 | 6.46e-01 | -6.09e-02 | 0.92600 |
| GOCC NUCLEOSOME | 34 | 5.39e-01 | 6.09e-02 | 0.89700 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 16 | 6.73e-01 | -6.09e-02 | 0.93200 |
| GOBP MACROPHAGE CHEMOTAXIS | 32 | 5.51e-01 | 6.09e-02 | 0.90100 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 106 | 2.80e-01 | -6.08e-02 | 0.79000 |
| GOBP ELASTIC FIBER ASSEMBLY | 6 | 7.96e-01 | 6.08e-02 | 0.96200 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 5.91e-01 | 6.08e-02 | 0.91300 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 53 | 4.44e-01 | -6.08e-02 | 0.87100 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 8.14e-01 | -6.08e-02 | 0.96800 |
| GOBP PONS DEVELOPMENT | 7 | 7.81e-01 | 6.08e-02 | 0.96100 |
| GOBP MEMBRANE INVAGINATION | 51 | 4.53e-01 | -6.07e-02 | 0.87400 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 57 | 4.28e-01 | 6.07e-02 | 0.86400 |
| GOBP PROTEIN TARGETING | 288 | 7.71e-02 | -6.07e-02 | 0.58600 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 16 | 6.74e-01 | 6.07e-02 | 0.93200 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 27 | 5.86e-01 | 6.06e-02 | 0.91300 |
| GOBP BODY MORPHOGENESIS | 30 | 5.66e-01 | -6.06e-02 | 0.90600 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 91 | 3.18e-01 | 6.06e-02 | 0.81200 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 43 | 4.92e-01 | -6.06e-02 | 0.88500 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 7.28e-01 | 6.06e-02 | 0.95100 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 7.82e-01 | -6.05e-02 | 0.96200 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 171 | 1.73e-01 | 6.05e-02 | 0.71500 |
| GOCC NEURON PROJECTION CYTOPLASM | 66 | 3.96e-01 | -6.05e-02 | 0.85400 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 9 | 7.53e-01 | 6.05e-02 | 0.95600 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 28 | 5.80e-01 | 6.04e-02 | 0.91000 |
| GOCC KERATIN FILAMENT | 8 | 7.67e-01 | 6.04e-02 | 0.95900 |
| GOMF CHEMOKINE RECEPTOR BINDING | 28 | 5.80e-01 | 6.04e-02 | 0.91100 |
| GOBP TELOMERE LOCALIZATION | 7 | 7.82e-01 | 6.04e-02 | 0.96200 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 84 | 3.39e-01 | -6.04e-02 | 0.82700 |
| GOCC ESCRT COMPLEX | 25 | 6.01e-01 | -6.04e-02 | 0.91500 |
| GOBP NEURON REMODELING | 8 | 7.68e-01 | -6.04e-02 | 0.95900 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 5.61e-01 | 6.03e-02 | 0.90500 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 54 | 4.44e-01 | 6.03e-02 | 0.87100 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 6.41e-01 | -6.03e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION | 5 | 8.16e-01 | -6.03e-02 | 0.96800 |
| GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL | 7 | 7.83e-01 | 6.02e-02 | 0.96200 |
| GOBP LACTATE METABOLIC PROCESS | 14 | 6.97e-01 | 6.02e-02 | 0.93800 |
| GOCC NUCLEAR PERIPHERY | 133 | 2.32e-01 | 6.01e-02 | 0.75600 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 116 | 2.64e-01 | 6.01e-02 | 0.78300 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 174 | 1.72e-01 | 6.01e-02 | 0.71400 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 20 | 6.42e-01 | -6.01e-02 | 0.92400 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 7.30e-01 | -6.01e-02 | 0.95200 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 34 | 5.45e-01 | 6.00e-02 | 0.89900 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 8.16e-01 | -6.00e-02 | 0.96800 |
| GOCC CYTOPLASMIC STRESS GRANULE | 78 | 3.60e-01 | -6.00e-02 | 0.83800 |
| GOBP REGULATION OF XENOPHAGY | 9 | 7.55e-01 | -6.00e-02 | 0.95600 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 7.69e-01 | -5.99e-02 | 0.95900 |
| GOBP OSSIFICATION | 244 | 1.08e-01 | 5.99e-02 | 0.63700 |
| GOBP REGULATION OF CHEMOTAXIS | 147 | 2.10e-01 | 5.99e-02 | 0.73900 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 12 | 7.20e-01 | 5.99e-02 | 0.94900 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 7.43e-01 | -5.98e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 6.12e-01 | 5.98e-02 | 0.91800 |
| GOBP RNA 3 END PROCESSING | 89 | 3.30e-01 | -5.98e-02 | 0.81800 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 11 | 7.32e-01 | 5.97e-02 | 0.95200 |
| GOBP SNO S RNA PROCESSING | 12 | 7.20e-01 | -5.97e-02 | 0.94900 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 5 | 8.17e-01 | -5.97e-02 | 0.96800 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 15 | 6.89e-01 | -5.97e-02 | 0.93700 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 99 | 3.06e-01 | 5.96e-02 | 0.80600 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 17 | 6.70e-01 | 5.96e-02 | 0.93200 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 13 | 7.10e-01 | 5.96e-02 | 0.94400 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 7 | 7.85e-01 | 5.96e-02 | 0.96200 |
| GOBP PROSTATE GLAND DEVELOPMENT | 26 | 5.99e-01 | -5.95e-02 | 0.91400 |
| GOBP KERATINOCYTE PROLIFERATION | 27 | 5.92e-01 | 5.95e-02 | 0.91300 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 255 | 1.03e-01 | 5.95e-02 | 0.63000 |
| GOBP FOLIC ACID TRANSPORT | 7 | 7.85e-01 | -5.95e-02 | 0.96200 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 7.57e-01 | -5.95e-02 | 0.95600 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 13 | 7.11e-01 | 5.95e-02 | 0.94500 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 112 | 2.78e-01 | -5.94e-02 | 0.79000 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 51 | 4.63e-01 | 5.94e-02 | 0.87900 |
| GOBP PROTEIN DEPHOSPHORYLATION | 165 | 1.89e-01 | 5.93e-02 | 0.72900 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 141 | 2.25e-01 | -5.93e-02 | 0.75100 |
| GOBP LAMELLIPODIUM ORGANIZATION | 70 | 3.91e-01 | 5.93e-02 | 0.85300 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 8 | 7.72e-01 | -5.93e-02 | 0.96000 |
| GOBP CALCIUM ION HOMEOSTASIS | 191 | 1.59e-01 | 5.92e-02 | 0.69900 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 29 | 5.81e-01 | -5.92e-02 | 0.91100 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 749 | 6.17e-03 | 5.92e-02 | 0.27000 |
| GOBP RESPONSE TO HORMONE | 558 | 1.75e-02 | 5.91e-02 | 0.38400 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 8.19e-01 | 5.91e-02 | 0.96900 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 18 | 6.64e-01 | -5.91e-02 | 0.93200 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 7.87e-01 | 5.91e-02 | 0.96200 |
| GOBP BLASTOCYST FORMATION | 32 | 5.63e-01 | -5.91e-02 | 0.90600 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 30 | 5.76e-01 | 5.91e-02 | 0.90800 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 8 | 7.72e-01 | -5.91e-02 | 0.96000 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 7.12e-01 | -5.90e-02 | 0.94500 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 163 | 1.94e-01 | 5.90e-02 | 0.73300 |
| GOBP TRNA 5 END PROCESSING | 16 | 6.83e-01 | 5.90e-02 | 0.93400 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 742 | 6.64e-03 | 5.90e-02 | 0.27800 |
| GOBP REGULATION OF METAL ION TRANSPORT | 225 | 1.28e-01 | 5.89e-02 | 0.67500 |
| GOMF PROFILIN BINDING | 8 | 7.73e-01 | -5.89e-02 | 0.96000 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 7.24e-01 | 5.89e-02 | 0.94900 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 94 | 3.24e-01 | 5.89e-02 | 0.81500 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 6 | 8.03e-01 | 5.89e-02 | 0.96400 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 11 | 7.35e-01 | 5.89e-02 | 0.95400 |
| GOMF HISTONE DEACETYLASE BINDING | 93 | 3.27e-01 | -5.89e-02 | 0.81700 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 20 | 6.49e-01 | -5.89e-02 | 0.92700 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 34 | 5.53e-01 | -5.89e-02 | 0.90100 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 25 | 6.11e-01 | 5.89e-02 | 0.91800 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 6.66e-01 | 5.89e-02 | 0.93200 |
| GOBP REGULATION OF DNA RECOMBINATION | 114 | 2.79e-01 | 5.88e-02 | 0.79000 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 34 | 5.53e-01 | -5.88e-02 | 0.90100 |
| GOBP RESPONSE TO NUTRIENT | 94 | 3.25e-01 | 5.88e-02 | 0.81600 |
| GOBP REGULATION OF PHAGOCYTOSIS | 72 | 3.89e-01 | 5.87e-02 | 0.85100 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 14 | 7.04e-01 | 5.87e-02 | 0.94200 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 10 | 7.48e-01 | -5.87e-02 | 0.95600 |
| GOMF CALMODULIN BINDING | 127 | 2.54e-01 | 5.87e-02 | 0.77600 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 936 | 2.57e-03 | 5.87e-02 | 0.20500 |
| GOBP PROTEIN STABILIZATION | 174 | 1.83e-01 | -5.87e-02 | 0.72100 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 109 | 2.90e-01 | 5.87e-02 | 0.79300 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 22 | 6.34e-01 | 5.87e-02 | 0.92400 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 7.04e-01 | -5.87e-02 | 0.94200 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 136 | 2.38e-01 | -5.87e-02 | 0.76200 |
| GOBP RESPONSE TO STEROID HORMONE | 218 | 1.36e-01 | 5.86e-02 | 0.68000 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 11 | 7.36e-01 | -5.86e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 6.94e-01 | -5.86e-02 | 0.93800 |
| GOMF CARD DOMAIN BINDING | 15 | 6.94e-01 | 5.86e-02 | 0.93800 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 42 | 5.12e-01 | -5.86e-02 | 0.89000 |
| GOMF KINASE ACTIVITY | 577 | 1.68e-02 | 5.85e-02 | 0.37900 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 7.61e-01 | -5.85e-02 | 0.95700 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 16 | 6.85e-01 | 5.85e-02 | 0.93500 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 29 | 5.86e-01 | 5.85e-02 | 0.91300 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 24 | 6.20e-01 | -5.84e-02 | 0.92100 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 175 | 1.83e-01 | -5.84e-02 | 0.72100 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 76 | 3.79e-01 | 5.84e-02 | 0.84400 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 8 | 7.75e-01 | 5.84e-02 | 0.96100 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 72 | 3.92e-01 | 5.84e-02 | 0.85300 |
| GOBP CMP METABOLIC PROCESS | 7 | 7.89e-01 | -5.84e-02 | 0.96200 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1101 | 1.23e-03 | 5.84e-02 | 0.17900 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 42 | 5.13e-01 | 5.83e-02 | 0.89100 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 221 | 1.36e-01 | -5.83e-02 | 0.68000 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1031 | 1.73e-03 | 5.83e-02 | 0.19300 |
| GOBP ADAPTIVE THERMOGENESIS | 122 | 2.67e-01 | -5.83e-02 | 0.78400 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 6.52e-01 | 5.83e-02 | 0.92700 |
| GOBP GLIAL CELL ACTIVATION | 38 | 5.34e-01 | 5.83e-02 | 0.89700 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 40 | 5.24e-01 | -5.82e-02 | 0.89200 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 7.76e-01 | -5.82e-02 | 0.96100 |
| GOBP RETINAL CONE CELL DIFFERENTIATION | 5 | 8.22e-01 | -5.81e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 38 | 5.35e-01 | -5.81e-02 | 0.89700 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 51 | 4.73e-01 | -5.81e-02 | 0.88000 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 7.90e-01 | 5.81e-02 | 0.96200 |
| GOCC CYTOPLASMIC MICROTUBULE | 68 | 4.08e-01 | -5.81e-02 | 0.85800 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 99 | 3.19e-01 | 5.81e-02 | 0.81300 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 8.05e-01 | 5.81e-02 | 0.96600 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 13 | 7.17e-01 | -5.81e-02 | 0.94800 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 7.39e-01 | 5.80e-02 | 0.95400 |
| GOMF CARBON CARBON LYASE ACTIVITY | 36 | 5.47e-01 | -5.80e-02 | 0.89900 |
| GOBP INCLUSION BODY ASSEMBLY | 18 | 6.70e-01 | 5.80e-02 | 0.93200 |
| GOBP RESPONSE TO RADIATION | 314 | 7.81e-02 | 5.80e-02 | 0.58900 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 23 | 6.30e-01 | -5.80e-02 | 0.92400 |
| GOBP NEPHRON DEVELOPMENT | 70 | 4.02e-01 | 5.80e-02 | 0.85600 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 50 | 4.78e-01 | 5.80e-02 | 0.88200 |
| GOBP AMP SALVAGE | 5 | 8.23e-01 | 5.79e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 109 | 2.97e-01 | 5.79e-02 | 0.80000 |
| GOBP ENDOSOME ORGANIZATION | 86 | 3.54e-01 | -5.79e-02 | 0.83600 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 6.17e-01 | -5.79e-02 | 0.91900 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 12 | 7.29e-01 | 5.79e-02 | 0.95100 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 9 | 7.64e-01 | -5.78e-02 | 0.95900 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 53 | 4.67e-01 | 5.78e-02 | 0.87900 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 22 | 6.39e-01 | 5.78e-02 | 0.92400 |
| GOBP REGULATION OF BODY FLUID LEVELS | 224 | 1.37e-01 | -5.78e-02 | 0.68000 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 110 | 2.96e-01 | -5.78e-02 | 0.79900 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 161 | 2.07e-01 | 5.77e-02 | 0.73900 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 27 | 6.04e-01 | -5.77e-02 | 0.91600 |
| GOMF RRNA BINDING | 63 | 4.29e-01 | -5.77e-02 | 0.86400 |
| GOCC SPECIFIC GRANULE LUMEN | 48 | 4.90e-01 | -5.77e-02 | 0.88500 |
| GOBP CELLULAR RESPONSE TO VIRUS | 46 | 4.99e-01 | -5.76e-02 | 0.88600 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 6 | 8.07e-01 | -5.76e-02 | 0.96600 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1310 | 5.54e-04 | 5.76e-02 | 0.11600 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 7.41e-01 | 5.75e-02 | 0.95400 |
| GOBP RESPONSE TO ANTIBIOTIC | 32 | 5.73e-01 | 5.75e-02 | 0.90800 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 8 | 7.78e-01 | -5.75e-02 | 0.96100 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 107 | 3.05e-01 | 5.75e-02 | 0.80600 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 6.64e-01 | -5.75e-02 | 0.93200 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 150 | 2.25e-01 | 5.74e-02 | 0.75100 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 213 | 1.49e-01 | 5.74e-02 | 0.69000 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 6 | 8.08e-01 | 5.74e-02 | 0.96600 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1227 | 8.24e-04 | 5.74e-02 | 0.13200 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 48 | 4.92e-01 | -5.74e-02 | 0.88500 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 4.24e-01 | 5.74e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 7.42e-01 | -5.73e-02 | 0.95400 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 36 | 5.52e-01 | -5.73e-02 | 0.90100 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 32 | 5.75e-01 | -5.73e-02 | 0.90800 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 8.24e-01 | -5.73e-02 | 0.97100 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 8.24e-01 | -5.73e-02 | 0.97100 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 13 | 7.21e-01 | -5.73e-02 | 0.94900 |
| GOBP REGULATION OF CELL SHAPE | 105 | 3.11e-01 | -5.73e-02 | 0.80800 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 33 | 5.69e-01 | -5.72e-02 | 0.90700 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 7.79e-01 | 5.72e-02 | 0.96100 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 22 | 6.42e-01 | 5.72e-02 | 0.92400 |
| GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT | 5 | 8.25e-01 | -5.72e-02 | 0.97100 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 11 | 7.43e-01 | -5.72e-02 | 0.95400 |
| GOCC MICROBODY | 117 | 2.87e-01 | 5.71e-02 | 0.79100 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 7.43e-01 | -5.71e-02 | 0.95400 |
| GOCC POSTSYNAPTIC ENDOSOME | 10 | 7.55e-01 | 5.71e-02 | 0.95600 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 6.75e-01 | 5.71e-02 | 0.93200 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 16 | 6.93e-01 | 5.71e-02 | 0.93700 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 33 | 5.71e-01 | -5.71e-02 | 0.90800 |
| GOBP PROTEIN ACYLATION | 119 | 2.83e-01 | -5.70e-02 | 0.79100 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1088 | 1.68e-03 | 5.70e-02 | 0.19300 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 29 | 5.96e-01 | 5.70e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 13 | 7.22e-01 | -5.70e-02 | 0.94900 |
| GOBP CELL CYCLE PROCESS | 1000 | 2.55e-03 | 5.70e-02 | 0.20500 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 643 | 1.44e-02 | 5.69e-02 | 0.37200 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 77 | 3.88e-01 | 5.69e-02 | 0.85000 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 7 | 7.94e-01 | -5.69e-02 | 0.96200 |
| GOBP OXIDATIVE PHOSPHORYLATION | 130 | 2.63e-01 | 5.69e-02 | 0.78300 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 17 | 6.85e-01 | -5.69e-02 | 0.93500 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 535 | 2.53e-02 | 5.68e-02 | 0.43200 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 7 | 7.95e-01 | -5.68e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 50 | 4.87e-01 | -5.68e-02 | 0.88300 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 23 | 6.37e-01 | -5.68e-02 | 0.92400 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 8.10e-01 | 5.67e-02 | 0.96700 |
| GOMF EPHRIN RECEPTOR ACTIVITY | 7 | 7.95e-01 | 5.67e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 16 | 6.95e-01 | -5.67e-02 | 0.93800 |
| GOBP T CELL DIFFERENTIATION | 247 | 1.26e-01 | 5.67e-02 | 0.67300 |
| GOCC TRAPP COMPLEX | 15 | 7.04e-01 | 5.66e-02 | 0.94200 |
| GOCC ACTOMYOSIN | 57 | 4.60e-01 | 5.66e-02 | 0.87700 |
| GOMF FERROUS IRON BINDING | 20 | 6.61e-01 | -5.66e-02 | 0.93200 |
| GOBP MACROPHAGE DIFFERENTIATION | 46 | 5.07e-01 | -5.66e-02 | 0.88800 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 446 | 4.14e-02 | 5.66e-02 | 0.49700 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 28 | 6.04e-01 | 5.66e-02 | 0.91600 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 61 | 4.45e-01 | -5.66e-02 | 0.87300 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 7.35e-01 | 5.65e-02 | 0.95300 |
| GOBP MITOCHONDRION MORPHOGENESIS | 20 | 6.62e-01 | -5.64e-02 | 0.93200 |
| GOMF OPSONIN BINDING | 9 | 7.69e-01 | 5.64e-02 | 0.95900 |
| GOMF NUCLEOSIDE BINDING | 7 | 7.96e-01 | -5.64e-02 | 0.96200 |
| GOCC MITOCHONDRIAL ENVELOPE | 686 | 1.24e-02 | 5.64e-02 | 0.35700 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 19 | 6.70e-01 | 5.64e-02 | 0.93200 |
| GOBP NADP METABOLIC PROCESS | 38 | 5.48e-01 | 5.64e-02 | 0.90000 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 8.27e-01 | 5.64e-02 | 0.97100 |
| GOBP OOCYTE MATURATION | 17 | 6.88e-01 | -5.64e-02 | 0.93600 |
| GOCC MICROTUBULE | 338 | 7.63e-02 | 5.63e-02 | 0.58500 |
| GOBP L LYSINE TRANSPORT | 5 | 8.28e-01 | -5.62e-02 | 0.97100 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.28e-01 | -5.62e-02 | 0.97100 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 431 | 4.62e-02 | -5.62e-02 | 0.50700 |
| GOMF PROTEIN KINASE ACTIVITY | 440 | 4.43e-02 | 5.62e-02 | 0.50300 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 9 | 7.71e-01 | 5.62e-02 | 0.96000 |
| GOBP MEMBRANE FUSION | 131 | 2.68e-01 | -5.61e-02 | 0.78500 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 151 | 2.35e-01 | -5.61e-02 | 0.75900 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 65 | 4.34e-01 | 5.61e-02 | 0.86600 |
| GOCC VESICLE MEMBRANE | 911 | 4.43e-03 | -5.61e-02 | 0.24700 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 7.71e-01 | 5.61e-02 | 0.96000 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 48 | 5.02e-01 | 5.61e-02 | 0.88700 |
| GOBP POSITIVE T CELL SELECTION | 34 | 5.72e-01 | -5.61e-02 | 0.90800 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 67 | 4.28e-01 | -5.61e-02 | 0.86400 |
| GOCC TUBULAR ENDOSOME | 5 | 8.28e-01 | -5.60e-02 | 0.97100 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 121 | 2.88e-01 | -5.60e-02 | 0.79300 |
| GOBP CELLULAR RESPONSE TO HEAT | 54 | 4.77e-01 | 5.60e-02 | 0.88100 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 39 | 5.45e-01 | -5.60e-02 | 0.89900 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 84 | 3.76e-01 | 5.60e-02 | 0.84200 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 11 | 7.48e-01 | -5.60e-02 | 0.95600 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 25 | 6.29e-01 | -5.59e-02 | 0.92400 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 31 | 5.91e-01 | 5.59e-02 | 0.91300 |
| GOBP LIPID OXIDATION | 89 | 3.63e-01 | 5.58e-02 | 0.83900 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 9 | 7.72e-01 | -5.57e-02 | 0.96000 |
| GOBP MICROTUBULE ANCHORING | 19 | 6.74e-01 | 5.57e-02 | 0.93200 |
| GOBP MAPK CASCADE | 486 | 3.65e-02 | 5.56e-02 | 0.48200 |
| GOBP CYTOKINE PRODUCTION | 579 | 2.30e-02 | 5.56e-02 | 0.42100 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 112 | 3.10e-01 | -5.56e-02 | 0.80800 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 6.04e-01 | 5.56e-02 | 0.91600 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 30 | 5.98e-01 | -5.56e-02 | 0.91400 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 331 | 8.31e-02 | 5.56e-02 | 0.60000 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 7.50e-01 | -5.56e-02 | 0.95600 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 256 | 1.27e-01 | 5.55e-02 | 0.67300 |
| GOBP ERYTHROCYTE DEVELOPMENT | 29 | 6.05e-01 | -5.55e-02 | 0.91600 |
| GOMF LNCRNA BINDING | 12 | 7.40e-01 | -5.54e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 36 | 5.65e-01 | -5.54e-02 | 0.90600 |
| GOBP UBIQUITIN RECYCLING | 11 | 7.50e-01 | 5.54e-02 | 0.95600 |
| GOBP HEART GROWTH | 47 | 5.11e-01 | -5.54e-02 | 0.89000 |
| GOBP ALPHA BETA T CELL ACTIVATION | 148 | 2.46e-01 | 5.54e-02 | 0.76800 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 62 | 4.51e-01 | -5.54e-02 | 0.87400 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 41 | 5.40e-01 | 5.53e-02 | 0.89700 |
| GOBP CARDIAC CELL FATE COMMITMENT | 5 | 8.31e-01 | -5.52e-02 | 0.97100 |
| GOCC DENDRITIC TREE | 369 | 6.95e-02 | 5.52e-02 | 0.57400 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 7.87e-01 | -5.51e-02 | 0.96200 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 8.31e-01 | -5.51e-02 | 0.97100 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 85 | 3.80e-01 | -5.51e-02 | 0.84400 |
| GOBP INTESTINAL LIPID ABSORPTION | 7 | 8.01e-01 | 5.51e-02 | 0.96400 |
| GOCC RIBOSOME | 221 | 1.59e-01 | -5.51e-02 | 0.69900 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 644 | 1.77e-02 | 5.51e-02 | 0.38600 |
| GOBP BICARBONATE TRANSPORT | 21 | 6.62e-01 | 5.51e-02 | 0.93200 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 7.63e-01 | -5.51e-02 | 0.95800 |
| GOBP INTERLEUKIN 6 PRODUCTION | 117 | 3.04e-01 | 5.51e-02 | 0.80600 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 76 | 4.07e-01 | -5.51e-02 | 0.85800 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 14 | 7.21e-01 | -5.50e-02 | 0.94900 |
| GOCC SPERM CONNECTING PIECE | 5 | 8.31e-01 | 5.50e-02 | 0.97100 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 823 | 7.85e-03 | 5.50e-02 | 0.29400 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 26 | 6.28e-01 | 5.50e-02 | 0.92400 |
| GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 7 | 8.01e-01 | 5.49e-02 | 0.96400 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 20 | 6.71e-01 | 5.48e-02 | 0.93200 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 40 | 5.49e-01 | -5.48e-02 | 0.90000 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 22 | 6.56e-01 | -5.48e-02 | 0.93000 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 148 | 2.50e-01 | 5.48e-02 | 0.77100 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 75 | 4.12e-01 | 5.48e-02 | 0.86000 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 20 | 6.71e-01 | -5.48e-02 | 0.93200 |
| GOBP IMMUNE EFFECTOR PROCESS | 462 | 4.45e-02 | 5.48e-02 | 0.50300 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 8.32e-01 | -5.48e-02 | 0.97100 |
| GOBP MICROTUBULE NUCLEATION | 43 | 5.35e-01 | 5.48e-02 | 0.89700 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 7.43e-01 | -5.47e-02 | 0.95400 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 128 | 2.86e-01 | -5.47e-02 | 0.79100 |
| GOBP DEPYRIMIDINATION | 8 | 7.89e-01 | 5.47e-02 | 0.96200 |
| GOMF COA HYDROLASE ACTIVITY | 14 | 7.23e-01 | 5.47e-02 | 0.94900 |
| GOCC SEX CHROMATIN | 5 | 8.32e-01 | 5.46e-02 | 0.97100 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 15 | 7.14e-01 | -5.46e-02 | 0.94600 |
| GOBP DIGESTIVE SYSTEM PROCESS | 44 | 5.31e-01 | -5.46e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 80 | 3.99e-01 | -5.46e-02 | 0.85600 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 9 | 7.77e-01 | 5.46e-02 | 0.96100 |
| GOCC T CELL RECEPTOR COMPLEX | 16 | 7.05e-01 | -5.46e-02 | 0.94200 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 51 | 5.01e-01 | 5.46e-02 | 0.88600 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 7.33e-01 | 5.46e-02 | 0.95300 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 25 | 6.37e-01 | -5.45e-02 | 0.92400 |
| GOMF SNARE BINDING | 79 | 4.02e-01 | -5.45e-02 | 0.85600 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 8.17e-01 | 5.44e-02 | 0.96800 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 7.44e-01 | -5.44e-02 | 0.95400 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 47 | 5.19e-01 | -5.44e-02 | 0.89100 |
| GOBP DAMP METABOLIC PROCESS | 5 | 8.33e-01 | -5.44e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 8.33e-01 | -5.44e-02 | 0.97100 |
| GOMF SYMPORTER ACTIVITY | 76 | 4.13e-01 | 5.44e-02 | 0.86000 |
| GOBP AGGREPHAGY | 8 | 7.90e-01 | -5.44e-02 | 0.96200 |
| GOBP RESPONSE TO TUMOR CELL | 33 | 5.89e-01 | 5.43e-02 | 0.91300 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 273 | 1.24e-01 | 5.43e-02 | 0.67100 |
| GOBP MONONUCLEAR CELL MIGRATION | 134 | 2.79e-01 | 5.43e-02 | 0.79000 |
| GOBP REGULATION OF BEHAVIOR | 38 | 5.63e-01 | 5.43e-02 | 0.90600 |
| GOBP PEPTIDYL SERINE MODIFICATION | 224 | 1.63e-01 | 5.42e-02 | 0.70300 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 7.91e-01 | 5.42e-02 | 0.96200 |
| GOBP VIRAL GENOME REPLICATION | 113 | 3.20e-01 | 5.42e-02 | 0.81400 |
| GOCC CILIARY PLASM | 88 | 3.80e-01 | 5.42e-02 | 0.84400 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 45 | 5.30e-01 | 5.42e-02 | 0.89600 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 5.90e-01 | -5.41e-02 | 0.91300 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 8 | 7.91e-01 | 5.41e-02 | 0.96200 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 64 | 4.55e-01 | 5.41e-02 | 0.87500 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 24 | 6.47e-01 | -5.41e-02 | 0.92600 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 70 | 4.35e-01 | 5.40e-02 | 0.86600 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 8.19e-01 | 5.40e-02 | 0.96900 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 92 | 3.71e-01 | 5.40e-02 | 0.84100 |
| GOBP AXIS ELONGATION | 11 | 7.56e-01 | 5.40e-02 | 0.95600 |
| GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 5 | 8.34e-01 | 5.40e-02 | 0.97100 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.68e-01 | -5.40e-02 | 0.95900 |
| GOBP CERAMIDE TRANSPORT | 12 | 7.46e-01 | -5.40e-02 | 0.95600 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 22 | 6.61e-01 | -5.39e-02 | 0.93200 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 134 | 2.82e-01 | -5.39e-02 | 0.79000 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 29 | 6.15e-01 | -5.39e-02 | 0.91900 |
| GOBP FIBROBLAST MIGRATION | 43 | 5.41e-01 | -5.39e-02 | 0.89700 |
| GOMF PROTEASOME BINDING | 15 | 7.18e-01 | 5.39e-02 | 0.94800 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 8.35e-01 | 5.39e-02 | 0.97100 |
| GOBP NEUROMUSCULAR PROCESS | 88 | 3.83e-01 | -5.39e-02 | 0.84500 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 82 | 4.00e-01 | -5.39e-02 | 0.85600 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 28 | 6.22e-01 | 5.38e-02 | 0.92100 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 168 | 2.29e-01 | 5.38e-02 | 0.75400 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 6.85e-01 | 5.38e-02 | 0.93500 |
| GOBP PROTEIN OXIDATION | 8 | 7.92e-01 | -5.38e-02 | 0.96200 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 48 | 5.19e-01 | 5.38e-02 | 0.89100 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 762 | 1.22e-02 | 5.38e-02 | 0.35400 |
| GOBP POSITIVE CHEMOTAXIS | 32 | 5.99e-01 | -5.37e-02 | 0.91400 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 278 | 1.24e-01 | 5.37e-02 | 0.67200 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 8.20e-01 | 5.37e-02 | 0.97000 |
| GOBP STEROL TRANSPORT | 81 | 4.04e-01 | -5.37e-02 | 0.85600 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 401 | 6.62e-02 | 5.37e-02 | 0.56500 |
| GOBP REGULATION OF EXOCYTOSIS | 135 | 2.82e-01 | -5.37e-02 | 0.79000 |
| GOBP TOXIN METABOLIC PROCESS | 5 | 8.35e-01 | -5.36e-02 | 0.97100 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 17 | 7.02e-01 | -5.36e-02 | 0.94200 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 6 | 8.20e-01 | 5.36e-02 | 0.97000 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 26 | 6.36e-01 | -5.36e-02 | 0.92400 |
| GOBP MALE SEX DIFFERENTIATION | 95 | 3.67e-01 | -5.36e-02 | 0.84000 |
| GOBP LAMELLIPODIUM ASSEMBLY | 53 | 5.00e-01 | 5.36e-02 | 0.88600 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 25 | 6.43e-01 | 5.36e-02 | 0.92500 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 5.39e-01 | 5.35e-02 | 0.89700 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 21 | 6.71e-01 | -5.35e-02 | 0.93200 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 8.36e-01 | -5.35e-02 | 0.97100 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 13 | 7.39e-01 | -5.35e-02 | 0.95400 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 24 | 6.51e-01 | 5.34e-02 | 0.92700 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 25 | 6.44e-01 | 5.34e-02 | 0.92500 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 6 | 8.21e-01 | 5.34e-02 | 0.97000 |
| GOMF ENZYME REGULATOR ACTIVITY | 933 | 6.16e-03 | 5.34e-02 | 0.27000 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 15 | 7.20e-01 | 5.34e-02 | 0.94900 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 25 | 6.44e-01 | -5.34e-02 | 0.92500 |
| GOBP REGULATION OF MYELINATION | 30 | 6.13e-01 | -5.34e-02 | 0.91800 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 13 | 7.39e-01 | -5.34e-02 | 0.95400 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 34 | 5.91e-01 | -5.33e-02 | 0.91300 |
| GOCC TIGHT JUNCTION | 70 | 4.41e-01 | 5.33e-02 | 0.86900 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 46 | 5.32e-01 | -5.33e-02 | 0.89700 |
| GOCC MICROTUBULE CYTOSKELETON | 1072 | 3.57e-03 | 5.33e-02 | 0.22500 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 8.07e-01 | -5.32e-02 | 0.96600 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 160 | 2.46e-01 | -5.32e-02 | 0.76800 |
| GOBP BLASTOCYST GROWTH | 17 | 7.04e-01 | 5.32e-02 | 0.94200 |
| GOCC PRESYNAPTIC MEMBRANE | 81 | 4.08e-01 | -5.32e-02 | 0.85800 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 9 | 7.82e-01 | -5.32e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 213 | 1.82e-01 | 5.31e-02 | 0.72100 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 5.04e-01 | 5.31e-02 | 0.88800 |
| GOBP LEUKOCYTE DIFFERENTIATION | 466 | 5.06e-02 | 5.31e-02 | 0.52200 |
| GOBP RESPONSE TO CARBOHYDRATE | 140 | 2.79e-01 | 5.31e-02 | 0.79000 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 22 | 6.67e-01 | 5.30e-02 | 0.93200 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 7.05e-01 | -5.30e-02 | 0.94200 |
| GOMF PROTEIN FOLDING CHAPERONE | 48 | 5.25e-01 | 5.30e-02 | 0.89300 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 147 | 2.68e-01 | 5.30e-02 | 0.78500 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 7.95e-01 | -5.30e-02 | 0.96200 |
| GOBP AXONEME ASSEMBLY | 39 | 5.67e-01 | 5.29e-02 | 0.90600 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 7.96e-01 | 5.29e-02 | 0.96200 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 7 | 8.09e-01 | -5.29e-02 | 0.96700 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 8.38e-01 | 5.28e-02 | 0.97200 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 7.96e-01 | 5.28e-02 | 0.96200 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 62 | 4.72e-01 | 5.28e-02 | 0.88000 |
| GOBP REGULATION OF LIPID LOCALIZATION | 99 | 3.64e-01 | -5.28e-02 | 0.83900 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 5 | 8.38e-01 | 5.28e-02 | 0.97200 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 7.52e-01 | -5.28e-02 | 0.95600 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 527 | 3.93e-02 | 5.27e-02 | 0.48900 |
| GOBP RNA SPLICING | 408 | 6.90e-02 | -5.27e-02 | 0.57400 |
| GOBP HYPEROSMOTIC RESPONSE | 20 | 6.84e-01 | 5.27e-02 | 0.93400 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 13 | 7.43e-01 | -5.26e-02 | 0.95400 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 295 | 1.21e-01 | 5.26e-02 | 0.66700 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 13 | 7.43e-01 | 5.26e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 22 | 6.70e-01 | -5.26e-02 | 0.93200 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 7.53e-01 | 5.26e-02 | 0.95600 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 20 | 6.84e-01 | 5.26e-02 | 0.93500 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 8.39e-01 | 5.25e-02 | 0.97200 |
| GOMF EXOGENOUS PROTEIN BINDING | 56 | 4.97e-01 | 5.25e-02 | 0.88600 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 345 | 9.51e-02 | 5.25e-02 | 0.61900 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 49 | 5.25e-01 | -5.25e-02 | 0.89300 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 30 | 6.19e-01 | -5.25e-02 | 0.92100 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 21 | 6.77e-01 | 5.24e-02 | 0.93200 |
| GOMF PROTON CHANNEL ACTIVITY | 19 | 6.92e-01 | 5.24e-02 | 0.93700 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 164 | 2.48e-01 | 5.24e-02 | 0.76800 |
| GOBP WATER TRANSPORT | 8 | 7.98e-01 | 5.23e-02 | 0.96300 |
| GOBP DUMP METABOLIC PROCESS | 6 | 8.24e-01 | 5.23e-02 | 0.97100 |
| GOBP MEMBRANE BIOGENESIS | 50 | 5.22e-01 | -5.23e-02 | 0.89200 |
| GOBP INTERLEUKIN 13 PRODUCTION | 12 | 7.54e-01 | 5.23e-02 | 0.95600 |
| GOCC AZUROPHIL GRANULE LUMEN | 78 | 4.25e-01 | 5.23e-02 | 0.86400 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 70 | 4.50e-01 | 5.23e-02 | 0.87300 |
| GOBP SISTER CHROMATID SEGREGATION | 185 | 2.21e-01 | 5.23e-02 | 0.75000 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 12 | 7.54e-01 | -5.23e-02 | 0.95600 |
| GOBP ACTIN FILAMENT BASED PROCESS | 543 | 3.82e-02 | 5.23e-02 | 0.48400 |
| GOBP REGULATION OF RESPONSE TO FOOD | 8 | 7.98e-01 | 5.23e-02 | 0.96300 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 16 | 7.18e-01 | -5.22e-02 | 0.94800 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 7.75e-01 | -5.22e-02 | 0.96100 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 7.26e-01 | -5.22e-02 | 0.95100 |
| GOBP NEGATIVE REGULATION OF GROWTH | 160 | 2.55e-01 | -5.22e-02 | 0.77700 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 415 | 6.92e-02 | 5.22e-02 | 0.57400 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 7.75e-01 | 5.22e-02 | 0.96100 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 97 | 3.75e-01 | -5.22e-02 | 0.84200 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 251 | 1.56e-01 | -5.22e-02 | 0.69300 |
| GOBP THYMUS DEVELOPMENT | 34 | 5.99e-01 | -5.21e-02 | 0.91400 |
| GOCC CLEAVAGE FURROW | 46 | 5.41e-01 | 5.21e-02 | 0.89700 |
| GOBP GDP METABOLIC PROCESS | 11 | 7.65e-01 | 5.21e-02 | 0.95900 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 140 | 2.88e-01 | 5.21e-02 | 0.79300 |
| GOMF HSP70 PROTEIN BINDING | 39 | 5.74e-01 | -5.21e-02 | 0.90800 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 22 | 6.73e-01 | 5.21e-02 | 0.93200 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 262 | 1.48e-01 | 5.20e-02 | 0.68800 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 35 | 5.94e-01 | -5.20e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 7.87e-01 | 5.20e-02 | 0.96200 |
| GOBP CD40 SIGNALING PATHWAY | 13 | 7.46e-01 | -5.20e-02 | 0.95500 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 39 | 5.75e-01 | -5.20e-02 | 0.90800 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 7 | 8.12e-01 | -5.19e-02 | 0.96800 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 100 | 3.70e-01 | 5.19e-02 | 0.84000 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 12 | 7.56e-01 | -5.19e-02 | 0.95600 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 17 | 7.11e-01 | 5.19e-02 | 0.94500 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 36 | 5.90e-01 | 5.19e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 377 | 8.52e-02 | 5.18e-02 | 0.60400 |
| GOBP REGULATION OF CYTOKINESIS | 65 | 4.70e-01 | 5.18e-02 | 0.88000 |
| GOCC U2 SNRNP | 25 | 6.54e-01 | 5.18e-02 | 0.92800 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 8.41e-01 | -5.18e-02 | 0.97200 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 11 | 7.66e-01 | 5.18e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 19 | 6.96e-01 | 5.18e-02 | 0.93800 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 7.37e-01 | -5.18e-02 | 0.95400 |
| GOBP MEIOTIC CYTOKINESIS | 7 | 8.13e-01 | -5.17e-02 | 0.96800 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 8.26e-01 | 5.17e-02 | 0.97100 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 263 | 1.50e-01 | 5.17e-02 | 0.69000 |
| GOBP DEFENSE RESPONSE | 1184 | 3.08e-03 | 5.17e-02 | 0.21300 |
| GOBP STRESS FIBER ASSEMBLY | 86 | 4.09e-01 | -5.16e-02 | 0.85900 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 8.42e-01 | -5.16e-02 | 0.97200 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 7.05e-01 | -5.16e-02 | 0.94200 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 7 | 8.13e-01 | 5.15e-02 | 0.96800 |
| GOBP NEUROBLAST PROLIFERATION | 38 | 5.83e-01 | 5.15e-02 | 0.91200 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 8.42e-01 | 5.15e-02 | 0.97200 |
| GOBP REGULATION OF CELL CELL ADHESION | 345 | 1.01e-01 | 5.15e-02 | 0.62700 |
| GOBP VESICLE LOCALIZATION | 183 | 2.30e-01 | -5.15e-02 | 0.75400 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 16 | 7.21e-01 | 5.15e-02 | 0.94900 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 23 | 6.69e-01 | -5.15e-02 | 0.93200 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 265 | 1.50e-01 | -5.15e-02 | 0.69000 |
| GOBP EATING BEHAVIOR | 16 | 7.22e-01 | -5.15e-02 | 0.94900 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 23 | 6.70e-01 | -5.14e-02 | 0.93200 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 22 | 6.77e-01 | 5.14e-02 | 0.93200 |
| GOBP RESPONSE TO HYDROPEROXIDE | 13 | 7.49e-01 | -5.14e-02 | 0.95600 |
| GOBP SENSORY PERCEPTION OF SMELL | 16 | 7.22e-01 | 5.14e-02 | 0.94900 |
| GOCC SARCOLEMMA | 85 | 4.14e-01 | 5.13e-02 | 0.86100 |
| GOCC NUCLEOLUS | 894 | 9.89e-03 | 5.13e-02 | 0.32100 |
| GOCC MYELIN SHEATH | 32 | 6.16e-01 | 5.13e-02 | 0.91900 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 6.99e-01 | 5.12e-02 | 0.94000 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 7.07e-01 | 5.12e-02 | 0.94300 |
| GOMF FIBRONECTIN BINDING | 18 | 7.07e-01 | -5.12e-02 | 0.94300 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 10 | 7.79e-01 | -5.11e-02 | 0.96100 |
| GOCC PREFOLDIN COMPLEX | 7 | 8.15e-01 | -5.11e-02 | 0.96800 |
| GOCC ENVELOPE | 1072 | 5.14e-03 | 5.11e-02 | 0.25400 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 28 | 6.40e-01 | 5.11e-02 | 0.92400 |
| GOMF CARBOHYDRATE BINDING | 173 | 2.47e-01 | 5.11e-02 | 0.76800 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 148 | 2.84e-01 | 5.11e-02 | 0.79100 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 179 | 2.39e-01 | 5.11e-02 | 0.76200 |
| GOBP CYTOSKELETON ORGANIZATION | 1025 | 6.19e-03 | 5.11e-02 | 0.27000 |
| GOMF AMIDE BINDING | 261 | 1.57e-01 | 5.11e-02 | 0.69400 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 37 | 5.91e-01 | -5.10e-02 | 0.91300 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 8.29e-01 | -5.10e-02 | 0.97100 |
| GOBP PROTEIN CATABOLIC PROCESS | 827 | 1.34e-02 | -5.10e-02 | 0.37200 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 41 | 5.72e-01 | -5.10e-02 | 0.90800 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 144 | 2.91e-01 | 5.10e-02 | 0.79500 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 63 | 4.84e-01 | -5.10e-02 | 0.88300 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 5.97e-01 | 5.10e-02 | 0.91300 |
| GOMF PROTEASE BINDING | 98 | 3.84e-01 | -5.10e-02 | 0.84500 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 68 | 4.68e-01 | -5.10e-02 | 0.87900 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 22 | 6.79e-01 | 5.09e-02 | 0.93400 |
| GOBP REGULATION OF NEUROGENESIS | 228 | 1.86e-01 | 5.09e-02 | 0.72300 |
| GOCC TRANSPORTER COMPLEX | 231 | 1.83e-01 | 5.09e-02 | 0.72100 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 8 | 8.03e-01 | 5.09e-02 | 0.96400 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 654 | 2.74e-02 | -5.09e-02 | 0.44700 |
| GOBP T CELL ACTIVATION | 432 | 7.12e-02 | 5.08e-02 | 0.57700 |
| GOBP MACROAUTOPHAGY | 301 | 1.30e-01 | -5.08e-02 | 0.67600 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 23 | 6.73e-01 | 5.08e-02 | 0.93200 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 5.88e-01 | 5.08e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 7.52e-01 | -5.07e-02 | 0.95600 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 12 | 7.61e-01 | -5.07e-02 | 0.95700 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 870 | 1.19e-02 | 5.07e-02 | 0.34900 |
| GOBP ASTROCYTE ACTIVATION | 17 | 7.18e-01 | -5.07e-02 | 0.94800 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 85 | 4.20e-01 | -5.07e-02 | 0.86400 |
| GOBP BONE DEVELOPMENT | 118 | 3.43e-01 | 5.06e-02 | 0.82900 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 8.45e-01 | -5.06e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 11 | 7.71e-01 | 5.06e-02 | 0.96000 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 386 | 8.90e-02 | -5.06e-02 | 0.61300 |
| GOBP VESICLE COATING | 38 | 5.90e-01 | -5.06e-02 | 0.91300 |
| GOBP ALCOHOL METABOLIC PROCESS | 236 | 1.82e-01 | -5.06e-02 | 0.72000 |
| GOBP ICOSANOID METABOLIC PROCESS | 63 | 4.88e-01 | 5.06e-02 | 0.88300 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 100 | 3.83e-01 | -5.05e-02 | 0.84500 |
| GOBP POSTSYNAPSE ORGANIZATION | 124 | 3.32e-01 | 5.05e-02 | 0.81900 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 7 | 8.17e-01 | -5.05e-02 | 0.96800 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 10 | 7.82e-01 | -5.05e-02 | 0.96200 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 8 | 8.05e-01 | 5.05e-02 | 0.96600 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 85 | 4.22e-01 | -5.04e-02 | 0.86400 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 95 | 3.96e-01 | 5.04e-02 | 0.85400 |
| GOBP RESPONSE TO CAMP | 46 | 5.55e-01 | 5.03e-02 | 0.90200 |
| GOBP PHOSPHOLIPID TRANSPORT | 65 | 4.83e-01 | 5.03e-02 | 0.88300 |
| GOBP CHOLESTEROL IMPORT | 6 | 8.31e-01 | 5.03e-02 | 0.97100 |
| GOBP NOSE DEVELOPMENT | 6 | 8.31e-01 | -5.03e-02 | 0.97100 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 7.83e-01 | 5.03e-02 | 0.96200 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 8 | 8.05e-01 | 5.03e-02 | 0.96600 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 7.36e-01 | 5.02e-02 | 0.95400 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 49 | 5.43e-01 | -5.02e-02 | 0.89900 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 42 | 5.74e-01 | 5.02e-02 | 0.90800 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 5 | 8.46e-01 | -5.02e-02 | 0.97200 |
| GOCC ENDONUCLEASE COMPLEX | 36 | 6.03e-01 | 5.02e-02 | 0.91600 |
| GOBP PIGMENT METABOLIC PROCESS | 52 | 5.32e-01 | 5.01e-02 | 0.89700 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 40 | 5.84e-01 | -5.01e-02 | 0.91200 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 7.37e-01 | 5.01e-02 | 0.95400 |
| GOMF LIPOPEPTIDE BINDING | 8 | 8.06e-01 | 5.00e-02 | 0.96600 |
| GOBP CELL JUNCTION ASSEMBLY | 247 | 1.77e-01 | 5.00e-02 | 0.71600 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 10 | 7.84e-01 | 5.00e-02 | 0.96200 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 83 | 4.32e-01 | 5.00e-02 | 0.86600 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 23 | 6.78e-01 | -5.00e-02 | 0.93300 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 8.32e-01 | 4.99e-02 | 0.97100 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 7.14e-01 | -4.99e-02 | 0.94600 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 8.07e-01 | -4.99e-02 | 0.96600 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 11 | 7.75e-01 | 4.99e-02 | 0.96100 |
| GOBP MAST CELL MEDIATED IMMUNITY | 47 | 5.54e-01 | -4.99e-02 | 0.90100 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 26 | 6.60e-01 | 4.98e-02 | 0.93200 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 15 | 7.39e-01 | 4.98e-02 | 0.95400 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 5 | 8.47e-01 | -4.98e-02 | 0.97200 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 17 | 7.23e-01 | -4.97e-02 | 0.94900 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 139 | 3.13e-01 | -4.96e-02 | 0.81000 |
| GOBP VIRAL PROCESS | 350 | 1.12e-01 | 4.96e-02 | 0.64500 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 241 | 1.86e-01 | 4.96e-02 | 0.72300 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 7.76e-01 | 4.96e-02 | 0.96100 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 8.33e-01 | -4.96e-02 | 0.97100 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 107 | 3.76e-01 | -4.96e-02 | 0.84200 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 54 | 5.29e-01 | -4.96e-02 | 0.89500 |
| GOBP VISUAL BEHAVIOR | 29 | 6.44e-01 | 4.95e-02 | 0.92500 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 6 | 8.34e-01 | 4.95e-02 | 0.97100 |
| GOCC SPECIFIC GRANULE | 136 | 3.19e-01 | -4.95e-02 | 0.81400 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 6 | 8.34e-01 | -4.94e-02 | 0.97100 |
| GOBP SARCOMERE ORGANIZATION | 22 | 6.88e-01 | -4.94e-02 | 0.93600 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 131 | 3.29e-01 | 4.94e-02 | 0.81800 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 48 | 5.54e-01 | -4.94e-02 | 0.90100 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 153 | 2.92e-01 | 4.94e-02 | 0.79500 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 84 | 4.34e-01 | -4.94e-02 | 0.86600 |
| GOBP ORGANELLE MEMBRANE FUSION | 100 | 3.94e-01 | -4.94e-02 | 0.85400 |
| GOCC COATED VESICLE | 250 | 1.80e-01 | -4.94e-02 | 0.71800 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 79 | 4.49e-01 | -4.94e-02 | 0.87300 |
| GOBP PROTEIN SUMOYLATION | 62 | 5.02e-01 | 4.94e-02 | 0.88700 |
| GOCC AXON CYTOPLASM | 49 | 5.50e-01 | -4.93e-02 | 0.90100 |
| GOBP INFLAMMATORY RESPONSE | 568 | 4.58e-02 | 4.93e-02 | 0.50600 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 11 | 7.77e-01 | 4.93e-02 | 0.96100 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 158 | 2.86e-01 | -4.92e-02 | 0.79100 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 7.77e-01 | 4.92e-02 | 0.96100 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 11 | 7.78e-01 | -4.92e-02 | 0.96100 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 6.58e-01 | -4.92e-02 | 0.93100 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 7.34e-01 | 4.91e-02 | 0.95300 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 8.49e-01 | 4.91e-02 | 0.97200 |
| GOBP T CELL PROLIFERATION | 161 | 2.83e-01 | 4.91e-02 | 0.79000 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 16 | 7.34e-01 | -4.91e-02 | 0.95300 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 92 | 4.17e-01 | -4.90e-02 | 0.86300 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 56 | 5.26e-01 | 4.90e-02 | 0.89300 |
| GOBP MALE GAMETE GENERATION | 327 | 1.29e-01 | -4.90e-02 | 0.67500 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 68 | 4.85e-01 | 4.90e-02 | 0.88300 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 6.32e-01 | 4.89e-02 | 0.92400 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 7 | 8.23e-01 | -4.89e-02 | 0.97100 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 19 | 7.12e-01 | 4.89e-02 | 0.94500 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 61 | 5.09e-01 | -4.89e-02 | 0.88900 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 19 | 7.12e-01 | -4.89e-02 | 0.94500 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 8.50e-01 | -4.88e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 883 | 1.47e-02 | 4.88e-02 | 0.37400 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1289 | 3.66e-03 | -4.88e-02 | 0.22700 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 11 | 7.79e-01 | 4.88e-02 | 0.96100 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 7.44e-01 | -4.88e-02 | 0.95400 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 8.50e-01 | 4.87e-02 | 0.97200 |
| GOBP T CELL LINEAGE COMMITMENT | 25 | 6.74e-01 | -4.87e-02 | 0.93200 |
| GOCC CYTOCHROME COMPLEX | 31 | 6.39e-01 | -4.86e-02 | 0.92400 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 8.51e-01 | 4.86e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 163 | 2.85e-01 | 4.86e-02 | 0.79100 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 160 | 2.89e-01 | -4.86e-02 | 0.79300 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 14 | 7.53e-01 | 4.85e-02 | 0.95600 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 44 | 5.78e-01 | 4.85e-02 | 0.90900 |
| GOBP MATURE B CELL DIFFERENTIATION | 30 | 6.46e-01 | 4.85e-02 | 0.92600 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 309 | 1.44e-01 | 4.85e-02 | 0.68500 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 16 | 7.37e-01 | 4.85e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 198 | 2.40e-01 | 4.85e-02 | 0.76300 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 7.01e-01 | -4.85e-02 | 0.94100 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 6.46e-01 | 4.84e-02 | 0.92600 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 231 | 2.06e-01 | -4.84e-02 | 0.73900 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 47 | 5.66e-01 | 4.84e-02 | 0.90600 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 41 | 5.92e-01 | 4.84e-02 | 0.91300 |
| GOBP REGULATION OF LOCOMOTION | 664 | 3.48e-02 | 4.83e-02 | 0.48200 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 7.72e-01 | -4.83e-02 | 0.96000 |
| GOBP MUSCLE CELL DIFFERENTIATION | 237 | 2.01e-01 | 4.83e-02 | 0.73700 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 35 | 6.21e-01 | -4.83e-02 | 0.92100 |
| GOBP FACE MORPHOGENESIS | 18 | 7.23e-01 | -4.82e-02 | 0.94900 |
| GOBP MICROGLIAL CELL MIGRATION | 5 | 8.52e-01 | -4.82e-02 | 0.97200 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 8.52e-01 | 4.82e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 70 | 4.86e-01 | -4.82e-02 | 0.88300 |
| GOBP RESPONSE TO CYTOKINE | 640 | 3.86e-02 | 4.82e-02 | 0.48700 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 49 | 5.60e-01 | -4.82e-02 | 0.90400 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 776 | 2.35e-02 | 4.82e-02 | 0.42300 |
| GOBP RESPONSE TO LECTIN | 20 | 7.09e-01 | 4.82e-02 | 0.94400 |
| GOBP REGULATION OF CELL ACTIVATION | 488 | 6.99e-02 | 4.81e-02 | 0.57400 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 128 | 3.48e-01 | 4.81e-02 | 0.83300 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 131 | 3.43e-01 | 4.81e-02 | 0.82900 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1069 | 8.64e-03 | -4.81e-02 | 0.29800 |
| GOBP NEURON PROJECTION REGENERATION | 35 | 6.23e-01 | 4.80e-02 | 0.92200 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 24 | 6.84e-01 | 4.79e-02 | 0.93500 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 15 | 7.48e-01 | 4.79e-02 | 0.95600 |
| GOMF TAU PROTEIN BINDING | 36 | 6.19e-01 | 4.79e-02 | 0.92100 |
| GOBP LEUKOCYTE PROLIFERATION | 242 | 2.00e-01 | 4.79e-02 | 0.73700 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 193 | 2.52e-01 | 4.79e-02 | 0.77200 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 86 | 4.44e-01 | -4.78e-02 | 0.87100 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 42 | 5.92e-01 | 4.78e-02 | 0.91300 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 304 | 1.53e-01 | 4.78e-02 | 0.69000 |
| GOBP INTERLEUKIN 4 PRODUCTION | 24 | 6.86e-01 | 4.78e-02 | 0.93500 |
| GOBP ETHANOL CATABOLIC PROCESS | 7 | 8.27e-01 | 4.77e-02 | 0.97100 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 20 | 7.12e-01 | 4.77e-02 | 0.94500 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 44 | 5.84e-01 | -4.77e-02 | 0.91300 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 24 | 6.86e-01 | -4.77e-02 | 0.93500 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 7.85e-01 | 4.76e-02 | 0.96200 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 28 | 6.63e-01 | 4.76e-02 | 0.93200 |
| GOBP REGULATION OF RNA SPLICING | 154 | 3.09e-01 | -4.76e-02 | 0.80800 |
| GOBP FACE DEVELOPMENT | 32 | 6.42e-01 | -4.75e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 12 | 7.76e-01 | -4.75e-02 | 0.96100 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 6 | 8.40e-01 | 4.75e-02 | 0.97200 |
| GOBP HEART FORMATION | 14 | 7.59e-01 | -4.75e-02 | 0.95700 |
| GOMF CYTOKINE ACTIVITY | 85 | 4.50e-01 | 4.75e-02 | 0.87400 |
| GOBP CHROMOSOME SEGREGATION | 349 | 1.29e-01 | 4.74e-02 | 0.67500 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 39 | 6.09e-01 | -4.74e-02 | 0.91700 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 8.16e-01 | 4.74e-02 | 0.96800 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 17 | 7.35e-01 | -4.74e-02 | 0.95400 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 93 | 4.30e-01 | -4.74e-02 | 0.86500 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 50 | 5.62e-01 | -4.74e-02 | 0.90600 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 10 | 7.95e-01 | -4.74e-02 | 0.96200 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 7.21e-01 | -4.74e-02 | 0.94900 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 152 | 3.14e-01 | 4.73e-02 | 0.81000 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 8.17e-01 | 4.73e-02 | 0.96800 |
| GOCC SAGA COMPLEX | 23 | 6.95e-01 | 4.73e-02 | 0.93800 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 9 | 8.06e-01 | 4.73e-02 | 0.96600 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 33 | 6.39e-01 | 4.73e-02 | 0.92400 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 23 | 6.95e-01 | -4.72e-02 | 0.93800 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 7.44e-01 | -4.72e-02 | 0.95400 |
| GOBP NEUROTRANSMITTER TRANSPORT | 116 | 3.80e-01 | -4.72e-02 | 0.84400 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 19 | 7.22e-01 | 4.72e-02 | 0.94900 |
| GOBP SERTOLI CELL DIFFERENTIATION | 11 | 7.86e-01 | 4.72e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 7.69e-01 | -4.71e-02 | 0.95900 |
| GOBP MITOTIC NUCLEAR DIVISION | 211 | 2.39e-01 | 4.71e-02 | 0.76200 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1300 | 4.84e-03 | 4.71e-02 | 0.25000 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 30 | 6.56e-01 | 4.71e-02 | 0.92900 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 102 | 4.12e-01 | 4.71e-02 | 0.86000 |
| GOBP GOLGI VESICLE BUDDING | 10 | 7.97e-01 | -4.70e-02 | 0.96200 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 7.37e-01 | -4.70e-02 | 0.95400 |
| GOBP SEGMENT SPECIFICATION | 6 | 8.42e-01 | -4.70e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 66 | 5.09e-01 | 4.70e-02 | 0.88900 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 6.67e-01 | -4.70e-02 | 0.93200 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 41 | 6.03e-01 | 4.70e-02 | 0.91600 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 8.18e-01 | 4.69e-02 | 0.96900 |
| GOBP MESODERM MORPHOGENESIS | 36 | 6.26e-01 | -4.69e-02 | 0.92400 |
| GOBP METANEPHROS DEVELOPMENT | 36 | 6.26e-01 | -4.69e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 24 | 6.91e-01 | -4.69e-02 | 0.93700 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 8 | 8.18e-01 | -4.69e-02 | 0.96900 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 73 | 4.89e-01 | 4.69e-02 | 0.88400 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 8.08e-01 | 4.68e-02 | 0.96600 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 28 | 6.68e-01 | 4.68e-02 | 0.93200 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 9 | 8.08e-01 | 4.68e-02 | 0.96600 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 36 | 6.27e-01 | 4.68e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 42 | 6.01e-01 | -4.67e-02 | 0.91400 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 6.87e-01 | -4.66e-02 | 0.93500 |
| GOCC SUPER ELONGATION COMPLEX | 6 | 8.43e-01 | 4.66e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF BINDING | 92 | 4.40e-01 | -4.66e-02 | 0.86900 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 502 | 7.55e-02 | 4.66e-02 | 0.58300 |
| GOBP RIBOSOME ASSEMBLY | 57 | 5.43e-01 | 4.66e-02 | 0.89900 |
| GOBP INTERLEUKIN 18 PRODUCTION | 9 | 8.09e-01 | -4.65e-02 | 0.96700 |
| GOBP VIRAL GENE EXPRESSION | 94 | 4.36e-01 | 4.65e-02 | 0.86700 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 35 | 6.34e-01 | -4.65e-02 | 0.92400 |
| GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX | 6 | 8.44e-01 | 4.65e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 36 | 6.29e-01 | -4.65e-02 | 0.92400 |
| GOBP T CELL MIGRATION | 53 | 5.59e-01 | 4.65e-02 | 0.90400 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 8.31e-01 | -4.65e-02 | 0.97100 |
| GOBP MITOTIC CELL CYCLE PROCESS | 613 | 5.11e-02 | 4.64e-02 | 0.52400 |
| GOBP MATURATION OF LSU RRNA | 28 | 6.71e-01 | 4.64e-02 | 0.93200 |
| GOCC RISC LOADING COMPLEX | 8 | 8.20e-01 | 4.64e-02 | 0.97000 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 285 | 1.79e-01 | -4.64e-02 | 0.71700 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 35 | 6.35e-01 | 4.63e-02 | 0.92400 |
| GOBP RECEPTOR CATABOLIC PROCESS | 24 | 6.95e-01 | 4.63e-02 | 0.93800 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 37 | 6.27e-01 | -4.62e-02 | 0.92400 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 7.91e-01 | 4.61e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 304 | 1.68e-01 | 4.61e-02 | 0.70800 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 17 | 7.42e-01 | -4.61e-02 | 0.95400 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 24 | 6.96e-01 | 4.61e-02 | 0.93800 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 23 | 7.02e-01 | -4.60e-02 | 0.94200 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 8.11e-01 | 4.60e-02 | 0.96700 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 66 | 5.18e-01 | -4.60e-02 | 0.89100 |
| GOBP REGULATION OF CHROMATIN BINDING | 9 | 8.11e-01 | 4.60e-02 | 0.96700 |
| GOBP RENAL FILTRATION | 13 | 7.74e-01 | 4.60e-02 | 0.96100 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 7.66e-01 | -4.59e-02 | 0.95900 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 18 | 7.36e-01 | -4.59e-02 | 0.95400 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 10 | 8.02e-01 | -4.59e-02 | 0.96400 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 411 | 1.13e-01 | 4.58e-02 | 0.64800 |
| GOMF GTPASE BINDING | 268 | 1.98e-01 | 4.58e-02 | 0.73600 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 93 | 4.46e-01 | 4.58e-02 | 0.87300 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 187 | 2.81e-01 | -4.58e-02 | 0.79000 |
| GOBP MRNA SPLICE SITE RECOGNITION | 29 | 6.70e-01 | -4.58e-02 | 0.93200 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 8.46e-01 | -4.57e-02 | 0.97200 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 267 | 2.00e-01 | 4.57e-02 | 0.73700 |
| GOBP VASCULAR WOUND HEALING | 10 | 8.03e-01 | -4.56e-02 | 0.96400 |
| GOMF CHROMATIN BINDING | 450 | 9.84e-02 | 4.56e-02 | 0.62400 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 15 | 7.60e-01 | -4.56e-02 | 0.95700 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 42 | 6.09e-01 | -4.56e-02 | 0.91700 |
| GOBP MUSCLE SYSTEM PROCESS | 247 | 2.18e-01 | 4.56e-02 | 0.74700 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 6.50e-01 | -4.56e-02 | 0.92700 |
| GOBP MUSCLE ADAPTATION | 62 | 5.35e-01 | -4.56e-02 | 0.89700 |
| GOBP VACUOLAR TRANSPORT | 144 | 3.46e-01 | -4.56e-02 | 0.83200 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 13 | 7.76e-01 | -4.55e-02 | 0.96100 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 13 | 7.76e-01 | -4.55e-02 | 0.96100 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 64 | 5.29e-01 | -4.55e-02 | 0.89500 |
| GOBP CELL RECOGNITION | 83 | 4.74e-01 | 4.55e-02 | 0.88000 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 39 | 6.23e-01 | -4.55e-02 | 0.92200 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 4.99e-01 | 4.55e-02 | 0.88600 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 6.28e-01 | -4.55e-02 | 0.92400 |
| GOBP REGULATION OF MUCUS SECRETION | 5 | 8.60e-01 | 4.55e-02 | 0.97400 |
| GOBP POLYAMINE METABOLIC PROCESS | 16 | 7.53e-01 | 4.54e-02 | 0.95600 |
| GOBP MITOCHONDRION LOCALIZATION | 38 | 6.28e-01 | 4.54e-02 | 0.92400 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 59 | 5.47e-01 | -4.54e-02 | 0.89900 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 31 | 6.63e-01 | -4.53e-02 | 0.93200 |
| GOBP AORTIC VALVE MORPHOGENESIS | 18 | 7.39e-01 | 4.53e-02 | 0.95400 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1074 | 1.32e-02 | 4.53e-02 | 0.37200 |
| GOMF BUBBLE DNA BINDING | 7 | 8.36e-01 | 4.53e-02 | 0.97100 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 320 | 1.66e-01 | 4.52e-02 | 0.70500 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 29 | 6.74e-01 | 4.52e-02 | 0.93200 |
| GOBP HISTONE METHYLATION | 34 | 6.49e-01 | 4.52e-02 | 0.92700 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 8.48e-01 | -4.51e-02 | 0.97200 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1149 | 1.08e-02 | 4.51e-02 | 0.33500 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 329 | 1.61e-01 | 4.51e-02 | 0.69900 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 8.15e-01 | 4.51e-02 | 0.96800 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 162 | 3.23e-01 | -4.50e-02 | 0.81500 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 7.96e-01 | -4.50e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 85 | 4.74e-01 | 4.50e-02 | 0.88000 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 7.96e-01 | 4.50e-02 | 0.96200 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 700 | 4.40e-02 | 4.50e-02 | 0.50200 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 187 | 2.90e-01 | 4.50e-02 | 0.79300 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 7.03e-01 | -4.50e-02 | 0.94200 |
| GOBP SIRNA PROCESSING | 8 | 8.26e-01 | 4.49e-02 | 0.97100 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 8.26e-01 | -4.49e-02 | 0.97100 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 15 | 7.63e-01 | 4.49e-02 | 0.95800 |
| GOBP MIRNA CATABOLIC PROCESS | 15 | 7.63e-01 | -4.49e-02 | 0.95800 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 13 | 7.79e-01 | 4.49e-02 | 0.96100 |
| GOBP ENSHEATHMENT OF NEURONS | 92 | 4.57e-01 | -4.49e-02 | 0.87700 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 151 | 3.42e-01 | 4.49e-02 | 0.82900 |
| GOBP GERMINAL CENTER FORMATION | 13 | 7.79e-01 | -4.49e-02 | 0.96100 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 80 | 4.88e-01 | 4.48e-02 | 0.88300 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 12 | 7.88e-01 | 4.48e-02 | 0.96200 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 8.37e-01 | -4.48e-02 | 0.97100 |
| GOCC GLUTAMATERGIC SYNAPSE | 253 | 2.21e-01 | 4.48e-02 | 0.75000 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 139 | 3.62e-01 | -4.48e-02 | 0.83900 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 8.49e-01 | -4.48e-02 | 0.97200 |
| GOCC DNA REPAIR COMPLEX | 22 | 7.16e-01 | 4.48e-02 | 0.94800 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 16 | 7.57e-01 | 4.48e-02 | 0.95600 |
| GOCC CHROMOSOME | 1308 | 7.30e-03 | 4.48e-02 | 0.29100 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 108 | 4.22e-01 | 4.48e-02 | 0.86400 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 8.62e-01 | -4.47e-02 | 0.97400 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 52 | 5.77e-01 | -4.47e-02 | 0.90900 |
| GOBP RESPONSE TO CADMIUM ION | 41 | 6.21e-01 | 4.47e-02 | 0.92100 |
| GOBP EPIDERMIS MORPHOGENESIS | 14 | 7.72e-01 | -4.47e-02 | 0.96000 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 37 | 6.39e-01 | -4.46e-02 | 0.92400 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 143 | 3.58e-01 | 4.46e-02 | 0.83600 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 21 | 7.23e-01 | 4.46e-02 | 0.94900 |
| GOBP PSEUDOPODIUM ORGANIZATION | 10 | 8.07e-01 | -4.46e-02 | 0.96600 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 6 | 8.50e-01 | 4.45e-02 | 0.97200 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 8.07e-01 | 4.45e-02 | 0.96600 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 7.65e-01 | -4.45e-02 | 0.95900 |
| GOBP CELL KILLING | 140 | 3.64e-01 | 4.45e-02 | 0.83900 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 8.50e-01 | 4.45e-02 | 0.97200 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 161 | 3.31e-01 | 4.45e-02 | 0.81800 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 144 | 3.58e-01 | -4.44e-02 | 0.83600 |
| GOBP REGULATION OF WOUND HEALING | 70 | 5.21e-01 | -4.44e-02 | 0.89100 |
| GOBP LYMPHOCYTE ACTIVATION | 615 | 6.18e-02 | 4.44e-02 | 0.54900 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 185 | 2.99e-01 | 4.44e-02 | 0.80200 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 44 | 6.11e-01 | 4.43e-02 | 0.91800 |
| GOBP RENAL ABSORPTION | 15 | 7.66e-01 | 4.43e-02 | 0.95900 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 332 | 1.67e-01 | 4.43e-02 | 0.70700 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 49 | 5.92e-01 | -4.43e-02 | 0.91300 |
| GOBP REGULATION OF BONE MINERALIZATION | 46 | 6.04e-01 | -4.43e-02 | 0.91600 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 5 | 8.64e-01 | -4.43e-02 | 0.97400 |
| GOCC MALE GERM CELL NUCLEUS | 38 | 6.37e-01 | -4.42e-02 | 0.92400 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 138 | 3.70e-01 | 4.42e-02 | 0.84000 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 8.64e-01 | -4.42e-02 | 0.97400 |
| GOCC SPECTRIN | 6 | 8.51e-01 | 4.42e-02 | 0.97200 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 7.60e-01 | -4.42e-02 | 0.95700 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 45 | 6.09e-01 | 4.41e-02 | 0.91700 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 8.09e-01 | -4.41e-02 | 0.96700 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 368 | 1.48e-01 | 4.41e-02 | 0.68700 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 60 | 5.55e-01 | 4.41e-02 | 0.90200 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 7.46e-01 | -4.41e-02 | 0.95600 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 50 | 5.90e-01 | 4.41e-02 | 0.91300 |
| GOBP CELL MIGRATION IN HINDBRAIN | 11 | 8.00e-01 | -4.41e-02 | 0.96400 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 7 | 8.40e-01 | 4.40e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 130 | 3.87e-01 | -4.40e-02 | 0.84800 |
| GOBP CELLULAR SENESCENCE | 80 | 4.97e-01 | 4.40e-02 | 0.88600 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 152 | 3.50e-01 | -4.40e-02 | 0.83400 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 57 | 5.66e-01 | 4.40e-02 | 0.90600 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 802 | 3.56e-02 | 4.40e-02 | 0.48200 |
| GOBP EXOCYTIC PROCESS | 66 | 5.37e-01 | -4.40e-02 | 0.89700 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 7.47e-01 | -4.40e-02 | 0.95600 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 11 | 8.01e-01 | 4.39e-02 | 0.96400 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 60 | 5.57e-01 | -4.39e-02 | 0.90300 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 7 | 8.41e-01 | 4.39e-02 | 0.97200 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 8.20e-01 | 4.38e-02 | 0.97000 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 90 | 4.73e-01 | 4.38e-02 | 0.88000 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 55 | 5.74e-01 | 4.38e-02 | 0.90800 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 26 | 6.99e-01 | -4.38e-02 | 0.94000 |
| GOBP PIGMENT GRANULE ORGANIZATION | 35 | 6.54e-01 | 4.38e-02 | 0.92800 |
| GOBP NUCLEAR TRANSPORT | 287 | 2.03e-01 | 4.38e-02 | 0.73800 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 339 | 1.68e-01 | 4.37e-02 | 0.70800 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 8.66e-01 | 4.37e-02 | 0.97400 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 7 | 8.41e-01 | 4.37e-02 | 0.97200 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 15 | 7.70e-01 | -4.37e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 19 | 7.42e-01 | -4.37e-02 | 0.95400 |
| GOBP PHOSPHORYLATION | 1131 | 1.43e-02 | 4.37e-02 | 0.37200 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 157 | 3.46e-01 | 4.37e-02 | 0.83200 |
| GOCC SECRETORY VESICLE | 730 | 4.65e-02 | -4.36e-02 | 0.50700 |
| GOBP REGULATION OF MACROAUTOPHAGY | 141 | 3.73e-01 | -4.36e-02 | 0.84100 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 12 | 7.94e-01 | -4.35e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 37 | 6.47e-01 | 4.35e-02 | 0.92600 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 8.03e-01 | 4.35e-02 | 0.96400 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 7.86e-01 | 4.35e-02 | 0.96200 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 21 | 7.30e-01 | 4.35e-02 | 0.95200 |
| GOBP SCHWANN CELL DEVELOPMENT | 22 | 7.24e-01 | -4.35e-02 | 0.95000 |
| GOBP CELL CYCLE | 1390 | 7.44e-03 | 4.34e-02 | 0.29300 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 7.86e-01 | 4.34e-02 | 0.96200 |
| GOBP PROSTANOID METABOLIC PROCESS | 31 | 6.76e-01 | 4.34e-02 | 0.93200 |
| GOBP FRUCTOSE METABOLIC PROCESS | 12 | 7.95e-01 | -4.34e-02 | 0.96200 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 8.43e-01 | -4.34e-02 | 0.97200 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 553 | 8.30e-02 | 4.33e-02 | 0.60000 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 8 | 8.32e-01 | -4.33e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 44 | 6.19e-01 | -4.33e-02 | 0.92100 |
| GOBP REGULATION OF CELL ADHESION | 537 | 8.78e-02 | 4.33e-02 | 0.61300 |
| GOMF SPHINGOLIPID BINDING | 20 | 7.38e-01 | 4.32e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 819 | 3.70e-02 | 4.32e-02 | 0.48200 |
| GOBP ASSOCIATIVE LEARNING | 45 | 6.16e-01 | -4.32e-02 | 0.91900 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 268 | 2.25e-01 | -4.32e-02 | 0.75100 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 96 | 4.65e-01 | 4.32e-02 | 0.87900 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 14 | 7.80e-01 | -4.30e-02 | 0.96100 |
| GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY | 5 | 8.68e-01 | 4.30e-02 | 0.97400 |
| GOBP HEART MORPHOGENESIS | 138 | 3.83e-01 | -4.30e-02 | 0.84500 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 25 | 7.10e-01 | 4.30e-02 | 0.94400 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 68 | 5.40e-01 | -4.30e-02 | 0.89700 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 18 | 7.52e-01 | -4.30e-02 | 0.95600 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 250 | 2.43e-01 | 4.30e-02 | 0.76500 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 57 | 5.75e-01 | -4.29e-02 | 0.90800 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 124 | 4.10e-01 | 4.29e-02 | 0.86000 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 7.89e-01 | 4.29e-02 | 0.96200 |
| GOBP DETECTION OF STIMULUS | 126 | 4.06e-01 | 4.29e-02 | 0.85800 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 8 | 8.34e-01 | 4.28e-02 | 0.97100 |
| GOBP CUT CATABOLIC PROCESS | 5 | 8.68e-01 | 4.28e-02 | 0.97500 |
| GOMF GTPASE ACTIVITY | 247 | 2.48e-01 | -4.28e-02 | 0.76800 |
| GOBP REGULATION OF PROTEIN STABILITY | 268 | 2.29e-01 | -4.28e-02 | 0.75400 |
| GOBP GROWTH | 591 | 7.74e-02 | -4.28e-02 | 0.58600 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 117 | 4.25e-01 | -4.28e-02 | 0.86400 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 19 | 7.47e-01 | -4.28e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 29 | 6.90e-01 | 4.28e-02 | 0.93700 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 66 | 5.48e-01 | 4.27e-02 | 0.90000 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 110 | 4.39e-01 | -4.27e-02 | 0.86900 |
| GOBP CERAMIDE METABOLIC PROCESS | 74 | 5.26e-01 | -4.27e-02 | 0.89300 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 76 | 5.20e-01 | -4.27e-02 | 0.89100 |
| GOCC CHROMAFFIN GRANULE | 9 | 8.25e-01 | 4.27e-02 | 0.97100 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 19 | 7.48e-01 | 4.27e-02 | 0.95600 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 59 | 5.71e-01 | 4.27e-02 | 0.90800 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 22 | 7.29e-01 | -4.26e-02 | 0.95200 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 6 | 8.57e-01 | -4.26e-02 | 0.97400 |
| GOBP LIPID HOMEOSTASIS | 99 | 4.65e-01 | -4.26e-02 | 0.87900 |
| GOBP NEUROINFLAMMATORY RESPONSE | 53 | 5.92e-01 | 4.25e-02 | 0.91300 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 231 | 2.66e-01 | 4.25e-02 | 0.78400 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 7.13e-01 | -4.25e-02 | 0.94500 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 301 | 2.06e-01 | 4.25e-02 | 0.73800 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 8.69e-01 | -4.25e-02 | 0.97500 |
| GOMF HSP90 PROTEIN BINDING | 31 | 6.82e-01 | -4.25e-02 | 0.93400 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 12 | 7.99e-01 | -4.25e-02 | 0.96300 |
| GOBP MRNA METABOLIC PROCESS | 650 | 6.63e-02 | -4.25e-02 | 0.56500 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 8.46e-01 | -4.25e-02 | 0.97200 |
| GOCC STEREOCILIUM BUNDLE | 36 | 6.60e-01 | -4.24e-02 | 0.93200 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 23 | 7.25e-01 | -4.24e-02 | 0.95000 |
| GOBP DEVELOPMENTAL MATURATION | 183 | 3.23e-01 | -4.24e-02 | 0.81500 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 61 | 5.67e-01 | 4.24e-02 | 0.90600 |
| GOCC SUPRAMOLECULAR COMPLEX | 885 | 3.39e-02 | 4.24e-02 | 0.48200 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 24 | 7.19e-01 | -4.24e-02 | 0.94900 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 8.57e-01 | 4.24e-02 | 0.97400 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 6 | 8.57e-01 | 4.24e-02 | 0.97400 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 59 | 5.74e-01 | 4.23e-02 | 0.90800 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 221 | 2.79e-01 | -4.23e-02 | 0.79000 |
| GOBP UTP METABOLIC PROCESS | 10 | 8.17e-01 | -4.23e-02 | 0.96800 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 8.46e-01 | 4.23e-02 | 0.97200 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 166 | 3.48e-01 | 4.23e-02 | 0.83300 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 8.17e-01 | -4.23e-02 | 0.96800 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 12 | 8.00e-01 | -4.23e-02 | 0.96400 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 774 | 4.71e-02 | 4.23e-02 | 0.50800 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 10 | 8.17e-01 | -4.22e-02 | 0.96800 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 6 | 8.58e-01 | 4.22e-02 | 0.97400 |
| GOBP DEPHOSPHORYLATION | 238 | 2.63e-01 | 4.22e-02 | 0.78300 |
| GOBP RNA EXPORT FROM NUCLEUS | 83 | 5.07e-01 | 4.21e-02 | 0.88800 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 139 | 3.92e-01 | 4.21e-02 | 0.85300 |
| GOBP AUTOCRINE SIGNALING | 5 | 8.70e-01 | 4.21e-02 | 0.97500 |
| GOBP REGULATION OF PHOSPHORYLATION | 703 | 5.88e-02 | 4.21e-02 | 0.53800 |
| GOBP TEMPERATURE HOMEOSTASIS | 132 | 4.04e-01 | -4.21e-02 | 0.85600 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 8.37e-01 | 4.21e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 54 | 5.93e-01 | -4.21e-02 | 0.91300 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 146 | 3.81e-01 | -4.21e-02 | 0.84400 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 33 | 6.76e-01 | 4.21e-02 | 0.93200 |
| GOMF STAT FAMILY PROTEIN BINDING | 9 | 8.27e-01 | -4.21e-02 | 0.97100 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 293 | 2.17e-01 | 4.21e-02 | 0.74500 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 8.01e-01 | 4.20e-02 | 0.96400 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 106 | 4.56e-01 | 4.20e-02 | 0.87500 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 48 | 6.15e-01 | -4.20e-02 | 0.91900 |
| GOBP NEURON APOPTOTIC PROCESS | 182 | 3.30e-01 | -4.20e-02 | 0.81800 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 42 | 6.38e-01 | -4.20e-02 | 0.92400 |
| GOMF PEPTIDOGLYCAN BINDING | 9 | 8.28e-01 | -4.19e-02 | 0.97100 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 10 | 8.19e-01 | 4.19e-02 | 0.96900 |
| GOBP MUSCLE CELL PROLIFERATION | 130 | 4.10e-01 | -4.19e-02 | 0.86000 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 23 | 7.28e-01 | 4.18e-02 | 0.95100 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 27 | 7.07e-01 | -4.18e-02 | 0.94300 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 45 | 6.28e-01 | 4.18e-02 | 0.92400 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 507 | 1.09e-01 | -4.18e-02 | 0.63900 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 29 | 6.97e-01 | 4.18e-02 | 0.93800 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 98 | 4.75e-01 | 4.18e-02 | 0.88100 |
| GOBP CELLULAR RESPONSE TO LIPID | 406 | 1.50e-01 | 4.18e-02 | 0.69000 |
| GOBP FAT CELL DIFFERENTIATION | 153 | 3.73e-01 | -4.17e-02 | 0.84100 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 8.38e-01 | -4.17e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 17 | 7.66e-01 | -4.17e-02 | 0.95900 |
| GOMF RNA POLYMERASE BINDING | 55 | 5.94e-01 | -4.16e-02 | 0.91300 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 6 | 8.60e-01 | -4.16e-02 | 0.97400 |
| GOBP DNA DEALKYLATION | 30 | 6.94e-01 | 4.16e-02 | 0.93800 |
| GOMF SULFUR COMPOUND BINDING | 147 | 3.85e-01 | 4.16e-02 | 0.84600 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 9 | 8.29e-01 | -4.16e-02 | 0.97100 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 319 | 2.03e-01 | 4.15e-02 | 0.73800 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 7.88e-01 | -4.15e-02 | 0.96200 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 28 | 7.04e-01 | 4.15e-02 | 0.94200 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 57 | 5.88e-01 | 4.15e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 8.49e-01 | -4.14e-02 | 0.97200 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 8.49e-01 | -4.14e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 536 | 1.03e-01 | 4.14e-02 | 0.63000 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 19 | 7.55e-01 | 4.14e-02 | 0.95600 |
| GOBP PROTEIN AUTOPROCESSING | 16 | 7.74e-01 | 4.14e-02 | 0.96100 |
| GOBP REGULATION OF GLUCONEOGENESIS | 43 | 6.39e-01 | -4.14e-02 | 0.92400 |
| GOBP REGULATION OF CELL DIVISION | 117 | 4.40e-01 | 4.14e-02 | 0.86900 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 137 | 4.04e-01 | 4.14e-02 | 0.85600 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 8.40e-01 | 4.13e-02 | 0.97200 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 8.30e-01 | -4.13e-02 | 0.97100 |
| GOMF VITAMIN B6 BINDING | 33 | 6.82e-01 | 4.13e-02 | 0.93400 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 246 | 2.66e-01 | 4.13e-02 | 0.78400 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 8.05e-01 | 4.13e-02 | 0.96500 |
| GOBP POSITIVE REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 6 | 8.61e-01 | 4.13e-02 | 0.97400 |
| GOBP ARTERY MORPHOGENESIS | 35 | 6.73e-01 | -4.13e-02 | 0.93200 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 8.50e-01 | 4.12e-02 | 0.97200 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 33 | 6.82e-01 | 4.12e-02 | 0.93400 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 8.40e-01 | 4.12e-02 | 0.97200 |
| GOBP DOSAGE COMPENSATION | 28 | 7.06e-01 | 4.12e-02 | 0.94200 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 121 | 4.34e-01 | -4.12e-02 | 0.86600 |
| GOBP REGULATION OF GROWTH | 389 | 1.65e-01 | -4.12e-02 | 0.70500 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 15 | 7.83e-01 | -4.11e-02 | 0.96200 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 9 | 8.31e-01 | 4.11e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 40 | 6.53e-01 | 4.11e-02 | 0.92700 |
| GOBP REGULATION OF GTPASE ACTIVITY | 214 | 3.02e-01 | 4.10e-02 | 0.80400 |
| GOBP ISOPRENOID METABOLIC PROCESS | 76 | 5.37e-01 | 4.10e-02 | 0.89700 |
| GOBP REGULATION OF SECRETION | 376 | 1.74e-01 | -4.10e-02 | 0.71600 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 394 | 1.65e-01 | 4.09e-02 | 0.70500 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 295 | 2.28e-01 | 4.09e-02 | 0.75300 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 19 | 7.58e-01 | -4.09e-02 | 0.95600 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 8.14e-01 | 4.09e-02 | 0.96800 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 8 | 8.41e-01 | -4.09e-02 | 0.97200 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 13 | 7.99e-01 | 4.09e-02 | 0.96300 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.74e-01 | 4.09e-02 | 0.97600 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 8.32e-01 | -4.09e-02 | 0.97100 |
| GOMF CHOLESTEROL BINDING | 35 | 6.76e-01 | -4.08e-02 | 0.93200 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 15 | 7.85e-01 | -4.08e-02 | 0.96200 |
| GOBP ICOSANOID CATABOLIC PROCESS | 5 | 8.75e-01 | -4.08e-02 | 0.97600 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 45 | 6.36e-01 | 4.08e-02 | 0.92400 |
| GOCC CAJAL BODY | 58 | 5.92e-01 | 4.07e-02 | 0.91300 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 15 | 7.85e-01 | 4.07e-02 | 0.96200 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 126 | 4.31e-01 | 4.07e-02 | 0.86500 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 93 | 4.98e-01 | 4.07e-02 | 0.88600 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 8.52e-01 | -4.07e-02 | 0.97200 |
| GOBP HOMOLOGOUS RECOMBINATION | 49 | 6.22e-01 | 4.07e-02 | 0.92100 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 58 | 5.92e-01 | -4.07e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 18 | 7.65e-01 | -4.07e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 39 | 6.61e-01 | -4.06e-02 | 0.93200 |
| GOBP INTERLEUKIN 17 PRODUCTION | 28 | 7.10e-01 | 4.06e-02 | 0.94400 |
| GOCC NUCLEAR ENVELOPE | 410 | 1.60e-01 | 4.06e-02 | 0.69900 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 191 | 3.35e-01 | 4.06e-02 | 0.82200 |
| GOBP CELLULAR EXTRAVASATION | 54 | 6.06e-01 | 4.06e-02 | 0.91700 |
| GOMF AMINOPEPTIDASE ACTIVITY | 30 | 7.01e-01 | 4.05e-02 | 0.94100 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 16 | 7.79e-01 | -4.05e-02 | 0.96100 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 8 | 8.43e-01 | 4.05e-02 | 0.97200 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 53 | 6.10e-01 | 4.05e-02 | 0.91800 |
| GOCC ACTIN FILAMENT | 75 | 5.45e-01 | 4.05e-02 | 0.89900 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 72 | 5.53e-01 | 4.05e-02 | 0.90100 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 21 | 7.48e-01 | 4.05e-02 | 0.95600 |
| GOBP PROTEOLYSIS | 1180 | 2.06e-02 | -4.05e-02 | 0.40700 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 415 | 1.59e-01 | 4.04e-02 | 0.69900 |
| GOCC SECRETORY GRANULE | 623 | 8.71e-02 | -4.04e-02 | 0.61100 |
| GOCC SUPRAMOLECULAR POLYMER | 585 | 9.71e-02 | 4.04e-02 | 0.62300 |
| GOMF MHC CLASS I PROTEIN COMPLEX BINDING | 7 | 8.53e-01 | -4.04e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 8.53e-01 | -4.03e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 8.53e-01 | -4.03e-02 | 0.97200 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2 COMPLEX | 5 | 8.76e-01 | 4.03e-02 | 0.97600 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 60 | 5.89e-01 | 4.03e-02 | 0.91300 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 28 | 7.12e-01 | 4.03e-02 | 0.94500 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 20 | 7.55e-01 | 4.03e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 11 | 8.17e-01 | -4.03e-02 | 0.96800 |
| GOBP MRNA EXPORT FROM NUCLEUS | 64 | 5.78e-01 | 4.03e-02 | 0.90900 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 618 | 8.94e-02 | 4.03e-02 | 0.61300 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 793 | 5.60e-02 | 4.02e-02 | 0.53600 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 8.76e-01 | -4.02e-02 | 0.97600 |
| GOMF TRANSITION METAL ION BINDING | 740 | 6.45e-02 | -4.02e-02 | 0.56000 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 46 | 6.37e-01 | -4.02e-02 | 0.92400 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 59 | 5.94e-01 | -4.02e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 7 | 8.54e-01 | 4.02e-02 | 0.97300 |
| GOCC CONDENSIN COMPLEX | 7 | 8.54e-01 | 4.02e-02 | 0.97300 |
| GOBP VITAMIN TRANSPORT | 28 | 7.13e-01 | -4.02e-02 | 0.94500 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 7.95e-01 | -4.01e-02 | 0.96200 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 7.95e-01 | -4.01e-02 | 0.96200 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 8.77e-01 | -4.01e-02 | 0.97600 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 9 | 8.35e-01 | -4.01e-02 | 0.97100 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 201 | 3.28e-01 | 4.01e-02 | 0.81800 |
| GOCC PIGMENT GRANULE | 98 | 4.94e-01 | -4.01e-02 | 0.88600 |
| GOCC CHECKPOINT CLAMP COMPLEX | 5 | 8.77e-01 | 4.00e-02 | 0.97600 |
| GOBP T CELL TOLERANCE INDUCTION | 11 | 8.19e-01 | -3.99e-02 | 0.96900 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 74 | 5.53e-01 | 3.99e-02 | 0.90100 |
| GOBP TERPENOID METABOLIC PROCESS | 43 | 6.51e-01 | 3.99e-02 | 0.92700 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 15 | 7.90e-01 | 3.98e-02 | 0.96200 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 21 | 7.53e-01 | 3.97e-02 | 0.95600 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 36 | 6.80e-01 | -3.97e-02 | 0.93400 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 367 | 1.93e-01 | 3.97e-02 | 0.73300 |
| GOBP COLLECTING DUCT DEVELOPMENT | 5 | 8.78e-01 | 3.97e-02 | 0.97600 |
| GOBP SALIVARY GLAND DEVELOPMENT | 19 | 7.65e-01 | 3.97e-02 | 0.95900 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 23 | 7.42e-01 | -3.96e-02 | 0.95400 |
| GOBP AMINO ACID TRANSPORT | 86 | 5.26e-01 | 3.96e-02 | 0.89300 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 80 | 5.40e-01 | -3.96e-02 | 0.89700 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 17 | 7.78e-01 | -3.96e-02 | 0.96100 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 28 | 7.17e-01 | -3.96e-02 | 0.94800 |
| GOBP REGULATION OF DNA BINDING | 59 | 6.00e-01 | -3.95e-02 | 0.91400 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 15 | 7.91e-01 | -3.95e-02 | 0.96200 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 896 | 4.70e-02 | -3.95e-02 | 0.50800 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 8.67e-01 | 3.94e-02 | 0.97400 |
| GOBP MEMORY | 57 | 6.07e-01 | -3.94e-02 | 0.91700 |
| GOBP GLIAL CELL MIGRATION | 44 | 6.51e-01 | 3.94e-02 | 0.92700 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 8 | 8.47e-01 | 3.94e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 20 | 7.60e-01 | 3.94e-02 | 0.95700 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 200 | 3.38e-01 | 3.94e-02 | 0.82700 |
| GOBP SCHWANN CELL DIFFERENTIATION | 27 | 7.23e-01 | 3.94e-02 | 0.94900 |
| GOMF ALCOHOL BINDING | 52 | 6.24e-01 | -3.94e-02 | 0.92200 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 504 | 1.33e-01 | -3.93e-02 | 0.67800 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 66 | 5.81e-01 | 3.93e-02 | 0.91100 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 33 | 6.96e-01 | -3.93e-02 | 0.93800 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 12 | 8.14e-01 | 3.93e-02 | 0.96800 |
| GOBP NEGATIVE REGULATION OF SECRETION | 96 | 5.07e-01 | 3.93e-02 | 0.88800 |
| GOMF HORMONE RECEPTOR BINDING | 10 | 8.30e-01 | -3.92e-02 | 0.97100 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 8.48e-01 | 3.92e-02 | 0.97200 |
| GOBP REGULATION OF HORMONE LEVELS | 276 | 2.64e-01 | -3.92e-02 | 0.78300 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 63 | 5.92e-01 | 3.91e-02 | 0.91300 |
| GOBP NEUTROPHIL MIGRATION | 83 | 5.39e-01 | -3.91e-02 | 0.89700 |
| GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY | 7 | 8.58e-01 | -3.91e-02 | 0.97400 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 64 | 5.89e-01 | -3.90e-02 | 0.91300 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 8.15e-01 | 3.90e-02 | 0.96800 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 53 | 6.23e-01 | 3.90e-02 | 0.92200 |
| GOCC SYMMETRIC SYNAPSE | 6 | 8.69e-01 | 3.90e-02 | 0.97500 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 7 | 8.58e-01 | 3.90e-02 | 0.97400 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 50 | 6.34e-01 | -3.90e-02 | 0.92400 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 170 | 3.82e-01 | -3.89e-02 | 0.84500 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 6 | 8.69e-01 | -3.89e-02 | 0.97500 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 55 | 6.18e-01 | -3.89e-02 | 0.92000 |
| GOBP AXO DENDRITIC TRANSPORT | 61 | 6.00e-01 | -3.88e-02 | 0.91400 |
| GOBP MYOBLAST DIFFERENTIATION | 73 | 5.67e-01 | 3.88e-02 | 0.90600 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 18 | 7.76e-01 | -3.88e-02 | 0.96100 |
| GOBP CELL JUNCTION ORGANIZATION | 434 | 1.68e-01 | 3.88e-02 | 0.70800 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 8.59e-01 | -3.88e-02 | 0.97400 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 7 | 8.59e-01 | -3.88e-02 | 0.97400 |
| GOCC INCLUSION BODY | 57 | 6.13e-01 | -3.88e-02 | 0.91800 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 8 | 8.50e-01 | 3.87e-02 | 0.97200 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 750 | 7.34e-02 | 3.87e-02 | 0.58000 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 240 | 3.03e-01 | 3.87e-02 | 0.80500 |
| GOBP REGULATION OF HISTONE MODIFICATION | 36 | 6.88e-01 | 3.87e-02 | 0.93600 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 57 | 6.14e-01 | 3.87e-02 | 0.91800 |
| GOCC RECEPTOR COMPLEX | 222 | 3.23e-01 | 3.86e-02 | 0.81500 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1071 | 3.49e-02 | 3.86e-02 | 0.48200 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 978 | 4.32e-02 | 3.86e-02 | 0.50100 |
| GOBP NOTCH SIGNALING PATHWAY | 110 | 4.85e-01 | -3.85e-02 | 0.88300 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 232 | 3.15e-01 | 3.84e-02 | 0.81000 |
| GOMF TRAIL BINDING | 5 | 8.82e-01 | 3.84e-02 | 0.97900 |
| GOBP POLYOL METABOLIC PROCESS | 74 | 5.69e-01 | -3.83e-02 | 0.90700 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 8.51e-01 | -3.83e-02 | 0.97200 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 58 | 6.14e-01 | -3.83e-02 | 0.91800 |
| GOBP REGULATORY NCRNA PROCESSING | 65 | 5.94e-01 | -3.83e-02 | 0.91300 |
| GOBP GAMETE GENERATION | 428 | 1.76e-01 | -3.83e-02 | 0.71600 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 18 | 7.79e-01 | 3.82e-02 | 0.96100 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 8.82e-01 | -3.82e-02 | 0.97900 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 7.41e-01 | -3.82e-02 | 0.95400 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 12 | 8.19e-01 | 3.82e-02 | 0.96900 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 6.41e-01 | -3.82e-02 | 0.92400 |
| GOMF DEMETHYLASE ACTIVITY | 35 | 6.96e-01 | -3.82e-02 | 0.93800 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 122 | 4.67e-01 | -3.82e-02 | 0.87900 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 192 | 3.63e-01 | -3.82e-02 | 0.83900 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 13 | 8.12e-01 | 3.81e-02 | 0.96800 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 250 | 3.01e-01 | 3.81e-02 | 0.80400 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 16 | 7.92e-01 | -3.80e-02 | 0.96200 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 30 | 7.19e-01 | -3.80e-02 | 0.94900 |
| GOBP REGULATION OF INSULIN SECRETION | 99 | 5.14e-01 | 3.80e-02 | 0.89100 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 20 | 7.69e-01 | -3.79e-02 | 0.95900 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 8.62e-01 | -3.79e-02 | 0.97400 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 120 | 4.74e-01 | 3.79e-02 | 0.88000 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 8.62e-01 | 3.79e-02 | 0.97400 |
| GOBP N GLYCAN PROCESSING | 13 | 8.13e-01 | 3.78e-02 | 0.96800 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 151 | 4.23e-01 | 3.78e-02 | 0.86400 |
| GOBP REGULATION OF CELL SIZE | 129 | 4.59e-01 | 3.78e-02 | 0.87700 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 8.84e-01 | -3.78e-02 | 0.97900 |
| GOBP FATTY ACID TRANSPORT | 57 | 6.22e-01 | 3.78e-02 | 0.92100 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 45 | 6.62e-01 | 3.77e-02 | 0.93200 |
| GOBP EPIDERMIS DEVELOPMENT | 163 | 4.07e-01 | -3.77e-02 | 0.85800 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 25 | 7.44e-01 | 3.77e-02 | 0.95400 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 96 | 5.24e-01 | -3.77e-02 | 0.89200 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 32 | 7.12e-01 | 3.77e-02 | 0.94500 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 17 | 7.88e-01 | 3.77e-02 | 0.96200 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 167 | 4.01e-01 | 3.77e-02 | 0.85600 |
| GOBP MITOTIC CELL CYCLE | 722 | 8.68e-02 | 3.77e-02 | 0.61000 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 347 | 2.30e-01 | 3.77e-02 | 0.75400 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 7.55e-01 | 3.76e-02 | 0.95600 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 17 | 7.88e-01 | -3.76e-02 | 0.96200 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 67 | 5.94e-01 | -3.76e-02 | 0.91300 |
| GOBP MEMBRANE RAFT ASSEMBLY | 6 | 8.73e-01 | 3.76e-02 | 0.97500 |
| GOBP SECRETION BY TISSUE | 21 | 7.66e-01 | -3.76e-02 | 0.95900 |
| GOBP DEVELOPMENTAL CELL GROWTH | 149 | 4.29e-01 | 3.76e-02 | 0.86400 |
| GOBP OPSONIZATION | 5 | 8.84e-01 | 3.76e-02 | 0.97900 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 8.37e-01 | 3.75e-02 | 0.97100 |
| GOBP REGULATION OF CELL GROWTH | 282 | 2.79e-01 | -3.75e-02 | 0.79000 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 8.22e-01 | -3.75e-02 | 0.97100 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 11 | 8.29e-01 | 3.75e-02 | 0.97100 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 91 | 5.37e-01 | 3.75e-02 | 0.89700 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 17 | 7.89e-01 | 3.75e-02 | 0.96200 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 8.30e-01 | 3.75e-02 | 0.97100 |
| GOBP MEMBRANE REPOLARIZATION | 24 | 7.51e-01 | 3.75e-02 | 0.95600 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 9 | 8.46e-01 | -3.74e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.55e-01 | -3.74e-02 | 0.97300 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 8.22e-01 | 3.74e-02 | 0.97100 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 8.74e-01 | 3.74e-02 | 0.97600 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 85 | 5.52e-01 | 3.74e-02 | 0.90100 |
| GOBP SELF PROTEOLYSIS | 8 | 8.55e-01 | 3.73e-02 | 0.97300 |
| GOBP PROTEIN ACETYLATION | 87 | 5.48e-01 | 3.73e-02 | 0.90000 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 8.85e-01 | 3.73e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 59 | 6.21e-01 | -3.72e-02 | 0.92100 |
| GOMF E BOX BINDING | 25 | 7.48e-01 | 3.71e-02 | 0.95600 |
| GOBP GLAND MORPHOGENESIS | 63 | 6.10e-01 | 3.71e-02 | 0.91800 |
| GOBP SYNAPTIC VESICLE RECYCLING | 64 | 6.08e-01 | -3.71e-02 | 0.91700 |
| GOBP EXOCYTOSIS | 251 | 3.13e-01 | -3.70e-02 | 0.81000 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 8.48e-01 | -3.70e-02 | 0.97200 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 7.80e-01 | -3.70e-02 | 0.96100 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 287 | 2.83e-01 | -3.70e-02 | 0.79000 |
| GOMF PHOSPHATE ION BINDING | 7 | 8.66e-01 | 3.69e-02 | 0.97400 |
| GOBP HUMORAL IMMUNE RESPONSE | 106 | 5.12e-01 | 3.69e-02 | 0.89000 |
| GOMF ACYLTRANSFERASE ACTIVITY | 561 | 1.37e-01 | -3.69e-02 | 0.68000 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 8 | 8.57e-01 | 3.69e-02 | 0.97400 |
| GOBP NEUROTRANSMITTER SECRETION | 93 | 5.39e-01 | -3.69e-02 | 0.89700 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 39 | 6.90e-01 | 3.69e-02 | 0.93700 |
| GOBP GLUCOSE CATABOLIC PROCESS | 20 | 7.75e-01 | -3.69e-02 | 0.96100 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 41 | 6.83e-01 | 3.69e-02 | 0.93400 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 8.66e-01 | -3.69e-02 | 0.97400 |
| GOBP FOREBRAIN REGIONALIZATION | 5 | 8.87e-01 | -3.68e-02 | 0.98000 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 37 | 6.98e-01 | 3.68e-02 | 0.94000 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 8.76e-01 | -3.68e-02 | 0.97600 |
| GOMF LIPID TRANSPORTER ACTIVITY | 104 | 5.17e-01 | -3.68e-02 | 0.89100 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 24 | 7.55e-01 | -3.68e-02 | 0.95600 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 83 | 5.63e-01 | 3.68e-02 | 0.90600 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 189 | 3.84e-01 | 3.68e-02 | 0.84500 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 8.87e-01 | 3.68e-02 | 0.98000 |
| GOBP GLAND DEVELOPMENT | 244 | 3.24e-01 | -3.68e-02 | 0.81500 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 45 | 6.70e-01 | -3.68e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 137 | 4.58e-01 | -3.67e-02 | 0.87700 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 30 | 7.28e-01 | -3.67e-02 | 0.95100 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 36 | 7.03e-01 | -3.67e-02 | 0.94200 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 8.87e-01 | -3.67e-02 | 0.98000 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 98 | 5.31e-01 | 3.66e-02 | 0.89700 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 8.26e-01 | 3.66e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 11 | 8.34e-01 | -3.66e-02 | 0.97100 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 35 | 7.08e-01 | -3.66e-02 | 0.94400 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 34 | 7.13e-01 | -3.65e-02 | 0.94500 |
| GOBP PEPTIDE TRANSPORT | 151 | 4.40e-01 | 3.65e-02 | 0.86900 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 7 | 8.67e-01 | -3.65e-02 | 0.97400 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 5.83e-01 | -3.65e-02 | 0.91200 |
| GOBP MACROPHAGE MIGRATION | 45 | 6.73e-01 | 3.64e-02 | 0.93200 |
| GOBP NEURON PROJECTION ARBORIZATION | 24 | 7.58e-01 | -3.64e-02 | 0.95600 |
| GOBP EXTRACELLULAR TRANSPORT | 29 | 7.35e-01 | 3.64e-02 | 0.95300 |
| GOCC SPINDLE POLE | 149 | 4.44e-01 | 3.64e-02 | 0.87100 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 12 | 8.27e-01 | 3.63e-02 | 0.97100 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 12 | 8.28e-01 | 3.63e-02 | 0.97100 |
| GOBP DEVELOPMENTAL GROWTH | 401 | 2.14e-01 | -3.63e-02 | 0.74000 |
| GOMF MRNA BINDING | 267 | 3.08e-01 | -3.63e-02 | 0.80700 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 8.78e-01 | 3.63e-02 | 0.97600 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 8.02e-01 | -3.62e-02 | 0.96400 |
| GOBP SPECIFICATION OF SYMMETRY | 75 | 5.88e-01 | -3.62e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 41 | 6.89e-01 | -3.62e-02 | 0.93600 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 8.78e-01 | -3.62e-02 | 0.97600 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 97 | 5.39e-01 | 3.62e-02 | 0.89700 |
| GOBP REGULATION OF GLUCOSE IMPORT | 41 | 6.89e-01 | 3.62e-02 | 0.93600 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 8.89e-01 | -3.61e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 17 | 7.97e-01 | 3.61e-02 | 0.96200 |
| GOBP VESICLE MEDIATED TRANSPORT | 1181 | 3.90e-02 | -3.61e-02 | 0.48800 |
| GOMF CLATHRIN BINDING | 49 | 6.62e-01 | -3.61e-02 | 0.93200 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 16 | 8.03e-01 | 3.61e-02 | 0.96400 |
| GOBP ACTIVATED T CELL PROLIFERATION | 33 | 7.20e-01 | 3.61e-02 | 0.94900 |
| GOCC DENDRITE CYTOPLASM | 19 | 7.86e-01 | -3.60e-02 | 0.96200 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 81 | 5.75e-01 | 3.60e-02 | 0.90800 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 83 | 5.71e-01 | 3.60e-02 | 0.90800 |
| GOCC DISTAL AXON | 172 | 4.16e-01 | 3.60e-02 | 0.86300 |
| GOCC SPECIFIC GRANULE MEMBRANE | 82 | 5.74e-01 | -3.60e-02 | 0.90800 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 59 | 6.33e-01 | -3.60e-02 | 0.92400 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 10 | 8.44e-01 | -3.60e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 37 | 7.05e-01 | 3.59e-02 | 0.94200 |
| GOBP PROTEIN DESTABILIZATION | 45 | 6.77e-01 | 3.59e-02 | 0.93200 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 56 | 6.43e-01 | 3.59e-02 | 0.92400 |
| GOBP CELLULAR RESPONSE TO ALDOSTERONE | 5 | 8.90e-01 | -3.59e-02 | 0.98000 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 8.30e-01 | 3.58e-02 | 0.97100 |
| GOMF VINCULIN BINDING | 10 | 8.45e-01 | 3.58e-02 | 0.97200 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 7.93e-01 | -3.58e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 38 | 7.03e-01 | 3.58e-02 | 0.94200 |
| GOBP VASCULOGENESIS | 43 | 6.85e-01 | 3.57e-02 | 0.93500 |
| GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 6 | 8.80e-01 | 3.57e-02 | 0.97700 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 34 | 7.19e-01 | 3.57e-02 | 0.94900 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 8.53e-01 | 3.57e-02 | 0.97200 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 8.61e-01 | -3.56e-02 | 0.97400 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 249 | 3.34e-01 | -3.56e-02 | 0.82200 |
| GOCC SOMATODENDRITIC COMPARTMENT | 496 | 1.76e-01 | 3.56e-02 | 0.71600 |
| GOBP PROTEIN PHOSPHORYLATION | 926 | 6.86e-02 | 3.56e-02 | 0.57300 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 13 | 8.24e-01 | -3.56e-02 | 0.97100 |
| GOBP TRNA 3 END PROCESSING | 7 | 8.71e-01 | 3.56e-02 | 0.97500 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 41 | 6.94e-01 | -3.56e-02 | 0.93800 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.91e-01 | 3.56e-02 | 0.98000 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 57 | 6.43e-01 | 3.55e-02 | 0.92400 |
| GOMF SCAFFOLD PROTEIN BINDING | 44 | 6.84e-01 | 3.55e-02 | 0.93400 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 34 | 7.20e-01 | -3.55e-02 | 0.94900 |
| GOBP INTEGRIN ACTIVATION | 18 | 7.94e-01 | -3.55e-02 | 0.96200 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 136 | 4.76e-01 | 3.55e-02 | 0.88100 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 272 | 3.16e-01 | 3.55e-02 | 0.81100 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 66 | 6.19e-01 | -3.54e-02 | 0.92100 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 8.39e-01 | 3.54e-02 | 0.97200 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 94 | 5.54e-01 | -3.54e-02 | 0.90100 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 23 | 7.69e-01 | -3.54e-02 | 0.95900 |
| GOBP PRESYNAPSE ORGANIZATION | 26 | 7.55e-01 | 3.54e-02 | 0.95600 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 7.90e-01 | -3.54e-02 | 0.96200 |
| GOBP EMBRYONIC MORPHOGENESIS | 319 | 2.79e-01 | -3.53e-02 | 0.79000 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 27 | 7.51e-01 | -3.53e-02 | 0.95600 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 231 | 3.56e-01 | -3.53e-02 | 0.83600 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 45 | 6.83e-01 | 3.53e-02 | 0.93400 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 59 | 6.40e-01 | -3.52e-02 | 0.92400 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 8.92e-01 | 3.52e-02 | 0.98000 |
| GOBP WOUND HEALING | 271 | 3.20e-01 | -3.52e-02 | 0.81400 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 8.63e-01 | 3.52e-02 | 0.97400 |
| GOBP HAIR FOLLICLE MATURATION | 8 | 8.63e-01 | 3.51e-02 | 0.97400 |
| GOMF PDZ DOMAIN BINDING | 56 | 6.50e-01 | -3.51e-02 | 0.92700 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 27 | 7.52e-01 | -3.51e-02 | 0.95600 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1124 | 4.98e-02 | -3.51e-02 | 0.51700 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 62 | 6.33e-01 | -3.51e-02 | 0.92400 |
| GOBP CELLULAR HOMEOSTASIS | 526 | 1.71e-01 | 3.50e-02 | 0.71400 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 243 | 3.48e-01 | 3.50e-02 | 0.83300 |
| GOBP RENAL SODIUM ION ABSORPTION | 7 | 8.72e-01 | -3.50e-02 | 0.97500 |
| GOBP RENAL SODIUM ION TRANSPORT | 7 | 8.72e-01 | -3.50e-02 | 0.97500 |
| GOBP DEDIFFERENTIATION | 5 | 8.92e-01 | 3.50e-02 | 0.98000 |
| GOCC DOPAMINERGIC SYNAPSE | 7 | 8.73e-01 | -3.50e-02 | 0.97500 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 804 | 9.43e-02 | 3.50e-02 | 0.61700 |
| GOBP PATTERN SPECIFICATION PROCESS | 213 | 3.80e-01 | -3.50e-02 | 0.84400 |
| GOBP RESPONSE TO PROTOZOAN | 24 | 7.67e-01 | 3.50e-02 | 0.95900 |
| GOBP VIRAL TRANSCRIPTION | 45 | 6.86e-01 | 3.49e-02 | 0.93500 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 106 | 5.35e-01 | 3.49e-02 | 0.89700 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 194 | 4.03e-01 | 3.49e-02 | 0.85600 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 19 | 7.93e-01 | -3.48e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 8 | 8.65e-01 | -3.48e-02 | 0.97400 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 127 | 4.99e-01 | 3.48e-02 | 0.88600 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 168 | 4.37e-01 | 3.48e-02 | 0.86800 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 101 | 5.46e-01 | 3.48e-02 | 0.89900 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1073 | 5.71e-02 | -3.48e-02 | 0.53600 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 65 | 6.28e-01 | 3.47e-02 | 0.92400 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 14 | 8.22e-01 | -3.47e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 8.65e-01 | 3.47e-02 | 0.97400 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 13 | 8.29e-01 | 3.46e-02 | 0.97100 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 62 | 6.38e-01 | 3.46e-02 | 0.92400 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 8 | 8.65e-01 | -3.46e-02 | 0.97400 |
| GOCC CONTRACTILE FIBER | 145 | 4.73e-01 | -3.46e-02 | 0.88000 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 74 | 6.07e-01 | -3.46e-02 | 0.91700 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 10 | 8.50e-01 | 3.46e-02 | 0.97200 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 152 | 4.63e-01 | -3.46e-02 | 0.87900 |
| GOBP CARDIOCYTE DIFFERENTIATION | 89 | 5.74e-01 | 3.45e-02 | 0.90800 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 27 | 7.56e-01 | -3.45e-02 | 0.95600 |
| GOBP RECEPTOR METABOLIC PROCESS | 61 | 6.42e-01 | 3.45e-02 | 0.92400 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 317 | 2.93e-01 | 3.45e-02 | 0.79500 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 8.94e-01 | 3.45e-02 | 0.98000 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 125 | 5.07e-01 | 3.44e-02 | 0.88800 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 80 | 5.95e-01 | 3.44e-02 | 0.91300 |
| GOBP RESPONSE TO POTASSIUM ION | 13 | 8.30e-01 | -3.44e-02 | 0.97100 |
| GOBP VIRAL RNA GENOME REPLICATION | 26 | 7.61e-01 | -3.44e-02 | 0.95700 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 8.75e-01 | 3.44e-02 | 0.97600 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 6 | 8.84e-01 | -3.44e-02 | 0.97900 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 169 | 4.42e-01 | -3.43e-02 | 0.87000 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 24 | 7.71e-01 | -3.43e-02 | 0.96000 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 7.53e-01 | -3.43e-02 | 0.95600 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 26 | 7.62e-01 | 3.43e-02 | 0.95800 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 8 | 8.67e-01 | -3.43e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 64 | 6.36e-01 | 3.43e-02 | 0.92400 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 12 | 8.37e-01 | -3.42e-02 | 0.97100 |
| GOBP CELLULAR RESPONSE TO STRESS | 1562 | 2.63e-02 | 3.42e-02 | 0.43600 |
| GOCC RNAI EFFECTOR COMPLEX | 23 | 7.76e-01 | -3.42e-02 | 0.96100 |
| GOBP LYSOSOMAL TRANSPORT | 112 | 5.32e-01 | -3.42e-02 | 0.89700 |
| GOBP PEROXISOMAL TRANSPORT | 21 | 7.86e-01 | -3.42e-02 | 0.96200 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 8.25e-01 | -3.42e-02 | 0.97100 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 102 | 5.51e-01 | -3.42e-02 | 0.90100 |
| GOMF CERAMIDE BINDING | 14 | 8.25e-01 | -3.41e-02 | 0.97100 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 8.45e-01 | -3.41e-02 | 0.97200 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 10 | 8.52e-01 | -3.41e-02 | 0.97200 |
| GOBP RESPONSE TO RETINOIC ACID | 49 | 6.80e-01 | 3.41e-02 | 0.93400 |
| GOCC OUTER DYNEIN ARM | 5 | 8.95e-01 | -3.41e-02 | 0.98000 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 89 | 5.79e-01 | 3.40e-02 | 0.91000 |
| GOBP LOCOMOTION | 778 | 1.09e-01 | 3.40e-02 | 0.63900 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 11 | 8.45e-01 | -3.40e-02 | 0.97200 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 8.95e-01 | -3.40e-02 | 0.98000 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 6 | 8.86e-01 | 3.39e-02 | 0.98000 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 21 | 7.88e-01 | -3.39e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION | 5 | 8.96e-01 | -3.39e-02 | 0.98000 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 187 | 4.25e-01 | -3.39e-02 | 0.86400 |
| GOBP CYTOSOLIC TRANSPORT | 162 | 4.58e-01 | 3.38e-02 | 0.87700 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 233 | 3.75e-01 | 3.38e-02 | 0.84200 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 72 | 6.20e-01 | 3.38e-02 | 0.92100 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 36 | 7.26e-01 | -3.38e-02 | 0.95000 |
| GOBP NOTCH RECEPTOR PROCESSING | 9 | 8.61e-01 | 3.38e-02 | 0.97400 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 17 | 8.10e-01 | 3.37e-02 | 0.96700 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 14 | 8.27e-01 | 3.37e-02 | 0.97100 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 41 | 7.09e-01 | 3.37e-02 | 0.94400 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 16 | 8.15e-01 | -3.37e-02 | 0.96800 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 294 | 3.22e-01 | 3.37e-02 | 0.81400 |
| GOMF VITAMIN BINDING | 91 | 5.79e-01 | -3.37e-02 | 0.91000 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 64 | 6.42e-01 | 3.37e-02 | 0.92400 |
| GOMF PEPTIDE BINDING | 200 | 4.13e-01 | 3.37e-02 | 0.86000 |
| GOBP TYPE I INTERFERON PRODUCTION | 108 | 5.46e-01 | 3.36e-02 | 0.89900 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 8.78e-01 | -3.36e-02 | 0.97600 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 7 | 8.78e-01 | -3.36e-02 | 0.97600 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 677 | 1.39e-01 | 3.36e-02 | 0.68200 |
| GOBP GLYCOLYTIC PROCESS | 67 | 6.35e-01 | -3.36e-02 | 0.92400 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 8.28e-01 | 3.36e-02 | 0.97100 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 8.87e-01 | -3.36e-02 | 0.98000 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 8.28e-01 | 3.36e-02 | 0.97100 |
| GOCC FICOLIN 1 RICH GRANULE | 174 | 4.46e-01 | -3.35e-02 | 0.87300 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 26 | 7.68e-01 | 3.34e-02 | 0.95900 |
| GOCC STEREOCILIUM TIP | 9 | 8.62e-01 | -3.34e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 8.06e-01 | -3.34e-02 | 0.96600 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 23 | 7.82e-01 | 3.33e-02 | 0.96200 |
| GOCC GLYCOPROTEIN COMPLEX | 16 | 8.18e-01 | -3.33e-02 | 0.96800 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 29 | 7.56e-01 | -3.33e-02 | 0.95600 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 44 | 7.03e-01 | 3.33e-02 | 0.94200 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 19 | 8.02e-01 | 3.33e-02 | 0.96400 |
| GOBP MRNA TRANSPORT | 114 | 5.40e-01 | 3.33e-02 | 0.89700 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 38 | 7.23e-01 | -3.33e-02 | 0.94900 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 8.49e-01 | 3.33e-02 | 0.97200 |
| GOBP CELL MOTILITY | 1043 | 7.24e-02 | 3.32e-02 | 0.57900 |
| GOCC ACROSOMAL MEMBRANE | 14 | 8.30e-01 | -3.32e-02 | 0.97100 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 43 | 7.07e-01 | 3.32e-02 | 0.94300 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 15 | 8.24e-01 | 3.32e-02 | 0.97100 |
| GOBP HEMOPOIESIS | 704 | 1.36e-01 | 3.32e-02 | 0.68000 |
| GOBP ACTIN FILAMENT ORGANIZATION | 330 | 3.02e-01 | 3.32e-02 | 0.80400 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 8.13e-01 | 3.32e-02 | 0.96800 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 45 | 7.01e-01 | -3.31e-02 | 0.94100 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 8.71e-01 | -3.31e-02 | 0.97500 |
| GOCC MIDBODY | 181 | 4.43e-01 | -3.31e-02 | 0.87100 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 143 | 4.96e-01 | 3.30e-02 | 0.88600 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 8.89e-01 | 3.30e-02 | 0.98000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 89 | 5.91e-01 | 3.30e-02 | 0.91300 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 115 | 5.42e-01 | -3.30e-02 | 0.89800 |
| GOBP FATTY ACID METABOLIC PROCESS | 262 | 3.60e-01 | 3.30e-02 | 0.83700 |
| GOBP DNA DEAMINATION | 11 | 8.50e-01 | 3.29e-02 | 0.97200 |
| GOMF ANTIPORTER ACTIVITY | 92 | 5.86e-01 | 3.29e-02 | 0.91300 |
| GOMF DNA EXONUCLEASE ACTIVITY | 21 | 7.94e-01 | 3.29e-02 | 0.96200 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 121 | 5.32e-01 | -3.29e-02 | 0.89700 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 8.72e-01 | -3.29e-02 | 0.97500 |
| GOBP REGULATION OF AUTOPHAGY | 304 | 3.26e-01 | -3.29e-02 | 0.81700 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 8.99e-01 | 3.29e-02 | 0.98000 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 110 | 5.53e-01 | 3.28e-02 | 0.90100 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 8.99e-01 | 3.28e-02 | 0.98000 |
| GOBP RETINAL METABOLIC PROCESS | 10 | 8.57e-01 | 3.28e-02 | 0.97400 |
| GOBP CELL FATE SPECIFICATION | 36 | 7.34e-01 | 3.28e-02 | 0.95300 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 94 | 5.84e-01 | -3.27e-02 | 0.91200 |
| GOBP REGULATION OF PROTEIN TARGETING | 69 | 6.39e-01 | -3.27e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 15 | 8.26e-01 | -3.27e-02 | 0.97100 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 529 | 2.00e-01 | -3.27e-02 | 0.73700 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 8 | 8.73e-01 | 3.27e-02 | 0.97500 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 6.41e-01 | 3.27e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 8 | 8.73e-01 | 3.27e-02 | 0.97500 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 67 | 6.44e-01 | -3.27e-02 | 0.92500 |
| GOBP POSITIVE REGULATION OF GROWTH | 153 | 4.86e-01 | -3.27e-02 | 0.88300 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 45 | 7.05e-01 | -3.27e-02 | 0.94200 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 8.65e-01 | 3.26e-02 | 0.97400 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 144 | 5.00e-01 | 3.26e-02 | 0.88600 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 6 | 8.90e-01 | -3.26e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 8.90e-01 | 3.26e-02 | 0.98000 |
| GOMF RNA NUCLEASE ACTIVITY | 109 | 5.57e-01 | 3.26e-02 | 0.90300 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE | 5 | 9.00e-01 | -3.26e-02 | 0.98000 |
| GOCC IGA IMMUNOGLOBULIN COMPLEX | 5 | 9.00e-01 | -3.26e-02 | 0.98000 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 5 | 9.00e-01 | 3.25e-02 | 0.98000 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 17 | 8.17e-01 | 3.24e-02 | 0.96800 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 9.00e-01 | -3.24e-02 | 0.98000 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 745 | 1.35e-01 | -3.24e-02 | 0.68000 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 11 | 8.53e-01 | 3.24e-02 | 0.97200 |
| GOCC U5 SNRNP | 19 | 8.07e-01 | 3.24e-02 | 0.96600 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 8.60e-01 | 3.23e-02 | 0.97400 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 22 | 7.93e-01 | -3.23e-02 | 0.96200 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 6.96e-01 | -3.22e-02 | 0.93800 |
| GOBP LIPID LOCALIZATION | 293 | 3.44e-01 | -3.22e-02 | 0.83000 |
| GOBP CELL CELL SIGNALING BY WNT | 284 | 3.52e-01 | -3.22e-02 | 0.83500 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 16 | 8.24e-01 | -3.22e-02 | 0.97100 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 187 | 4.49e-01 | 3.22e-02 | 0.87300 |
| GOBP RESPONSE TO ETHER | 9 | 8.67e-01 | 3.22e-02 | 0.97400 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 27 | 7.73e-01 | 3.21e-02 | 0.96000 |
| GOBP GOLGI LOCALIZATION | 13 | 8.41e-01 | -3.21e-02 | 0.97200 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 186 | 4.51e-01 | -3.21e-02 | 0.87400 |
| GOBP INTERLEUKIN 8 PRODUCTION | 64 | 6.57e-01 | 3.21e-02 | 0.93000 |
| GOCC GOLGI STACK | 110 | 5.61e-01 | -3.21e-02 | 0.90500 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 52 | 6.89e-01 | 3.21e-02 | 0.93600 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 19 | 8.09e-01 | 3.21e-02 | 0.96700 |
| GOBP METENCEPHALON DEVELOPMENT | 71 | 6.40e-01 | -3.21e-02 | 0.92400 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 86 | 6.08e-01 | -3.20e-02 | 0.91700 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 230 | 4.04e-01 | 3.20e-02 | 0.85600 |
| GOCC CLATHRIN COATED VESICLE | 159 | 4.87e-01 | -3.20e-02 | 0.88300 |
| GOCC GTPASE COMPLEX | 29 | 7.66e-01 | 3.20e-02 | 0.95900 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 8.25e-01 | 3.20e-02 | 0.97100 |
| GOBP CHONDROCYTE PROLIFERATION | 10 | 8.61e-01 | -3.20e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 9.02e-01 | 3.20e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 9.02e-01 | 3.20e-02 | 0.98000 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 8.76e-01 | 3.19e-02 | 0.97600 |
| GOBP TISSUE HOMEOSTASIS | 163 | 4.82e-01 | -3.19e-02 | 0.88300 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 67 | 6.52e-01 | 3.19e-02 | 0.92700 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 33 | 7.51e-01 | 3.19e-02 | 0.95600 |
| GOBP CELL PROJECTION ORGANIZATION | 1054 | 8.38e-02 | 3.18e-02 | 0.60000 |
| GOBP L SERINE METABOLIC PROCESS | 8 | 8.76e-01 | 3.18e-02 | 0.97600 |
| GOBP RNA DECAPPING | 19 | 8.10e-01 | -3.18e-02 | 0.96700 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 9.02e-01 | 3.18e-02 | 0.98000 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 21 | 8.01e-01 | 3.17e-02 | 0.96400 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 13 | 8.43e-01 | -3.17e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 201 | 4.40e-01 | 3.17e-02 | 0.86900 |
| GOCC U1 SNRNP | 19 | 8.11e-01 | 3.16e-02 | 0.96700 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 102 | 5.81e-01 | -3.16e-02 | 0.91200 |
| GOMF KINASE ACTIVATOR ACTIVITY | 97 | 5.91e-01 | 3.16e-02 | 0.91300 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 33 | 7.54e-01 | -3.16e-02 | 0.95600 |
| GOBP MACROMOLECULE DEACYLATION | 61 | 6.70e-01 | 3.16e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 93 | 5.99e-01 | -3.15e-02 | 0.91400 |
| GOCC ACTIN CYTOSKELETON | 347 | 3.15e-01 | 3.15e-02 | 0.81000 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 23 | 7.94e-01 | 3.15e-02 | 0.96200 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 5 | 9.03e-01 | -3.15e-02 | 0.98000 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 14 | 8.39e-01 | -3.14e-02 | 0.97200 |
| GOBP SEXUAL REPRODUCTION | 589 | 1.96e-01 | -3.14e-02 | 0.73400 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 99 | 5.90e-01 | -3.14e-02 | 0.91300 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 365 | 3.05e-01 | 3.14e-02 | 0.80600 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 13 | 8.45e-01 | 3.14e-02 | 0.97200 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 8.64e-01 | -3.13e-02 | 0.97400 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 336 | 3.26e-01 | -3.13e-02 | 0.81700 |
| GOCC ENDOLYSOSOME | 24 | 7.91e-01 | -3.13e-02 | 0.96200 |
| GOBP CELLULAR RESPONSE TO UV | 75 | 6.40e-01 | 3.13e-02 | 0.92400 |
| GOBP REGULATION OF HORMONE SECRETION | 143 | 5.19e-01 | -3.13e-02 | 0.89100 |
| GOCC COATED VESICLE MEMBRANE | 162 | 4.93e-01 | -3.12e-02 | 0.88600 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 51 | 7.00e-01 | 3.12e-02 | 0.94100 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 9 | 8.71e-01 | -3.12e-02 | 0.97500 |
| GOCC ADHERENS JUNCTION | 126 | 5.45e-01 | 3.12e-02 | 0.89900 |
| GOCC VESICLE TETHERING COMPLEX | 53 | 6.94e-01 | 3.12e-02 | 0.93800 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 8.45e-01 | 3.12e-02 | 0.97200 |
| GOBP AMINO ACID CATABOLIC PROCESS | 74 | 6.43e-01 | -3.12e-02 | 0.92400 |
| GOBP ACETYL COA METABOLIC PROCESS | 27 | 7.79e-01 | -3.12e-02 | 0.96100 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 8.95e-01 | -3.12e-02 | 0.98000 |
| GOMF MRNA 3 UTR BINDING | 85 | 6.20e-01 | 3.11e-02 | 0.92100 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 9 | 8.72e-01 | 3.11e-02 | 0.97500 |
| GOMF PRERIBOSOME BINDING | 8 | 8.79e-01 | 3.11e-02 | 0.97700 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 17 | 8.24e-01 | -3.11e-02 | 0.97100 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 35 | 7.51e-01 | -3.11e-02 | 0.95600 |
| GOBP ATP TRANSPORT | 13 | 8.46e-01 | 3.11e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 14 | 8.41e-01 | 3.10e-02 | 0.97200 |
| GOCC ESCRT I COMPLEX | 10 | 8.65e-01 | -3.10e-02 | 0.97400 |
| GOBP REGULATION OF CELL KILLING | 82 | 6.28e-01 | 3.10e-02 | 0.92400 |
| GOBP PLATELET DEGRANULATION | 6 | 8.95e-01 | 3.10e-02 | 0.98000 |
| GOCC KINESIN COMPLEX | 32 | 7.62e-01 | -3.10e-02 | 0.95700 |
| GOBP NEURAL TUBE FORMATION | 79 | 6.34e-01 | -3.10e-02 | 0.92400 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 18 | 8.20e-01 | 3.10e-02 | 0.97000 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 222 | 4.28e-01 | 3.10e-02 | 0.86400 |
| GOBP RESPONSE TO BACTERIUM | 414 | 2.82e-01 | 3.09e-02 | 0.79000 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 8.96e-01 | -3.09e-02 | 0.98000 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 9.05e-01 | -3.09e-02 | 0.98000 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 19 | 8.16e-01 | 3.09e-02 | 0.96800 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 8.87e-01 | -3.09e-02 | 0.98000 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 8.96e-01 | -3.08e-02 | 0.98000 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 8.96e-01 | -3.08e-02 | 0.98000 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 51 | 7.04e-01 | 3.08e-02 | 0.94200 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 12 | 8.53e-01 | -3.08e-02 | 0.97200 |
| GOCC BRUSH BORDER | 61 | 6.78e-01 | 3.08e-02 | 0.93200 |
| GOMF ADP BINDING | 33 | 7.60e-01 | 3.07e-02 | 0.95700 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 20 | 8.12e-01 | -3.07e-02 | 0.96800 |
| GOBP SEGMENTATION | 50 | 7.07e-01 | -3.07e-02 | 0.94300 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 6.71e-01 | -3.07e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 6 | 8.96e-01 | -3.07e-02 | 0.98000 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 8.60e-01 | -3.07e-02 | 0.97400 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 24 | 7.95e-01 | 3.07e-02 | 0.96200 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 8.32e-01 | 3.07e-02 | 0.97100 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 15 | 8.37e-01 | 3.06e-02 | 0.97100 |
| GOBP SECRETION | 592 | 2.06e-01 | -3.06e-02 | 0.73800 |
| GOBP REGULATION OF COAGULATION | 39 | 7.41e-01 | -3.06e-02 | 0.95400 |
| GOMF CGMP BINDING | 10 | 8.67e-01 | -3.06e-02 | 0.97400 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 32 | 7.65e-01 | 3.05e-02 | 0.95900 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 18 | 8.23e-01 | -3.05e-02 | 0.97100 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 36 | 7.52e-01 | 3.05e-02 | 0.95600 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 269 | 3.90e-01 | 3.05e-02 | 0.85200 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 12 | 8.55e-01 | -3.05e-02 | 0.97300 |
| GOBP AMIDE TRANSPORT | 206 | 4.52e-01 | 3.04e-02 | 0.87400 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 11 | 8.61e-01 | 3.04e-02 | 0.97400 |
| GOBP REGULATION OF PROTEIN BINDING | 105 | 5.91e-01 | 3.04e-02 | 0.91300 |
| GOBP COLLAGEN METABOLIC PROCESS | 57 | 6.92e-01 | -3.04e-02 | 0.93700 |
| GOBP ADULT BEHAVIOR | 81 | 6.37e-01 | -3.04e-02 | 0.92400 |
| GOBP RESPONSE TO LIPID | 583 | 2.13e-01 | 3.04e-02 | 0.74000 |
| GOBP CEREBELLAR CORTEX FORMATION | 17 | 8.29e-01 | -3.03e-02 | 0.97100 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 149 | 5.24e-01 | -3.03e-02 | 0.89200 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 5 | 9.07e-01 | 3.03e-02 | 0.98000 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 89 | 6.22e-01 | 3.03e-02 | 0.92100 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 27 | 7.86e-01 | -3.03e-02 | 0.96200 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 155 | 5.16e-01 | -3.02e-02 | 0.89100 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 34 | 7.60e-01 | -3.02e-02 | 0.95700 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 154 | 5.18e-01 | -3.02e-02 | 0.89100 |
| GOBP B CELL DIFFERENTIATION | 107 | 5.89e-01 | 3.02e-02 | 0.91300 |
| GOBP GLUCOSE IMPORT | 52 | 7.06e-01 | 3.02e-02 | 0.94300 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 159 | 5.11e-01 | 3.02e-02 | 0.89000 |
| GOMF GATED CHANNEL ACTIVITY | 133 | 5.48e-01 | 3.02e-02 | 0.90000 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 26 | 7.90e-01 | -3.02e-02 | 0.96200 |
| GOBP REGENERATION | 108 | 5.88e-01 | 3.02e-02 | 0.91300 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 29 | 7.78e-01 | -3.02e-02 | 0.96100 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 70 | 6.62e-01 | 3.02e-02 | 0.93200 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 103 | 5.97e-01 | 3.02e-02 | 0.91300 |
| GOBP RESPONSE TO THYROID HORMONE | 20 | 8.15e-01 | -3.02e-02 | 0.96800 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1144 | 8.90e-02 | 3.02e-02 | 0.61300 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 8.98e-01 | -3.02e-02 | 0.98000 |
| GOBP REGULATION OF HEART CONTRACTION | 102 | 5.99e-01 | 3.01e-02 | 0.91400 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 8.11e-01 | 3.01e-02 | 0.96700 |
| GOBP CELLULAR RESPONSE TO KETONE | 68 | 6.68e-01 | 3.01e-02 | 0.93200 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 128 | 5.58e-01 | 3.01e-02 | 0.90400 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 45 | 7.27e-01 | 3.00e-02 | 0.95100 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 6 | 8.99e-01 | 3.00e-02 | 0.98000 |
| GOBP REGULATION OF HISTONE ACETYLATION | 17 | 8.30e-01 | 3.00e-02 | 0.97100 |
| GOBP HEART PROCESS | 134 | 5.49e-01 | 3.00e-02 | 0.90000 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 8.46e-01 | 3.00e-02 | 0.97200 |
| GOBP MYELIN ASSEMBLY | 15 | 8.41e-01 | 3.00e-02 | 0.97200 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 77 | 6.50e-01 | -3.00e-02 | 0.92700 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 13 | 8.52e-01 | 3.00e-02 | 0.97200 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 8.91e-01 | -2.99e-02 | 0.98000 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 52 | 7.09e-01 | -2.99e-02 | 0.94400 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 85 | 6.34e-01 | -2.99e-02 | 0.92400 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 25 | 7.96e-01 | 2.98e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 97 | 6.12e-01 | -2.98e-02 | 0.91800 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 42 | 7.38e-01 | -2.98e-02 | 0.95400 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 8.09e-01 | 2.98e-02 | 0.96700 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 116 | 5.80e-01 | 2.98e-02 | 0.91000 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 78 | 6.50e-01 | 2.98e-02 | 0.92700 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.00e-01 | -2.97e-02 | 0.98000 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 278 | 3.95e-01 | 2.97e-02 | 0.85400 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 169 | 5.05e-01 | 2.97e-02 | 0.88800 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 109 | 5.92e-01 | 2.97e-02 | 0.91300 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 8.84e-01 | -2.97e-02 | 0.97900 |
| GOBP ANIMAL ORGAN FORMATION | 27 | 7.89e-01 | -2.97e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 66 | 6.77e-01 | -2.97e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 8.42e-01 | -2.97e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 24 | 8.01e-01 | 2.97e-02 | 0.96400 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 99 | 6.11e-01 | -2.96e-02 | 0.91800 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 208 | 4.63e-01 | -2.96e-02 | 0.87900 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 10 | 8.71e-01 | 2.96e-02 | 0.97500 |
| GOMF PHOSPHOLIPID BINDING | 344 | 3.48e-01 | 2.96e-02 | 0.83300 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 30 | 7.79e-01 | -2.95e-02 | 0.96100 |
| GOCC CELL CELL JUNCTION | 299 | 3.81e-01 | 2.95e-02 | 0.84400 |
| GOMF DAMAGED DNA BINDING | 67 | 6.76e-01 | 2.95e-02 | 0.93200 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 43 | 7.38e-01 | 2.95e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 79 | 6.51e-01 | 2.95e-02 | 0.92700 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 25 | 7.99e-01 | 2.95e-02 | 0.96300 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 8.72e-01 | -2.94e-02 | 0.97500 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 16 | 8.39e-01 | -2.94e-02 | 0.97200 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 79 | 6.52e-01 | -2.94e-02 | 0.92700 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 8.93e-01 | 2.94e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 56 | 7.04e-01 | 2.94e-02 | 0.94200 |
| GOCC CORTICAL CYTOSKELETON | 67 | 6.78e-01 | 2.94e-02 | 0.93300 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 9.01e-01 | -2.93e-02 | 0.98000 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 212 | 4.63e-01 | 2.93e-02 | 0.87900 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 8.08e-01 | 2.93e-02 | 0.96600 |
| GOBP REGULATION OF MICROTUBULE BINDING | 6 | 9.01e-01 | -2.92e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 36 | 7.62e-01 | -2.92e-02 | 0.95800 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 60 | 6.96e-01 | 2.92e-02 | 0.93800 |
| GOCC MITOTIC SPINDLE | 149 | 5.40e-01 | -2.92e-02 | 0.89700 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 15 | 8.45e-01 | -2.92e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 11 | 8.67e-01 | 2.91e-02 | 0.97400 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1163 | 9.78e-02 | 2.91e-02 | 0.62300 |
| GOCC CILIUM | 465 | 2.84e-01 | 2.91e-02 | 0.79100 |
| GOBP GOLGI ORGANIZATION | 131 | 5.66e-01 | 2.91e-02 | 0.90600 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 7.39e-01 | -2.91e-02 | 0.95400 |
| GOBP PYRUVATE METABOLIC PROCESS | 91 | 6.32e-01 | -2.91e-02 | 0.92400 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 690 | 1.96e-01 | -2.91e-02 | 0.73400 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 7.77e-01 | 2.90e-02 | 0.96100 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 27 | 7.95e-01 | 2.89e-02 | 0.96200 |
| GOCC HETEROCHROMATIN | 66 | 6.85e-01 | 2.89e-02 | 0.93500 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 6.79e-01 | 2.88e-02 | 0.93300 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 12 | 8.63e-01 | -2.88e-02 | 0.97400 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 97 | 6.24e-01 | -2.88e-02 | 0.92200 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 116 | 5.93e-01 | 2.88e-02 | 0.91300 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 8.57e-01 | 2.88e-02 | 0.97400 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 22 | 8.15e-01 | 2.88e-02 | 0.96800 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 9.03e-01 | 2.88e-02 | 0.98000 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 113 | 5.98e-01 | 2.88e-02 | 0.91300 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 8.52e-01 | -2.87e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 144 | 5.53e-01 | 2.87e-02 | 0.90100 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 7.66e-01 | -2.86e-02 | 0.95900 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 146 | 5.51e-01 | 2.86e-02 | 0.90100 |
| GOBP PIGMENT GRANULE LOCALIZATION | 19 | 8.29e-01 | -2.86e-02 | 0.97100 |
| GOBP LONG TERM MEMORY | 18 | 8.34e-01 | -2.86e-02 | 0.97100 |
| GOBP SPERM MOTILITY | 59 | 7.04e-01 | 2.86e-02 | 0.94200 |
| GOCC SIDE OF MEMBRANE | 440 | 3.06e-01 | 2.86e-02 | 0.80700 |
| GOCC MICROTUBULE END | 27 | 7.97e-01 | -2.86e-02 | 0.96300 |
| GOBP PROTEIN MONOUBIQUITINATION | 40 | 7.55e-01 | 2.85e-02 | 0.95600 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 8.05e-01 | 2.85e-02 | 0.96600 |
| GOMF CYTOKINE RECEPTOR BINDING | 137 | 5.66e-01 | 2.84e-02 | 0.90600 |
| GOBP EXPORT FROM CELL | 569 | 2.49e-01 | -2.84e-02 | 0.76800 |
| GOCC PROTEIN KINASE COMPLEX | 119 | 5.93e-01 | 2.84e-02 | 0.91300 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 8.60e-01 | 2.83e-02 | 0.97400 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 31 | 7.85e-01 | 2.83e-02 | 0.96200 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 92 | 6.39e-01 | 2.83e-02 | 0.92400 |
| GOCC ENDOSOME | 796 | 1.78e-01 | -2.83e-02 | 0.71700 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 43 | 7.49e-01 | 2.82e-02 | 0.95600 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 23 | 8.15e-01 | -2.82e-02 | 0.96800 |
| GOBP CELL GROWTH | 336 | 3.76e-01 | -2.82e-02 | 0.84300 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 12 | 8.66e-01 | 2.81e-02 | 0.97400 |
| GOMF CARBOXY LYASE ACTIVITY | 23 | 8.15e-01 | 2.81e-02 | 0.96800 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 8.56e-01 | 2.81e-02 | 0.97400 |
| GOCC SPERM PRINCIPAL PIECE | 18 | 8.37e-01 | 2.81e-02 | 0.97100 |
| GOBP PROTEIN DESUMOYLATION | 8 | 8.91e-01 | -2.81e-02 | 0.98000 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 23 | 8.16e-01 | -2.81e-02 | 0.96800 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 356 | 3.65e-01 | 2.80e-02 | 0.84000 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 115 | 6.04e-01 | -2.80e-02 | 0.91600 |
| GOCC MEMBRANE MICRODOMAIN | 187 | 5.10e-01 | 2.80e-02 | 0.88900 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 33 | 7.81e-01 | -2.80e-02 | 0.96100 |
| GOBP ANIMAL ORGAN REGENERATION | 37 | 7.69e-01 | 2.80e-02 | 0.95900 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 12 | 8.67e-01 | 2.80e-02 | 0.97400 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 16 | 8.47e-01 | 2.79e-02 | 0.97200 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 45 | 7.46e-01 | -2.79e-02 | 0.95600 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 47 | 7.41e-01 | 2.79e-02 | 0.95400 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 7.82e-01 | -2.79e-02 | 0.96200 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 18 | 8.38e-01 | -2.79e-02 | 0.97200 |
| GOBP LENS FIBER CELL DEVELOPMENT | 8 | 8.91e-01 | -2.79e-02 | 0.98000 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 16 | 8.47e-01 | 2.79e-02 | 0.97200 |
| GOCC A BAND | 19 | 8.34e-01 | -2.79e-02 | 0.97100 |
| GOBP EMBRYO DEVELOPMENT | 678 | 2.20e-01 | -2.78e-02 | 0.74900 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 90 | 6.49e-01 | 2.78e-02 | 0.92700 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 7 | 8.99e-01 | 2.78e-02 | 0.98000 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 8.79e-01 | 2.78e-02 | 0.97700 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 5 | 9.14e-01 | 2.78e-02 | 0.98100 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 9.14e-01 | 2.78e-02 | 0.98100 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 31 | 7.89e-01 | -2.78e-02 | 0.96200 |
| GOMF NUCLEASE ACTIVITY | 182 | 5.20e-01 | 2.77e-02 | 0.89100 |
| GOBP TISSUE REMODELING | 102 | 6.30e-01 | 2.76e-02 | 0.92400 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 61 | 7.09e-01 | -2.76e-02 | 0.94400 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 69 | 6.92e-01 | -2.76e-02 | 0.93700 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 8.59e-01 | -2.75e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 81 | 6.69e-01 | -2.75e-02 | 0.93200 |
| GOBP CELL ADHESION | 901 | 1.66e-01 | 2.75e-02 | 0.70500 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 8 | 8.93e-01 | 2.74e-02 | 0.98000 |
| GOBP TOR SIGNALING | 140 | 5.76e-01 | -2.74e-02 | 0.90800 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 523 | 2.86e-01 | -2.74e-02 | 0.79100 |
| GOBP STEROID METABOLIC PROCESS | 179 | 5.28e-01 | -2.74e-02 | 0.89400 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 387 | 3.56e-01 | -2.74e-02 | 0.83600 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 9.08e-01 | 2.73e-02 | 0.98000 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 219 | 4.86e-01 | 2.73e-02 | 0.88300 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 673 | 2.30e-01 | 2.73e-02 | 0.75400 |
| GOMF 7SK SNRNA BINDING | 8 | 8.94e-01 | 2.73e-02 | 0.98000 |
| GOMF KINASE REGULATOR ACTIVITY | 191 | 5.16e-01 | 2.73e-02 | 0.89100 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 9.16e-01 | -2.73e-02 | 0.98100 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 136 | 5.83e-01 | 2.73e-02 | 0.91200 |
| GOBP T CELL SELECTION | 41 | 7.63e-01 | -2.73e-02 | 0.95800 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 179 | 5.30e-01 | -2.72e-02 | 0.89700 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 20 | 8.33e-01 | -2.72e-02 | 0.97100 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 9.01e-01 | 2.72e-02 | 0.98000 |
| GOBP VESICLE TETHERING | 32 | 7.90e-01 | -2.72e-02 | 0.96200 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 31 | 7.94e-01 | -2.72e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 8.88e-01 | -2.71e-02 | 0.98000 |
| GOMF RIBOSOME BINDING | 103 | 6.35e-01 | -2.71e-02 | 0.92400 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 8 | 8.95e-01 | 2.71e-02 | 0.98000 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 8.88e-01 | 2.71e-02 | 0.98000 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 71 | 6.94e-01 | 2.70e-02 | 0.93800 |
| GOBP REGULATION OF MITOPHAGY | 14 | 8.61e-01 | -2.70e-02 | 0.97400 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 8.95e-01 | 2.70e-02 | 0.98000 |
| GOCC BORC COMPLEX | 8 | 8.95e-01 | 2.70e-02 | 0.98000 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 57 | 7.25e-01 | -2.70e-02 | 0.95000 |
| GOBP RESPONSE TO WOUNDING | 350 | 3.88e-01 | -2.70e-02 | 0.85000 |
| GOCC SYNAPSE | 886 | 1.77e-01 | -2.69e-02 | 0.71700 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 22 | 8.27e-01 | -2.69e-02 | 0.97100 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 8.67e-01 | -2.69e-02 | 0.97400 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 454 | 3.29e-01 | 2.69e-02 | 0.81800 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 55 | 7.31e-01 | -2.69e-02 | 0.95200 |
| GOMF HEPARIN BINDING | 76 | 6.86e-01 | 2.68e-02 | 0.93500 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 63 | 7.13e-01 | -2.68e-02 | 0.94600 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 7.49e-01 | -2.67e-02 | 0.95600 |
| GOBP ETHANOL METABOLIC PROCESS | 10 | 8.84e-01 | -2.67e-02 | 0.97900 |
| GOBP SENSORY PERCEPTION | 234 | 4.83e-01 | -2.67e-02 | 0.88300 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 8 | 8.96e-01 | 2.67e-02 | 0.98000 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 18 | 8.45e-01 | 2.67e-02 | 0.97200 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1263 | 1.17e-01 | 2.66e-02 | 0.65700 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 106 | 6.37e-01 | -2.66e-02 | 0.92400 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 9.03e-01 | 2.66e-02 | 0.98000 |
| GOCC SYNAPTIC MEMBRANE | 185 | 5.34e-01 | -2.66e-02 | 0.89700 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 9.03e-01 | 2.66e-02 | 0.98000 |
| GOBP REGULATION OF HEART RATE | 53 | 7.38e-01 | 2.65e-02 | 0.95400 |
| GOBP MEMBRANE DEPOLARIZATION | 42 | 7.66e-01 | 2.65e-02 | 0.95900 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 8.97e-01 | -2.65e-02 | 0.98000 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1140 | 1.36e-01 | -2.65e-02 | 0.68000 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 8.91e-01 | -2.65e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 38 | 7.78e-01 | 2.65e-02 | 0.96100 |
| GOBP POTASSIUM ION TRANSPORT | 104 | 6.41e-01 | 2.65e-02 | 0.92400 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 45 | 7.59e-01 | 2.65e-02 | 0.95700 |
| GOCC RECYCLING ENDOSOME | 153 | 5.73e-01 | -2.64e-02 | 0.90800 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 13 | 8.69e-01 | -2.64e-02 | 0.97500 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 40 | 7.73e-01 | -2.64e-02 | 0.96000 |
| GOMF SULFOTRANSFERASE ACTIVITY | 20 | 8.38e-01 | -2.64e-02 | 0.97200 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 241 | 4.82e-01 | 2.64e-02 | 0.88300 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 43 | 7.65e-01 | 2.63e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 519 | 3.07e-01 | 2.63e-02 | 0.80700 |
| GOMF NUCLEAR RECEPTOR BINDING | 119 | 6.20e-01 | -2.63e-02 | 0.92100 |
| GOCC LYSOSOMAL LUMEN | 70 | 7.04e-01 | -2.63e-02 | 0.94200 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 43 | 7.66e-01 | 2.63e-02 | 0.95900 |
| GOBP PHOTOTRANSDUCTION | 21 | 8.35e-01 | 2.63e-02 | 0.97100 |
| GOBP CYTOKINESIS | 148 | 5.83e-01 | 2.62e-02 | 0.91200 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 43 | 7.66e-01 | -2.62e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 34 | 7.92e-01 | -2.62e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 848 | 1.99e-01 | -2.62e-02 | 0.73600 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 47 | 7.57e-01 | 2.62e-02 | 0.95600 |
| GOMF S ADENOSYL L METHIONINE BINDING | 17 | 8.52e-01 | -2.61e-02 | 0.97200 |
| GOCC IMMUNOLOGICAL SYNAPSE | 43 | 7.67e-01 | 2.61e-02 | 0.95900 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 34 | 7.92e-01 | -2.61e-02 | 0.96200 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 219 | 5.06e-01 | 2.61e-02 | 0.88800 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 21 | 8.36e-01 | 2.61e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 39 | 7.78e-01 | 2.61e-02 | 0.96100 |
| GOBP REGULATION OF HEAT GENERATION | 8 | 8.99e-01 | 2.60e-02 | 0.98000 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 44 | 7.65e-01 | 2.60e-02 | 0.95900 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 110 | 6.38e-01 | -2.60e-02 | 0.92400 |
| GOMF CYCLASE ACTIVITY | 14 | 8.66e-01 | -2.60e-02 | 0.97400 |
| GOBP INNER EAR MORPHOGENESIS | 37 | 7.85e-01 | -2.59e-02 | 0.96200 |
| GOBP CARTILAGE CONDENSATION | 6 | 9.12e-01 | 2.59e-02 | 0.98100 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 9.20e-01 | -2.59e-02 | 0.98200 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 679 | 2.54e-01 | -2.59e-02 | 0.77500 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 85 | 6.80e-01 | 2.59e-02 | 0.93400 |
| GOBP HYALURONAN CATABOLIC PROCESS | 12 | 8.77e-01 | -2.58e-02 | 0.97600 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 83 | 6.85e-01 | 2.58e-02 | 0.93500 |
| GOBP CIRCULATORY SYSTEM PROCESS | 328 | 4.23e-01 | 2.58e-02 | 0.86400 |
| GOBP RESPONSE TO LITHIUM ION | 7 | 9.06e-01 | 2.58e-02 | 0.98000 |
| GOBP SPERM EGG RECOGNITION | 24 | 8.27e-01 | -2.58e-02 | 0.97100 |
| GOMF G QUADRUPLEX DNA BINDING | 10 | 8.88e-01 | -2.58e-02 | 0.98000 |
| GOBP MICROVILLUS ORGANIZATION | 22 | 8.34e-01 | -2.57e-02 | 0.97100 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 8 | 9.00e-01 | -2.57e-02 | 0.98000 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 8 | 9.00e-01 | -2.57e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 29 | 8.11e-01 | 2.57e-02 | 0.96700 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 258 | 4.80e-01 | 2.56e-02 | 0.88200 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 14 | 8.68e-01 | -2.56e-02 | 0.97500 |
| GOBP MESENCHYME DEVELOPMENT | 169 | 5.67e-01 | 2.56e-02 | 0.90600 |
| GOBP PROTEIN POLYMERIZATION | 219 | 5.15e-01 | 2.56e-02 | 0.89100 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 8.78e-01 | -2.56e-02 | 0.97600 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 22 | 8.36e-01 | 2.56e-02 | 0.97100 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 8.15e-01 | 2.55e-02 | 0.96800 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 209 | 5.26e-01 | 2.55e-02 | 0.89300 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 81 | 6.92e-01 | -2.55e-02 | 0.93700 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 8.95e-01 | 2.55e-02 | 0.98000 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 21 | 8.40e-01 | -2.54e-02 | 0.97200 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 118 | 6.34e-01 | -2.54e-02 | 0.92400 |
| GOBP HEAD DEVELOPMENT | 456 | 3.55e-01 | 2.54e-02 | 0.83600 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 9.08e-01 | -2.53e-02 | 0.98000 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 69 | 7.16e-01 | -2.53e-02 | 0.94800 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 104 | 6.56e-01 | -2.53e-02 | 0.93000 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 9.22e-01 | 2.53e-02 | 0.98200 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 13 | 8.75e-01 | -2.52e-02 | 0.97600 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 29 | 8.15e-01 | 2.52e-02 | 0.96800 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 13 | 8.75e-01 | -2.51e-02 | 0.97600 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 8.71e-01 | -2.51e-02 | 0.97500 |
| GOBP HORMONE TRANSPORT | 179 | 5.63e-01 | -2.51e-02 | 0.90600 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 59 | 7.40e-01 | 2.50e-02 | 0.95400 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 34 | 8.01e-01 | 2.49e-02 | 0.96400 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 88 | 6.87e-01 | -2.49e-02 | 0.93500 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 7 | 9.09e-01 | -2.48e-02 | 0.98000 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 144 | 6.07e-01 | 2.48e-02 | 0.91700 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 10 | 8.92e-01 | 2.48e-02 | 0.98000 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 29 | 8.17e-01 | -2.48e-02 | 0.96800 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 9.24e-01 | 2.48e-02 | 0.98200 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 38 | 7.92e-01 | 2.48e-02 | 0.96200 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 191 | 5.56e-01 | -2.48e-02 | 0.90200 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 63 | 7.34e-01 | -2.48e-02 | 0.95300 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 16 | 8.64e-01 | -2.47e-02 | 0.97400 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 469 | 3.61e-01 | 2.47e-02 | 0.83900 |
| GOBP MAINTENANCE OF CELL POLARITY | 15 | 8.68e-01 | 2.47e-02 | 0.97500 |
| GOBP INSULIN SECRETION | 117 | 6.44e-01 | 2.47e-02 | 0.92500 |
| GOBP BLASTOCYST DEVELOPMENT | 87 | 6.91e-01 | -2.47e-02 | 0.93700 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 16 | 8.64e-01 | -2.47e-02 | 0.97400 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 37 | 7.96e-01 | 2.46e-02 | 0.96200 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 12 | 8.83e-01 | -2.46e-02 | 0.97900 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 8.93e-01 | 2.46e-02 | 0.98000 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 9.24e-01 | -2.46e-02 | 0.98200 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 43 | 7.81e-01 | -2.46e-02 | 0.96100 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 8.99e-01 | -2.45e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 29 | 8.20e-01 | -2.45e-02 | 0.97000 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 187 | 5.65e-01 | -2.44e-02 | 0.90600 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 8.94e-01 | 2.44e-02 | 0.98000 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 11 | 8.88e-01 | -2.44e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 814 | 2.40e-01 | 2.44e-02 | 0.76300 |
| GOMF MICROTUBULE BINDING | 207 | 5.46e-01 | -2.44e-02 | 0.89900 |
| GOCC MICROBODY MEMBRANE | 56 | 7.52e-01 | -2.44e-02 | 0.95600 |
| GOBP PEPTIDE CROSS LINKING | 9 | 8.99e-01 | -2.44e-02 | 0.98000 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 17 | 8.62e-01 | -2.44e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.66e-01 | 2.43e-02 | 0.97400 |
| GOBP MUSCLE HYPERTROPHY | 58 | 7.49e-01 | -2.43e-02 | 0.95600 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 9.05e-01 | 2.43e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 9.11e-01 | -2.43e-02 | 0.98100 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 140 | 6.20e-01 | 2.43e-02 | 0.92100 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 131 | 6.33e-01 | -2.42e-02 | 0.92400 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 16 | 8.67e-01 | -2.42e-02 | 0.97400 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 107 | 6.66e-01 | 2.42e-02 | 0.93200 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 48 | 7.72e-01 | 2.42e-02 | 0.96000 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 13 | 8.80e-01 | -2.42e-02 | 0.97700 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 8.35e-01 | -2.41e-02 | 0.97100 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 940 | 2.15e-01 | 2.41e-02 | 0.74200 |
| GOCC SAGA TYPE COMPLEX | 36 | 8.03e-01 | -2.40e-02 | 0.96400 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 21 | 8.49e-01 | 2.40e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 12 | 8.85e-01 | -2.40e-02 | 0.98000 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 15 | 8.72e-01 | -2.40e-02 | 0.97500 |
| GOMF KINASE INHIBITOR ACTIVITY | 59 | 7.50e-01 | -2.40e-02 | 0.95600 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 8.76e-01 | 2.40e-02 | 0.97600 |
| GOMF CHEMOREPELLENT ACTIVITY | 15 | 8.72e-01 | -2.40e-02 | 0.97500 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 5 | 9.26e-01 | 2.39e-02 | 0.98200 |
| GOCC DENDRITE TERMINUS | 9 | 9.01e-01 | 2.39e-02 | 0.98000 |
| GOBP REGULATION OF PLATELET ACTIVATION | 34 | 8.10e-01 | 2.39e-02 | 0.96700 |
| GOBP ENDOSOMAL TRANSPORT | 215 | 5.47e-01 | -2.39e-02 | 0.89900 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 61 | 7.47e-01 | -2.39e-02 | 0.95600 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 159 | 6.04e-01 | 2.39e-02 | 0.91600 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 253 | 5.15e-01 | 2.38e-02 | 0.89100 |
| GOBP INTRACELLULAR TRANSPORT | 1346 | 1.48e-01 | -2.38e-02 | 0.68700 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 273 | 4.99e-01 | 2.38e-02 | 0.88600 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 8.69e-01 | 2.38e-02 | 0.97500 |
| GOBP MEMBRANE FISSION | 40 | 7.94e-01 | 2.38e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 14 | 8.78e-01 | -2.38e-02 | 0.97600 |
| GOBP HEART FIELD SPECIFICATION | 7 | 9.13e-01 | 2.38e-02 | 0.98100 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 66 | 7.39e-01 | 2.37e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 409 | 4.13e-01 | 2.37e-02 | 0.86000 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 12 | 8.87e-01 | 2.37e-02 | 0.98000 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 9.02e-01 | -2.37e-02 | 0.98000 |
| GOBP GRANULOCYTE CHEMOTAXIS | 84 | 7.08e-01 | 2.37e-02 | 0.94300 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 39 | 7.98e-01 | -2.37e-02 | 0.96300 |
| GOBP REGULATION OF VASOCONSTRICTION | 29 | 8.26e-01 | -2.37e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 6 | 9.20e-01 | 2.36e-02 | 0.98200 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 9.27e-01 | -2.36e-02 | 0.98200 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 31 | 8.20e-01 | 2.36e-02 | 0.97000 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 13 | 8.83e-01 | -2.36e-02 | 0.97900 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 24 | 8.42e-01 | -2.36e-02 | 0.97200 |
| GOBP SODIUM ION TRANSPORT | 117 | 6.60e-01 | -2.36e-02 | 0.93200 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 5 | 9.27e-01 | -2.36e-02 | 0.98200 |
| GOCC VESICLE LUMEN | 257 | 5.17e-01 | -2.36e-02 | 0.89100 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 8.59e-01 | 2.36e-02 | 0.97400 |
| GOBP TRANSLATIONAL INITIATION | 114 | 6.65e-01 | -2.35e-02 | 0.93200 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 52 | 7.69e-01 | 2.35e-02 | 0.95900 |
| GOBP PANCREAS DEVELOPMENT | 38 | 8.02e-01 | 2.35e-02 | 0.96400 |
| GOBP DIGESTION | 46 | 7.83e-01 | -2.35e-02 | 0.96200 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 56 | 7.61e-01 | -2.35e-02 | 0.95700 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 71 | 7.32e-01 | -2.35e-02 | 0.95300 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 9.28e-01 | -2.35e-02 | 0.98200 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 31 | 8.21e-01 | -2.35e-02 | 0.97000 |
| GOBP MIRNA PROCESSING | 42 | 7.93e-01 | -2.35e-02 | 0.96200 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 27 | 8.33e-01 | -2.34e-02 | 0.97100 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 8.98e-01 | -2.34e-02 | 0.98000 |
| GOBP MICROTUBULE BUNDLE FORMATION | 59 | 7.56e-01 | -2.34e-02 | 0.95600 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 155 | 6.17e-01 | 2.33e-02 | 0.91900 |
| GOMF PEPTIDASE ACTIVITY | 354 | 4.53e-01 | -2.33e-02 | 0.87400 |
| GOCC EXOCYST | 12 | 8.89e-01 | -2.33e-02 | 0.98000 |
| GOBP TRANSPOSITION | 22 | 8.50e-01 | -2.33e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 24 | 8.44e-01 | -2.33e-02 | 0.97200 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 8 | 9.09e-01 | 2.32e-02 | 0.98000 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 9.04e-01 | 2.32e-02 | 0.98000 |
| GOCC NUCLEAR BODY | 729 | 2.89e-01 | -2.32e-02 | 0.79300 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 8.68e-01 | -2.32e-02 | 0.97500 |
| GOCC POSTSYNAPTIC MEMBRANE | 116 | 6.67e-01 | -2.31e-02 | 0.93200 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 8.99e-01 | -2.31e-02 | 0.98000 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 8.45e-01 | 2.31e-02 | 0.97200 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 38 | 8.05e-01 | -2.31e-02 | 0.96600 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 16 | 8.73e-01 | 2.31e-02 | 0.97500 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 15 | 8.77e-01 | -2.31e-02 | 0.97600 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 378 | 4.43e-01 | -2.31e-02 | 0.87100 |
| GOBP BONE MORPHOGENESIS | 41 | 7.98e-01 | 2.31e-02 | 0.96300 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 8.73e-01 | -2.31e-02 | 0.97500 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 7 | 9.16e-01 | 2.30e-02 | 0.98100 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 266 | 5.19e-01 | 2.30e-02 | 0.89100 |
| GOMF PHOSPHOPROTEIN BINDING | 79 | 7.24e-01 | -2.30e-02 | 0.94900 |
| GOBP RESPONSE TO GROWTH FACTOR | 439 | 4.10e-01 | 2.30e-02 | 0.86000 |
| GOBP SODIUM ION HOMEOSTASIS | 20 | 8.59e-01 | 2.30e-02 | 0.97400 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 17 | 8.70e-01 | -2.30e-02 | 0.97500 |
| GOBP TRANSPORT ALONG MICROTUBULE | 142 | 6.37e-01 | 2.30e-02 | 0.92400 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 72 | 7.37e-01 | -2.29e-02 | 0.95400 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 12 | 8.91e-01 | -2.29e-02 | 0.98000 |
| GOBP MESENCHYMAL CELL MIGRATION | 29 | 8.31e-01 | -2.29e-02 | 0.97100 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 24 | 8.46e-01 | 2.29e-02 | 0.97200 |
| GOBP PRENYLATION | 11 | 8.96e-01 | 2.28e-02 | 0.98000 |
| GOBP REGULATION OF DNA DEMETHYLATION | 8 | 9.11e-01 | 2.28e-02 | 0.98100 |
| GOMF ENZYME INHIBITOR ACTIVITY | 226 | 5.55e-01 | 2.28e-02 | 0.90200 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 9.06e-01 | -2.28e-02 | 0.98000 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 30 | 8.29e-01 | 2.28e-02 | 0.97100 |
| GOMF LIPID KINASE ACTIVITY | 35 | 8.16e-01 | -2.28e-02 | 0.96800 |
| GOBP MEMBRANE DOCKING | 77 | 7.30e-01 | -2.28e-02 | 0.95200 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 332 | 4.78e-01 | 2.28e-02 | 0.88100 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 483 | 3.94e-01 | 2.27e-02 | 0.85400 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 9.17e-01 | 2.27e-02 | 0.98100 |
| GOBP NADPH REGENERATION | 21 | 8.57e-01 | 2.27e-02 | 0.97400 |
| GOBP RESPONSE TO LIGHT STIMULUS | 225 | 5.59e-01 | 2.27e-02 | 0.90400 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 107 | 6.86e-01 | 2.26e-02 | 0.93500 |
| GOCC CELL CELL CONTACT ZONE | 47 | 7.89e-01 | -2.26e-02 | 0.96200 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 38 | 8.09e-01 | 2.26e-02 | 0.96700 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 11 | 8.97e-01 | 2.26e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 26 | 8.42e-01 | 2.26e-02 | 0.97200 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 9.07e-01 | -2.25e-02 | 0.98000 |
| GOMF PRE MIRNA BINDING | 8 | 9.12e-01 | 2.25e-02 | 0.98100 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 60 | 7.64e-01 | -2.25e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 268 | 5.28e-01 | 2.25e-02 | 0.89500 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 120 | 6.71e-01 | 2.25e-02 | 0.93200 |
| GOBP BLOOD VESSEL MATURATION | 7 | 9.18e-01 | -2.25e-02 | 0.98100 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 14 | 8.84e-01 | -2.24e-02 | 0.97900 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 6 | 9.24e-01 | 2.24e-02 | 0.98200 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 47 | 7.91e-01 | 2.24e-02 | 0.96200 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 17 | 8.73e-01 | 2.24e-02 | 0.97500 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 7 | 9.19e-01 | 2.23e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 93 | 7.10e-01 | 2.23e-02 | 0.94500 |
| GOCC SECRETORY GRANULE MEMBRANE | 243 | 5.51e-01 | -2.23e-02 | 0.90100 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 8.67e-01 | -2.23e-02 | 0.97400 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 21 | 8.60e-01 | -2.23e-02 | 0.97400 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 15 | 8.81e-01 | 2.23e-02 | 0.97800 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 52 | 7.82e-01 | -2.22e-02 | 0.96200 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 42 | 8.03e-01 | 2.22e-02 | 0.96400 |
| GOBP SPINDLE ORGANIZATION | 175 | 6.13e-01 | 2.22e-02 | 0.91800 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 175 | 6.13e-01 | 2.22e-02 | 0.91800 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 9.19e-01 | 2.22e-02 | 0.98100 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 19 | 8.67e-01 | 2.22e-02 | 0.97400 |
| GOBP MOTOR BEHAVIOR | 16 | 8.78e-01 | -2.22e-02 | 0.97600 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 9.25e-01 | 2.22e-02 | 0.98200 |
| GOCC FLOTILLIN COMPLEX | 7 | 9.19e-01 | 2.21e-02 | 0.98100 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 16 | 8.78e-01 | -2.21e-02 | 0.97600 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 5 | 9.32e-01 | 2.21e-02 | 0.98300 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 7 | 9.19e-01 | -2.21e-02 | 0.98100 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 10 | 9.04e-01 | 2.21e-02 | 0.98000 |
| GOBP PRE MIRNA PROCESSING | 14 | 8.86e-01 | 2.21e-02 | 0.98000 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 9.25e-01 | 2.20e-02 | 0.98200 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 133 | 6.61e-01 | -2.20e-02 | 0.93200 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 10 | 9.04e-01 | 2.20e-02 | 0.98000 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 42 | 8.05e-01 | -2.20e-02 | 0.96600 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 49 | 7.90e-01 | 2.20e-02 | 0.96200 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 87 | 7.24e-01 | -2.19e-02 | 0.94900 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 8.65e-01 | -2.19e-02 | 0.97400 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 148 | 6.46e-01 | -2.19e-02 | 0.92600 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 362 | 4.76e-01 | 2.19e-02 | 0.88100 |
| GOBP ACTION POTENTIAL | 72 | 7.49e-01 | 2.18e-02 | 0.95600 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 30 | 8.36e-01 | -2.18e-02 | 0.97100 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 41 | 8.09e-01 | 2.18e-02 | 0.96700 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 78 | 7.39e-01 | -2.18e-02 | 0.95400 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 396 | 4.58e-01 | -2.18e-02 | 0.87700 |
| GOMF ACTIN FILAMENT BINDING | 145 | 6.51e-01 | 2.18e-02 | 0.92700 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 718 | 3.24e-01 | 2.18e-02 | 0.81500 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 160 | 6.36e-01 | -2.17e-02 | 0.92400 |
| GOMF ALPHA ACTININ BINDING | 14 | 8.88e-01 | -2.17e-02 | 0.98000 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 9.05e-01 | -2.17e-02 | 0.98000 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 83 | 7.33e-01 | 2.17e-02 | 0.95300 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 66 | 7.61e-01 | -2.17e-02 | 0.95700 |
| GOBP ORGANELLE FISSION | 354 | 4.85e-01 | 2.17e-02 | 0.88300 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 278 | 5.35e-01 | 2.17e-02 | 0.89700 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 40 | 8.13e-01 | 2.17e-02 | 0.96800 |
| GOBP MICROTUBULE BASED TRANSPORT | 167 | 6.30e-01 | 2.16e-02 | 0.92400 |
| GOBP APOPTOTIC PROCESS | 1366 | 1.86e-01 | 2.16e-02 | 0.72300 |
| GOBP REGULATION OF BLOOD CIRCULATION | 129 | 6.72e-01 | 2.16e-02 | 0.93200 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.11e-01 | -2.15e-02 | 0.98100 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 407 | 4.58e-01 | 2.15e-02 | 0.87700 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 23 | 8.58e-01 | 2.15e-02 | 0.97400 |
| GOBP MITOTIC DNA REPLICATION | 13 | 8.93e-01 | 2.15e-02 | 0.98000 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 12 | 8.98e-01 | 2.15e-02 | 0.98000 |
| GOMF MYOSIN II BINDING | 7 | 9.22e-01 | -2.15e-02 | 0.98200 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 405 | 4.61e-01 | 2.14e-02 | 0.87800 |
| GOBP CALCIUM ION TRANSPORT | 253 | 5.59e-01 | 2.14e-02 | 0.90400 |
| GOMF PROTEIN KINASE C BINDING | 39 | 8.18e-01 | -2.14e-02 | 0.96800 |
| GOMF SIGNALING RECEPTOR BINDING | 788 | 3.12e-01 | 2.13e-02 | 0.80900 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 51 | 7.92e-01 | -2.13e-02 | 0.96200 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 48 | 7.98e-01 | -2.13e-02 | 0.96300 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 13 | 8.94e-01 | -2.13e-02 | 0.98000 |
| GOBP MEMBRANE ORGANIZATION | 632 | 3.64e-01 | -2.13e-02 | 0.83900 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 19 | 8.72e-01 | -2.13e-02 | 0.97500 |
| GOCC MICROTUBULE PLUS END | 19 | 8.72e-01 | 2.13e-02 | 0.97500 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 134 | 6.72e-01 | 2.12e-02 | 0.93200 |
| GOBP MUSCLE CELL DEVELOPMENT | 104 | 7.09e-01 | 2.12e-02 | 0.94400 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 8.76e-01 | -2.12e-02 | 0.97600 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 12 | 8.99e-01 | 2.11e-02 | 0.98000 |
| GOCC SCAR COMPLEX | 10 | 9.08e-01 | 2.11e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 9.03e-01 | 2.11e-02 | 0.98000 |
| GOBP NEUTROPHIL CHEMOTAXIS | 68 | 7.64e-01 | -2.11e-02 | 0.95900 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 9.18e-01 | -2.11e-02 | 0.98100 |
| GOBP RNA STABILIZATION | 54 | 7.89e-01 | 2.11e-02 | 0.96200 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 9.29e-01 | 2.11e-02 | 0.98200 |
| GOCC CELL CORTEX | 218 | 5.93e-01 | 2.11e-02 | 0.91300 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 664 | 3.58e-01 | 2.10e-02 | 0.83600 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 562 | 3.96e-01 | 2.10e-02 | 0.85400 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 9.35e-01 | 2.10e-02 | 0.98300 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 9.13e-01 | -2.10e-02 | 0.98100 |
| GOBP MICROTUBULE BASED MOVEMENT | 269 | 5.54e-01 | 2.10e-02 | 0.90100 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 28 | 8.48e-01 | -2.10e-02 | 0.97200 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 112 | 7.02e-01 | 2.10e-02 | 0.94100 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 62 | 7.75e-01 | -2.10e-02 | 0.96100 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 428 | 4.59e-01 | 2.09e-02 | 0.87700 |
| GOCC DENDRITIC SPINE MEMBRANE | 7 | 9.24e-01 | 2.09e-02 | 0.98200 |
| GOBP SYNAPTIC SIGNALING | 405 | 4.73e-01 | 2.09e-02 | 0.88000 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 49 | 8.01e-01 | -2.09e-02 | 0.96400 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 9.09e-01 | 2.09e-02 | 0.98000 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 11 | 9.05e-01 | 2.08e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 9.30e-01 | -2.08e-02 | 0.98200 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 9.24e-01 | -2.08e-02 | 0.98200 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 31 | 8.41e-01 | -2.08e-02 | 0.97200 |
| GOBP AXON DEVELOPMENT | 284 | 5.48e-01 | 2.08e-02 | 0.90000 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 151 | 6.60e-01 | 2.08e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 8 | 9.19e-01 | -2.08e-02 | 0.98100 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 9.01e-01 | -2.08e-02 | 0.98000 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 123 | 6.91e-01 | -2.08e-02 | 0.93700 |
| GOMF NF KAPPAB BINDING | 28 | 8.49e-01 | 2.07e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 9.14e-01 | 2.07e-02 | 0.98100 |
| GOBP NK T CELL ACTIVATION | 10 | 9.10e-01 | -2.07e-02 | 0.98000 |
| GOCC APICAL PART OF CELL | 239 | 5.83e-01 | 2.07e-02 | 0.91200 |
| GOCC NUCLEAR MEMBRANE | 261 | 5.67e-01 | 2.06e-02 | 0.90600 |
| GOBP PROTEIN DEPOLYMERIZATION | 85 | 7.42e-01 | 2.06e-02 | 0.95400 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 59 | 7.84e-01 | -2.06e-02 | 0.96200 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 27 | 8.53e-01 | -2.06e-02 | 0.97200 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 16 | 8.87e-01 | 2.06e-02 | 0.98000 |
| GOCC GOLGI MEMBRANE | 513 | 4.28e-01 | -2.06e-02 | 0.86400 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 9.15e-01 | 2.05e-02 | 0.98100 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 209 | 6.10e-01 | -2.05e-02 | 0.91700 |
| GOMF FOLIC ACID BINDING | 9 | 9.15e-01 | -2.05e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 43 | 8.16e-01 | 2.05e-02 | 0.96800 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 6 | 9.31e-01 | 2.05e-02 | 0.98300 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 533 | 4.22e-01 | -2.04e-02 | 0.86400 |
| GOBP PIGMENTATION | 79 | 7.54e-01 | -2.04e-02 | 0.95600 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 15 | 8.91e-01 | 2.04e-02 | 0.98000 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 137 | 6.81e-01 | 2.04e-02 | 0.93400 |
| GOCC CELL SUBSTRATE JUNCTION | 354 | 5.12e-01 | 2.04e-02 | 0.89000 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 8.78e-01 | -2.03e-02 | 0.97600 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 85 | 7.46e-01 | -2.03e-02 | 0.95600 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 8.66e-01 | -2.03e-02 | 0.97400 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 8.99e-01 | -2.03e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 9.31e-01 | -2.03e-02 | 0.98300 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 9 | 9.16e-01 | 2.03e-02 | 0.98100 |
| GOCC AGGRESOME | 28 | 8.52e-01 | 2.03e-02 | 0.97200 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 28 | 8.52e-01 | -2.03e-02 | 0.97200 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 9.31e-01 | -2.03e-02 | 0.98300 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 91 | 7.38e-01 | 2.03e-02 | 0.95400 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 20 | 8.75e-01 | 2.03e-02 | 0.97600 |
| GOBP STEM CELL DIFFERENTIATION | 145 | 6.74e-01 | 2.02e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 8.79e-01 | 2.02e-02 | 0.97700 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 9 | 9.16e-01 | -2.02e-02 | 0.98100 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 72 | 7.67e-01 | -2.02e-02 | 0.95900 |
| GOBP NEURAL TUBE PATTERNING | 24 | 8.64e-01 | -2.02e-02 | 0.97400 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 8.76e-01 | 2.02e-02 | 0.97600 |
| GOBP NEURAL CREST FORMATION | 8 | 9.21e-01 | 2.02e-02 | 0.98200 |
| GOBP ERBB SIGNALING PATHWAY | 91 | 7.40e-01 | 2.02e-02 | 0.95400 |
| GOMF EXONUCLEASE ACTIVITY | 77 | 7.60e-01 | 2.02e-02 | 0.95700 |
| GOBP TUBE FORMATION | 94 | 7.36e-01 | -2.01e-02 | 0.95400 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 44 | 8.17e-01 | -2.01e-02 | 0.96800 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 57 | 7.93e-01 | 2.01e-02 | 0.96200 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 29 | 8.52e-01 | 2.01e-02 | 0.97200 |
| GOCC PML BODY | 101 | 7.28e-01 | -2.01e-02 | 0.95100 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 32 | 8.44e-01 | -2.01e-02 | 0.97200 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 262 | 5.77e-01 | 2.00e-02 | 0.90900 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 55 | 7.97e-01 | -2.00e-02 | 0.96300 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 16 | 8.90e-01 | -2.00e-02 | 0.98000 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 12 | 9.04e-01 | 2.00e-02 | 0.98000 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 8.93e-01 | 2.00e-02 | 0.98000 |
| GOBP MYELOID CELL HOMEOSTASIS | 140 | 6.83e-01 | -2.00e-02 | 0.93400 |
| GOCC EARLY ENDOSOME | 328 | 5.35e-01 | 2.00e-02 | 0.89700 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 16 | 8.90e-01 | 2.00e-02 | 0.98000 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 8 | 9.22e-01 | -1.99e-02 | 0.98200 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 37 | 8.34e-01 | 1.99e-02 | 0.97100 |
| GOBP COGNITION | 172 | 6.53e-01 | 1.99e-02 | 0.92700 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 14 | 8.97e-01 | 1.99e-02 | 0.98000 |
| GOBP OSTEOCLAST PROLIFERATION | 5 | 9.39e-01 | 1.99e-02 | 0.98500 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 58 | 7.94e-01 | -1.99e-02 | 0.96200 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 9.39e-01 | -1.99e-02 | 0.98500 |
| GOMF MYOSIN V BINDING | 11 | 9.09e-01 | -1.98e-02 | 0.98000 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 80 | 7.59e-01 | -1.98e-02 | 0.95700 |
| GOBP MRNA POLYADENYLATION | 23 | 8.69e-01 | -1.98e-02 | 0.97500 |
| GOBP RESPIRATORY SYSTEM PROCESS | 23 | 8.69e-01 | -1.98e-02 | 0.97500 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 424 | 4.86e-01 | 1.98e-02 | 0.88300 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 8.69e-01 | -1.98e-02 | 0.97500 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 9.18e-01 | 1.98e-02 | 0.98100 |
| GOMF DEUBIQUITINASE ACTIVITY | 87 | 7.51e-01 | -1.97e-02 | 0.95600 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 9.33e-01 | 1.97e-02 | 0.98300 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.18e-01 | -1.97e-02 | 0.98100 |
| GOBP EPITHELIAL TUBE FORMATION | 86 | 7.52e-01 | -1.97e-02 | 0.95600 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 285 | 5.68e-01 | 1.97e-02 | 0.90700 |
| GOBP INORGANIC ION HOMEOSTASIS | 324 | 5.44e-01 | 1.97e-02 | 0.89900 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 7 | 9.28e-01 | -1.97e-02 | 0.98200 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 9.39e-01 | 1.97e-02 | 0.98500 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 25 | 8.65e-01 | 1.97e-02 | 0.97400 |
| GOBP TRACHEA MORPHOGENESIS | 8 | 9.23e-01 | -1.96e-02 | 0.98200 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 12 | 9.06e-01 | 1.96e-02 | 0.98000 |
| GOBP MAINTENANCE OF CELL NUMBER | 137 | 6.92e-01 | -1.96e-02 | 0.93700 |
| GOCC TORC2 COMPLEX | 9 | 9.19e-01 | 1.96e-02 | 0.98100 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 84 | 7.56e-01 | 1.96e-02 | 0.95600 |
| GOBP PHAGOCYTOSIS | 181 | 6.50e-01 | -1.96e-02 | 0.92700 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 48 | 8.15e-01 | -1.96e-02 | 0.96800 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 69 | 7.79e-01 | 1.95e-02 | 0.96100 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 51 | 8.10e-01 | 1.95e-02 | 0.96700 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 55 | 8.03e-01 | -1.95e-02 | 0.96400 |
| GOBP RNA CATABOLIC PROCESS | 263 | 5.88e-01 | 1.94e-02 | 0.91300 |
| GOCC CIS GOLGI NETWORK | 54 | 8.05e-01 | -1.94e-02 | 0.96600 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 8.59e-01 | -1.94e-02 | 0.97400 |
| GOCC GOLGI CISTERNA | 84 | 7.59e-01 | -1.94e-02 | 0.95700 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 8.90e-01 | 1.93e-02 | 0.98000 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.00e-01 | 1.93e-02 | 0.98000 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 34 | 8.45e-01 | 1.93e-02 | 0.97200 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 9.16e-01 | 1.93e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 153 | 6.82e-01 | 1.92e-02 | 0.93400 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 5 | 9.41e-01 | -1.92e-02 | 0.98500 |
| GOCC PROTEIN DNA COMPLEX | 861 | 3.43e-01 | 1.92e-02 | 0.82900 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 9.35e-01 | -1.92e-02 | 0.98300 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 61 | 7.96e-01 | 1.91e-02 | 0.96200 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 9.01e-01 | 1.91e-02 | 0.98000 |
| GOBP OPTIC NERVE DEVELOPMENT | 10 | 9.17e-01 | -1.91e-02 | 0.98100 |
| GOMF PH DOMAIN BINDING | 7 | 9.30e-01 | 1.91e-02 | 0.98300 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 9.41e-01 | -1.91e-02 | 0.98500 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 38 | 8.39e-01 | 1.90e-02 | 0.97200 |
| GOCC NON MOTILE CILIUM | 100 | 7.43e-01 | -1.90e-02 | 0.95400 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 688 | 3.99e-01 | 1.90e-02 | 0.85600 |
| GOBP PIGMENT ACCUMULATION | 10 | 9.17e-01 | 1.90e-02 | 0.98100 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 9.17e-01 | 1.90e-02 | 0.98100 |
| GOBP NEURON MIGRATION | 106 | 7.37e-01 | 1.89e-02 | 0.95400 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 9.42e-01 | -1.89e-02 | 0.98500 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 35 | 8.47e-01 | 1.89e-02 | 0.97200 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 164 | 6.77e-01 | 1.89e-02 | 0.93200 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 92 | 7.55e-01 | 1.89e-02 | 0.95600 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1380 | 2.47e-01 | 1.89e-02 | 0.76800 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 68 | 7.89e-01 | -1.88e-02 | 0.96200 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 19 | 8.87e-01 | 1.88e-02 | 0.98000 |
| GOBP REGULATION OF CATABOLIC PROCESS | 831 | 3.62e-01 | -1.88e-02 | 0.83900 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 9.14e-01 | -1.87e-02 | 0.98100 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 82 | 7.70e-01 | -1.87e-02 | 0.96000 |
| GOCC ENDOCYTIC VESICLE | 265 | 6.01e-01 | -1.87e-02 | 0.91500 |
| GOBP EMBRYO IMPLANTATION | 31 | 8.57e-01 | -1.87e-02 | 0.97400 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 11 | 9.15e-01 | -1.87e-02 | 0.98100 |
| GOBP CHROMOSOME CONDENSATION | 25 | 8.72e-01 | -1.86e-02 | 0.97500 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 9.23e-01 | 1.86e-02 | 0.98200 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 9.27e-01 | -1.86e-02 | 0.98200 |
| GOBP PALLIUM DEVELOPMENT | 115 | 7.31e-01 | 1.86e-02 | 0.95200 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 88 | 7.64e-01 | 1.85e-02 | 0.95900 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 59 | 8.06e-01 | -1.85e-02 | 0.96600 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 9 | 9.24e-01 | -1.84e-02 | 0.98200 |
| GOCC NEURON PROJECTION | 778 | 3.85e-01 | 1.84e-02 | 0.84600 |
| GOCC RUFFLE MEMBRANE | 80 | 7.76e-01 | 1.84e-02 | 0.96100 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 380 | 5.40e-01 | 1.84e-02 | 0.89700 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 14 | 9.05e-01 | -1.84e-02 | 0.98000 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 9.33e-01 | 1.84e-02 | 0.98300 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 14 | 9.05e-01 | -1.83e-02 | 0.98000 |
| GOBP EXPLORATION BEHAVIOR | 10 | 9.20e-01 | 1.83e-02 | 0.98200 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 9.43e-01 | -1.83e-02 | 0.98600 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 282 | 5.97e-01 | 1.83e-02 | 0.91300 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 416 | 5.23e-01 | 1.83e-02 | 0.89200 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 14 | 9.06e-01 | 1.83e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 8 | 9.29e-01 | -1.83e-02 | 0.98200 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 167 | 6.84e-01 | 1.83e-02 | 0.93500 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 87 | 7.69e-01 | 1.82e-02 | 0.95900 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1350 | 2.69e-01 | -1.82e-02 | 0.78600 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 7 | 9.34e-01 | -1.82e-02 | 0.98300 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 35 | 8.53e-01 | -1.82e-02 | 0.97200 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 8.88e-01 | 1.82e-02 | 0.98000 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 26 | 8.73e-01 | 1.81e-02 | 0.97500 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 12 | 9.13e-01 | 1.81e-02 | 0.98100 |
| GOBP CELL ACTIVATION | 823 | 3.81e-01 | 1.81e-02 | 0.84400 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 8 | 9.29e-01 | 1.81e-02 | 0.98200 |
| GOBP HETEROCHROMATIN ORGANIZATION | 82 | 7.78e-01 | 1.81e-02 | 0.96100 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 9.18e-01 | -1.80e-02 | 0.98100 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 131 | 7.22e-01 | 1.80e-02 | 0.94900 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 20 | 8.89e-01 | 1.80e-02 | 0.98000 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 166 | 6.90e-01 | 1.79e-02 | 0.93700 |
| GOBP PHAGOCYTOSIS RECOGNITION | 11 | 9.18e-01 | 1.79e-02 | 0.98100 |
| GOBP MYOBLAST PROLIFERATION | 13 | 9.11e-01 | -1.79e-02 | 0.98100 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 9.15e-01 | -1.78e-02 | 0.98100 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 32 | 8.61e-01 | 1.78e-02 | 0.97400 |
| GOMF FAD BINDING | 34 | 8.57e-01 | -1.78e-02 | 0.97400 |
| GOCC SPINDLE MICROTUBULE | 68 | 7.99e-01 | -1.78e-02 | 0.96400 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 15 | 9.05e-01 | -1.78e-02 | 0.98000 |
| GOBP COMPLEMENT ACTIVATION | 30 | 8.66e-01 | 1.77e-02 | 0.97400 |
| GOBP CELL SUBSTRATE ADHESION | 222 | 6.49e-01 | 1.77e-02 | 0.92700 |
| GOBP LYMPHOCYTE MIGRATION | 74 | 7.92e-01 | 1.77e-02 | 0.96200 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 54 | 8.22e-01 | 1.77e-02 | 0.97100 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 269 | 6.18e-01 | 1.77e-02 | 0.92000 |
| GOBP CGMP METABOLIC PROCESS | 9 | 9.27e-01 | -1.77e-02 | 0.98200 |
| GOBP REGULATION OF SYSTEM PROCESS | 284 | 6.09e-01 | -1.77e-02 | 0.91700 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 7 | 9.36e-01 | 1.77e-02 | 0.98300 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 361 | 5.66e-01 | 1.76e-02 | 0.90600 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 53 | 8.24e-01 | 1.76e-02 | 0.97100 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 148 | 7.13e-01 | -1.76e-02 | 0.94500 |
| GOCC RESPIRASOME | 89 | 7.75e-01 | 1.75e-02 | 0.96100 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 9.13e-01 | -1.75e-02 | 0.98100 |
| GOBP GLUCOSE METABOLIC PROCESS | 145 | 7.16e-01 | 1.75e-02 | 0.94800 |
| GOBP MIRNA METABOLIC PROCESS | 78 | 7.89e-01 | -1.75e-02 | 0.96200 |
| GOBP EPITHELIAL CELL PROLIFERATION | 244 | 6.39e-01 | 1.75e-02 | 0.92400 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 9.28e-01 | 1.75e-02 | 0.98200 |
| GOBP GLIAL CELL DEVELOPMENT | 75 | 7.94e-01 | -1.74e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 36 | 8.56e-01 | -1.74e-02 | 0.97400 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 114 | 7.48e-01 | 1.74e-02 | 0.95600 |
| GOBP MITOCHONDRION ORGANIZATION | 488 | 5.12e-01 | 1.74e-02 | 0.89000 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 6 | 9.41e-01 | 1.74e-02 | 0.98500 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 14 | 9.10e-01 | 1.74e-02 | 0.98000 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 719 | 4.31e-01 | 1.74e-02 | 0.86600 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 7 | 9.37e-01 | 1.73e-02 | 0.98300 |
| GOBP HEAT GENERATION | 12 | 9.17e-01 | -1.73e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF MYELINATION | 10 | 9.24e-01 | 1.73e-02 | 0.98200 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 510 | 5.06e-01 | 1.73e-02 | 0.88800 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 70 | 8.02e-01 | -1.73e-02 | 0.96400 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 95 | 7.71e-01 | -1.73e-02 | 0.96000 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 10 | 9.25e-01 | -1.73e-02 | 0.98200 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 10 | 9.25e-01 | -1.73e-02 | 0.98200 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 935 | 3.76e-01 | 1.73e-02 | 0.84200 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 60 | 8.18e-01 | 1.72e-02 | 0.96800 |
| GOBP ORGANELLE ASSEMBLY | 775 | 4.19e-01 | 1.72e-02 | 0.86400 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 51 | 8.32e-01 | 1.72e-02 | 0.97100 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 9.21e-01 | 1.72e-02 | 0.98200 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 8.87e-01 | 1.72e-02 | 0.98000 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 9.47e-01 | -1.72e-02 | 0.98700 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 57 | 8.23e-01 | -1.71e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 24 | 8.85e-01 | -1.71e-02 | 0.97900 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 53 | 8.29e-01 | -1.71e-02 | 0.97100 |
| GOBP NCRNA CATABOLIC PROCESS | 49 | 8.36e-01 | 1.71e-02 | 0.97100 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 10 | 9.26e-01 | 1.71e-02 | 0.98200 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 9.00e-01 | 1.71e-02 | 0.98000 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 144 | 7.24e-01 | -1.70e-02 | 0.95000 |
| GOBP GRANULOCYTE DIFFERENTIATION | 31 | 8.70e-01 | -1.70e-02 | 0.97500 |
| GOCC CATSPER COMPLEX | 6 | 9.43e-01 | 1.70e-02 | 0.98600 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 12 | 9.19e-01 | -1.70e-02 | 0.98100 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 48 | 8.39e-01 | 1.70e-02 | 0.97200 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 219 | 6.66e-01 | 1.70e-02 | 0.93200 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 19 | 8.98e-01 | -1.69e-02 | 0.98000 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 221 | 6.65e-01 | -1.69e-02 | 0.93200 |
| GOCC ANAPHASE PROMOTING COMPLEX | 18 | 9.01e-01 | 1.69e-02 | 0.98000 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 9.48e-01 | -1.69e-02 | 0.98700 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 279 | 6.29e-01 | 1.69e-02 | 0.92400 |
| GOBP AMINE METABOLIC PROCESS | 66 | 8.13e-01 | 1.68e-02 | 0.96800 |
| GOMF LYASE ACTIVITY | 142 | 7.29e-01 | 1.68e-02 | 0.95200 |
| GOBP HINDBRAIN DEVELOPMENT | 93 | 7.79e-01 | -1.68e-02 | 0.96100 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 8 | 9.34e-01 | -1.68e-02 | 0.98300 |
| GOCC MKS COMPLEX | 11 | 9.23e-01 | -1.68e-02 | 0.98200 |
| GOBP MRNA CATABOLIC PROCESS | 213 | 6.73e-01 | 1.68e-02 | 0.93200 |
| GOBP ENDOTHELIAL CELL MIGRATION | 140 | 7.32e-01 | 1.68e-02 | 0.95200 |
| GOBP GLIAL CELL PROLIFERATION | 39 | 8.56e-01 | -1.68e-02 | 0.97400 |
| GOBP CELLULAR RESPONSE TO STEROL | 14 | 9.13e-01 | 1.68e-02 | 0.98100 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 9.48e-01 | 1.67e-02 | 0.98700 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 208 | 6.78e-01 | 1.67e-02 | 0.93300 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 116 | 7.56e-01 | 1.67e-02 | 0.95600 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 5 | 9.48e-01 | -1.67e-02 | 0.98700 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 197 | 6.87e-01 | 1.67e-02 | 0.93500 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 9 | 9.31e-01 | -1.67e-02 | 0.98300 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 171 | 7.07e-01 | -1.67e-02 | 0.94300 |
| GOBP TRANSMEMBRANE TRANSPORT | 900 | 4.01e-01 | 1.67e-02 | 0.85600 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 20 | 8.98e-01 | -1.66e-02 | 0.98000 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 16 | 9.08e-01 | 1.66e-02 | 0.98000 |
| GOBP MYELOID CELL DIFFERENTIATION | 319 | 6.11e-01 | -1.66e-02 | 0.91800 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 9.06e-01 | -1.66e-02 | 0.98000 |
| GOBP REGULATION OF PINOCYTOSIS | 10 | 9.28e-01 | 1.66e-02 | 0.98200 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 84 | 7.93e-01 | 1.66e-02 | 0.96200 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 26 | 8.84e-01 | 1.66e-02 | 0.97900 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 105 | 7.70e-01 | 1.66e-02 | 0.95900 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 58 | 8.28e-01 | 1.66e-02 | 0.97100 |
| GOBP MICROTUBULE SEVERING | 7 | 9.40e-01 | -1.65e-02 | 0.98500 |
| GOBP IMPORT INTO CELL | 629 | 4.82e-01 | 1.65e-02 | 0.88300 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 102 | 7.74e-01 | -1.65e-02 | 0.96100 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 8.96e-01 | -1.65e-02 | 0.98000 |
| GOBP TORC1 SIGNALING | 91 | 7.86e-01 | -1.65e-02 | 0.96200 |
| GOBP MONOCYTE EXTRAVASATION | 8 | 9.36e-01 | -1.64e-02 | 0.98300 |
| GOBP GTP METABOLIC PROCESS | 21 | 8.96e-01 | 1.64e-02 | 0.98000 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 25 | 8.87e-01 | -1.64e-02 | 0.98000 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 112 | 7.65e-01 | -1.64e-02 | 0.95900 |
| GOBP HISTIDINE METABOLIC PROCESS | 6 | 9.45e-01 | 1.63e-02 | 0.98600 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 287 | 6.35e-01 | 1.63e-02 | 0.92400 |
| GOBP GRANULOCYTE ACTIVATION | 39 | 8.60e-01 | 1.63e-02 | 0.97400 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 9.10e-01 | 1.63e-02 | 0.98000 |
| GOCC TOR COMPLEX | 11 | 9.26e-01 | 1.62e-02 | 0.98200 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 10 | 9.29e-01 | -1.62e-02 | 0.98200 |
| GOBP ORGANIC ACID TRANSPORT | 190 | 7.01e-01 | -1.62e-02 | 0.94100 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 161 | 7.23e-01 | -1.62e-02 | 0.94900 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 19 | 9.03e-01 | 1.62e-02 | 0.98000 |
| GOBP RESPONSE TO STARVATION | 169 | 7.17e-01 | 1.62e-02 | 0.94800 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 44 | 8.53e-01 | -1.62e-02 | 0.97200 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 54 | 8.37e-01 | -1.62e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 9.41e-01 | -1.62e-02 | 0.98500 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 14 | 9.17e-01 | -1.61e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 53 | 8.39e-01 | 1.61e-02 | 0.97200 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 26 | 8.87e-01 | -1.61e-02 | 0.98000 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 105 | 7.76e-01 | 1.61e-02 | 0.96100 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 9.37e-01 | -1.61e-02 | 0.98400 |
| GOMF AMYLOID BETA BINDING | 61 | 8.28e-01 | 1.61e-02 | 0.97100 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 17 | 9.09e-01 | 1.61e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 9.46e-01 | -1.60e-02 | 0.98600 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 202 | 6.95e-01 | 1.60e-02 | 0.93800 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 8.24e-01 | 1.60e-02 | 0.97100 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 9.21e-01 | 1.59e-02 | 0.98200 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 60 | 8.31e-01 | -1.59e-02 | 0.97100 |
| GOBP HISTONE MODIFICATION | 109 | 7.74e-01 | 1.59e-02 | 0.96100 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 26 | 8.88e-01 | -1.59e-02 | 0.98000 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 9 | 9.34e-01 | -1.59e-02 | 0.98300 |
| GOBP LEUKOCYTE AGGREGATION | 11 | 9.28e-01 | 1.58e-02 | 0.98200 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 10 | 9.31e-01 | 1.58e-02 | 0.98300 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 566 | 5.22e-01 | 1.58e-02 | 0.89200 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 48 | 8.50e-01 | -1.58e-02 | 0.97200 |
| GOBP PROTEIN MATURATION | 403 | 5.87e-01 | -1.58e-02 | 0.91300 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 58 | 8.35e-01 | -1.58e-02 | 0.97100 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 18 | 9.08e-01 | 1.58e-02 | 0.98000 |
| GOBP BLEB ASSEMBLY | 9 | 9.35e-01 | -1.58e-02 | 0.98300 |
| GOCC MEIOTIC SPINDLE | 9 | 9.35e-01 | -1.58e-02 | 0.98300 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 34 | 8.73e-01 | -1.58e-02 | 0.97500 |
| GOMF LIPID BINDING | 562 | 5.25e-01 | 1.58e-02 | 0.89300 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 8.39e-01 | 1.57e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 54 | 8.42e-01 | 1.57e-02 | 0.97200 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 570 | 5.25e-01 | 1.57e-02 | 0.89300 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 15 | 9.16e-01 | -1.57e-02 | 0.98100 |
| GOMF MOLECULAR CARRIER ACTIVITY | 83 | 8.06e-01 | 1.56e-02 | 0.96600 |
| GOBP CELLULAR RESPONSE TO STARVATION | 143 | 7.48e-01 | 1.56e-02 | 0.95600 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 80 | 8.11e-01 | -1.55e-02 | 0.96700 |
| GOMF BETA CATENIN BINDING | 60 | 8.36e-01 | -1.55e-02 | 0.97100 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 25 | 8.94e-01 | 1.54e-02 | 0.98000 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 67 | 8.27e-01 | 1.54e-02 | 0.97100 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 14 | 9.20e-01 | 1.54e-02 | 0.98200 |
| GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING | 5 | 9.52e-01 | 1.54e-02 | 0.98700 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 22 | 9.00e-01 | 1.54e-02 | 0.98000 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 25 | 8.94e-01 | -1.54e-02 | 0.98000 |
| GOBP MAMMARY GLAND INVOLUTION | 5 | 9.53e-01 | -1.54e-02 | 0.98700 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 10 | 9.33e-01 | 1.54e-02 | 0.98300 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 50 | 8.51e-01 | -1.53e-02 | 0.97200 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 29 | 8.87e-01 | 1.53e-02 | 0.98000 |
| GOBP SIGNAL RELEASE | 281 | 6.60e-01 | -1.53e-02 | 0.93200 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 6 | 9.48e-01 | 1.53e-02 | 0.98700 |
| GOBP CYTIDINE TO URIDINE EDITING | 8 | 9.40e-01 | 1.53e-02 | 0.98500 |
| GOMF GABA RECEPTOR BINDING | 10 | 9.33e-01 | -1.53e-02 | 0.98300 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 9.48e-01 | 1.52e-02 | 0.98700 |
| GOBP MESODERM DEVELOPMENT | 62 | 8.36e-01 | 1.52e-02 | 0.97100 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 9.41e-01 | 1.52e-02 | 0.98500 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 19 | 9.09e-01 | 1.51e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 9.09e-01 | 1.51e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 922 | 4.42e-01 | -1.51e-02 | 0.87000 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 33 | 8.81e-01 | 1.50e-02 | 0.97800 |
| GOBP GENERATION OF NEURONS | 882 | 4.53e-01 | 1.50e-02 | 0.87400 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1059 | 4.13e-01 | 1.50e-02 | 0.86100 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 32 | 8.83e-01 | -1.50e-02 | 0.97900 |
| GOBP DETECTION OF VISIBLE LIGHT | 25 | 8.97e-01 | -1.50e-02 | 0.98000 |
| GOBP REGULATION OF PROTEIN SECRETION | 166 | 7.39e-01 | 1.50e-02 | 0.95400 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 144 | 7.56e-01 | -1.50e-02 | 0.95600 |
| GOBP CELL PART MORPHOGENESIS | 412 | 6.03e-01 | 1.50e-02 | 0.91600 |
| GOBP MEMBRANOUS SEPTUM MORPHOGENESIS | 5 | 9.54e-01 | 1.50e-02 | 0.98700 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 460 | 5.84e-01 | -1.50e-02 | 0.91200 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 9.32e-01 | 1.50e-02 | 0.98300 |
| GOCC INTERCELLULAR BRIDGE | 58 | 8.44e-01 | -1.49e-02 | 0.97200 |
| GOBP ORGANIC ANION TRANSPORT | 242 | 6.90e-01 | 1.49e-02 | 0.93700 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 9.32e-01 | 1.49e-02 | 0.98300 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 88 | 8.10e-01 | 1.49e-02 | 0.96700 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 95 | 8.03e-01 | -1.48e-02 | 0.96400 |
| GOBP REGULATION OF ACTION POTENTIAL | 33 | 8.83e-01 | 1.48e-02 | 0.97900 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 9.32e-01 | 1.48e-02 | 0.98300 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 9.46e-01 | 1.48e-02 | 0.98600 |
| GOMF TRANSPORTER ACTIVITY | 708 | 5.06e-01 | 1.48e-02 | 0.88800 |
| GOBP RESPONSE TO COCAINE | 24 | 9.00e-01 | 1.48e-02 | 0.98000 |
| GOMF PHOSPHATASE ACTIVITY | 201 | 7.19e-01 | 1.47e-02 | 0.94900 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 8.93e-01 | 1.47e-02 | 0.98000 |
| GOBP MONOATOMIC CATION TRANSPORT | 593 | 5.45e-01 | 1.46e-02 | 0.89900 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 9.12e-01 | -1.46e-02 | 0.98100 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 53 | 8.54e-01 | 1.46e-02 | 0.97300 |
| GOBP ALCOHOL CATABOLIC PROCESS | 22 | 9.06e-01 | -1.46e-02 | 0.98000 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 9.22e-01 | -1.46e-02 | 0.98200 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 38 | 8.77e-01 | -1.46e-02 | 0.97600 |
| GOMF FLOPPASE ACTIVITY | 14 | 9.25e-01 | 1.46e-02 | 0.98200 |
| GOBP RESPONSE TO MAGNESIUM ION | 13 | 9.28e-01 | 1.45e-02 | 0.98200 |
| GOBP MITOCHONDRIAL FISSION | 35 | 8.82e-01 | -1.45e-02 | 0.97900 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 45 | 8.67e-01 | 1.44e-02 | 0.97400 |
| GOMF PROTEIN SELF ASSOCIATION | 56 | 8.52e-01 | 1.44e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 11 | 9.34e-01 | -1.44e-02 | 0.98300 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 9.34e-01 | -1.44e-02 | 0.98300 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 24 | 9.03e-01 | 1.44e-02 | 0.98000 |
| GOMF ISOMERASE ACTIVITY | 135 | 7.73e-01 | 1.44e-02 | 0.96000 |
| GOBP NEURAL TUBE DEVELOPMENT | 114 | 7.91e-01 | -1.44e-02 | 0.96200 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 8 | 9.44e-01 | 1.44e-02 | 0.98600 |
| GOBP GLYCOSYLATION | 168 | 7.49e-01 | 1.43e-02 | 0.95600 |
| GOBP PROTEIN POLYUBIQUITINATION | 198 | 7.30e-01 | 1.43e-02 | 0.95200 |
| GOBP VASCULAR TRANSPORT | 51 | 8.60e-01 | 1.43e-02 | 0.97400 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 58 | 8.51e-01 | 1.43e-02 | 0.97200 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 404 | 6.25e-01 | 1.42e-02 | 0.92300 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 133 | 7.79e-01 | 1.41e-02 | 0.96100 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 23 | 9.07e-01 | 1.41e-02 | 0.98000 |
| GOCC CORNIFIED ENVELOPE | 15 | 9.25e-01 | -1.41e-02 | 0.98200 |
| GOMF DNA NUCLEASE ACTIVITY | 53 | 8.59e-01 | -1.41e-02 | 0.97400 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 97 | 8.11e-01 | -1.41e-02 | 0.96700 |
| GOCC ACETYLTRANSFERASE COMPLEX | 92 | 8.16e-01 | -1.41e-02 | 0.96800 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 10 | 9.39e-01 | 1.40e-02 | 0.98500 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 73 | 8.36e-01 | 1.40e-02 | 0.97100 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 6 | 9.53e-01 | 1.40e-02 | 0.98700 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 546 | 5.78e-01 | 1.40e-02 | 0.90900 |
| GOBP VIRAL TRANSLATION | 20 | 9.14e-01 | 1.40e-02 | 0.98100 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 17 | 9.21e-01 | 1.40e-02 | 0.98200 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 228 | 7.17e-01 | 1.40e-02 | 0.94800 |
| GOCC 9PLUS2 MOTILE CILIUM | 92 | 8.17e-01 | -1.40e-02 | 0.96800 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 59 | 8.53e-01 | 1.39e-02 | 0.97200 |
| GOCC ANCHORING JUNCTION | 616 | 5.58e-01 | 1.39e-02 | 0.90400 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 66 | 8.45e-01 | -1.39e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 7 | 9.49e-01 | 1.39e-02 | 0.98700 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 156 | 7.66e-01 | -1.39e-02 | 0.95900 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 54 | 8.60e-01 | -1.39e-02 | 0.97400 |
| GOBP CARBOHYDRATE TRANSPORT | 108 | 8.04e-01 | 1.38e-02 | 0.96500 |
| GOBP REGULATION OF URINE VOLUME | 9 | 9.43e-01 | 1.38e-02 | 0.98600 |
| GOBP SEROTONIN TRANSPORT | 8 | 9.46e-01 | -1.38e-02 | 0.98700 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 20 | 9.15e-01 | -1.38e-02 | 0.98100 |
| GOBP NEGATIVE REGULATION OF BINDING | 86 | 8.26e-01 | 1.37e-02 | 0.97100 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 36 | 8.87e-01 | 1.37e-02 | 0.98000 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 138 | 7.82e-01 | 1.36e-02 | 0.96200 |
| GOCC VACUOLE | 691 | 5.45e-01 | -1.36e-02 | 0.89900 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 123 | 7.95e-01 | 1.36e-02 | 0.96200 |
| GOBP GLIOGENESIS | 202 | 7.40e-01 | 1.35e-02 | 0.95400 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 635 | 5.63e-01 | 1.35e-02 | 0.90600 |
| GOBP B CELL APOPTOTIC PROCESS | 25 | 9.07e-01 | 1.35e-02 | 0.98000 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 22 | 9.13e-01 | -1.35e-02 | 0.98100 |
| GOBP SPROUTING ANGIOGENESIS | 74 | 8.42e-01 | 1.34e-02 | 0.97200 |
| GOMF TUBULIN BINDING | 293 | 6.93e-01 | 1.34e-02 | 0.93800 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 209 | 7.39e-01 | 1.34e-02 | 0.95400 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 16 | 9.26e-01 | 1.34e-02 | 0.98200 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 9.34e-01 | 1.33e-02 | 0.98300 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 5 | 9.59e-01 | -1.33e-02 | 0.98900 |
| GOBP REGULATION OF PROTEOLYSIS | 448 | 6.32e-01 | -1.32e-02 | 0.92400 |
| GOBP RNA PROCESSING | 868 | 5.12e-01 | 1.32e-02 | 0.89000 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 29 | 9.02e-01 | -1.32e-02 | 0.98000 |
| GOBP MYELIN MAINTENANCE | 13 | 9.34e-01 | 1.32e-02 | 0.98300 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 9 | 9.45e-01 | -1.32e-02 | 0.98600 |
| GOBP TAXIS | 291 | 7.00e-01 | 1.32e-02 | 0.94100 |
| GOBP EPIBOLY | 26 | 9.08e-01 | 1.32e-02 | 0.98000 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 32 | 8.98e-01 | -1.32e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 9.19e-01 | 1.32e-02 | 0.98100 |
| GOBP CHEMOKINE PRODUCTION | 68 | 8.52e-01 | -1.31e-02 | 0.97200 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 466 | 6.29e-01 | 1.31e-02 | 0.92400 |
| GOBP INTESTINAL ABSORPTION | 20 | 9.19e-01 | -1.31e-02 | 0.98100 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 72 | 8.48e-01 | -1.31e-02 | 0.97200 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 188 | 7.57e-01 | 1.31e-02 | 0.95600 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 9 | 9.46e-01 | -1.31e-02 | 0.98600 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 20 | 9.19e-01 | 1.31e-02 | 0.98100 |
| GOMF SULFATIDE BINDING | 5 | 9.60e-01 | 1.31e-02 | 0.98900 |
| GOMF SUPERCOILED DNA BINDING | 6 | 9.56e-01 | -1.31e-02 | 0.98800 |
| GOMF MYOSIN BINDING | 44 | 8.81e-01 | 1.30e-02 | 0.97800 |
| GOBP MITOTIC CYTOKINESIS | 74 | 8.47e-01 | -1.30e-02 | 0.97200 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 78 | 8.43e-01 | 1.30e-02 | 0.97200 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 387 | 6.62e-01 | 1.30e-02 | 0.93200 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 18 | 9.24e-01 | 1.30e-02 | 0.98200 |
| GOCC APICAL JUNCTION COMPLEX | 85 | 8.36e-01 | 1.30e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 9.49e-01 | -1.30e-02 | 0.98700 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 8.93e-01 | 1.29e-02 | 0.98000 |
| GOBP VASCULATURE DEVELOPMENT | 446 | 6.41e-01 | 1.29e-02 | 0.92400 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 25 | 9.11e-01 | 1.29e-02 | 0.98100 |
| GOCC LSM2 8 COMPLEX | 7 | 9.53e-01 | 1.29e-02 | 0.98700 |
| GOCC SIN3 TYPE COMPLEX | 22 | 9.17e-01 | -1.29e-02 | 0.98100 |
| GOBP EPITHELIUM DEVELOPMENT | 661 | 5.74e-01 | 1.29e-02 | 0.90800 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 9.41e-01 | 1.29e-02 | 0.98500 |
| GOBP MELANOSOME ASSEMBLY | 19 | 9.23e-01 | 1.29e-02 | 0.98200 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 26 | 9.10e-01 | 1.28e-02 | 0.98000 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 59 | 8.65e-01 | 1.28e-02 | 0.97400 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 385 | 6.67e-01 | 1.28e-02 | 0.93200 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 67 | 8.56e-01 | -1.28e-02 | 0.97400 |
| GOCC VACUOLAR MEMBRANE | 415 | 6.56e-01 | -1.28e-02 | 0.93000 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 127 | 8.04e-01 | -1.28e-02 | 0.96500 |
| GOBP ERYTHROCYTE MATURATION | 13 | 9.36e-01 | -1.28e-02 | 0.98300 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 9.47e-01 | -1.28e-02 | 0.98700 |
| GOBP CELL MATRIX ADHESION | 151 | 7.87e-01 | -1.27e-02 | 0.96200 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 170 | 7.75e-01 | 1.27e-02 | 0.96100 |
| GOBP NATURAL KILLER CELL ACTIVATION | 66 | 8.58e-01 | 1.27e-02 | 0.97400 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 59 | 8.66e-01 | 1.27e-02 | 0.97400 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 76 | 8.49e-01 | 1.26e-02 | 0.97200 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 555 | 6.14e-01 | 1.26e-02 | 0.91800 |
| GOCC CELL PROJECTION MEMBRANE | 214 | 7.52e-01 | 1.26e-02 | 0.95600 |
| GOBP POLYOL CATABOLIC PROCESS | 8 | 9.51e-01 | 1.25e-02 | 0.98700 |
| GOMF UNFOLDED PROTEIN BINDING | 95 | 8.33e-01 | -1.25e-02 | 0.97100 |
| GOBP RESPONSE TO ESTRADIOL | 66 | 8.60e-01 | 1.25e-02 | 0.97400 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 37 | 8.95e-01 | 1.25e-02 | 0.98000 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 68 | 8.58e-01 | 1.25e-02 | 0.97400 |
| GOBP REGULATION OF B CELL ACTIVATION | 107 | 8.23e-01 | 1.25e-02 | 0.97100 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 410 | 6.66e-01 | 1.25e-02 | 0.93200 |
| GOBP RESPONSE TO UV | 127 | 8.08e-01 | -1.25e-02 | 0.96600 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 29 | 9.08e-01 | -1.24e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 8.65e-01 | -1.24e-02 | 0.97400 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 93 | 8.36e-01 | -1.24e-02 | 0.97100 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 80 | 8.48e-01 | 1.24e-02 | 0.97200 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 9 | 9.49e-01 | 1.24e-02 | 0.98700 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 9.32e-01 | 1.24e-02 | 0.98300 |
| GOCC CELL CORTEX REGION | 26 | 9.13e-01 | -1.23e-02 | 0.98100 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 9.36e-01 | -1.23e-02 | 0.98300 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 85 | 8.45e-01 | -1.23e-02 | 0.97200 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 17 | 9.30e-01 | 1.23e-02 | 0.98300 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 664 | 5.92e-01 | -1.23e-02 | 0.91300 |
| GOMF GLUTAMATE RECEPTOR BINDING | 26 | 9.14e-01 | 1.23e-02 | 0.98100 |
| GOBP REGULATION OF BONE REMODELING | 30 | 9.08e-01 | -1.22e-02 | 0.98000 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 44 | 8.88e-01 | -1.22e-02 | 0.98000 |
| GOBP MOTILE CILIUM ASSEMBLY | 35 | 9.00e-01 | 1.22e-02 | 0.98000 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 9.52e-01 | -1.22e-02 | 0.98700 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 590 | 6.15e-01 | 1.22e-02 | 0.91800 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 954 | 5.28e-01 | 1.22e-02 | 0.89400 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 76 | 8.54e-01 | -1.22e-02 | 0.97300 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 18 | 9.29e-01 | -1.21e-02 | 0.98200 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 6 | 9.59e-01 | -1.21e-02 | 0.98900 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 39 | 8.96e-01 | -1.21e-02 | 0.98000 |
| GOMF CADHERIN BINDING | 274 | 7.32e-01 | -1.21e-02 | 0.95200 |
| GOBP CELL FATE COMMITMENT | 114 | 8.24e-01 | -1.21e-02 | 0.97100 |
| GOMF ARYLSULFATASE ACTIVITY | 9 | 9.50e-01 | -1.20e-02 | 0.98700 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 683 | 5.95e-01 | 1.20e-02 | 0.91300 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 385 | 6.88e-01 | 1.20e-02 | 0.93600 |
| GOCC LATERAL PLASMA MEMBRANE | 40 | 8.96e-01 | -1.20e-02 | 0.98000 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 36 | 9.01e-01 | 1.20e-02 | 0.98000 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 9.16e-01 | 1.19e-02 | 0.98100 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 53 | 8.81e-01 | -1.19e-02 | 0.97800 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 106 | 8.33e-01 | 1.19e-02 | 0.97100 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 17 | 9.32e-01 | 1.19e-02 | 0.98300 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 109 | 8.30e-01 | -1.19e-02 | 0.97100 |
| GOBP NUCLEAR EXPORT | 155 | 7.99e-01 | 1.19e-02 | 0.96300 |
| GOBP B CELL ACTIVATION | 208 | 7.68e-01 | 1.19e-02 | 0.95900 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 9.08e-01 | 1.18e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 78 | 8.57e-01 | -1.18e-02 | 0.97400 |
| GOMF RNA CAP BINDING | 19 | 9.29e-01 | 1.18e-02 | 0.98200 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 73 | 8.62e-01 | 1.18e-02 | 0.97400 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 7 | 9.57e-01 | 1.18e-02 | 0.98800 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 49 | 8.87e-01 | -1.18e-02 | 0.98000 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 9.57e-01 | -1.18e-02 | 0.98800 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 29 | 9.13e-01 | -1.17e-02 | 0.98100 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 9.44e-01 | 1.17e-02 | 0.98600 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 9.12e-01 | 1.17e-02 | 0.98100 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 9.64e-01 | -1.17e-02 | 0.99000 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 10 | 9.49e-01 | -1.16e-02 | 0.98700 |
| GOCC CELL SURFACE | 504 | 6.56e-01 | -1.16e-02 | 0.93000 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 110 | 8.33e-01 | 1.16e-02 | 0.97100 |
| GOCC LATE ENDOSOME | 250 | 7.52e-01 | -1.16e-02 | 0.95600 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 87 | 8.52e-01 | 1.16e-02 | 0.97200 |
| GOBP RENAL SYSTEM DEVELOPMENT | 171 | 7.95e-01 | 1.16e-02 | 0.96200 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 21 | 9.27e-01 | 1.15e-02 | 0.98200 |
| GOBP MITOPHAGY | 35 | 9.06e-01 | -1.15e-02 | 0.98000 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 61 | 8.77e-01 | -1.15e-02 | 0.97600 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 9.61e-01 | -1.14e-02 | 0.98900 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 45 | 8.95e-01 | 1.14e-02 | 0.98000 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 27 | 9.19e-01 | -1.14e-02 | 0.98100 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 598 | 6.37e-01 | 1.14e-02 | 0.92400 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 112 | 8.36e-01 | 1.13e-02 | 0.97100 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 12 | 9.46e-01 | 1.13e-02 | 0.98600 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 40 | 9.02e-01 | 1.13e-02 | 0.98000 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 9.32e-01 | 1.12e-02 | 0.98300 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 8 | 9.56e-01 | -1.12e-02 | 0.98800 |
| GOBP REGULATION OF PLATELET AGGREGATION | 20 | 9.31e-01 | -1.12e-02 | 0.98300 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 9.31e-01 | -1.12e-02 | 0.98300 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 65 | 8.76e-01 | 1.12e-02 | 0.97600 |
| GOMF TRANSCRIPTION FACTOR BINDING | 477 | 6.77e-01 | 1.12e-02 | 0.93200 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 187 | 7.93e-01 | -1.12e-02 | 0.96200 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 9.40e-01 | 1.12e-02 | 0.98500 |
| GOCC T TUBULE | 29 | 9.17e-01 | 1.11e-02 | 0.98100 |
| GOBP NEURAL RETINA DEVELOPMENT | 38 | 9.06e-01 | 1.11e-02 | 0.98000 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 9.59e-01 | -1.11e-02 | 0.98900 |
| GOBP CARDIAC CELL DEVELOPMENT | 50 | 8.92e-01 | 1.11e-02 | 0.98000 |
| GOBP RENAL TUBULE DEVELOPMENT | 40 | 9.04e-01 | -1.11e-02 | 0.98000 |
| GOBP MRNA TRANSCRIPTION | 48 | 8.95e-01 | 1.11e-02 | 0.98000 |
| GOMF KINASE BINDING | 596 | 6.47e-01 | 1.11e-02 | 0.92600 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 13 | 9.45e-01 | -1.10e-02 | 0.98600 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 533 | 6.66e-01 | -1.10e-02 | 0.93200 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 9.63e-01 | 1.10e-02 | 0.99000 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 40 | 9.04e-01 | 1.10e-02 | 0.98000 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 24 | 9.26e-01 | -1.10e-02 | 0.98200 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 92 | 8.56e-01 | 1.09e-02 | 0.97400 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 9.66e-01 | -1.09e-02 | 0.99100 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 25 | 9.25e-01 | 1.09e-02 | 0.98200 |
| GOBP MITOCHONDRIAL TRANSPORT | 171 | 8.06e-01 | -1.09e-02 | 0.96600 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 30 | 9.18e-01 | -1.09e-02 | 0.98100 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 12 | 9.48e-01 | -1.09e-02 | 0.98700 |
| GOBP REGULATION OF GLIOGENESIS | 61 | 8.83e-01 | -1.09e-02 | 0.97900 |
| GOBP RETINA HOMEOSTASIS | 43 | 9.02e-01 | 1.09e-02 | 0.98000 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 36 | 9.10e-01 | -1.09e-02 | 0.98000 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 21 | 9.31e-01 | 1.09e-02 | 0.98300 |
| GOBP REGULATION OF ENDOCYTOSIS | 207 | 7.88e-01 | -1.09e-02 | 0.96200 |
| GOCC NEURON TO NEURON SYNAPSE | 224 | 7.80e-01 | 1.08e-02 | 0.96100 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 123 | 8.36e-01 | -1.08e-02 | 0.97100 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 9 | 9.55e-01 | 1.08e-02 | 0.98800 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 19 | 9.35e-01 | -1.08e-02 | 0.98300 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 6 | 9.63e-01 | -1.08e-02 | 0.99000 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 182 | 8.02e-01 | -1.08e-02 | 0.96400 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 468 | 6.91e-01 | 1.08e-02 | 0.93700 |
| GOBP PLASMA MEMBRANE TUBULATION | 16 | 9.41e-01 | 1.08e-02 | 0.98500 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 9 | 9.55e-01 | 1.07e-02 | 0.98800 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 9.53e-01 | 1.07e-02 | 0.98700 |
| GOCC PSEUDOPODIUM | 12 | 9.49e-01 | 1.07e-02 | 0.98700 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 35 | 9.13e-01 | -1.07e-02 | 0.98100 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 15 | 9.43e-01 | -1.07e-02 | 0.98600 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 14 | 9.45e-01 | -1.07e-02 | 0.98600 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 108 | 8.48e-01 | 1.07e-02 | 0.97200 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 9.21e-01 | -1.07e-02 | 0.98200 |
| GOCC TRANSFERASE COMPLEX | 745 | 6.24e-01 | -1.06e-02 | 0.92200 |
| GOBP TRANSPORT OF VIRUS | 17 | 9.40e-01 | -1.06e-02 | 0.98500 |
| GOBP AMINO ACID BETAINE TRANSPORT | 10 | 9.54e-01 | 1.06e-02 | 0.98700 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 9.56e-01 | 1.05e-02 | 0.98800 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 47 | 9.01e-01 | -1.05e-02 | 0.98000 |
| GOBP ENERGY HOMEOSTASIS | 48 | 9.00e-01 | -1.05e-02 | 0.98000 |
| GOMF HEAT SHOCK PROTEIN BINDING | 101 | 8.57e-01 | -1.04e-02 | 0.97400 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 30 | 9.21e-01 | 1.04e-02 | 0.98200 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 150 | 8.26e-01 | -1.04e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 9.57e-01 | 1.04e-02 | 0.98800 |
| GOBP LEARNING | 82 | 8.71e-01 | 1.04e-02 | 0.97500 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 34 | 9.17e-01 | 1.03e-02 | 0.98100 |
| GOBP LEUKOCYTE CHEMOTAXIS | 159 | 8.22e-01 | 1.03e-02 | 0.97100 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 10 | 9.55e-01 | -1.03e-02 | 0.98800 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 97 | 8.61e-01 | 1.03e-02 | 0.97400 |
| GOBP CELL DIVISION | 493 | 6.96e-01 | 1.03e-02 | 0.93800 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 8 | 9.60e-01 | -1.03e-02 | 0.98900 |
| GOBP TUBE DEVELOPMENT | 642 | 6.58e-01 | -1.03e-02 | 0.93100 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 9.41e-01 | 1.03e-02 | 0.98500 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 151 | 8.28e-01 | -1.03e-02 | 0.97100 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 8 | 9.60e-01 | 1.02e-02 | 0.98900 |
| GOBP EYE MORPHOGENESIS | 79 | 8.75e-01 | -1.02e-02 | 0.97600 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 9.68e-01 | 1.02e-02 | 0.99200 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 9.63e-01 | 1.02e-02 | 0.99000 |
| GOBP REPRODUCTION | 823 | 6.24e-01 | -1.01e-02 | 0.92200 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 148 | 8.32e-01 | -1.01e-02 | 0.97100 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 28 | 9.26e-01 | -1.01e-02 | 0.98200 |
| GOCC U6 SNRNP | 8 | 9.61e-01 | 1.01e-02 | 0.98900 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 508 | 6.99e-01 | -1.01e-02 | 0.94000 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 26 | 9.29e-01 | 1.00e-02 | 0.98200 |
| GOMF DEAMINASE ACTIVITY | 25 | 9.31e-01 | 1.00e-02 | 0.98300 |
| GOBP SPINAL CORD DEVELOPMENT | 44 | 9.08e-01 | 1.00e-02 | 0.98000 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 66 | 8.88e-01 | -1.00e-02 | 0.98000 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 373 | 7.41e-01 | -1.00e-02 | 0.95400 |
| GOCC GOLGI APPARATUS | 1189 | 5.66e-01 | -1.00e-02 | 0.90600 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 93 | 8.68e-01 | 1.00e-02 | 0.97400 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 93 | 8.68e-01 | -9.99e-03 | 0.97400 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 9.64e-01 | 9.97e-03 | 0.99000 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.59e-01 | 9.96e-03 | 0.98900 |
| GOBP NERVOUS SYSTEM PROCESS | 525 | 6.99e-01 | -9.92e-03 | 0.94000 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 9.53e-01 | -9.86e-03 | 0.98700 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 141 | 8.40e-01 | -9.85e-03 | 0.97200 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 17 | 9.44e-01 | 9.83e-03 | 0.98600 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 71 | 8.86e-01 | 9.82e-03 | 0.98000 |
| GOMF PHOSPHATASE BINDING | 156 | 8.33e-01 | 9.82e-03 | 0.97100 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 9.51e-01 | 9.81e-03 | 0.98700 |
| GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY | 5 | 9.70e-01 | -9.79e-03 | 0.99200 |
| GOBP TISSUE MORPHOGENESIS | 347 | 7.58e-01 | 9.67e-03 | 0.95600 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 21 | 9.39e-01 | 9.66e-03 | 0.98500 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 25 | 9.33e-01 | -9.66e-03 | 0.98300 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 99 | 8.69e-01 | -9.63e-03 | 0.97500 |
| GOBP DETECTION OF LIGHT STIMULUS | 33 | 9.24e-01 | 9.62e-03 | 0.98200 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 127 | 8.52e-01 | -9.61e-03 | 0.97200 |
| GOCC CILIARY TRANSITION ZONE | 55 | 9.02e-01 | -9.58e-03 | 0.98000 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 71 | 8.89e-01 | -9.57e-03 | 0.98000 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 109 | 8.63e-01 | -9.54e-03 | 0.97400 |
| GOCC OUTER MEMBRANE | 207 | 8.14e-01 | -9.52e-03 | 0.96800 |
| GOCC FILOPODIUM | 74 | 8.88e-01 | 9.52e-03 | 0.98000 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 149 | 8.42e-01 | -9.49e-03 | 0.97200 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 390 | 7.49e-01 | 9.49e-03 | 0.95600 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 506 | 7.16e-01 | 9.48e-03 | 0.94800 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 49 | 9.09e-01 | 9.44e-03 | 0.98000 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 158 | 8.38e-01 | 9.43e-03 | 0.97200 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 10 | 9.59e-01 | 9.40e-03 | 0.98900 |
| GOMF TOXIC SUBSTANCE BINDING | 6 | 9.68e-01 | 9.39e-03 | 0.99200 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 14 | 9.52e-01 | -9.39e-03 | 0.98700 |
| GOBP PINOCYTOSIS | 19 | 9.44e-01 | 9.38e-03 | 0.98600 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 389 | 7.53e-01 | -9.34e-03 | 0.95600 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 44 | 9.15e-01 | -9.33e-03 | 0.98100 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 13 | 9.54e-01 | -9.29e-03 | 0.98700 |
| GOBP OOCYTE DIFFERENTIATION | 32 | 9.28e-01 | -9.28e-03 | 0.98200 |
| GOMF PROTEIN PHOSPHATASE BINDING | 117 | 8.63e-01 | 9.27e-03 | 0.97400 |
| GOBP TYPE 2 IMMUNE RESPONSE | 33 | 9.27e-01 | 9.26e-03 | 0.98200 |
| GOCC VACUOLAR LUMEN | 135 | 8.53e-01 | 9.24e-03 | 0.97200 |
| GOBP NEURON DEVELOPMENT | 706 | 6.78e-01 | 9.22e-03 | 0.93300 |
| GOBP CHEMICAL HOMEOSTASIS | 623 | 6.97e-01 | -9.21e-03 | 0.93800 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 7 | 9.66e-01 | -9.18e-03 | 0.99100 |
| GOBP REGULATION OF CILIUM MOVEMENT | 15 | 9.51e-01 | -9.13e-03 | 0.98700 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 55 | 9.07e-01 | 9.06e-03 | 0.98000 |
| GOBP STRIATED MUSCLE ADAPTATION | 22 | 9.42e-01 | -9.01e-03 | 0.98500 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 206 | 8.24e-01 | -8.99e-03 | 0.97100 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 277 | 7.97e-01 | -8.98e-03 | 0.96300 |
| GOCC CHITOSOME | 13 | 9.55e-01 | 8.97e-03 | 0.98800 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 61 | 9.04e-01 | -8.95e-03 | 0.98000 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 9.20e-01 | 8.92e-03 | 0.98200 |
| GOCC TERTIARY GRANULE MEMBRANE | 63 | 9.03e-01 | 8.90e-03 | 0.98000 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 16 | 9.51e-01 | -8.88e-03 | 0.98700 |
| GOBP CELL MORPHOGENESIS | 597 | 7.13e-01 | -8.87e-03 | 0.94500 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 29 | 9.34e-01 | 8.85e-03 | 0.98300 |
| GOBP CELL CELL ADHESION | 571 | 7.19e-01 | 8.85e-03 | 0.94900 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 63 | 9.04e-01 | -8.79e-03 | 0.98000 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 905 | 6.57e-01 | -8.78e-03 | 0.93000 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 17 | 9.50e-01 | -8.75e-03 | 0.98700 |
| GOCC SPINDLE | 358 | 7.77e-01 | -8.74e-03 | 0.96100 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 51 | 9.14e-01 | 8.72e-03 | 0.98100 |
| GOMF RNA STEM LOOP BINDING | 14 | 9.55e-01 | 8.69e-03 | 0.98800 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 142 | 8.58e-01 | -8.69e-03 | 0.97400 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 9.60e-01 | 8.65e-03 | 0.98900 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 81 | 8.93e-01 | 8.65e-03 | 0.98000 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 544 | 7.33e-01 | -8.60e-03 | 0.95300 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 9.69e-01 | 8.59e-03 | 0.99200 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 71 | 9.00e-01 | -8.59e-03 | 0.98000 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 76 | 8.97e-01 | 8.58e-03 | 0.98000 |
| GOBP RECEPTOR RECYCLING | 38 | 9.28e-01 | 8.52e-03 | 0.98200 |
| GOBP PRO B CELL DIFFERENTIATION | 11 | 9.61e-01 | -8.49e-03 | 0.98900 |
| GOCC SHELTERIN COMPLEX | 6 | 9.71e-01 | 8.45e-03 | 0.99300 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 18 | 9.51e-01 | 8.45e-03 | 0.98700 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 13 | 9.58e-01 | -8.44e-03 | 0.98900 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 38 | 9.28e-01 | -8.44e-03 | 0.98200 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 9.48e-01 | 8.43e-03 | 0.98700 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 41 | 9.26e-01 | -8.42e-03 | 0.98200 |
| GOBP PROTEIN FOLDING | 178 | 8.47e-01 | 8.40e-03 | 0.97200 |
| GOBP BEHAVIOR | 342 | 7.90e-01 | 8.40e-03 | 0.96200 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 681 | 7.14e-01 | -8.30e-03 | 0.94600 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 33 | 9.34e-01 | -8.28e-03 | 0.98300 |
| GOCC KATANIN COMPLEX | 5 | 9.74e-01 | 8.27e-03 | 0.99300 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1172 | 6.37e-01 | 8.27e-03 | 0.92400 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 9.37e-01 | 8.26e-03 | 0.98300 |
| GOBP RRNA 3 END PROCESSING | 10 | 9.64e-01 | -8.25e-03 | 0.99000 |
| GOMF CELL ADHESION MOLECULE BINDING | 393 | 7.80e-01 | 8.25e-03 | 0.96100 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 604 | 7.31e-01 | 8.24e-03 | 0.95200 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 8 | 9.68e-01 | 8.24e-03 | 0.99200 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 9.75e-01 | -8.22e-03 | 0.99300 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 9.72e-01 | 8.19e-03 | 0.99300 |
| GOBP REGULATION OF BINDING | 190 | 8.46e-01 | -8.18e-03 | 0.97200 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 19 | 9.51e-01 | 8.16e-03 | 0.98700 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 8.78e-01 | -8.14e-03 | 0.97600 |
| GOBP RNA DESTABILIZATION | 98 | 8.89e-01 | -8.13e-03 | 0.98000 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 9.66e-01 | -8.13e-03 | 0.99100 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 67 | 9.09e-01 | 8.10e-03 | 0.98000 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 37 | 9.32e-01 | 8.07e-03 | 0.98300 |
| GOBP MAMMARY GLAND DEVELOPMENT | 72 | 9.07e-01 | 8.01e-03 | 0.98000 |
| GOBP TRANSLESION SYNTHESIS | 23 | 9.47e-01 | 8.01e-03 | 0.98700 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 101 | 8.90e-01 | 7.98e-03 | 0.98000 |
| GOCC TRANS GOLGI NETWORK | 209 | 8.43e-01 | -7.95e-03 | 0.97200 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 48 | 9.24e-01 | -7.92e-03 | 0.98200 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 11 | 9.64e-01 | -7.92e-03 | 0.99000 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 18 | 9.54e-01 | -7.88e-03 | 0.98700 |
| GOMF ZINC ION BINDING | 581 | 7.47e-01 | -7.88e-03 | 0.95600 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 19 | 9.53e-01 | -7.87e-03 | 0.98700 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 196 | 8.50e-01 | -7.86e-03 | 0.97200 |
| GOBP CELL CHEMOTAXIS | 198 | 8.50e-01 | -7.82e-03 | 0.97200 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 26 | 9.45e-01 | 7.80e-03 | 0.98600 |
| GOBP RENAL SYSTEM PROCESS | 54 | 9.21e-01 | -7.79e-03 | 0.98200 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 7 | 9.72e-01 | -7.79e-03 | 0.99300 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 6 | 9.74e-01 | 7.76e-03 | 0.99300 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 76 | 9.07e-01 | -7.76e-03 | 0.98000 |
| GOBP SENSORY ORGAN DEVELOPMENT | 279 | 8.24e-01 | 7.76e-03 | 0.97100 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 22 | 9.50e-01 | 7.75e-03 | 0.98700 |
| GOBP REGULATED EXOCYTOSIS | 157 | 8.67e-01 | -7.75e-03 | 0.97400 |
| GOBP VALINE METABOLIC PROCESS | 7 | 9.72e-01 | -7.73e-03 | 0.99300 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 185 | 8.57e-01 | 7.71e-03 | 0.97400 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 6 | 9.74e-01 | -7.70e-03 | 0.99300 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 770 | 7.20e-01 | 7.65e-03 | 0.94900 |
| GOCC AXON | 395 | 7.96e-01 | 7.63e-03 | 0.96200 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 34 | 9.39e-01 | 7.61e-03 | 0.98500 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 9.67e-01 | -7.57e-03 | 0.99200 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 9.57e-01 | 7.54e-03 | 0.98800 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 172 | 8.65e-01 | 7.51e-03 | 0.97400 |
| GOBP LYMPHOCYTE ANERGY | 6 | 9.75e-01 | -7.51e-03 | 0.99300 |
| GOBP GLIAL CELL DIFFERENTIATION | 138 | 8.79e-01 | -7.50e-03 | 0.97700 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 8 | 9.71e-01 | 7.50e-03 | 0.99300 |
| GOCC MRNA EDITING COMPLEX | 13 | 9.63e-01 | -7.46e-03 | 0.99000 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 186 | 8.61e-01 | -7.43e-03 | 0.97400 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 9.77e-01 | 7.42e-03 | 0.99400 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 11 | 9.66e-01 | -7.41e-03 | 0.99100 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 9.33e-01 | -7.41e-03 | 0.98300 |
| GOBP SPINDLE ASSEMBLY | 116 | 8.91e-01 | -7.41e-03 | 0.98000 |
| GOMF METHYL CPG BINDING | 22 | 9.52e-01 | -7.38e-03 | 0.98700 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 551 | 7.69e-01 | 7.37e-03 | 0.95900 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 268 | 8.36e-01 | -7.35e-03 | 0.97100 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1101 | 6.84e-01 | -7.34e-03 | 0.93500 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 21 | 9.54e-01 | 7.29e-03 | 0.98700 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 9.70e-01 | -7.27e-03 | 0.99200 |
| GOCC ACTIN FILAMENT BUNDLE | 56 | 9.25e-01 | -7.26e-03 | 0.98200 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 254 | 8.43e-01 | 7.26e-03 | 0.97200 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 679 | 7.50e-01 | 7.22e-03 | 0.95600 |
| GOCC NEUROMUSCULAR JUNCTION | 51 | 9.29e-01 | -7.21e-03 | 0.98200 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 102 | 9.00e-01 | 7.18e-03 | 0.98000 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 67 | 9.19e-01 | 7.16e-03 | 0.98100 |
| GOBP THIOESTER METABOLIC PROCESS | 69 | 9.19e-01 | 7.12e-03 | 0.98100 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 56 | 9.27e-01 | 7.09e-03 | 0.98200 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 17 | 9.60e-01 | 7.07e-03 | 0.98900 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 13 | 9.65e-01 | 7.07e-03 | 0.99100 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 9.71e-01 | 7.06e-03 | 0.99300 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 54 | 9.29e-01 | 7.04e-03 | 0.98200 |
| GOCC OXIDOREDUCTASE COMPLEX | 111 | 8.99e-01 | 7.00e-03 | 0.98000 |
| GOBP DNA MODIFICATION | 83 | 9.12e-01 | 6.99e-03 | 0.98100 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 9.78e-01 | -6.99e-03 | 0.99400 |
| GOBP ANDROGEN METABOLIC PROCESS | 14 | 9.64e-01 | -6.96e-03 | 0.99000 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 387 | 8.15e-01 | -6.96e-03 | 0.96800 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 9.63e-01 | 6.94e-03 | 0.99000 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 32 | 9.46e-01 | 6.93e-03 | 0.98600 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 28 | 9.50e-01 | 6.89e-03 | 0.98700 |
| GOCC MAIN AXON | 38 | 9.41e-01 | 6.89e-03 | 0.98500 |
| GOMF SMAD BINDING | 61 | 9.26e-01 | 6.86e-03 | 0.98200 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 15 | 9.64e-01 | -6.82e-03 | 0.99000 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 9.77e-01 | 6.76e-03 | 0.99400 |
| GOMF MAGNESIUM ION BINDING | 183 | 8.75e-01 | 6.74e-03 | 0.97600 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 524 | 7.93e-01 | 6.72e-03 | 0.96200 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 32 | 9.48e-01 | 6.72e-03 | 0.98700 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 9.43e-01 | 6.67e-03 | 0.98600 |
| GOBP AMYLOID BETA CLEARANCE | 29 | 9.51e-01 | 6.66e-03 | 0.98700 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 16 | 9.63e-01 | 6.66e-03 | 0.99000 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 9.79e-01 | -6.65e-03 | 0.99400 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 9.61e-01 | 6.62e-03 | 0.98900 |
| GOBP DENDRITE SELF AVOIDANCE | 7 | 9.76e-01 | 6.59e-03 | 0.99400 |
| GOBP PHOSPHOLIPID EFFLUX | 5 | 9.80e-01 | 6.58e-03 | 0.99400 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 166 | 8.84e-01 | 6.57e-03 | 0.97900 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 13 | 9.67e-01 | -6.57e-03 | 0.99200 |
| GOBP DNA METHYLATION | 38 | 9.44e-01 | 6.53e-03 | 0.98600 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 32 | 9.49e-01 | -6.51e-03 | 0.98700 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 9.76e-01 | -6.44e-03 | 0.99400 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 56 | 9.34e-01 | 6.42e-03 | 0.98300 |
| GOMF SINGLE STRANDED DNA BINDING | 106 | 9.09e-01 | 6.40e-03 | 0.98000 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 76 | 9.23e-01 | 6.39e-03 | 0.98200 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 32 | 9.50e-01 | 6.37e-03 | 0.98700 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 9.80e-01 | -6.37e-03 | 0.99500 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 101 | 9.12e-01 | 6.36e-03 | 0.98100 |
| GOBP HEPATOCYTE DIFFERENTIATION | 5 | 9.80e-01 | -6.34e-03 | 0.99500 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 80 | 9.22e-01 | 6.33e-03 | 0.98200 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 97 | 9.15e-01 | -6.30e-03 | 0.98100 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 30 | 9.53e-01 | -6.27e-03 | 0.98700 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 42 | 9.44e-01 | -6.26e-03 | 0.98600 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 9.69e-01 | -6.22e-03 | 0.99200 |
| GOBP RESPONSE TO X RAY | 23 | 9.59e-01 | -6.21e-03 | 0.98900 |
| GOBP BONE MINERALIZATION | 71 | 9.28e-01 | 6.20e-03 | 0.98200 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 146 | 8.97e-01 | -6.19e-03 | 0.98000 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 20 | 9.62e-01 | -6.14e-03 | 0.99000 |
| GOBP MEIOTIC CELL CYCLE | 181 | 8.87e-01 | 6.14e-03 | 0.98000 |
| GOBP FEMALE SEX DIFFERENTIATION | 63 | 9.33e-01 | 6.12e-03 | 0.98300 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 9.28e-01 | -6.12e-03 | 0.98200 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 268 | 8.64e-01 | -6.10e-03 | 0.97400 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 9.78e-01 | -6.06e-03 | 0.99400 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 38 | 9.49e-01 | 6.05e-03 | 0.98700 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 198 | 8.84e-01 | -6.03e-03 | 0.97900 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 50 | 9.41e-01 | -6.01e-03 | 0.98500 |
| GOCC PODOSOME | 26 | 9.58e-01 | -5.98e-03 | 0.98900 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 9.65e-01 | 5.98e-03 | 0.99100 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 194 | 8.87e-01 | -5.95e-03 | 0.98000 |
| GOCC SPERM HEAD | 5 | 9.82e-01 | -5.91e-03 | 0.99500 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 7 | 9.79e-01 | -5.87e-03 | 0.99400 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 88 | 9.24e-01 | -5.86e-03 | 0.98200 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 537 | 8.17e-01 | -5.86e-03 | 0.96800 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 37 | 9.51e-01 | -5.84e-03 | 0.98700 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 36 | 9.52e-01 | -5.83e-03 | 0.98700 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 501 | 8.24e-01 | -5.82e-03 | 0.97100 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 9.62e-01 | 5.81e-03 | 0.99000 |
| GOCC ORIGIN RECOGNITION COMPLEX | 8 | 9.77e-01 | 5.81e-03 | 0.99400 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 221 | 8.82e-01 | -5.78e-03 | 0.97900 |
| GOBP VASOCONSTRICTION | 38 | 9.51e-01 | 5.78e-03 | 0.98700 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 9.74e-01 | -5.78e-03 | 0.99300 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 58 | 9.39e-01 | 5.77e-03 | 0.98500 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 223 | 8.83e-01 | 5.74e-03 | 0.97900 |
| GOCC ACTIN BASED CELL PROJECTION | 145 | 9.05e-01 | 5.73e-03 | 0.98000 |
| GOBP AMIDE METABOLIC PROCESS | 933 | 7.69e-01 | -5.72e-03 | 0.95900 |
| GOMF NUCLEOTIDASE ACTIVITY | 9 | 9.76e-01 | 5.68e-03 | 0.99400 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 48 | 9.46e-01 | 5.65e-03 | 0.98600 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 8 | 9.78e-01 | 5.63e-03 | 0.99400 |
| GOBP ORGANELLE LOCALIZATION | 498 | 8.32e-01 | -5.59e-03 | 0.97100 |
| GOBP GANGLION DEVELOPMENT | 9 | 9.77e-01 | -5.58e-03 | 0.99400 |
| GOBP OXIDATIVE DEMETHYLATION | 6 | 9.81e-01 | 5.58e-03 | 0.99500 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 446 | 8.41e-01 | 5.57e-03 | 0.97200 |
| GOBP DNA CYTOSINE DEAMINATION | 7 | 9.80e-01 | -5.56e-03 | 0.99400 |
| GOMF PRE MRNA INTRONIC BINDING | 9 | 9.77e-01 | -5.54e-03 | 0.99400 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 481 | 8.37e-01 | -5.52e-03 | 0.97100 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 169 | 9.02e-01 | -5.51e-03 | 0.98000 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 9.69e-01 | -5.50e-03 | 0.99200 |
| GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION | 5 | 9.83e-01 | 5.47e-03 | 0.99500 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 116 | 9.19e-01 | 5.47e-03 | 0.98100 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 9.77e-01 | 5.46e-03 | 0.99400 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 9.74e-01 | -5.45e-03 | 0.99300 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 10 | 9.76e-01 | -5.41e-03 | 0.99400 |
| GOBP THYROID HORMONE GENERATION | 10 | 9.76e-01 | 5.39e-03 | 0.99400 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 29 | 9.60e-01 | 5.38e-03 | 0.98900 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 30 | 9.59e-01 | 5.38e-03 | 0.98900 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 9 | 9.78e-01 | 5.36e-03 | 0.99400 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 235 | 8.88e-01 | -5.34e-03 | 0.98000 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 9.61e-01 | -5.31e-03 | 0.98900 |
| GOBP CELL CELL SIGNALING | 910 | 7.91e-01 | 5.24e-03 | 0.96200 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 9.81e-01 | 5.18e-03 | 0.99500 |
| GOBP RESPONSE TO ACID CHEMICAL | 89 | 9.33e-01 | 5.17e-03 | 0.98300 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 9.84e-01 | -5.16e-03 | 0.99600 |
| GOCC BASAL PART OF CELL | 174 | 9.07e-01 | 5.16e-03 | 0.98000 |
| GOBP CELLULAR RESPONSE TO DSRNA | 17 | 9.71e-01 | -5.09e-03 | 0.99300 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 6 | 9.83e-01 | 5.08e-03 | 0.99500 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 9.74e-01 | -5.07e-03 | 0.99300 |
| GOBP CELLULAR CATABOLIC PROCESS | 1219 | 7.72e-01 | -4.99e-03 | 0.96000 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 180 | 9.09e-01 | -4.97e-03 | 0.98000 |
| GOCC PRESPLICEOSOME | 16 | 9.73e-01 | 4.95e-03 | 0.99300 |
| GOBP CELL JUNCTION DISASSEMBLY | 19 | 9.70e-01 | -4.94e-03 | 0.99300 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 97 | 9.33e-01 | 4.94e-03 | 0.98300 |
| GOBP AMYLOID FIBRIL FORMATION | 32 | 9.61e-01 | -4.93e-03 | 0.98900 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 17 | 9.72e-01 | 4.90e-03 | 0.99300 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 9.73e-01 | 4.90e-03 | 0.99300 |
| GOBP LIPID MODIFICATION | 144 | 9.20e-01 | 4.88e-03 | 0.98100 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 87 | 9.38e-01 | 4.86e-03 | 0.98400 |
| GOBP LEUKOCYTE DEGRANULATION | 67 | 9.46e-01 | 4.83e-03 | 0.98600 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 55 | 9.51e-01 | 4.82e-03 | 0.98700 |
| GOBP NEUROGENESIS | 1030 | 7.96e-01 | -4.80e-03 | 0.96200 |
| GOBP HOMEOSTATIC PROCESS | 1103 | 7.92e-01 | 4.77e-03 | 0.96200 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 349 | 8.79e-01 | -4.75e-03 | 0.97700 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 85 | 9.40e-01 | -4.74e-03 | 0.98500 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 674 | 8.35e-01 | 4.73e-03 | 0.97100 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 25 | 9.67e-01 | -4.72e-03 | 0.99200 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 11 | 9.78e-01 | 4.71e-03 | 0.99400 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 216 | 9.05e-01 | 4.71e-03 | 0.98000 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 9.70e-01 | 4.70e-03 | 0.99200 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 46 | 9.56e-01 | -4.68e-03 | 0.98800 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 10 | 9.80e-01 | 4.67e-03 | 0.99400 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 9.74e-01 | 4.65e-03 | 0.99300 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 9.79e-01 | 4.65e-03 | 0.99400 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 16 | 9.74e-01 | 4.64e-03 | 0.99300 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 115 | 9.32e-01 | 4.62e-03 | 0.98300 |
| GOBP REGULATION OF TISSUE REMODELING | 46 | 9.57e-01 | -4.61e-03 | 0.98800 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 37 | 9.61e-01 | -4.60e-03 | 0.98900 |
| GOBP LOCOMOTORY BEHAVIOR | 105 | 9.36e-01 | 4.55e-03 | 0.98300 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 95 | 9.40e-01 | 4.50e-03 | 0.98500 |
| GOBP GLOMERULUS DEVELOPMENT | 35 | 9.63e-01 | 4.49e-03 | 0.99000 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 9 | 9.82e-01 | 4.45e-03 | 0.99500 |
| GOCC MICROVILLUS | 56 | 9.54e-01 | -4.44e-03 | 0.98700 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 9.51e-01 | -4.43e-03 | 0.98700 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 5 | 9.87e-01 | 4.36e-03 | 0.99600 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 77 | 9.48e-01 | 4.34e-03 | 0.98700 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 63 | 9.53e-01 | 4.32e-03 | 0.98700 |
| GOMF UBIQUINONE BINDING | 6 | 9.86e-01 | -4.27e-03 | 0.99600 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 27 | 9.70e-01 | -4.21e-03 | 0.99200 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 9 | 9.83e-01 | -4.20e-03 | 0.99500 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 9.81e-01 | 4.20e-03 | 0.99500 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 602 | 8.63e-01 | 4.15e-03 | 0.97400 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 9.64e-01 | -4.14e-03 | 0.99000 |
| GOBP CELLULAR PIGMENTATION | 53 | 9.58e-01 | 4.14e-03 | 0.98900 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 35 | 9.67e-01 | 4.09e-03 | 0.99100 |
| GOCC MEMBRANE PROTEIN COMPLEX | 838 | 8.42e-01 | -4.08e-03 | 0.97200 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 8 | 9.84e-01 | -4.04e-03 | 0.99600 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 214 | 9.20e-01 | 4.01e-03 | 0.98100 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 9.83e-01 | 4.00e-03 | 0.99500 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 62 | 9.57e-01 | -3.96e-03 | 0.98800 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 390 | 8.95e-01 | -3.92e-03 | 0.98000 |
| GOBP FEMALE GAMETE GENERATION | 88 | 9.49e-01 | -3.92e-03 | 0.98700 |
| GOBP MALE GENITALIA DEVELOPMENT | 7 | 9.86e-01 | -3.91e-03 | 0.99600 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 58 | 9.59e-01 | -3.88e-03 | 0.98900 |
| GOBP RESPONSE TO BMP | 82 | 9.52e-01 | -3.84e-03 | 0.98700 |
| GOBP LEUKOCYTE MIGRATION | 261 | 9.16e-01 | -3.80e-03 | 0.98100 |
| GOBP ASTROCYTE CELL MIGRATION | 8 | 9.85e-01 | 3.76e-03 | 0.99600 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 37 | 9.69e-01 | -3.74e-03 | 0.99200 |
| GOCC CLATHRIN COATED PIT | 61 | 9.61e-01 | 3.66e-03 | 0.98900 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 208 | 9.28e-01 | 3.63e-03 | 0.98200 |
| GOMF METALLOPEPTIDASE ACTIVITY | 103 | 9.49e-01 | -3.62e-03 | 0.98700 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 731 | 8.70e-01 | 3.59e-03 | 0.97500 |
| GOBP MONOATOMIC ION TRANSPORT | 698 | 8.73e-01 | 3.57e-03 | 0.97500 |
| GOCC SITE OF POLARIZED GROWTH | 128 | 9.45e-01 | -3.51e-03 | 0.98600 |
| GOBP EAR MORPHOGENESIS | 46 | 9.67e-01 | -3.51e-03 | 0.99200 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 100 | 9.52e-01 | -3.48e-03 | 0.98700 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 59 | 9.64e-01 | 3.44e-03 | 0.99000 |
| GOBP GASTRULATION | 109 | 9.51e-01 | -3.41e-03 | 0.98700 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 151 | 9.43e-01 | 3.39e-03 | 0.98600 |
| GOMF CD4 RECEPTOR BINDING | 7 | 9.88e-01 | -3.37e-03 | 0.99700 |
| GOMF GUANYL NUCLEOTIDE BINDING | 302 | 9.21e-01 | -3.33e-03 | 0.98200 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 22 | 9.78e-01 | -3.33e-03 | 0.99400 |
| GOBP CAMP MEDIATED SIGNALING | 27 | 9.76e-01 | -3.32e-03 | 0.99400 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 173 | 9.40e-01 | 3.32e-03 | 0.98500 |
| GOCC MOTILE CILIUM | 145 | 9.45e-01 | -3.31e-03 | 0.98600 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 104 | 9.54e-01 | -3.31e-03 | 0.98700 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 9.86e-01 | 3.30e-03 | 0.99600 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 129 | 9.49e-01 | 3.26e-03 | 0.98700 |
| GOBP SNRNA PROCESSING | 26 | 9.77e-01 | -3.26e-03 | 0.99400 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 9.90e-01 | 3.26e-03 | 0.99700 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 27 | 9.77e-01 | -3.23e-03 | 0.99400 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 9.83e-01 | 3.18e-03 | 0.99500 |
| GOCC GOLGI CISTERNA MEMBRANE | 63 | 9.66e-01 | 3.11e-03 | 0.99100 |
| GOCC MULTIVESICULAR BODY | 43 | 9.72e-01 | 3.08e-03 | 0.99300 |
| GOBP CELL CELL RECOGNITION | 39 | 9.74e-01 | -3.07e-03 | 0.99300 |
| GOBP RESPONSE TO AMYLOID BETA | 32 | 9.76e-01 | 3.04e-03 | 0.99400 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 33 | 9.76e-01 | 3.00e-03 | 0.99400 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 9.76e-01 | 2.90e-03 | 0.99400 |
| GOMF DEATH RECEPTOR ACTIVITY | 6 | 9.90e-01 | -2.90e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 21 | 9.82e-01 | 2.89e-03 | 0.99500 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 270 | 9.35e-01 | -2.87e-03 | 0.98300 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 801 | 8.91e-01 | -2.86e-03 | 0.98000 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 9.81e-01 | -2.86e-03 | 0.99500 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 9.88e-01 | -2.82e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 21 | 9.82e-01 | -2.80e-03 | 0.99500 |
| GOBP INORGANIC ANION TRANSPORT | 82 | 9.65e-01 | -2.77e-03 | 0.99100 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 68 | 9.69e-01 | -2.76e-03 | 0.99200 |
| GOCC I BAND | 84 | 9.65e-01 | -2.75e-03 | 0.99100 |
| GOBP HEART DEVELOPMENT | 354 | 9.30e-01 | 2.73e-03 | 0.98200 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 102 | 9.62e-01 | -2.71e-03 | 0.99000 |
| GOMF MHC CLASS I PROTEIN BINDING | 17 | 9.85e-01 | 2.70e-03 | 0.99600 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 9.92e-01 | 2.66e-03 | 0.99700 |
| GOMF ENDOPEPTIDASE ACTIVITY | 209 | 9.47e-01 | 2.65e-03 | 0.98700 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 13 | 9.87e-01 | -2.63e-03 | 0.99700 |
| GOBP GLUCAN METABOLIC PROCESS | 56 | 9.73e-01 | -2.60e-03 | 0.99300 |
| GOMF EXOPEPTIDASE ACTIVITY | 67 | 9.71e-01 | 2.59e-03 | 0.99300 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 26 | 9.82e-01 | -2.56e-03 | 0.99500 |
| GOCC U7 SNRNP | 7 | 9.91e-01 | 2.55e-03 | 0.99700 |
| GOCC CYTOPLASMIC REGION | 180 | 9.54e-01 | 2.49e-03 | 0.98700 |
| GOBP MACROPINOCYTOSIS | 10 | 9.89e-01 | -2.47e-03 | 0.99700 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 19 | 9.85e-01 | -2.46e-03 | 0.99600 |
| GOBP GERM CELL DEVELOPMENT | 177 | 9.55e-01 | -2.45e-03 | 0.98800 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 30 | 9.81e-01 | -2.45e-03 | 0.99500 |
| GOMF 5S RRNA BINDING | 9 | 9.90e-01 | 2.42e-03 | 0.99700 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 9.88e-01 | 2.42e-03 | 0.99700 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 9.92e-01 | -2.38e-03 | 0.99700 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 9.91e-01 | 2.36e-03 | 0.99700 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 14 | 9.88e-01 | 2.31e-03 | 0.99700 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 131 | 9.64e-01 | -2.29e-03 | 0.99000 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 42 | 9.80e-01 | 2.28e-03 | 0.99400 |
| GOBP GRANULOCYTE MIGRATION | 101 | 9.69e-01 | 2.27e-03 | 0.99200 |
| GOBP REGULATION OF TRANSPORT | 1110 | 9.02e-01 | 2.22e-03 | 0.98000 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 9.88e-01 | 2.21e-03 | 0.99700 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 9.91e-01 | -2.19e-03 | 0.99700 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 206 | 9.57e-01 | -2.18e-03 | 0.98800 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 9.89e-01 | 2.13e-03 | 0.99700 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 66 | 9.76e-01 | 2.13e-03 | 0.99400 |
| GOBP MICROTUBULE POLYMERIZATION | 81 | 9.74e-01 | -2.11e-03 | 0.99300 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 58 | 9.78e-01 | 2.11e-03 | 0.99400 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 8 | 9.92e-01 | 2.11e-03 | 0.99700 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 362 | 9.46e-01 | 2.09e-03 | 0.98600 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 9 | 9.91e-01 | -2.08e-03 | 0.99700 |
| GOBP GERM CELL PROLIFERATION | 7 | 9.93e-01 | 2.03e-03 | 0.99800 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 249 | 9.56e-01 | -2.03e-03 | 0.98800 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 297 | 9.52e-01 | -2.03e-03 | 0.98700 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 17 | 9.89e-01 | 2.02e-03 | 0.99700 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 13 | 9.90e-01 | 2.01e-03 | 0.99700 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 115 | 9.70e-01 | -2.00e-03 | 0.99300 |
| GOBP PEPTIDE METABOLIC PROCESS | 723 | 9.28e-01 | 1.99e-03 | 0.98200 |
| GOCC INTERCALATED DISC | 32 | 9.85e-01 | -1.95e-03 | 0.99600 |
| GOBP ZINC ION TRANSPORT | 19 | 9.88e-01 | 1.91e-03 | 0.99700 |
| GOMF COBALAMIN BINDING | 8 | 9.93e-01 | 1.90e-03 | 0.99800 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 9.87e-01 | 1.88e-03 | 0.99700 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 292 | 9.56e-01 | 1.87e-03 | 0.98800 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 130 | 9.71e-01 | 1.86e-03 | 0.99300 |
| GOBP B CELL PROLIFERATION | 63 | 9.80e-01 | -1.85e-03 | 0.99400 |
| GOCC AP 2 ADAPTOR COMPLEX | 9 | 9.93e-01 | -1.79e-03 | 0.99800 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 14 | 9.91e-01 | 1.77e-03 | 0.99700 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 7 | 9.94e-01 | 1.74e-03 | 0.99800 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 19 | 9.90e-01 | 1.70e-03 | 0.99700 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 367 | 9.56e-01 | -1.70e-03 | 0.98800 |
| GOBP TORC2 SIGNALING | 15 | 9.91e-01 | 1.69e-03 | 0.99700 |
| GOBP REGULATION OF B CELL PROLIFERATION | 50 | 9.85e-01 | 1.57e-03 | 0.99600 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 60 | 9.83e-01 | -1.56e-03 | 0.99500 |
| GOCC FILOPODIUM TIP | 16 | 9.91e-01 | 1.56e-03 | 0.99700 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 78 | 9.81e-01 | -1.55e-03 | 0.99500 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 21 | 9.90e-01 | 1.51e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 252 | 9.68e-01 | -1.49e-03 | 0.99200 |
| GOCC AZUROPHIL GRANULE | 136 | 9.76e-01 | -1.48e-03 | 0.99400 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 13 | 9.93e-01 | -1.46e-03 | 0.99800 |
| GOBP TISSUE MIGRATION | 201 | 9.72e-01 | -1.46e-03 | 0.99300 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 68 | 9.83e-01 | 1.45e-03 | 0.99500 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 9.94e-01 | 1.42e-03 | 0.99900 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 65 | 9.84e-01 | 1.40e-03 | 0.99600 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 10 | 9.94e-01 | -1.36e-03 | 0.99900 |
| GOBP LYMPHOCYTE COSTIMULATION | 31 | 9.90e-01 | 1.34e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 36 | 9.89e-01 | 1.33e-03 | 0.99700 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 9.94e-01 | -1.33e-03 | 0.99900 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 175 | 9.76e-01 | 1.31e-03 | 0.99400 |
| GOBP COBALAMIN TRANSPORT | 5 | 9.96e-01 | 1.25e-03 | 0.99900 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 89 | 9.84e-01 | 1.24e-03 | 0.99600 |
| GOBP ADP TRANSPORT | 8 | 9.95e-01 | -1.24e-03 | 0.99900 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 9.95e-01 | -1.22e-03 | 0.99900 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 85 | 9.85e-01 | 1.22e-03 | 0.99600 |
| GOBP SEX DIFFERENTIATION | 149 | 9.80e-01 | 1.22e-03 | 0.99400 |
| GOBP REGULATION OF LIPASE ACTIVITY | 43 | 9.89e-01 | 1.22e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 31 | 9.91e-01 | -1.21e-03 | 0.99700 |
| GOCC POSTSYNAPSE | 387 | 9.68e-01 | -1.18e-03 | 0.99200 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 290 | 9.73e-01 | -1.18e-03 | 0.99300 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 53 | 9.88e-01 | 1.15e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1320 | 9.45e-01 | -1.15e-03 | 0.98600 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 98 | 9.85e-01 | 1.12e-03 | 0.99600 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 6 | 9.96e-01 | -1.09e-03 | 0.99900 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 90 | 9.86e-01 | 1.09e-03 | 0.99600 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 9.96e-01 | -1.08e-03 | 0.99900 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 7 | 9.96e-01 | -1.04e-03 | 0.99900 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 36 | 9.92e-01 | -1.02e-03 | 0.99700 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 86 | 9.87e-01 | 9.94e-04 | 0.99700 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 9.96e-01 | -9.91e-04 | 0.99900 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 155 | 9.84e-01 | -9.06e-04 | 0.99600 |
| GOBP TUBE MORPHOGENESIS | 511 | 9.73e-01 | -8.94e-04 | 0.99300 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 9.97e-01 | 8.88e-04 | 0.99900 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 234 | 9.82e-01 | 8.42e-04 | 0.99500 |
| GOMF OXIDOREDUCTASE ACTIVITY | 527 | 9.74e-01 | -8.41e-04 | 0.99300 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 109 | 9.88e-01 | -8.36e-04 | 0.99700 |
| GOBP VIRAL RELEASE FROM HOST CELL | 24 | 9.95e-01 | -7.68e-04 | 0.99900 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 9.96e-01 | 7.54e-04 | 0.99900 |
| GOCC PLASMA MEMBRANE REGION | 727 | 9.74e-01 | 7.10e-04 | 0.99300 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1090 | 9.69e-01 | 7.08e-04 | 0.99200 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 9.95e-01 | 6.71e-04 | 0.99900 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 9.97e-01 | 6.33e-04 | 0.99900 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 122 | 9.91e-01 | 6.13e-04 | 0.99700 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 271 | 9.86e-01 | 6.10e-04 | 0.99600 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 209 | 9.88e-01 | 5.94e-04 | 0.99700 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 9.96e-01 | 5.92e-04 | 0.99900 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 30 | 9.96e-01 | 5.84e-04 | 0.99900 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 89 | 9.92e-01 | -5.78e-04 | 0.99800 |
| GOBP TISSUE REGENERATION | 41 | 9.95e-01 | -5.21e-04 | 0.99900 |
| GOBP LIPID METABOLIC PROCESS | 909 | 9.80e-01 | -4.97e-04 | 0.99400 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 20 | 9.97e-01 | -4.31e-04 | 0.99900 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 151 | 9.93e-01 | -4.12e-04 | 0.99800 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 9.99e-01 | -4.07e-04 | 0.99900 |
| GOBP T CELL APOPTOTIC PROCESS | 45 | 9.96e-01 | 3.83e-04 | 0.99900 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 45 | 9.97e-01 | -3.71e-04 | 0.99900 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 16 | 9.98e-01 | -3.62e-04 | 0.99900 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 27 | 9.97e-01 | 3.56e-04 | 0.99900 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 9.98e-01 | 3.22e-04 | 0.99900 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 62 | 9.97e-01 | 3.21e-04 | 0.99900 |
| GOCC GERM CELL NUCLEUS | 47 | 9.97e-01 | -2.84e-04 | 0.99900 |
| GOBP MAINTENANCE OF LOCATION | 253 | 9.94e-01 | -2.80e-04 | 0.99900 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 58 | 9.97e-01 | 2.67e-04 | 0.99900 |
| GOMF SERINE HYDROLASE ACTIVITY | 86 | 9.97e-01 | -2.57e-04 | 0.99900 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 281 | 9.94e-01 | -2.47e-04 | 0.99900 |
| GOCC CATALYTIC COMPLEX | 1489 | 9.91e-01 | 1.83e-04 | 0.99700 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 136 | 9.97e-01 | -1.68e-04 | 0.99900 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 23 | 9.99e-01 | -1.60e-04 | 1.00000 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 173 | 9.97e-01 | 1.54e-04 | 0.99900 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 18 | 9.99e-01 | 1.36e-04 | 1.00000 |
| GOBP ENDOCYTOSIS | 522 | 9.96e-01 | 1.25e-04 | 0.99900 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 11 | 9.99e-01 | -1.23e-04 | 1.00000 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 41 | 9.99e-01 | -9.91e-05 | 1.00000 |
| GOMF SIRNA BINDING | 10 | 1.00e+00 | 7.72e-05 | 1.00000 |
| GOBP SOMITE DEVELOPMENT | 40 | 9.99e-01 | 6.45e-05 | 1.00000 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 19 | 1.00e+00 | 5.76e-05 | 1.00000 |
Detailed Gene set reports
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOCC HEMOGLOBIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
Top enriched genes
Click HERE to show all gene set members
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOCC GID COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF ALPHA GLUCOSIDASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOCC SORTING ENDOSOME
Top enriched genes
Click HERE to show all gene set members
GOCC CILIARY TRANSITION FIBER
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF MAST CELL CHEMOTAXIS
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP TRACHEA CARTILAGE DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP PEPTIDYL LYSINE DIMETHYLATION
Top enriched genes
Click HERE to show all gene set members
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION
Top enriched genes
Click HERE to show all gene set members
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOBP CARBON DIOXIDE TRANSPORT
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP ZINC ION IMPORT INTO ORGANELLE
Top enriched genes
Click HERE to show all gene set members
GOCC CALCINEURIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC DENDRITIC SPINE HEAD
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY
Top enriched genes
Click HERE to show all gene set members
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS
Top enriched genes
Click HERE to show all gene set members
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP HEART VALVE FORMATION
Top enriched genes
Click HERE to show all gene set members
GOMF DNA DNA ANNEALING ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF HEAT GENERATION
Top enriched genes
Click HERE to show all gene set members
GOBP ISG15 PROTEIN CONJUGATION
Top enriched genes
Click HERE to show all gene set members
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE
Top enriched genes
Click HERE to show all gene set members
GOBP ANTRAL OVARIAN FOLLICLE GROWTH
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
Top enriched genes
Click HERE to show all gene set members
GOCC MUSCLE MYOSIN COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOCC SIGNAL PEPTIDASE COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
Top enriched genes
Click HERE to show all gene set members
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOCC PROCENTRIOLE REPLICATION COMPLEX
Top enriched genes
Click HERE to show all gene set members
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2END of report